id	sid	tid	token	lemma	pos
cord-337302-fpz2jfuj	1	1	key	key	JJ
cord-337302-fpz2jfuj	1	2	:	:	:
cord-337302-fpz2jfuj	1	3	cord-337302-fpz2jfuj	cord-337302-fpz2jfuj	NNP
cord-337302-fpz2jfuj	1	4	authors	author	NNS
cord-337302-fpz2jfuj	1	5	:	:	:
cord-337302-fpz2jfuj	1	6	Abdihamid	Abdihamid	NNP
cord-337302-fpz2jfuj	1	7	,	,	,
cord-337302-fpz2jfuj	1	8	Omar	Omar	NNP
cord-337302-fpz2jfuj	1	9	;	;	:
cord-337302-fpz2jfuj	1	10	Cai	Cai	NNP
cord-337302-fpz2jfuj	1	11	,	,	,
cord-337302-fpz2jfuj	1	12	Changjing	Changjing	NNP
cord-337302-fpz2jfuj	1	13	;	;	:
cord-337302-fpz2jfuj	1	14	Kapesa	Kapesa	NNP
cord-337302-fpz2jfuj	1	15	,	,	,
cord-337302-fpz2jfuj	1	16	Linda	Linda	NNP
cord-337302-fpz2jfuj	1	17	;	;	:
cord-337302-fpz2jfuj	1	18	Zeng	Zeng	NNP
cord-337302-fpz2jfuj	1	19	,	,	,
cord-337302-fpz2jfuj	2	1	Shan	Shan	NNP
cord-337302-fpz2jfuj	2	2	title	title	NN
cord-337302-fpz2jfuj	2	3	:	:	:
cord-337302-fpz2jfuj	3	1	The	the	DT
cord-337302-fpz2jfuj	3	2	Landscape	Landscape	NNP
cord-337302-fpz2jfuj	3	3	of	of	IN
cord-337302-fpz2jfuj	3	4	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	3	5	in	in	IN
cord-337302-fpz2jfuj	3	6	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	3	7	Patients	patient	NNS
cord-337302-fpz2jfuj	3	8	:	:	:
cord-337302-fpz2jfuj	3	9	Prevalence	prevalence	NN
cord-337302-fpz2jfuj	3	10	,	,	,
cord-337302-fpz2jfuj	3	11	Impacts	impact	NNS
cord-337302-fpz2jfuj	3	12	,	,	,
cord-337302-fpz2jfuj	3	13	and	and	CC
cord-337302-fpz2jfuj	3	14	Recommendations	Recommendations	NNPS
cord-337302-fpz2jfuj	3	15	date	date	NN
cord-337302-fpz2jfuj	3	16	:	:	:
cord-337302-fpz2jfuj	3	17	2020	2020	CD
cord-337302-fpz2jfuj	3	18	-	-	HYPH
cord-337302-fpz2jfuj	3	19	09	09	CD
cord-337302-fpz2jfuj	3	20	-	-	SYM
cord-337302-fpz2jfuj	3	21	23	23	CD
cord-337302-fpz2jfuj	3	22	journal	journal	NN
cord-337302-fpz2jfuj	3	23	:	:	:
cord-337302-fpz2jfuj	4	1	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	4	2	Manag	manag	NN
cord-337302-fpz2jfuj	4	3	Res	res	NN
cord-337302-fpz2jfuj	4	4	DOI	doi	NN
cord-337302-fpz2jfuj	4	5	:	:	:
cord-337302-fpz2jfuj	5	1	10.2147	10.2147	CD
cord-337302-fpz2jfuj	5	2	/	/	SYM
cord-337302-fpz2jfuj	5	3	cmar.s272008	cmar.s272008	CD
cord-337302-fpz2jfuj	5	4	sha	sha	NNP
cord-337302-fpz2jfuj	5	5	:	:	:
cord-337302-fpz2jfuj	5	6	50e5f7c264f5a9b578288426d55829c4f62fd54d	50e5f7c264f5a9b578288426d55829c4f62fd54d	NNP
cord-337302-fpz2jfuj	5	7	doc_id	doc_id	CD
cord-337302-fpz2jfuj	5	8	:	:	:
cord-337302-fpz2jfuj	5	9	337302	337302	CD
cord-337302-fpz2jfuj	5	10	cord_uid	cord_uid	NNS
cord-337302-fpz2jfuj	5	11	:	:	:
cord-337302-fpz2jfuj	6	1	fpz2jfuj	fpz2jfuj	NNP
cord-337302-fpz2jfuj	6	2	Cancer	cancer	NN
cord-337302-fpz2jfuj	6	3	patients	patient	NNS
cord-337302-fpz2jfuj	6	4	are	be	VBP
cord-337302-fpz2jfuj	6	5	susceptible	susceptible	JJ
cord-337302-fpz2jfuj	6	6	groups	group	NNS
cord-337302-fpz2jfuj	6	7	to	to	IN
cord-337302-fpz2jfuj	6	8	COVID-19	covid-19	VB
cord-337302-fpz2jfuj	6	9	,	,	,
cord-337302-fpz2jfuj	6	10	and	and	CC
cord-337302-fpz2jfuj	6	11	risk	risk	NN
cord-337302-fpz2jfuj	6	12	-	-	HYPH
cord-337302-fpz2jfuj	6	13	adjusted	adjust	VBN
cord-337302-fpz2jfuj	6	14	models	model	NNS
cord-337302-fpz2jfuj	6	15	show	show	VBP
cord-337302-fpz2jfuj	6	16	that	that	IN
cord-337302-fpz2jfuj	6	17	most	most	JJS
cord-337302-fpz2jfuj	6	18	cancer	cancer	NN
cord-337302-fpz2jfuj	6	19	patients	patient	NNS
cord-337302-fpz2jfuj	6	20	have	have	VBP
cord-337302-fpz2jfuj	6	21	a	a	DT
cord-337302-fpz2jfuj	6	22	25–39	25–39	CD
cord-337302-fpz2jfuj	6	23	%	%	NN
cord-337302-fpz2jfuj	6	24	mortality	mortality	NN
cord-337302-fpz2jfuj	6	25	risk	risk	NN
cord-337302-fpz2jfuj	6	26	if	if	IN
cord-337302-fpz2jfuj	6	27	infected	infect	VBN
cord-337302-fpz2jfuj	6	28	with	with	IN
cord-337302-fpz2jfuj	6	29	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	6	30	.	.	.
cord-337302-fpz2jfuj	7	1	The	the	DT
cord-337302-fpz2jfuj	7	2	infection	infection	NN
cord-337302-fpz2jfuj	7	3	rate	rate	NN
cord-337302-fpz2jfuj	7	4	of	of	IN
cord-337302-fpz2jfuj	7	5	SARS	SARS	NNP
cord-337302-fpz2jfuj	7	6	-	-	HYPH
cord-337302-fpz2jfuj	7	7	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	7	8	in	in	IN
cord-337302-fpz2jfuj	7	9	cancer	cancer	NN
cord-337302-fpz2jfuj	7	10	patients	patient	NNS
cord-337302-fpz2jfuj	7	11	in	in	IN
cord-337302-fpz2jfuj	7	12	China	China	NNP
cord-337302-fpz2jfuj	7	13	was	be	VBD
cord-337302-fpz2jfuj	7	14	0.79	0.79	CD
cord-337302-fpz2jfuj	7	15	%	%	NN
cord-337302-fpz2jfuj	7	16	(	(	-LRB-
cord-337302-fpz2jfuj	7	17	12	12	CD
cord-337302-fpz2jfuj	7	18	of	of	IN
cord-337302-fpz2jfuj	7	19	1524	1524	CD
cord-337302-fpz2jfuj	7	20	patients	patient	NNS
cord-337302-fpz2jfuj	7	21	;	;	:
cord-337302-fpz2jfuj	7	22	95	95	CD
cord-337302-fpz2jfuj	7	23	%	%	NN
cord-337302-fpz2jfuj	7	24	CI	CI	NNP
cord-337302-fpz2jfuj	7	25	,	,	,
cord-337302-fpz2jfuj	7	26	0.31.2	0.31.2	CD
cord-337302-fpz2jfuj	7	27	%	%	NN
cord-337302-fpz2jfuj	7	28	)	)	-RRB-
cord-337302-fpz2jfuj	7	29	.	.	.
cord-337302-fpz2jfuj	8	1	The	the	DT
cord-337302-fpz2jfuj	8	2	case	case	NN
cord-337302-fpz2jfuj	8	3	fatality	fatality	NN
cord-337302-fpz2jfuj	8	4	rate	rate	NN
cord-337302-fpz2jfuj	8	5	of	of	IN
cord-337302-fpz2jfuj	8	6	COVID-19	covid-19	NN
cord-337302-fpz2jfuj	8	7	in	in	IN
cord-337302-fpz2jfuj	8	8	the	the	DT
cord-337302-fpz2jfuj	8	9	overall	overall	JJ
cord-337302-fpz2jfuj	8	10	population	population	NN
cord-337302-fpz2jfuj	8	11	ranges	range	VBZ
cord-337302-fpz2jfuj	8	12	from	from	IN
cord-337302-fpz2jfuj	8	13	2.3	2.3	CD
cord-337302-fpz2jfuj	8	14	to	to	TO
cord-337302-fpz2jfuj	8	15	8.0	8.0	CD
cord-337302-fpz2jfuj	8	16	%	%	NN
cord-337302-fpz2jfuj	8	17	;	;	,
cord-337302-fpz2jfuj	8	18	among	among	IN
cord-337302-fpz2jfuj	8	19	these	these	DT
cord-337302-fpz2jfuj	8	20	,	,	,
cord-337302-fpz2jfuj	8	21	the	the	DT
cord-337302-fpz2jfuj	8	22	case	case	NN
cord-337302-fpz2jfuj	8	23	fatality	fatality	NN
cord-337302-fpz2jfuj	8	24	rate	rate	NN
cord-337302-fpz2jfuj	8	25	for	for	IN
cord-337302-fpz2jfuj	8	26	cancer	cancer	NN
cord-337302-fpz2jfuj	8	27	patients	patient	NNS
cord-337302-fpz2jfuj	8	28	is	be	VBZ
cord-337302-fpz2jfuj	8	29	at	at	IN
cord-337302-fpz2jfuj	8	30	5.6	5.6	CD
cord-337302-fpz2jfuj	8	31	%	%	NN
cord-337302-fpz2jfuj	8	32	.	.	.
cord-337302-fpz2jfuj	9	1	In	in	IN
cord-337302-fpz2jfuj	9	2	a	a	DT
cord-337302-fpz2jfuj	9	3	retrospective	retrospective	JJ
cord-337302-fpz2jfuj	9	4	cohort	cohort	NN
cord-337302-fpz2jfuj	9	5	study	study	NN
cord-337302-fpz2jfuj	9	6	of	of	IN
cord-337302-fpz2jfuj	9	7	28	28	CD
cord-337302-fpz2jfuj	9	8	COVID-19-infected	COVID-19-infected	NNP
cord-337302-fpz2jfuj	9	9	cancer	cancer	NN
cord-337302-fpz2jfuj	9	10	patients	patient	NNS
cord-337302-fpz2jfuj	9	11	,	,	,
cord-337302-fpz2jfuj	9	12	a	a	DT
cord-337302-fpz2jfuj	9	13	total	total	NN
cord-337302-fpz2jfuj	9	14	of	of	IN
cord-337302-fpz2jfuj	9	15	15	15	CD
cord-337302-fpz2jfuj	9	16	(	(	-LRB-
cord-337302-fpz2jfuj	9	17	53.6	53.6	CD
cord-337302-fpz2jfuj	9	18	%	%	NN
cord-337302-fpz2jfuj	9	19	)	)	-RRB-
cord-337302-fpz2jfuj	9	20	patients	patient	NNS
cord-337302-fpz2jfuj	9	21	had	have	VBD
cord-337302-fpz2jfuj	9	22	severe	severe	JJ
cord-337302-fpz2jfuj	9	23	outcomes	outcome	NNS
cord-337302-fpz2jfuj	9	24	with	with	IN
cord-337302-fpz2jfuj	9	25	a	a	DT
cord-337302-fpz2jfuj	9	26	mortality	mortality	NN
cord-337302-fpz2jfuj	9	27	rate	rate	NN
cord-337302-fpz2jfuj	9	28	of	of	IN
cord-337302-fpz2jfuj	9	29	28.6	28.6	CD
cord-337302-fpz2jfuj	9	30	%	%	NN
cord-337302-fpz2jfuj	9	31	.	.	.
cord-337302-fpz2jfuj	10	1	In	in	IN
cord-337302-fpz2jfuj	10	2	a	a	DT
cord-337302-fpz2jfuj	10	3	pooled	pool	VBN
cord-337302-fpz2jfuj	10	4	analysis	analysis	NN
cord-337302-fpz2jfuj	10	5	by	by	IN
cord-337302-fpz2jfuj	10	6	Aakash	Aakash	NNP
cord-337302-fpz2jfuj	10	7	et	et	NNP
cord-337302-fpz2jfuj	10	8	al	al	NNP
cord-337302-fpz2jfuj	10	9	,	,	,
cord-337302-fpz2jfuj	10	10	a	a	DT
cord-337302-fpz2jfuj	10	11	2	2	CD
cord-337302-fpz2jfuj	10	12	%	%	NN
cord-337302-fpz2jfuj	10	13	cancer	cancer	NN
cord-337302-fpz2jfuj	10	14	prevalence	prevalence	NN
cord-337302-fpz2jfuj	10	15	was	be	VBD
cord-337302-fpz2jfuj	10	16	found	find	VBN
cord-337302-fpz2jfuj	10	17	among	among	IN
cord-337302-fpz2jfuj	10	18	admitted	admit	VBN
cord-337302-fpz2jfuj	10	19	patients	patient	NNS
cord-337302-fpz2jfuj	10	20	with	with	IN
cord-337302-fpz2jfuj	10	21	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	10	22	.	.	.
cord-337302-fpz2jfuj	11	1	In	in	IN
cord-337302-fpz2jfuj	11	2	Italy	Italy	NNP
cord-337302-fpz2jfuj	11	3	,	,	,
cord-337302-fpz2jfuj	11	4	a	a	DT
cord-337302-fpz2jfuj	11	5	report	report	NN
cord-337302-fpz2jfuj	11	6	shows	show	VBZ
cord-337302-fpz2jfuj	11	7	that	that	IN
cord-337302-fpz2jfuj	11	8	among	among	IN
cord-337302-fpz2jfuj	11	9	the	the	DT
cord-337302-fpz2jfuj	11	10	3200	3200	CD
cord-337302-fpz2jfuj	11	11	patients	patient	NNS
cord-337302-fpz2jfuj	11	12	who	who	WP
cord-337302-fpz2jfuj	11	13	died	die	VBD
cord-337302-fpz2jfuj	11	14	of	of	IN
cord-337302-fpz2jfuj	11	15	SARS	SARS	NNP
cord-337302-fpz2jfuj	11	16	-	-	HYPH
cord-337302-fpz2jfuj	11	17	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	11	18	,	,	,
cord-337302-fpz2jfuj	11	19	19.4	19.4	CD
cord-337302-fpz2jfuj	11	20	%	%	NN
cord-337302-fpz2jfuj	11	21	were	be	VBD
cord-337302-fpz2jfuj	11	22	patients	patient	NNS
cord-337302-fpz2jfuj	11	23	with	with	IN
cord-337302-fpz2jfuj	11	24	cancer	cancer	NN
cord-337302-fpz2jfuj	11	25	.	.	.
cord-337302-fpz2jfuj	12	1	In	in	IN
cord-337302-fpz2jfuj	12	2	New	New	NNP
cord-337302-fpz2jfuj	12	3	York	York	NNP
cord-337302-fpz2jfuj	12	4	,	,	,
cord-337302-fpz2jfuj	12	5	61	61	CD
cord-337302-fpz2jfuj	12	6	(	(	-LRB-
cord-337302-fpz2jfuj	12	7	28	28	CD
cord-337302-fpz2jfuj	12	8	%	%	NN
cord-337302-fpz2jfuj	12	9	)	)	-RRB-
cord-337302-fpz2jfuj	12	10	cancer	cancer	NN
cord-337302-fpz2jfuj	12	11	patients	patient	NNS
cord-337302-fpz2jfuj	12	12	succumbed	succumb	VBD
cord-337302-fpz2jfuj	12	13	to	to	IN
cord-337302-fpz2jfuj	12	14	COVID-19	covid-19	VB
cord-337302-fpz2jfuj	12	15	with	with	IN
cord-337302-fpz2jfuj	12	16	a	a	DT
cord-337302-fpz2jfuj	12	17	case	case	NN
cord-337302-fpz2jfuj	12	18	fatality	fatality	NN
cord-337302-fpz2jfuj	12	19	rate	rate	NN
cord-337302-fpz2jfuj	12	20	of	of	IN
cord-337302-fpz2jfuj	12	21	37	37	CD
cord-337302-fpz2jfuj	12	22	%	%	NN
cord-337302-fpz2jfuj	12	23	(	(	-LRB-
cord-337302-fpz2jfuj	12	24	20/54	20/54	CD
cord-337302-fpz2jfuj	12	25	)	)	-RRB-
cord-337302-fpz2jfuj	12	26	and	and	CC
cord-337302-fpz2jfuj	12	27	25	25	CD
cord-337302-fpz2jfuj	12	28	%	%	NN
cord-337302-fpz2jfuj	12	29	(	(	-LRB-
cord-337302-fpz2jfuj	12	30	41/164	41/164	CD
cord-337302-fpz2jfuj	12	31	)	)	-RRB-
cord-337302-fpz2jfuj	12	32	for	for	IN
cord-337302-fpz2jfuj	12	33	hematologic	hematologic	JJ
cord-337302-fpz2jfuj	12	34	and	and	CC
cord-337302-fpz2jfuj	12	35	solid	solid	JJ
cord-337302-fpz2jfuj	12	36	malignancies	malignancy	NNS
cord-337302-fpz2jfuj	12	37	,	,	,
cord-337302-fpz2jfuj	12	38	respectively	respectively	RB
cord-337302-fpz2jfuj	12	39	.	.	.
cord-337302-fpz2jfuj	13	1	Impacts	impact	NNS
cord-337302-fpz2jfuj	13	2	of	of	IN
cord-337302-fpz2jfuj	13	3	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	13	4	in	in	IN
cord-337302-fpz2jfuj	13	5	cancer	cancer	NN
cord-337302-fpz2jfuj	13	6	care	care	NN
cord-337302-fpz2jfuj	13	7	include	include	VBP
cord-337302-fpz2jfuj	13	8	interruptions	interruption	NNS
cord-337302-fpz2jfuj	13	9	of	of	IN
cord-337302-fpz2jfuj	13	10	life	life	NN
cord-337302-fpz2jfuj	13	11	-	-	HYPH
cord-337302-fpz2jfuj	13	12	saving	save	VBG
cord-337302-fpz2jfuj	13	13	therapies	therapy	NNS
cord-337302-fpz2jfuj	13	14	,	,	,
cord-337302-fpz2jfuj	13	15	distraction	distraction	NN
cord-337302-fpz2jfuj	13	16	effects	effect	NNS
cord-337302-fpz2jfuj	13	17	,	,	,
cord-337302-fpz2jfuj	13	18	and	and	CC
cord-337302-fpz2jfuj	13	19	diagnostic	diagnostic	JJ
cord-337302-fpz2jfuj	13	20	overshadowing	overshadowing	NN
cord-337302-fpz2jfuj	13	21	that	that	WDT
cord-337302-fpz2jfuj	13	22	involve	involve	VBP
cord-337302-fpz2jfuj	13	23	diverting	divert	VBG
cord-337302-fpz2jfuj	13	24	attention	attention	NN
cord-337302-fpz2jfuj	13	25	to	to	IN
cord-337302-fpz2jfuj	13	26	the	the	DT
cord-337302-fpz2jfuj	13	27	pandemic	pandemic	NN
cord-337302-fpz2jfuj	13	28	rather	rather	RB
cord-337302-fpz2jfuj	13	29	than	than	IN
cord-337302-fpz2jfuj	13	30	to	to	IN
cord-337302-fpz2jfuj	13	31	cancer	cancer	NN
cord-337302-fpz2jfuj	13	32	patients	patient	NNS
cord-337302-fpz2jfuj	13	33	and	and	CC
cord-337302-fpz2jfuj	13	34	disruptions	disruption	NNS
cord-337302-fpz2jfuj	13	35	of	of	IN
cord-337302-fpz2jfuj	13	36	primary	primary	JJ
cord-337302-fpz2jfuj	13	37	palliative	palliative	JJ
cord-337302-fpz2jfuj	13	38	care	care	NN
cord-337302-fpz2jfuj	13	39	to	to	IN
cord-337302-fpz2jfuj	13	40	patients	patient	NNS
cord-337302-fpz2jfuj	13	41	due	due	JJ
cord-337302-fpz2jfuj	13	42	to	to	IN
cord-337302-fpz2jfuj	13	43	forced	force	VBN
cord-337302-fpz2jfuj	13	44	quarantine	quarantine	NN
cord-337302-fpz2jfuj	13	45	.	.	.
cord-337302-fpz2jfuj	14	1	Herein	herein	RB
cord-337302-fpz2jfuj	14	2	,	,	,
cord-337302-fpz2jfuj	14	3	we	-PRON-	PRP
cord-337302-fpz2jfuj	14	4	review	review	VBP
cord-337302-fpz2jfuj	14	5	the	the	DT
cord-337302-fpz2jfuj	14	6	landscape	landscape	NN
cord-337302-fpz2jfuj	14	7	of	of	IN
cord-337302-fpz2jfuj	14	8	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	14	9	in	in	IN
cord-337302-fpz2jfuj	14	10	cancer	cancer	NN
cord-337302-fpz2jfuj	14	11	care	care	NN
cord-337302-fpz2jfuj	14	12	.	.	.
cord-337302-fpz2jfuj	15	1	We	-PRON-	PRP
cord-337302-fpz2jfuj	15	2	also	also	RB
cord-337302-fpz2jfuj	15	3	briefly	briefly	RB
cord-337302-fpz2jfuj	15	4	share	share	VB
cord-337302-fpz2jfuj	15	5	our	-PRON-	PRP$
cord-337302-fpz2jfuj	15	6	experience	experience	NN
cord-337302-fpz2jfuj	15	7	and	and	CC
cord-337302-fpz2jfuj	15	8	the	the	DT
cord-337302-fpz2jfuj	15	9	measures	measure	NNS
cord-337302-fpz2jfuj	15	10	in	in	IN
cord-337302-fpz2jfuj	15	11	place	place	NN
cord-337302-fpz2jfuj	15	12	to	to	TO
cord-337302-fpz2jfuj	15	13	protect	protect	VB
cord-337302-fpz2jfuj	15	14	cancer	cancer	NN
cord-337302-fpz2jfuj	15	15	patients	patient	NNS
cord-337302-fpz2jfuj	15	16	against	against	IN
cord-337302-fpz2jfuj	15	17	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	15	18	in	in	IN
cord-337302-fpz2jfuj	15	19	our	-PRON-	PRP$
cord-337302-fpz2jfuj	15	20	center	center	NN
cord-337302-fpz2jfuj	15	21	.	.	.
cord-337302-fpz2jfuj	16	1	As	as	IN
cord-337302-fpz2jfuj	16	2	of	of	IN
cord-337302-fpz2jfuj	16	3	December	December	NNP
cord-337302-fpz2jfuj	16	4	2019	2019	CD
cord-337302-fpz2jfuj	16	5	,	,	,
cord-337302-fpz2jfuj	16	6	the	the	DT
cord-337302-fpz2jfuj	16	7	world	world	NN
cord-337302-fpz2jfuj	16	8	has	have	VBZ
cord-337302-fpz2jfuj	16	9	grappled	grapple	VBN
cord-337302-fpz2jfuj	16	10	with	with	IN
cord-337302-fpz2jfuj	16	11	a	a	DT
cord-337302-fpz2jfuj	16	12	novel	novel	JJ
cord-337302-fpz2jfuj	16	13	strain	strain	NN
cord-337302-fpz2jfuj	16	14	of	of	IN
cord-337302-fpz2jfuj	16	15	virus	virus	NN
cord-337302-fpz2jfuj	16	16	caused	cause	VBN
cord-337302-fpz2jfuj	16	17	by	by	IN
cord-337302-fpz2jfuj	16	18	severe	severe	JJ
cord-337302-fpz2jfuj	16	19	acute	acute	JJ
cord-337302-fpz2jfuj	16	20	respiratory	respiratory	JJ
cord-337302-fpz2jfuj	16	21	syndrome	syndrome	NN
cord-337302-fpz2jfuj	16	22	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	16	23	2	2	CD
cord-337302-fpz2jfuj	17	1	(	(	-LRB-
cord-337302-fpz2jfuj	17	2	SARS	SARS	NNP
cord-337302-fpz2jfuj	17	3	-	-	HYPH
cord-337302-fpz2jfuj	17	4	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	17	5	)	)	-RRB-
cord-337302-fpz2jfuj	17	6	that	that	WDT
cord-337302-fpz2jfuj	17	7	causes	cause	VBZ
cord-337302-fpz2jfuj	17	8	the	the	DT
cord-337302-fpz2jfuj	17	9	disease	disease	NN
cord-337302-fpz2jfuj	17	10	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	17	11	.	.	.
cord-337302-fpz2jfuj	18	1	The	the	DT
cord-337302-fpz2jfuj	18	2	first	first	JJ
cord-337302-fpz2jfuj	18	3	case	case	NN
cord-337302-fpz2jfuj	18	4	was	be	VBD
cord-337302-fpz2jfuj	18	5	identified	identify	VBN
cord-337302-fpz2jfuj	18	6	in	in	IN
cord-337302-fpz2jfuj	18	7	the	the	DT
cord-337302-fpz2jfuj	18	8	city	city	NN
cord-337302-fpz2jfuj	18	9	of	of	IN
cord-337302-fpz2jfuj	18	10	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	18	11	,	,	,
cord-337302-fpz2jfuj	18	12	Hubei	Hubei	NNP
cord-337302-fpz2jfuj	18	13	province	province	NN
cord-337302-fpz2jfuj	18	14	,	,	,
cord-337302-fpz2jfuj	18	15	China	China	NNP
cord-337302-fpz2jfuj	18	16	,	,	,
cord-337302-fpz2jfuj	18	17	and	and	CC
cord-337302-fpz2jfuj	18	18	rapidly	rapidly	RB
cord-337302-fpz2jfuj	18	19	spread	spread	VB
cord-337302-fpz2jfuj	18	20	globally	globally	RB
cord-337302-fpz2jfuj	18	21	.	.	.
cord-337302-fpz2jfuj	19	1	1	1	LS
cord-337302-fpz2jfuj	20	1	The	the	DT
cord-337302-fpz2jfuj	20	2	origin	origin	NN
cord-337302-fpz2jfuj	20	3	of	of	IN
cord-337302-fpz2jfuj	20	4	the	the	DT
cord-337302-fpz2jfuj	20	5	virus	virus	NN
cord-337302-fpz2jfuj	20	6	is	be	VBZ
cord-337302-fpz2jfuj	20	7	believed	believe	VBN
cord-337302-fpz2jfuj	20	8	to	to	TO
cord-337302-fpz2jfuj	20	9	be	be	VB
cord-337302-fpz2jfuj	20	10	from	from	IN
cord-337302-fpz2jfuj	20	11	bats	bat	NNS
cord-337302-fpz2jfuj	20	12	and	and	CC
cord-337302-fpz2jfuj	20	13	later	later	RB
cord-337302-fpz2jfuj	20	14	transmitted	transmit	VBN
cord-337302-fpz2jfuj	20	15	to	to	IN
cord-337302-fpz2jfuj	20	16	humans	human	NNS
cord-337302-fpz2jfuj	20	17	through	through	IN
cord-337302-fpz2jfuj	20	18	an	an	DT
cord-337302-fpz2jfuj	20	19	unknown	unknown	JJ
cord-337302-fpz2jfuj	20	20	intermediary	intermediary	NN
cord-337302-fpz2jfuj	20	21	in	in	IN
cord-337302-fpz2jfuj	20	22	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	20	23	wet	wet	JJ
cord-337302-fpz2jfuj	20	24	market	market	NN
cord-337302-fpz2jfuj	20	25	,	,	,
cord-337302-fpz2jfuj	20	26	Hubei	Hubei	NNP
cord-337302-fpz2jfuj	20	27	province	province	NN
cord-337302-fpz2jfuj	20	28	,	,	,
cord-337302-fpz2jfuj	20	29	China	China	NNP
cord-337302-fpz2jfuj	20	30	,	,	,
cord-337302-fpz2jfuj	20	31	in	in	IN
cord-337302-fpz2jfuj	20	32	December	December	NNP
cord-337302-fpz2jfuj	20	33	2019	2019	CD
cord-337302-fpz2jfuj	20	34	.	.	.
cord-337302-fpz2jfuj	21	1	2	2	LS
cord-337302-fpz2jfuj	22	1	Similar	similar	JJ
cord-337302-fpz2jfuj	22	2	incidents	incident	NNS
cord-337302-fpz2jfuj	22	3	of	of	IN
cord-337302-fpz2jfuj	22	4	transmission	transmission	NN
cord-337302-fpz2jfuj	22	5	happened	happen	VBD
cord-337302-fpz2jfuj	22	6	in	in	IN
cord-337302-fpz2jfuj	22	7	the	the	DT
cord-337302-fpz2jfuj	22	8	past	past	JJ
cord-337302-fpz2jfuj	22	9	two	two	CD
cord-337302-fpz2jfuj	22	10	decades	decade	NNS
cord-337302-fpz2jfuj	22	11	,	,	,
cord-337302-fpz2jfuj	22	12	where	where	WRB
cord-337302-fpz2jfuj	22	13	animals	animal	NNS
cord-337302-fpz2jfuj	22	14	to	to	IN
cord-337302-fpz2jfuj	22	15	human	human	JJ
cord-337302-fpz2jfuj	22	16	crossover	crossover	NN
cord-337302-fpz2jfuj	22	17	were	be	VBD
cord-337302-fpz2jfuj	22	18	witnessed	witness	VBN
cord-337302-fpz2jfuj	22	19	.	.	.
cord-337302-fpz2jfuj	23	1	The	the	DT
cord-337302-fpz2jfuj	23	2	first	first	JJ
cord-337302-fpz2jfuj	23	3	instance	instance	NN
cord-337302-fpz2jfuj	23	4	of	of	IN
cord-337302-fpz2jfuj	23	5	such	such	JJ
cord-337302-fpz2jfuj	23	6	was	be	VBD
cord-337302-fpz2jfuj	23	7	in	in	IN
cord-337302-fpz2jfuj	23	8	2002	2002	CD
cord-337302-fpz2jfuj	23	9	-	-	SYM
cord-337302-fpz2jfuj	23	10	2003	2003	CD
cord-337302-fpz2jfuj	23	11	,	,	,
cord-337302-fpz2jfuj	23	12	when	when	WRB
cord-337302-fpz2jfuj	23	13	a	a	DT
cord-337302-fpz2jfuj	23	14	crossover	crossover	NN
cord-337302-fpz2jfuj	23	15	transmission	transmission	NN
cord-337302-fpz2jfuj	23	16	of	of	IN
cord-337302-fpz2jfuj	23	17	a	a	DT
cord-337302-fpz2jfuj	23	18	new	new	JJ
cord-337302-fpz2jfuj	23	19	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	23	20	was	be	VBD
cord-337302-fpz2jfuj	23	21	identified	identify	VBN
cord-337302-fpz2jfuj	23	22	in	in	IN
cord-337302-fpz2jfuj	23	23	Guangdong	Guangdong	NNP
cord-337302-fpz2jfuj	23	24	province	province	NN
cord-337302-fpz2jfuj	23	25	of	of	IN
cord-337302-fpz2jfuj	23	26	China	China	NNP
cord-337302-fpz2jfuj	23	27	.	.	.
cord-337302-fpz2jfuj	24	1	3	3	CD
cord-337302-fpz2jfuj	24	2	,	,	,
cord-337302-fpz2jfuj	24	3	4	4	CD
cord-337302-fpz2jfuj	25	1	The	the	DT
cord-337302-fpz2jfuj	25	2	case	case	NN
cord-337302-fpz2jfuj	25	3	fatality	fatality	NN
cord-337302-fpz2jfuj	25	4	rate	rate	NN
cord-337302-fpz2jfuj	25	5	of	of	IN
cord-337302-fpz2jfuj	25	6	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	25	7	is	be	VBZ
cord-337302-fpz2jfuj	25	8	estimated	estimate	VBN
cord-337302-fpz2jfuj	25	9	to	to	TO
cord-337302-fpz2jfuj	25	10	range	range	VB
cord-337302-fpz2jfuj	25	11	from	from	IN
cord-337302-fpz2jfuj	25	12	2	2	CD
cord-337302-fpz2jfuj	25	13	to	to	IN
cord-337302-fpz2jfuj	25	14	3	3	CD
cord-337302-fpz2jfuj	25	15	%	%	NN
cord-337302-fpz2jfuj	25	16	.	.	.
cord-337302-fpz2jfuj	26	1	This	this	DT
cord-337302-fpz2jfuj	26	2	novel	novel	JJ
cord-337302-fpz2jfuj	26	3	virus	virus	NN
cord-337302-fpz2jfuj	26	4	is	be	VBZ
cord-337302-fpz2jfuj	26	5	more	more	RBR
cord-337302-fpz2jfuj	26	6	virulent	virulent	JJ
cord-337302-fpz2jfuj	26	7	but	but	CC
cord-337302-fpz2jfuj	26	8	genetically	genetically	RB
cord-337302-fpz2jfuj	26	9	different	different	JJ
cord-337302-fpz2jfuj	26	10	from	from	IN
cord-337302-fpz2jfuj	26	11	SARS	SARS	NNP
cord-337302-fpz2jfuj	26	12	-	-	HYPH
cord-337302-fpz2jfuj	26	13	CoV	CoV	NNP
cord-337302-fpz2jfuj	26	14	and	and	CC
cord-337302-fpz2jfuj	26	15	Middle	Middle	NNP
cord-337302-fpz2jfuj	26	16	East	East	NNP
cord-337302-fpz2jfuj	26	17	respiratory	respiratory	JJ
cord-337302-fpz2jfuj	26	18	syndrome	syndrome	NN
cord-337302-fpz2jfuj	26	19	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	26	20	(	(	-LRB-
cord-337302-fpz2jfuj	26	21	MERS	MERS	NNP
cord-337302-fpz2jfuj	26	22	-	-	HYPH
cord-337302-fpz2jfuj	26	23	CoV	CoV	NNP
cord-337302-fpz2jfuj	26	24	)	)	-RRB-
cord-337302-fpz2jfuj	26	25	,	,	,
cord-337302-fpz2jfuj	26	26	albeit	albeit	IN
cord-337302-fpz2jfuj	26	27	with	with	IN
cord-337302-fpz2jfuj	26	28	lower	low	JJR
cord-337302-fpz2jfuj	26	29	fatality	fatality	NN
cord-337302-fpz2jfuj	26	30	.	.	.
cord-337302-fpz2jfuj	27	1	5	5	CD
cord-337302-fpz2jfuj	27	2	,	,	,
cord-337302-fpz2jfuj	27	3	6	6	CD
cord-337302-fpz2jfuj	28	1	The	the	DT
cord-337302-fpz2jfuj	28	2	universal	universal	JJ
cord-337302-fpz2jfuj	28	3	impact	impact	NN
cord-337302-fpz2jfuj	28	4	of	of	IN
cord-337302-fpz2jfuj	28	5	this	this	DT
cord-337302-fpz2jfuj	28	6	new	new	JJ
cord-337302-fpz2jfuj	28	7	pandemic	pandemic	NN
cord-337302-fpz2jfuj	28	8	is	be	VBZ
cord-337302-fpz2jfuj	28	9	exponential	exponential	JJ
cord-337302-fpz2jfuj	28	10	with	with	IN
cord-337302-fpz2jfuj	28	11	countries	country	NNS
cord-337302-fpz2jfuj	28	12	like	like	IN
cord-337302-fpz2jfuj	28	13	the	the	DT
cord-337302-fpz2jfuj	28	14	USA	USA	NNP
cord-337302-fpz2jfuj	28	15	,	,	,
cord-337302-fpz2jfuj	28	16	Italy	Italy	NNP
cord-337302-fpz2jfuj	28	17	,	,	,
cord-337302-fpz2jfuj	28	18	Spain	Spain	NNP
cord-337302-fpz2jfuj	28	19	,	,	,
cord-337302-fpz2jfuj	28	20	and	and	CC
cord-337302-fpz2jfuj	28	21	the	the	DT
cord-337302-fpz2jfuj	28	22	UK	UK	NNP
cord-337302-fpz2jfuj	28	23	reporting	report	VBG
cord-337302-fpz2jfuj	28	24	staggering	staggering	JJ
cord-337302-fpz2jfuj	28	25	numbers	number	NNS
cord-337302-fpz2jfuj	28	26	of	of	IN
cord-337302-fpz2jfuj	28	27	cases	case	NNS
cord-337302-fpz2jfuj	28	28	and	and	CC
cord-337302-fpz2jfuj	28	29	deaths	death	NNS
cord-337302-fpz2jfuj	28	30	.	.	.
cord-337302-fpz2jfuj	29	1	7	7	CD
cord-337302-fpz2jfuj	30	1	Following	follow	VBG
cord-337302-fpz2jfuj	30	2	the	the	DT
cord-337302-fpz2jfuj	30	3	outbreak	outbreak	NN
cord-337302-fpz2jfuj	30	4	in	in	IN
cord-337302-fpz2jfuj	30	5	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	30	6	on	on	IN
cord-337302-fpz2jfuj	30	7	31st	31st	JJ
cord-337302-fpz2jfuj	30	8	December	December	NNP
cord-337302-fpz2jfuj	30	9	2019	2019	CD
cord-337302-fpz2jfuj	30	10	,	,	,
cord-337302-fpz2jfuj	30	11	China	China	NNP
cord-337302-fpz2jfuj	30	12	officially	officially	RB
cord-337302-fpz2jfuj	30	13	notified	notify	VBD
cord-337302-fpz2jfuj	30	14	the	the	DT
cord-337302-fpz2jfuj	30	15	World	World	NNP
cord-337302-fpz2jfuj	30	16	Health	Health	NNP
cord-337302-fpz2jfuj	30	17	Organization	Organization	NNP
cord-337302-fpz2jfuj	30	18	,	,	,
cord-337302-fpz2jfuj	30	19	and	and	CC
cord-337302-fpz2jfuj	30	20	on	on	IN
cord-337302-fpz2jfuj	30	21	1st	1st	JJ
cord-337302-fpz2jfuj	30	22	January	January	NNP
cord-337302-fpz2jfuj	30	23	2020	2020	CD
cord-337302-fpz2jfuj	30	24	,	,	,
cord-337302-fpz2jfuj	30	25	the	the	DT
cord-337302-fpz2jfuj	30	26	epicenter	epicenter	JJ
cord-337302-fpz2jfuj	30	27	market	market	NN
cord-337302-fpz2jfuj	30	28	was	be	VBD
cord-337302-fpz2jfuj	30	29	closed	close	VBN
cord-337302-fpz2jfuj	30	30	.	.	.
cord-337302-fpz2jfuj	31	1	6	6	CD
cord-337302-fpz2jfuj	32	1	As	as	IN
cord-337302-fpz2jfuj	32	2	of	of	IN
cord-337302-fpz2jfuj	32	3	August	August	NNP
cord-337302-fpz2jfuj	32	4	2020	2020	CD
cord-337302-fpz2jfuj	32	5	,	,	,
cord-337302-fpz2jfuj	32	6	worldwide	worldwide	RB
cord-337302-fpz2jfuj	32	7	confirmed	confirm	VBN
cord-337302-fpz2jfuj	32	8	cases	case	NNS
cord-337302-fpz2jfuj	32	9	stand	stand	VBP
cord-337302-fpz2jfuj	32	10	at	at	IN
cord-337302-fpz2jfuj	32	11	19.6	19.6	CD
cord-337302-fpz2jfuj	32	12	million	million	CD
cord-337302-fpz2jfuj	32	13	,	,	,
cord-337302-fpz2jfuj	32	14	with	with	IN
cord-337302-fpz2jfuj	32	15	over	over	IN
cord-337302-fpz2jfuj	32	16	727,258	727,258	CD
cord-337302-fpz2jfuj	32	17	deaths	death	NNS
cord-337302-fpz2jfuj	32	18	according	accord	VBG
cord-337302-fpz2jfuj	32	19	to	to	IN
cord-337302-fpz2jfuj	32	20	the	the	DT
cord-337302-fpz2jfuj	32	21	latest	late	JJS
cord-337302-fpz2jfuj	32	22	World	World	NNP
cord-337302-fpz2jfuj	32	23	Health	Health	NNP
cord-337302-fpz2jfuj	32	24	Organization	Organization	NNP
cord-337302-fpz2jfuj	32	25	(	(	-LRB-
cord-337302-fpz2jfuj	32	26	W.H.O	W.H.O	NNP
cord-337302-fpz2jfuj	32	27	)	)	-RRB-
cord-337302-fpz2jfuj	32	28	situation	situation	NN
cord-337302-fpz2jfuj	32	29	reports	report	VBZ
cord-337302-fpz2jfuj	32	30	.	.	.
cord-337302-fpz2jfuj	33	1	8	8	CD
cord-337302-fpz2jfuj	33	2	Coronaviruses	coronaviruse	NNS
cord-337302-fpz2jfuj	33	3	are	be	VBP
cord-337302-fpz2jfuj	33	4	a	a	DT
cord-337302-fpz2jfuj	33	5	type	type	NN
cord-337302-fpz2jfuj	33	6	of	of	IN
cord-337302-fpz2jfuj	33	7	enveloped	envelop	VBN
cord-337302-fpz2jfuj	33	8	RNA	RNA	NNP
cord-337302-fpz2jfuj	33	9	viruses	virus	NNS
cord-337302-fpz2jfuj	33	10	with	with	IN
cord-337302-fpz2jfuj	33	11	a	a	DT
cord-337302-fpz2jfuj	33	12	size	size	NN
cord-337302-fpz2jfuj	33	13	of	of	IN
cord-337302-fpz2jfuj	33	14	60	60	CD
cord-337302-fpz2jfuj	33	15	nm	nm	NN
cord-337302-fpz2jfuj	33	16	to	to	IN
cord-337302-fpz2jfuj	33	17	140	140	CD
cord-337302-fpz2jfuj	33	18	nm	nm	NN
cord-337302-fpz2jfuj	33	19	in	in	IN
cord-337302-fpz2jfuj	33	20	diameter	diameter	NN
cord-337302-fpz2jfuj	33	21	with	with	IN
cord-337302-fpz2jfuj	33	22	crownlike	crownlike	JJ
cord-337302-fpz2jfuj	33	23	projections	projection	NNS
cord-337302-fpz2jfuj	33	24	when	when	WRB
cord-337302-fpz2jfuj	33	25	viewed	view	VBN
cord-337302-fpz2jfuj	33	26	microscopically	microscopically	RB
cord-337302-fpz2jfuj	33	27	;	;	:
cord-337302-fpz2jfuj	33	28	hence	hence	RB
cord-337302-fpz2jfuj	33	29	the	the	DT
cord-337302-fpz2jfuj	33	30	name	name	NN
cord-337302-fpz2jfuj	33	31	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	33	32	.	.	.
cord-337302-fpz2jfuj	33	33	9	9	CD
cord-337302-fpz2jfuj	34	1	On	on	IN
cord-337302-fpz2jfuj	34	2	7th	7th	JJ
cord-337302-fpz2jfuj	34	3	January	January	NNP
cord-337302-fpz2jfuj	34	4	2020	2020	CD
cord-337302-fpz2jfuj	34	5	,	,	,
cord-337302-fpz2jfuj	34	6	the	the	DT
cord-337302-fpz2jfuj	34	7	genome	genome	NN
cord-337302-fpz2jfuj	34	8	sequence	sequence	NN
cord-337302-fpz2jfuj	34	9	of	of	IN
cord-337302-fpz2jfuj	34	10	virus	virus	NN
cord-337302-fpz2jfuj	34	11	was	be	VBD
cord-337302-fpz2jfuj	34	12	identified	identify	VBN
cord-337302-fpz2jfuj	34	13	by	by	IN
cord-337302-fpz2jfuj	34	14	the	the	DT
cord-337302-fpz2jfuj	34	15	Chinese	chinese	JJ
cord-337302-fpz2jfuj	34	16	scientists	scientist	NNS
cord-337302-fpz2jfuj	34	17	to	to	TO
cord-337302-fpz2jfuj	34	18	be	be	VB
cord-337302-fpz2jfuj	34	19	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	34	20	,	,	,
cord-337302-fpz2jfuj	34	21	which	which	WDT
cord-337302-fpz2jfuj	34	22	showed	show	VBD
cord-337302-fpz2jfuj	34	23	a	a	DT
cord-337302-fpz2jfuj	34	24	striking	striking	JJ
cord-337302-fpz2jfuj	34	25	similarity	similarity	NN
cord-337302-fpz2jfuj	34	26	of	of	IN
cord-337302-fpz2jfuj	34	27	>	>	$
cord-337302-fpz2jfuj	34	28	95	95	CD
cord-337302-fpz2jfuj	34	29	%	%	NN
cord-337302-fpz2jfuj	34	30	with	with	IN
cord-337302-fpz2jfuj	34	31	the	the	DT
cord-337302-fpz2jfuj	34	32	bat	bat	NN
cord-337302-fpz2jfuj	34	33	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	34	34	and	and	CC
cord-337302-fpz2jfuj	34	35	>	>	XX
cord-337302-fpz2jfuj	34	36	70	70	CD
cord-337302-fpz2jfuj	34	37	%	%	NN
cord-337302-fpz2jfuj	34	38	with	with	IN
cord-337302-fpz2jfuj	34	39	the	the	DT
cord-337302-fpz2jfuj	34	40	SARS	SARS	NNP
cord-337302-fpz2jfuj	34	41	-	-	HYPH
cord-337302-fpz2jfuj	34	42	CoV.	CoV.	NNP
cord-337302-fpz2jfuj	34	43	Samples	sample	NNS
cord-337302-fpz2jfuj	34	44	from	from	IN
cord-337302-fpz2jfuj	34	45	the	the	DT
cord-337302-fpz2jfuj	34	46	wet	wet	JJ
cord-337302-fpz2jfuj	34	47	market	market	NN
cord-337302-fpz2jfuj	34	48	tested	test	VBD
cord-337302-fpz2jfuj	34	49	positive	positive	JJ
cord-337302-fpz2jfuj	34	50	,	,	,
cord-337302-fpz2jfuj	34	51	confirming	confirm	VBG
cord-337302-fpz2jfuj	34	52	the	the	DT
cord-337302-fpz2jfuj	34	53	epicenter	epicenter	NN
cord-337302-fpz2jfuj	34	54	of	of	IN
cord-337302-fpz2jfuj	34	55	the	the	DT
cord-337302-fpz2jfuj	34	56	virus	virus	NN
cord-337302-fpz2jfuj	34	57	and	and	CC
cord-337302-fpz2jfuj	34	58	patient	patient	NN
cord-337302-fpz2jfuj	34	59	zero	zero	CD
cord-337302-fpz2jfuj	34	60	.	.	.
cord-337302-fpz2jfuj	35	1	10	10	CD
cord-337302-fpz2jfuj	36	1	Based	base	VBN
cord-337302-fpz2jfuj	36	2	on	on	IN
cord-337302-fpz2jfuj	36	3	this	this	DT
cord-337302-fpz2jfuj	36	4	,	,	,
cord-337302-fpz2jfuj	36	5	there	there	EX
cord-337302-fpz2jfuj	36	6	was	be	VBD
cord-337302-fpz2jfuj	36	7	clear	clear	JJ
cord-337302-fpz2jfuj	36	8	evidence	evidence	NN
cord-337302-fpz2jfuj	36	9	that	that	IN
cord-337302-fpz2jfuj	36	10	human	human	JJ
cord-337302-fpz2jfuj	36	11	-	-	HYPH
cord-337302-fpz2jfuj	36	12	tohuman	tohuman	NN
cord-337302-fpz2jfuj	36	13	transmission	transmission	NN
cord-337302-fpz2jfuj	36	14	was	be	VBD
cord-337302-fpz2jfuj	36	15	happening	happen	VBG
cord-337302-fpz2jfuj	36	16	among	among	IN
cord-337302-fpz2jfuj	36	17	close	close	JJ
cord-337302-fpz2jfuj	36	18	contacts	contact	NNS
cord-337302-fpz2jfuj	36	19	of	of	IN
cord-337302-fpz2jfuj	36	20	patient	patient	NN
cord-337302-fpz2jfuj	36	21	zero	zero	CD
cord-337302-fpz2jfuj	36	22	since	since	IN
cord-337302-fpz2jfuj	36	23	the	the	DT
cord-337302-fpz2jfuj	36	24	middle	middle	NN
cord-337302-fpz2jfuj	36	25	of	of	IN
cord-337302-fpz2jfuj	36	26	December	December	NNP
cord-337302-fpz2jfuj	36	27	2019	2019	CD
cord-337302-fpz2jfuj	36	28	.	.	.
cord-337302-fpz2jfuj	37	1	Concerted	concerted	JJ
cord-337302-fpz2jfuj	37	2	efforts	effort	NNS
cord-337302-fpz2jfuj	37	3	by	by	IN
cord-337302-fpz2jfuj	37	4	the	the	DT
cord-337302-fpz2jfuj	37	5	Chinese	chinese	JJ
cord-337302-fpz2jfuj	37	6	authorities	authority	NNS
cord-337302-fpz2jfuj	37	7	leading	lead	VBG
cord-337302-fpz2jfuj	37	8	up	up	IN
cord-337302-fpz2jfuj	37	9	to	to	IN
cord-337302-fpz2jfuj	37	10	the	the	DT
cord-337302-fpz2jfuj	37	11	total	total	JJ
cord-337302-fpz2jfuj	37	12	shutdown	shutdown	NN
cord-337302-fpz2jfuj	37	13	of	of	IN
cord-337302-fpz2jfuj	37	14	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	37	15	city	city	NN
cord-337302-fpz2jfuj	37	16	lead	lead	VB
cord-337302-fpz2jfuj	37	17	to	to	IN
cord-337302-fpz2jfuj	37	18	excellent	excellent	JJ
cord-337302-fpz2jfuj	37	19	control	control	NN
cord-337302-fpz2jfuj	37	20	of	of	IN
cord-337302-fpz2jfuj	37	21	transmission	transmission	NN
cord-337302-fpz2jfuj	37	22	in	in	IN
cord-337302-fpz2jfuj	37	23	China	China	NNP
cord-337302-fpz2jfuj	37	24	,	,	,
cord-337302-fpz2jfuj	37	25	albeit	albeit	IN
cord-337302-fpz2jfuj	37	26	with	with	IN
cord-337302-fpz2jfuj	37	27	over	over	IN
cord-337302-fpz2jfuj	37	28	3000	3000	CD
cord-337302-fpz2jfuj	37	29	deaths	death	NNS
cord-337302-fpz2jfuj	37	30	.	.	.
cord-337302-fpz2jfuj	38	1	11	11	CD
cord-337302-fpz2jfuj	39	1	The	the	DT
cord-337302-fpz2jfuj	39	2	decline	decline	NN
cord-337302-fpz2jfuj	39	3	in	in	IN
cord-337302-fpz2jfuj	39	4	the	the	DT
cord-337302-fpz2jfuj	39	5	number	number	NN
cord-337302-fpz2jfuj	39	6	of	of	IN
cord-337302-fpz2jfuj	39	7	cases	case	NNS
cord-337302-fpz2jfuj	39	8	in	in	IN
cord-337302-fpz2jfuj	39	9	China	China	NNP
cord-337302-fpz2jfuj	39	10	depicts	depict	VBZ
cord-337302-fpz2jfuj	39	11	,	,	,
cord-337302-fpz2jfuj	39	12	strict	strict	JJ
cord-337302-fpz2jfuj	39	13	public	public	JJ
cord-337302-fpz2jfuj	39	14	health	health	NN
cord-337302-fpz2jfuj	39	15	measures	measure	NNS
cord-337302-fpz2jfuj	39	16	can	can	MD
cord-337302-fpz2jfuj	39	17	be	be	VB
cord-337302-fpz2jfuj	39	18	successful	successful	JJ
cord-337302-fpz2jfuj	39	19	in	in	IN
cord-337302-fpz2jfuj	39	20	containing	contain	VBG
cord-337302-fpz2jfuj	39	21	epidemics	epidemic	NNS
cord-337302-fpz2jfuj	39	22	.	.	.
cord-337302-fpz2jfuj	40	1	1	1	CD
cord-337302-fpz2jfuj	40	2	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	40	3	patients	patient	NNS
cord-337302-fpz2jfuj	40	4	are	be	VBP
cord-337302-fpz2jfuj	40	5	caught	catch	VBN
cord-337302-fpz2jfuj	40	6	on	on	IN
cord-337302-fpz2jfuj	40	7	the	the	DT
cord-337302-fpz2jfuj	40	8	crossfire	crossfire	NN
cord-337302-fpz2jfuj	40	9	of	of	IN
cord-337302-fpz2jfuj	40	10	this	this	DT
cord-337302-fpz2jfuj	40	11	pandemic	pandemic	NN
cord-337302-fpz2jfuj	40	12	as	as	IN
cord-337302-fpz2jfuj	40	13	a	a	DT
cord-337302-fpz2jfuj	40	14	unique	unique	JJ
cord-337302-fpz2jfuj	40	15	group	group	NN
cord-337302-fpz2jfuj	40	16	with	with	IN
cord-337302-fpz2jfuj	40	17	increased	increase	VBN
cord-337302-fpz2jfuj	40	18	risks	risk	NNS
cord-337302-fpz2jfuj	40	19	of	of	IN
cord-337302-fpz2jfuj	40	20	contracting	contracting	NN
cord-337302-fpz2jfuj	40	21	COVID-19	covid-19	NN
cord-337302-fpz2jfuj	40	22	.	.	.
cord-337302-fpz2jfuj	41	1	Their	-PRON-	PRP$
cord-337302-fpz2jfuj	41	2	weakened	weaken	VBN
cord-337302-fpz2jfuj	41	3	immunity	immunity	NN
cord-337302-fpz2jfuj	41	4	is	be	VBZ
cord-337302-fpz2jfuj	41	5	resulting	result	VBG
cord-337302-fpz2jfuj	41	6	from	from	IN
cord-337302-fpz2jfuj	41	7	a	a	DT
cord-337302-fpz2jfuj	41	8	myriad	myriad	NN
cord-337302-fpz2jfuj	41	9	of	of	IN
cord-337302-fpz2jfuj	41	10	factors	factor	NNS
cord-337302-fpz2jfuj	41	11	including	include	VBG
cord-337302-fpz2jfuj	41	12	underlying	underlie	VBG
cord-337302-fpz2jfuj	41	13	malignancy	malignancy	NN
cord-337302-fpz2jfuj	41	14	burden	burden	NN
cord-337302-fpz2jfuj	41	15	and	and	CC
cord-337302-fpz2jfuj	41	16	active	active	JJ
cord-337302-fpz2jfuj	41	17	cancer	cancer	NN
cord-337302-fpz2jfuj	41	18	treatments	treatment	NNS
cord-337302-fpz2jfuj	41	19	like	like	IN
cord-337302-fpz2jfuj	41	20	cytotoxic	cytotoxic	JJ
cord-337302-fpz2jfuj	41	21	chemotherapy	chemotherapy	NN
cord-337302-fpz2jfuj	41	22	,	,	,
cord-337302-fpz2jfuj	41	23	radiotherapy	radiotherapy	NN
cord-337302-fpz2jfuj	41	24	,	,	,
cord-337302-fpz2jfuj	41	25	or	or	CC
cord-337302-fpz2jfuj	41	26	even	even	RB
cord-337302-fpz2jfuj	41	27	due	due	JJ
cord-337302-fpz2jfuj	41	28	to	to	IN
cord-337302-fpz2jfuj	41	29	patients	patient	NNS
cord-337302-fpz2jfuj	41	30	undergoing	undergo	VBG
cord-337302-fpz2jfuj	41	31	transplant	transplant	NN
cord-337302-fpz2jfuj	41	32	and	and	CC
cord-337302-fpz2jfuj	41	33	use	use	NN
cord-337302-fpz2jfuj	41	34	of	of	IN
cord-337302-fpz2jfuj	41	35	immunosuppressants	immunosuppressant	NNS
cord-337302-fpz2jfuj	41	36	to	to	TO
cord-337302-fpz2jfuj	41	37	avoid	avoid	VB
cord-337302-fpz2jfuj	41	38	rejection	rejection	NN
cord-337302-fpz2jfuj	41	39	.	.	.
cord-337302-fpz2jfuj	42	1	12	12	CD
cord-337302-fpz2jfuj	43	1	However	however	RB
cord-337302-fpz2jfuj	43	2	,	,	,
cord-337302-fpz2jfuj	43	3	recent	recent	JJ
cord-337302-fpz2jfuj	43	4	evidence	evidence	NN
cord-337302-fpz2jfuj	43	5	shows	show	VBZ
cord-337302-fpz2jfuj	43	6	that	that	IN
cord-337302-fpz2jfuj	43	7	mortality	mortality	NN
cord-337302-fpz2jfuj	43	8	in	in	IN
cord-337302-fpz2jfuj	43	9	cancer	cancer	NN
cord-337302-fpz2jfuj	43	10	patients	patient	NNS
cord-337302-fpz2jfuj	43	11	from	from	IN
cord-337302-fpz2jfuj	43	12	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	43	13	is	be	VBZ
cord-337302-fpz2jfuj	43	14	mainly	mainly	RB
cord-337302-fpz2jfuj	43	15	driven	drive	VBN
cord-337302-fpz2jfuj	43	16	by	by	IN
cord-337302-fpz2jfuj	43	17	old	old	JJ
cord-337302-fpz2jfuj	43	18	age	age	NN
cord-337302-fpz2jfuj	43	19	and	and	CC
cord-337302-fpz2jfuj	43	20	comorbidities	comorbiditie	NNS
cord-337302-fpz2jfuj	43	21	and	and	CC
cord-337302-fpz2jfuj	43	22	less	less	RBR
cord-337302-fpz2jfuj	43	23	likely	likely	JJ
cord-337302-fpz2jfuj	43	24	by	by	IN
cord-337302-fpz2jfuj	43	25	the	the	DT
cord-337302-fpz2jfuj	43	26	use	use	NN
cord-337302-fpz2jfuj	43	27	of	of	IN
cord-337302-fpz2jfuj	43	28	cytotoxic	cytotoxic	JJ
cord-337302-fpz2jfuj	43	29	drugs	drug	NNS
cord-337302-fpz2jfuj	43	30	.	.	.
cord-337302-fpz2jfuj	44	1	13	13	CD
cord-337302-fpz2jfuj	44	2	Risk	risk	NN
cord-337302-fpz2jfuj	44	3	-	-	HYPH
cord-337302-fpz2jfuj	44	4	adjusted	adjust	VBN
cord-337302-fpz2jfuj	44	5	models	model	NNS
cord-337302-fpz2jfuj	44	6	show	show	VBP
cord-337302-fpz2jfuj	44	7	that	that	IN
cord-337302-fpz2jfuj	44	8	most	most	JJS
cord-337302-fpz2jfuj	44	9	cancer	cancer	NN
cord-337302-fpz2jfuj	44	10	patients	patient	NNS
cord-337302-fpz2jfuj	44	11	have	have	VBP
cord-337302-fpz2jfuj	44	12	a	a	DT
cord-337302-fpz2jfuj	44	13	2528	2528	CD
cord-337302-fpz2jfuj	44	14	%	%	NN
cord-337302-fpz2jfuj	44	15	percent	percent	NN
cord-337302-fpz2jfuj	44	16	mortality	mortality	NN
cord-337302-fpz2jfuj	44	17	risk	risk	NN
cord-337302-fpz2jfuj	44	18	if	if	IN
cord-337302-fpz2jfuj	44	19	infected	infect	VBN
cord-337302-fpz2jfuj	44	20	with	with	IN
cord-337302-fpz2jfuj	44	21	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	44	22	.	.	.
cord-337302-fpz2jfuj	45	1	14	14	CD
cord-337302-fpz2jfuj	46	1	Also	also	RB
cord-337302-fpz2jfuj	46	2	,	,	,
cord-337302-fpz2jfuj	46	3	most	most	JJS
cord-337302-fpz2jfuj	46	4	cancer	cancer	NN
cord-337302-fpz2jfuj	46	5	patients	patient	NNS
cord-337302-fpz2jfuj	46	6	are	be	VBP
cord-337302-fpz2jfuj	46	7	frail	frail	JJ
cord-337302-fpz2jfuj	46	8	and	and	CC
cord-337302-fpz2jfuj	46	9	of	of	IN
cord-337302-fpz2jfuj	46	10	older	old	JJR
cord-337302-fpz2jfuj	46	11	age	age	NN
cord-337302-fpz2jfuj	46	12	with	with	IN
cord-337302-fpz2jfuj	46	13	comorbidities	comorbiditie	NNS
cord-337302-fpz2jfuj	46	14	compared	compare	VBN
cord-337302-fpz2jfuj	46	15	to	to	IN
cord-337302-fpz2jfuj	46	16	the	the	DT
cord-337302-fpz2jfuj	46	17	healthy	healthy	JJ
cord-337302-fpz2jfuj	46	18	population	population	NN
cord-337302-fpz2jfuj	46	19	;	;	:
cord-337302-fpz2jfuj	46	20	hence	hence	RB
cord-337302-fpz2jfuj	46	21	they	-PRON-	PRP
cord-337302-fpz2jfuj	46	22	tend	tend	VBP
cord-337302-fpz2jfuj	46	23	to	to	TO
cord-337302-fpz2jfuj	46	24	have	have	VB
cord-337302-fpz2jfuj	46	25	poor	poor	JJ
cord-337302-fpz2jfuj	46	26	outcomes	outcome	NNS
cord-337302-fpz2jfuj	46	27	.	.	.
cord-337302-fpz2jfuj	47	1	15	15	CD
cord-337302-fpz2jfuj	48	1	This	this	DT
cord-337302-fpz2jfuj	48	2	pandemic	pandemic	NN
cord-337302-fpz2jfuj	48	3	has	have	VBZ
cord-337302-fpz2jfuj	48	4	caused	cause	VBN
cord-337302-fpz2jfuj	48	5	a	a	DT
cord-337302-fpz2jfuj	48	6	huge	huge	JJ
cord-337302-fpz2jfuj	48	7	,	,	,
cord-337302-fpz2jfuj	48	8	unprecedented	unprecedented	JJ
cord-337302-fpz2jfuj	48	9	impact	impact	NN
cord-337302-fpz2jfuj	48	10	on	on	IN
cord-337302-fpz2jfuj	48	11	cancer	cancer	NN
cord-337302-fpz2jfuj	48	12	patients	patient	NNS
cord-337302-fpz2jfuj	48	13	'	'	POS
cord-337302-fpz2jfuj	48	14	care	care	NN
cord-337302-fpz2jfuj	48	15	continuum	continuum	NN
cord-337302-fpz2jfuj	48	16	in	in	IN
cord-337302-fpz2jfuj	48	17	terms	term	NNS
cord-337302-fpz2jfuj	48	18	of	of	IN
cord-337302-fpz2jfuj	48	19	diagnosis	diagnosis	NN
cord-337302-fpz2jfuj	48	20	,	,	,
cord-337302-fpz2jfuj	48	21	treatment	treatment	NN
cord-337302-fpz2jfuj	48	22	schedules	schedule	NNS
cord-337302-fpz2jfuj	48	23	,	,	,
cord-337302-fpz2jfuj	48	24	and	and	CC
cord-337302-fpz2jfuj	48	25	follow	follow	VB
cord-337302-fpz2jfuj	48	26	up	up	RP
cord-337302-fpz2jfuj	48	27	visits	visit	NNS
cord-337302-fpz2jfuj	48	28	.	.	.
cord-337302-fpz2jfuj	49	1	New	new	JJ
cord-337302-fpz2jfuj	49	2	and	and	CC
cord-337302-fpz2jfuj	49	3	old	old	JJ
cord-337302-fpz2jfuj	49	4	patients	patient	NNS
cord-337302-fpz2jfuj	49	5	are	be	VBP
cord-337302-fpz2jfuj	49	6	losing	lose	VBG
cord-337302-fpz2jfuj	49	7	valuable	valuable	JJ
cord-337302-fpz2jfuj	49	8	clinic	clinic	NN
cord-337302-fpz2jfuj	49	9	visits	visit	NNS
cord-337302-fpz2jfuj	49	10	due	due	JJ
cord-337302-fpz2jfuj	49	11	to	to	IN
cord-337302-fpz2jfuj	49	12	quarantine	quarantine	NN
cord-337302-fpz2jfuj	49	13	.	.	.
cord-337302-fpz2jfuj	50	1	Likewise	likewise	RB
cord-337302-fpz2jfuj	50	2	,	,	,
cord-337302-fpz2jfuj	50	3	new	new	JJ
cord-337302-fpz2jfuj	50	4	patients	patient	NNS
cord-337302-fpz2jfuj	50	5	could	could	MD
cord-337302-fpz2jfuj	50	6	potentially	potentially	RB
cord-337302-fpz2jfuj	50	7	miss	miss	VB
cord-337302-fpz2jfuj	50	8	early	early	JJ
cord-337302-fpz2jfuj	50	9	diagnosis	diagnosis	NN
cord-337302-fpz2jfuj	50	10	opportunities	opportunity	NNS
cord-337302-fpz2jfuj	50	11	and	and	CC
cord-337302-fpz2jfuj	50	12	patients	patient	NNS
cord-337302-fpz2jfuj	50	13	with	with	IN
cord-337302-fpz2jfuj	50	14	advanced	advanced	JJ
cord-337302-fpz2jfuj	50	15	cancer	cancer	NN
cord-337302-fpz2jfuj	50	16	experience	experience	NN
cord-337302-fpz2jfuj	50	17	delays	delay	NNS
cord-337302-fpz2jfuj	50	18	or	or	CC
cord-337302-fpz2jfuj	50	19	interruptions	interruption	NNS
cord-337302-fpz2jfuj	50	20	of	of	IN
cord-337302-fpz2jfuj	50	21	their	-PRON-	PRP$
cord-337302-fpz2jfuj	50	22	routine	routine	JJ
cord-337302-fpz2jfuj	50	23	treatment	treatment	NN
cord-337302-fpz2jfuj	50	24	leading	lead	VBG
cord-337302-fpz2jfuj	50	25	to	to	IN
cord-337302-fpz2jfuj	50	26	risks	risk	NNS
cord-337302-fpz2jfuj	50	27	of	of	IN
cord-337302-fpz2jfuj	50	28	disease	disease	NN
cord-337302-fpz2jfuj	50	29	progression	progression	NN
cord-337302-fpz2jfuj	50	30	.	.	.
cord-337302-fpz2jfuj	51	1	16	16	CD
cord-337302-fpz2jfuj	52	1	Additionally	additionally	RB
cord-337302-fpz2jfuj	52	2	,	,	,
cord-337302-fpz2jfuj	52	3	patients	patient	NNS
cord-337302-fpz2jfuj	52	4	who	who	WP
cord-337302-fpz2jfuj	52	5	develop	develop	VBP
cord-337302-fpz2jfuj	52	6	adverse	adverse	JJ
cord-337302-fpz2jfuj	52	7	side	side	NN
cord-337302-fpz2jfuj	52	8	-	-	HYPH
cord-337302-fpz2jfuj	52	9	effects	effect	NNS
cord-337302-fpz2jfuj	52	10	from	from	IN
cord-337302-fpz2jfuj	52	11	cancer	cancer	NN
cord-337302-fpz2jfuj	52	12	treatments	treatment	NNS
cord-337302-fpz2jfuj	52	13	could	could	MD
cord-337302-fpz2jfuj	52	14	lose	lose	VB
cord-337302-fpz2jfuj	52	15	valuable	valuable	JJ
cord-337302-fpz2jfuj	52	16	time	time	NN
cord-337302-fpz2jfuj	52	17	to	to	TO
cord-337302-fpz2jfuj	52	18	come	come	VB
cord-337302-fpz2jfuj	52	19	in	in	RP
cord-337302-fpz2jfuj	52	20	for	for	IN
cord-337302-fpz2jfuj	52	21	an	an	DT
cord-337302-fpz2jfuj	52	22	intervention	intervention	NN
cord-337302-fpz2jfuj	52	23	.	.	.
cord-337302-fpz2jfuj	53	1	These	these	DT
cord-337302-fpz2jfuj	53	2	include	include	VBP
cord-337302-fpz2jfuj	53	3	;	;	:
cord-337302-fpz2jfuj	53	4	immunotherapy	immunotherapy	NN
cord-337302-fpz2jfuj	53	5	related	relate	VBD
cord-337302-fpz2jfuj	53	6	adverse	adverse	JJ
cord-337302-fpz2jfuj	53	7	effects	effect	NNS
cord-337302-fpz2jfuj	53	8	,	,	,
cord-337302-fpz2jfuj	53	9	tumor	tumor	NN
cord-337302-fpz2jfuj	53	10	lysis	lysis	NN
cord-337302-fpz2jfuj	53	11	syndromes	syndrome	NNS
cord-337302-fpz2jfuj	53	12	,	,	,
cord-337302-fpz2jfuj	53	13	differentiation	differentiation	NN
cord-337302-fpz2jfuj	53	14	syndromes	syndrome	NNS
cord-337302-fpz2jfuj	53	15	,	,	,
cord-337302-fpz2jfuj	53	16	and	and	CC
cord-337302-fpz2jfuj	53	17	other	other	JJ
cord-337302-fpz2jfuj	53	18	severe	severe	JJ
cord-337302-fpz2jfuj	53	19	treatment	treatment	NN
cord-337302-fpz2jfuj	53	20	-	-	HYPH
cord-337302-fpz2jfuj	53	21	related	relate	VBN
cord-337302-fpz2jfuj	53	22	events	event	NNS
cord-337302-fpz2jfuj	53	23	.	.	.
cord-337302-fpz2jfuj	54	1	Also	also	RB
cord-337302-fpz2jfuj	54	2	critical	critical	JJ
cord-337302-fpz2jfuj	54	3	is	be	VBZ
cord-337302-fpz2jfuj	54	4	oncological	oncological	JJ
cord-337302-fpz2jfuj	54	5	emergencies	emergency	NNS
cord-337302-fpz2jfuj	54	6	commonly	commonly	RB
cord-337302-fpz2jfuj	54	7	seen	see	VBN
cord-337302-fpz2jfuj	54	8	,	,	,
cord-337302-fpz2jfuj	54	9	such	such	JJ
cord-337302-fpz2jfuj	54	10	as	as	IN
cord-337302-fpz2jfuj	54	11	;	;	:
cord-337302-fpz2jfuj	54	12	spinal	spinal	JJ
cord-337302-fpz2jfuj	54	13	cord	cord	NN
cord-337302-fpz2jfuj	54	14	compression	compression	NN
cord-337302-fpz2jfuj	54	15	,	,	,
cord-337302-fpz2jfuj	54	16	need	need	VBP
cord-337302-fpz2jfuj	54	17	for	for	IN
cord-337302-fpz2jfuj	54	18	acute	acute	JJ
cord-337302-fpz2jfuj	54	19	pain	pain	NN
cord-337302-fpz2jfuj	54	20	relief	relief	NN
cord-337302-fpz2jfuj	54	21	,	,	,
cord-337302-fpz2jfuj	54	22	electrolyte	electrolyte	JJ
cord-337302-fpz2jfuj	54	23	imbalances	imbalance	NNS
cord-337302-fpz2jfuj	54	24	,	,	,
cord-337302-fpz2jfuj	54	25	need	need	VBP
cord-337302-fpz2jfuj	54	26	for	for	IN
cord-337302-fpz2jfuj	54	27	blood	blood	NN
cord-337302-fpz2jfuj	54	28	transfusions	transfusion	NNS
cord-337302-fpz2jfuj	54	29	,	,	,
cord-337302-fpz2jfuj	54	30	febrile	febrile	JJ
cord-337302-fpz2jfuj	54	31	neutropenia	neutropenia	NN
cord-337302-fpz2jfuj	54	32	,	,	,
cord-337302-fpz2jfuj	54	33	among	among	IN
cord-337302-fpz2jfuj	54	34	other	other	JJ
cord-337302-fpz2jfuj	54	35	sudden	sudden	JJ
cord-337302-fpz2jfuj	54	36	detrimental	detrimental	JJ
cord-337302-fpz2jfuj	54	37	events	event	NNS
cord-337302-fpz2jfuj	54	38	.	.	.
cord-337302-fpz2jfuj	55	1	Moreover	moreover	RB
cord-337302-fpz2jfuj	55	2	,	,	,
cord-337302-fpz2jfuj	55	3	distraction	distraction	NN
cord-337302-fpz2jfuj	55	4	effects	effect	NNS
cord-337302-fpz2jfuj	55	5	that	that	WDT
cord-337302-fpz2jfuj	55	6	involve	involve	VBP
cord-337302-fpz2jfuj	55	7	diverting	divert	VBG
cord-337302-fpz2jfuj	55	8	attention	attention	NN
cord-337302-fpz2jfuj	55	9	to	to	IN
cord-337302-fpz2jfuj	55	10	the	the	DT
cord-337302-fpz2jfuj	55	11	pandemic	pandemic	NN
cord-337302-fpz2jfuj	55	12	as	as	IN
cord-337302-fpz2jfuj	55	13	compared	compare	VBN
cord-337302-fpz2jfuj	55	14	to	to	IN
cord-337302-fpz2jfuj	55	15	cancer	cancer	NN
cord-337302-fpz2jfuj	55	16	patients	patient	NNS
cord-337302-fpz2jfuj	55	17	cause	cause	VBP
cord-337302-fpz2jfuj	55	18	collateral	collateral	JJ
cord-337302-fpz2jfuj	55	19	loss	loss	NN
cord-337302-fpz2jfuj	55	20	and	and	CC
cord-337302-fpz2jfuj	55	21	unfavorable	unfavorable	JJ
cord-337302-fpz2jfuj	55	22	outcomes	outcome	NNS
cord-337302-fpz2jfuj	55	23	in	in	IN
cord-337302-fpz2jfuj	55	24	oncology	oncology	NN
cord-337302-fpz2jfuj	55	25	care	care	NN
cord-337302-fpz2jfuj	55	26	.	.	.
cord-337302-fpz2jfuj	56	1	Instances	instance	NNS
cord-337302-fpz2jfuj	56	2	,	,	,
cord-337302-fpz2jfuj	56	3	where	where	WRB
cord-337302-fpz2jfuj	56	4	even	even	RB
cord-337302-fpz2jfuj	56	5	oncology	oncology	NN
cord-337302-fpz2jfuj	56	6	care	care	NN
cord-337302-fpz2jfuj	56	7	clinicians	clinician	NNS
cord-337302-fpz2jfuj	56	8	are	be	VBP
cord-337302-fpz2jfuj	56	9	in	in	IN
cord-337302-fpz2jfuj	56	10	the	the	DT
cord-337302-fpz2jfuj	56	11	frontlines	frontline	NNS
cord-337302-fpz2jfuj	56	12	to	to	TO
cord-337302-fpz2jfuj	56	13	care	care	VB
cord-337302-fpz2jfuj	56	14	for	for	IN
cord-337302-fpz2jfuj	56	15	COVID	COVID	NNP
cord-337302-fpz2jfuj	56	16	−19	−19	NNP
cord-337302-fpz2jfuj	56	17	patients	patient	NNS
cord-337302-fpz2jfuj	56	18	,	,	,
cord-337302-fpz2jfuj	56	19	are	be	VBP
cord-337302-fpz2jfuj	56	20	reported	report	VBN
cord-337302-fpz2jfuj	56	21	in	in	IN
cord-337302-fpz2jfuj	56	22	many	many	JJ
cord-337302-fpz2jfuj	56	23	institutions	institution	NNS
cord-337302-fpz2jfuj	56	24	due	due	JJ
cord-337302-fpz2jfuj	56	25	to	to	IN
cord-337302-fpz2jfuj	56	26	shortages	shortage	NNS
cord-337302-fpz2jfuj	56	27	of	of	IN
cord-337302-fpz2jfuj	56	28	staff	staff	NN
cord-337302-fpz2jfuj	56	29	.	.	.
cord-337302-fpz2jfuj	57	1	17	17	CD
cord-337302-fpz2jfuj	58	1	In	in	IN
cord-337302-fpz2jfuj	58	2	the	the	DT
cord-337302-fpz2jfuj	58	3	middle	middle	NN
cord-337302-fpz2jfuj	58	4	-	-	HYPH
cord-337302-fpz2jfuj	58	5	and	and	CC
cord-337302-fpz2jfuj	58	6	low	low	JJ
cord-337302-fpz2jfuj	58	7	-	-	HYPH
cord-337302-fpz2jfuj	58	8	income	income	NN
cord-337302-fpz2jfuj	58	9	countries	country	NNS
cord-337302-fpz2jfuj	58	10	with	with	IN
cord-337302-fpz2jfuj	58	11	the	the	DT
cord-337302-fpz2jfuj	58	12	ailing	ailing	JJ
cord-337302-fpz2jfuj	58	13	healthcare	healthcare	NN
cord-337302-fpz2jfuj	58	14	system	system	NN
cord-337302-fpz2jfuj	58	15	and	and	CC
cord-337302-fpz2jfuj	58	16	sub	sub	JJ
cord-337302-fpz2jfuj	58	17	-	-	JJ
cord-337302-fpz2jfuj	58	18	optimal	optimal	JJ
cord-337302-fpz2jfuj	58	19	oncology	oncology	NN
cord-337302-fpz2jfuj	58	20	care	care	NN
cord-337302-fpz2jfuj	58	21	,	,	,
cord-337302-fpz2jfuj	58	22	these	these	DT
cord-337302-fpz2jfuj	58	23	distraction	distraction	NN
cord-337302-fpz2jfuj	58	24	effects	effect	NNS
cord-337302-fpz2jfuj	58	25	are	be	VBP
cord-337302-fpz2jfuj	58	26	far	far	RB
cord-337302-fpz2jfuj	58	27	worse	bad	JJR
cord-337302-fpz2jfuj	58	28	.	.	.
cord-337302-fpz2jfuj	59	1	18	18	CD
cord-337302-fpz2jfuj	60	1	The	the	DT
cord-337302-fpz2jfuj	60	2	inability	inability	NN
cord-337302-fpz2jfuj	60	3	to	to	TO
cord-337302-fpz2jfuj	60	4	deliver	deliver	VB
cord-337302-fpz2jfuj	60	5	palliative	palliative	JJ
cord-337302-fpz2jfuj	60	6	care	care	NN
cord-337302-fpz2jfuj	60	7	or	or	CC
cord-337302-fpz2jfuj	60	8	primary	primary	JJ
cord-337302-fpz2jfuj	60	9	palliative	palliative	JJ
cord-337302-fpz2jfuj	60	10	care	care	NN
cord-337302-fpz2jfuj	60	11	to	to	IN
cord-337302-fpz2jfuj	60	12	patients	patient	NNS
cord-337302-fpz2jfuj	60	13	is	be	VBZ
cord-337302-fpz2jfuj	60	14	another	another	DT
cord-337302-fpz2jfuj	60	15	significant	significant	JJ
cord-337302-fpz2jfuj	60	16	concern	concern	NN
cord-337302-fpz2jfuj	60	17	due	due	JJ
cord-337302-fpz2jfuj	60	18	to	to	IN
cord-337302-fpz2jfuj	60	19	forced	force	VBN
cord-337302-fpz2jfuj	60	20	quarantine	quarantine	NN
cord-337302-fpz2jfuj	60	21	.	.	.
cord-337302-fpz2jfuj	61	1	19	19	CD
cord-337302-fpz2jfuj	61	2	There	there	EX
cord-337302-fpz2jfuj	61	3	could	could	MD
cord-337302-fpz2jfuj	61	4	be	be	VB
cord-337302-fpz2jfuj	61	5	a	a	DT
cord-337302-fpz2jfuj	61	6	double	double	JJ
cord-337302-fpz2jfuj	61	7	wave	wave	NN
cord-337302-fpz2jfuj	61	8	of	of	IN
cord-337302-fpz2jfuj	61	9	cancer	cancer	NN
cord-337302-fpz2jfuj	61	10	patients	patient	NNS
cord-337302-fpz2jfuj	61	11	'	'	POS
cord-337302-fpz2jfuj	61	12	deaths	death	NNS
cord-337302-fpz2jfuj	61	13	:	:	:
cord-337302-fpz2jfuj	61	14	a	a	DT
cord-337302-fpz2jfuj	61	15	surge	surge	NN
cord-337302-fpz2jfuj	61	16	in	in	IN
cord-337302-fpz2jfuj	61	17	immunocompromised	immunocompromised	JJ
cord-337302-fpz2jfuj	61	18	patients	patient	NNS
cord-337302-fpz2jfuj	61	19	who	who	WP
cord-337302-fpz2jfuj	61	20	contract	contract	VBP
cord-337302-fpz2jfuj	61	21	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	61	22	or	or	CC
cord-337302-fpz2jfuj	61	23	those	those	DT
cord-337302-fpz2jfuj	61	24	whose	whose	WP$
cord-337302-fpz2jfuj	61	25	treatments	treatment	NNS
cord-337302-fpz2jfuj	61	26	were	be	VBD
cord-337302-fpz2jfuj	61	27	deescalated	deescalate	VBN
cord-337302-fpz2jfuj	61	28	,	,	,
cord-337302-fpz2jfuj	61	29	canceled	cancel	VBN
cord-337302-fpz2jfuj	61	30	,	,	,
cord-337302-fpz2jfuj	61	31	or	or	CC
cord-337302-fpz2jfuj	61	32	delayed	delay	VBN
cord-337302-fpz2jfuj	61	33	.	.	.
cord-337302-fpz2jfuj	62	1	As	as	IN
cord-337302-fpz2jfuj	62	2	one	one	CD
cord-337302-fpz2jfuj	62	3	medical	medical	JJ
cord-337302-fpz2jfuj	62	4	oncologist	oncologist	NN
cord-337302-fpz2jfuj	62	5	described	describe	VBN
cord-337302-fpz2jfuj	62	6	in	in	IN
cord-337302-fpz2jfuj	62	7	a	a	DT
cord-337302-fpz2jfuj	62	8	perspective	perspective	NN
cord-337302-fpz2jfuj	62	9	article	article	NN
cord-337302-fpz2jfuj	62	10	:	:	:
cord-337302-fpz2jfuj	62	11	"	"	``
cord-337302-fpz2jfuj	62	12	to	to	TO
cord-337302-fpz2jfuj	62	13	survive	survive	VB
cord-337302-fpz2jfuj	62	14	SARS	SARS	NNP
cord-337302-fpz2jfuj	62	15	-	-	HYPH
cord-337302-fpz2jfuj	62	16	CoV	CoV	NNP
cord-337302-fpz2jfuj	62	17	-2	-2	NN
cord-337302-fpz2jfuj	62	18	only	only	RB
cord-337302-fpz2jfuj	62	19	to	to	TO
cord-337302-fpz2jfuj	62	20	then	then	RB
cord-337302-fpz2jfuj	62	21	succumb	succumb	VB
cord-337302-fpz2jfuj	62	22	to	to	IN
cord-337302-fpz2jfuj	62	23	an	an	DT
cord-337302-fpz2jfuj	62	24	undertreated	undertreated	JJ
cord-337302-fpz2jfuj	62	25	cancer	cancer	NN
cord-337302-fpz2jfuj	62	26	would	would	MD
cord-337302-fpz2jfuj	62	27	be	be	VB
cord-337302-fpz2jfuj	62	28	a	a	DT
cord-337302-fpz2jfuj	62	29	Pyrrhic	pyrrhic	JJ
cord-337302-fpz2jfuj	62	30	victory	victory	NN
cord-337302-fpz2jfuj	62	31	"	"	''
cord-337302-fpz2jfuj	62	32	.	.	.
cord-337302-fpz2jfuj	63	1	20	20	CD
cord-337302-fpz2jfuj	64	1	This	this	DT
cord-337302-fpz2jfuj	64	2	article	article	NN
cord-337302-fpz2jfuj	64	3	gives	give	VBZ
cord-337302-fpz2jfuj	64	4	an	an	DT
cord-337302-fpz2jfuj	64	5	overview	overview	NN
cord-337302-fpz2jfuj	64	6	of	of	IN
cord-337302-fpz2jfuj	64	7	the	the	DT
cord-337302-fpz2jfuj	64	8	prevalence	prevalence	NN
cord-337302-fpz2jfuj	64	9	and	and	CC
cord-337302-fpz2jfuj	64	10	impacts	impact	NNS
cord-337302-fpz2jfuj	64	11	of	of	IN
cord-337302-fpz2jfuj	64	12	COVID-19	covid-19	CD
cord-337302-fpz2jfuj	64	13	in	in	IN
cord-337302-fpz2jfuj	64	14	cancer	cancer	NN
cord-337302-fpz2jfuj	64	15	patients	patient	NNS
cord-337302-fpz2jfuj	64	16	and	and	CC
cord-337302-fpz2jfuj	64	17	institutional	institutional	JJ
cord-337302-fpz2jfuj	64	18	recommendations	recommendation	NNS
cord-337302-fpz2jfuj	64	19	put	put	VBN
cord-337302-fpz2jfuj	64	20	in	in	IN
cord-337302-fpz2jfuj	64	21	place	place	NN
cord-337302-fpz2jfuj	64	22	to	to	TO
cord-337302-fpz2jfuj	64	23	mitigate	mitigate	VB
cord-337302-fpz2jfuj	64	24	the	the	DT
cord-337302-fpz2jfuj	64	25	virus	virus	NN
cord-337302-fpz2jfuj	64	26	in	in	IN
cord-337302-fpz2jfuj	64	27	this	this	DT
cord-337302-fpz2jfuj	64	28	patient	patient	JJ
cord-337302-fpz2jfuj	64	29	population	population	NN
cord-337302-fpz2jfuj	64	30	.	.	.
cord-337302-fpz2jfuj	65	1	We	-PRON-	PRP
cord-337302-fpz2jfuj	65	2	also	also	RB
cord-337302-fpz2jfuj	65	3	briefly	briefly	RB
cord-337302-fpz2jfuj	65	4	share	share	VB
cord-337302-fpz2jfuj	65	5	our	-PRON-	PRP$
cord-337302-fpz2jfuj	65	6	proposed	propose	VBN
cord-337302-fpz2jfuj	65	7	organizational	organizational	JJ
cord-337302-fpz2jfuj	65	8	model	model	NN
cord-337302-fpz2jfuj	65	9	in	in	IN
cord-337302-fpz2jfuj	65	10	our	-PRON-	PRP$
cord-337302-fpz2jfuj	65	11	institution	institution	NN
cord-337302-fpz2jfuj	65	12	on	on	IN
cord-337302-fpz2jfuj	65	13	the	the	DT
cord-337302-fpz2jfuj	65	14	measures	measure	NNS
cord-337302-fpz2jfuj	65	15	taken	take	VBN
cord-337302-fpz2jfuj	65	16	to	to	TO
cord-337302-fpz2jfuj	65	17	protect	protect	VB
cord-337302-fpz2jfuj	65	18	cancer	cancer	NN
cord-337302-fpz2jfuj	65	19	patients	patient	NNS
cord-337302-fpz2jfuj	65	20	.	.	.
cord-337302-fpz2jfuj	66	1	The	the	DT
cord-337302-fpz2jfuj	66	2	spread	spread	NN
cord-337302-fpz2jfuj	66	3	of	of	IN
cord-337302-fpz2jfuj	66	4	the	the	DT
cord-337302-fpz2jfuj	66	5	disease	disease	NN
cord-337302-fpz2jfuj	66	6	is	be	VBZ
cord-337302-fpz2jfuj	66	7	exponential	exponential	JJ
cord-337302-fpz2jfuj	66	8	in	in	IN
cord-337302-fpz2jfuj	66	9	immunocompromised	immunocompromised	JJ
cord-337302-fpz2jfuj	66	10	populations	population	NNS
cord-337302-fpz2jfuj	66	11	like	like	IN
cord-337302-fpz2jfuj	66	12	cancer	cancer	NN
cord-337302-fpz2jfuj	66	13	patients	patient	NNS
cord-337302-fpz2jfuj	66	14	during	during	IN
cord-337302-fpz2jfuj	66	15	outbreaks	outbreak	NNS
cord-337302-fpz2jfuj	66	16	,	,	,
cord-337302-fpz2jfuj	66	17	and	and	CC
cord-337302-fpz2jfuj	66	18	eventually	eventually	RB
cord-337302-fpz2jfuj	66	19	,	,	,
cord-337302-fpz2jfuj	66	20	immunity	immunity	NN
cord-337302-fpz2jfuj	66	21	limits	limit	VBZ
cord-337302-fpz2jfuj	66	22	transmission	transmission	NN
cord-337302-fpz2jfuj	66	23	.	.	.
cord-337302-fpz2jfuj	67	1	21	21	CD
cord-337302-fpz2jfuj	68	1	Similar	similar	JJ
cord-337302-fpz2jfuj	68	2	to	to	IN
cord-337302-fpz2jfuj	68	3	cases	case	NNS
cord-337302-fpz2jfuj	68	4	seen	see	VBN
cord-337302-fpz2jfuj	68	5	during	during	IN
cord-337302-fpz2jfuj	68	6	the	the	DT
cord-337302-fpz2jfuj	68	7	MERS	MERS	NNP
cord-337302-fpz2jfuj	68	8	-	-	HYPH
cord-337302-fpz2jfuj	68	9	outbreak	outbreak	NN
cord-337302-fpz2jfuj	68	10	where	where	WRB
cord-337302-fpz2jfuj	68	11	having	have	VBG
cord-337302-fpz2jfuj	68	12	cancer	cancer	NN
cord-337302-fpz2jfuj	68	13	was	be	VBD
cord-337302-fpz2jfuj	68	14	identified	identify	VBN
cord-337302-fpz2jfuj	68	15	as	as	IN
cord-337302-fpz2jfuj	68	16	a	a	DT
cord-337302-fpz2jfuj	68	17	risk	risk	NN
cord-337302-fpz2jfuj	68	18	factor	factor	NN
cord-337302-fpz2jfuj	68	19	for	for	IN
cord-337302-fpz2jfuj	68	20	MERS	MERS	NNP
cord-337302-fpz2jfuj	68	21	-	-	HYPH
cord-337302-fpz2jfuj	68	22	CoV	CoV	NNP
cord-337302-fpz2jfuj	68	23	mortality	mortality	NN
cord-337302-fpz2jfuj	68	24	,	,	,
cord-337302-fpz2jfuj	68	25	the	the	DT
cord-337302-fpz2jfuj	68	26	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	68	27	pandemic	pandemic	NN
cord-337302-fpz2jfuj	68	28	also	also	RB
cord-337302-fpz2jfuj	68	29	poses	pose	VBZ
cord-337302-fpz2jfuj	68	30	threats	threat	NNS
cord-337302-fpz2jfuj	68	31	to	to	IN
cord-337302-fpz2jfuj	68	32	cancer	cancer	NN
cord-337302-fpz2jfuj	68	33	patients	patient	NNS
cord-337302-fpz2jfuj	68	34	.	.	.
cord-337302-fpz2jfuj	69	1	12	12	CD
cord-337302-fpz2jfuj	70	1	The	the	DT
cord-337302-fpz2jfuj	70	2	burden	burden	NN
cord-337302-fpz2jfuj	70	3	and	and	CC
cord-337302-fpz2jfuj	70	4	risk	risk	NN
cord-337302-fpz2jfuj	70	5	of	of	IN
cord-337302-fpz2jfuj	70	6	developing	develop	VBG
cord-337302-fpz2jfuj	70	7	COVID-19	covid-19	CD
cord-337302-fpz2jfuj	70	8	in	in	IN
cord-337302-fpz2jfuj	70	9	cancer	cancer	NN
cord-337302-fpz2jfuj	70	10	patients	patient	NNS
cord-337302-fpz2jfuj	70	11	are	be	VBP
cord-337302-fpz2jfuj	70	12	compounded	compound	VBN
cord-337302-fpz2jfuj	70	13	by	by	IN
cord-337302-fpz2jfuj	70	14	their	-PRON-	PRP$
cord-337302-fpz2jfuj	70	15	age	age	NN
cord-337302-fpz2jfuj	70	16	and	and	CC
cord-337302-fpz2jfuj	70	17	litany	litany	JJ
cord-337302-fpz2jfuj	70	18	of	of	IN
cord-337302-fpz2jfuj	70	19	other	other	JJ
cord-337302-fpz2jfuj	70	20	comorbidities	comorbiditie	NNS
cord-337302-fpz2jfuj	70	21	.	.	.
cord-337302-fpz2jfuj	71	1	A	a	DT
cord-337302-fpz2jfuj	71	2	systematic	systematic	JJ
cord-337302-fpz2jfuj	71	3	review	review	NN
cord-337302-fpz2jfuj	71	4	that	that	WDT
cord-337302-fpz2jfuj	71	5	looked	look	VBD
cord-337302-fpz2jfuj	71	6	at	at	IN
cord-337302-fpz2jfuj	71	7	the	the	DT
cord-337302-fpz2jfuj	71	8	prevalence	prevalence	NN
cord-337302-fpz2jfuj	71	9	of	of	IN
cord-337302-fpz2jfuj	71	10	underlining	underline	VBG
cord-337302-fpz2jfuj	71	11	conditions	condition	NNS
cord-337302-fpz2jfuj	71	12	of	of	IN
cord-337302-fpz2jfuj	71	13	already	already	RB
cord-337302-fpz2jfuj	71	14	hospitalized	hospitalize	VBN
cord-337302-fpz2jfuj	71	15	COVID-19	COVID-19	JJR
cord-337302-fpz2jfuj	71	16	patients	patient	NNS
cord-337302-fpz2jfuj	71	17	showed	show	VBD
cord-337302-fpz2jfuj	71	18	cardiovascular	cardiovascular	JJ
cord-337302-fpz2jfuj	71	19	diseases	disease	NNS
cord-337302-fpz2jfuj	71	20	and	and	CC
cord-337302-fpz2jfuj	71	21	malignancy	malignancy	NN
cord-337302-fpz2jfuj	71	22	to	to	TO
cord-337302-fpz2jfuj	71	23	be	be	VB
cord-337302-fpz2jfuj	71	24	among	among	IN
cord-337302-fpz2jfuj	71	25	the	the	DT
cord-337302-fpz2jfuj	71	26	most	most	RBS
cord-337302-fpz2jfuj	71	27	prevalent	prevalent	JJ
cord-337302-fpz2jfuj	71	28	conditions	condition	NNS
cord-337302-fpz2jfuj	71	29	.	.	.
cord-337302-fpz2jfuj	72	1	22	22	CD
cord-337302-fpz2jfuj	73	1	As	as	IN
cord-337302-fpz2jfuj	73	2	the	the	DT
cord-337302-fpz2jfuj	73	3	world	world	NN
cord-337302-fpz2jfuj	73	4	population	population	NN
cord-337302-fpz2jfuj	73	5	continues	continue	VBZ
cord-337302-fpz2jfuj	73	6	to	to	TO
cord-337302-fpz2jfuj	73	7	live	live	VB
cord-337302-fpz2jfuj	73	8	longer	long	RBR
cord-337302-fpz2jfuj	73	9	,	,	,
cord-337302-fpz2jfuj	73	10	age	age	NN
cord-337302-fpz2jfuj	73	11	becomes	become	VBZ
cord-337302-fpz2jfuj	73	12	an	an	DT
cord-337302-fpz2jfuj	73	13	overall	overall	JJ
cord-337302-fpz2jfuj	73	14	risk	risk	NN
cord-337302-fpz2jfuj	73	15	factor	factor	NN
cord-337302-fpz2jfuj	73	16	for	for	IN
cord-337302-fpz2jfuj	73	17	cancer	cancer	NN
cord-337302-fpz2jfuj	73	18	.	.	.
cord-337302-fpz2jfuj	74	1	In	in	IN
cord-337302-fpz2jfuj	74	2	2018	2018	CD
cord-337302-fpz2jfuj	74	3	alone	alone	RB
cord-337302-fpz2jfuj	74	4	,	,	,
cord-337302-fpz2jfuj	74	5	6.6	6.6	CD
cord-337302-fpz2jfuj	74	6	million	million	CD
cord-337302-fpz2jfuj	74	7	cancer	cancer	NN
cord-337302-fpz2jfuj	74	8	cases	case	NNS
cord-337302-fpz2jfuj	74	9	were	be	VBD
cord-337302-fpz2jfuj	74	10	diagnosed	diagnose	VBN
cord-337302-fpz2jfuj	74	11	globally	globally	RB
cord-337302-fpz2jfuj	74	12	in	in	IN
cord-337302-fpz2jfuj	74	13	persons	person	NNS
cord-337302-fpz2jfuj	74	14	aged	age	VBN
cord-337302-fpz2jfuj	75	1	≥70	≥70	NNP
cord-337302-fpz2jfuj	75	2	.	.	.
cord-337302-fpz2jfuj	76	1	Many	many	JJ
cord-337302-fpz2jfuj	76	2	of	of	IN
cord-337302-fpz2jfuj	76	3	the	the	DT
cord-337302-fpz2jfuj	76	4	latest	late	JJS
cord-337302-fpz2jfuj	76	5	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	76	6	studies	study	NNS
cord-337302-fpz2jfuj	76	7	also	also	RB
cord-337302-fpz2jfuj	76	8	show	show	VBP
cord-337302-fpz2jfuj	76	9	advanced	advanced	JJ
cord-337302-fpz2jfuj	76	10	age	age	NN
cord-337302-fpz2jfuj	76	11	and	and	CC
cord-337302-fpz2jfuj	76	12	comorbidities	comorbiditie	NNS
cord-337302-fpz2jfuj	76	13	to	to	TO
cord-337302-fpz2jfuj	76	14	be	be	VB
cord-337302-fpz2jfuj	76	15	associated	associate	VBN
cord-337302-fpz2jfuj	76	16	with	with	IN
cord-337302-fpz2jfuj	76	17	poor	poor	JJ
cord-337302-fpz2jfuj	76	18	outcomes	outcome	NNS
cord-337302-fpz2jfuj	76	19	.	.	.
cord-337302-fpz2jfuj	77	1	Therefore	therefore	RB
cord-337302-fpz2jfuj	77	2	,	,	,
cord-337302-fpz2jfuj	77	3	age	age	NN
cord-337302-fpz2jfuj	77	4	-	-	HYPH
cord-337302-fpz2jfuj	77	5	stratified	stratify	VBN
cord-337302-fpz2jfuj	77	6	data	datum	NNS
cord-337302-fpz2jfuj	77	7	in	in	IN
cord-337302-fpz2jfuj	77	8	the	the	DT
cord-337302-fpz2jfuj	77	9	continuum	continuum	NN
cord-337302-fpz2jfuj	77	10	of	of	IN
cord-337302-fpz2jfuj	77	11	cancer	cancer	NN
cord-337302-fpz2jfuj	77	12	care	care	NN
cord-337302-fpz2jfuj	77	13	during	during	IN
cord-337302-fpz2jfuj	77	14	this	this	DT
cord-337302-fpz2jfuj	77	15	pandemic	pandemic	NN
cord-337302-fpz2jfuj	77	16	and	and	CC
cord-337302-fpz2jfuj	77	17	beyond	beyond	IN
cord-337302-fpz2jfuj	77	18	is	be	VBZ
cord-337302-fpz2jfuj	77	19	paramount	paramount	JJ
cord-337302-fpz2jfuj	77	20	.	.	.
cord-337302-fpz2jfuj	78	1	23	23	CD
cord-337302-fpz2jfuj	79	1	In	in	IN
cord-337302-fpz2jfuj	79	2	one	one	CD
cord-337302-fpz2jfuj	79	3	of	of	IN
cord-337302-fpz2jfuj	79	4	the	the	DT
cord-337302-fpz2jfuj	79	5	early	early	JJ
cord-337302-fpz2jfuj	79	6	data	datum	NNS
cord-337302-fpz2jfuj	79	7	by	by	IN
cord-337302-fpz2jfuj	79	8	Yu	Yu	NNP
cord-337302-fpz2jfuj	79	9	et	et	NNP
cord-337302-fpz2jfuj	79	10	al	al	NNP
cord-337302-fpz2jfuj	79	11	published	publish	VBD
cord-337302-fpz2jfuj	79	12	in	in	IN
cord-337302-fpz2jfuj	79	13	JAMA	JAMA	NNP
cord-337302-fpz2jfuj	79	14	Oncology	Oncology	NNP
cord-337302-fpz2jfuj	79	15	,	,	,
cord-337302-fpz2jfuj	79	16	the	the	DT
cord-337302-fpz2jfuj	79	17	infection	infection	NN
cord-337302-fpz2jfuj	79	18	rate	rate	NN
cord-337302-fpz2jfuj	79	19	of	of	IN
cord-337302-fpz2jfuj	79	20	SARS	SARS	NNP
cord-337302-fpz2jfuj	79	21	-	-	HYPH
cord-337302-fpz2jfuj	79	22	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	79	23	in	in	IN
cord-337302-fpz2jfuj	79	24	cancer	cancer	NN
cord-337302-fpz2jfuj	79	25	patients	patient	NNS
cord-337302-fpz2jfuj	79	26	from	from	IN
cord-337302-fpz2jfuj	79	27	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	79	28	,	,	,
cord-337302-fpz2jfuj	79	29	China	China	NNP
cord-337302-fpz2jfuj	79	30	,	,	,
cord-337302-fpz2jfuj	79	31	was	be	VBD
cord-337302-fpz2jfuj	79	32	at	at	IN
cord-337302-fpz2jfuj	79	33	0.79	0.79	CD
cord-337302-fpz2jfuj	79	34	%	%	NN
cord-337302-fpz2jfuj	79	35	(	(	-LRB-
cord-337302-fpz2jfuj	79	36	12	12	CD
cord-337302-fpz2jfuj	79	37	of	of	IN
cord-337302-fpz2jfuj	79	38	1524	1524	CD
cord-337302-fpz2jfuj	79	39	patients	patient	NNS
cord-337302-fpz2jfuj	79	40	;	;	:
cord-337302-fpz2jfuj	79	41	95	95	CD
cord-337302-fpz2jfuj	79	42	%	%	NN
cord-337302-fpz2jfuj	79	43	CI	CI	NNP
cord-337302-fpz2jfuj	79	44	,	,	,
cord-337302-fpz2jfuj	79	45	0.31.2	0.31.2	CD
cord-337302-fpz2jfuj	79	46	%	%	NN
cord-337302-fpz2jfuj	79	47	)	)	-RRB-
cord-337302-fpz2jfuj	79	48	.	.	.
cord-337302-fpz2jfuj	80	1	And	and	CC
cord-337302-fpz2jfuj	80	2	in	in	IN
cord-337302-fpz2jfuj	80	3	their	-PRON-	PRP$
cord-337302-fpz2jfuj	80	4	subgroup	subgroup	NN
cord-337302-fpz2jfuj	80	5	analysis	analysis	NN
cord-337302-fpz2jfuj	80	6	,	,	,
cord-337302-fpz2jfuj	80	7	they	-PRON-	PRP
cord-337302-fpz2jfuj	80	8	found	find	VBD
cord-337302-fpz2jfuj	80	9	that	that	IN
cord-337302-fpz2jfuj	80	10	the	the	DT
cord-337302-fpz2jfuj	80	11	prevalence	prevalence	NN
cord-337302-fpz2jfuj	80	12	was	be	VBD
cord-337302-fpz2jfuj	80	13	higher	high	JJR
cord-337302-fpz2jfuj	80	14	in	in	IN
cord-337302-fpz2jfuj	80	15	lung	lung	NN
cord-337302-fpz2jfuj	80	16	cancer	cancer	NN
cord-337302-fpz2jfuj	80	17	patients	patient	NNS
cord-337302-fpz2jfuj	80	18	older	old	JJR
cord-337302-fpz2jfuj	80	19	than	than	IN
cord-337302-fpz2jfuj	80	20	age	age	NN
cord-337302-fpz2jfuj	80	21	60	60	CD
cord-337302-fpz2jfuj	80	22	compared	compare	VBN
cord-337302-fpz2jfuj	80	23	to	to	IN
cord-337302-fpz2jfuj	80	24	those	those	DT
cord-337302-fpz2jfuj	80	25	younger	young	JJR
cord-337302-fpz2jfuj	80	26	than	than	IN
cord-337302-fpz2jfuj	80	27	60	60	CD
cord-337302-fpz2jfuj	80	28	years	year	NNS
cord-337302-fpz2jfuj	80	29	(	(	-LRB-
cord-337302-fpz2jfuj	80	30	4.3	4.3	CD
cord-337302-fpz2jfuj	80	31	%	%	NN
cord-337302-fpz2jfuj	80	32	vs	vs	IN
cord-337302-fpz2jfuj	80	33	1.8	1.8	CD
cord-337302-fpz2jfuj	80	34	%	%	NN
cord-337302-fpz2jfuj	80	35	)	)	-RRB-
cord-337302-fpz2jfuj	80	36	.	.	.
cord-337302-fpz2jfuj	81	1	24	24	CD
cord-337302-fpz2jfuj	81	2	Liang	Liang	NNP
cord-337302-fpz2jfuj	81	3	et	et	NNP
cord-337302-fpz2jfuj	81	4	al	al	NNP
cord-337302-fpz2jfuj	81	5	,	,	,
cord-337302-fpz2jfuj	81	6	15	15	CD
cord-337302-fpz2jfuj	81	7	also	also	RB
cord-337302-fpz2jfuj	81	8	looked	look	VBD
cord-337302-fpz2jfuj	81	9	at	at	IN
cord-337302-fpz2jfuj	81	10	the	the	DT
cord-337302-fpz2jfuj	81	11	prevalence	prevalence	NN
cord-337302-fpz2jfuj	81	12	of	of	IN
cord-337302-fpz2jfuj	81	13	cancer	cancer	NN
cord-337302-fpz2jfuj	81	14	in	in	IN
cord-337302-fpz2jfuj	81	15	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	81	16	cases	case	NNS
cord-337302-fpz2jfuj	81	17	in	in	IN
cord-337302-fpz2jfuj	81	18	a	a	DT
cord-337302-fpz2jfuj	81	19	nationwide	nationwide	JJ
cord-337302-fpz2jfuj	81	20	analysis	analysis	NN
cord-337302-fpz2jfuj	81	21	.	.	.
cord-337302-fpz2jfuj	82	1	They	-PRON-	PRP
cord-337302-fpz2jfuj	82	2	analyzed	analyze	VBD
cord-337302-fpz2jfuj	82	3	a	a	DT
cord-337302-fpz2jfuj	82	4	total	total	NN
cord-337302-fpz2jfuj	82	5	of	of	IN
cord-337302-fpz2jfuj	82	6	1590	1590	CD
cord-337302-fpz2jfuj	82	7	cases	case	NNS
cord-337302-fpz2jfuj	82	8	and	and	CC
cord-337302-fpz2jfuj	82	9	found	find	VBD
cord-337302-fpz2jfuj	82	10	a	a	DT
cord-337302-fpz2jfuj	82	11	prevalence	prevalence	NN
cord-337302-fpz2jfuj	82	12	of	of	IN
cord-337302-fpz2jfuj	82	13	1	1	CD
cord-337302-fpz2jfuj	82	14	%	%	NN
cord-337302-fpz2jfuj	82	15	(	(	-LRB-
cord-337302-fpz2jfuj	82	16	95	95	CD
cord-337302-fpz2jfuj	82	17	%	%	NN
cord-337302-fpz2jfuj	82	18	CI	CI	NNP
cord-337302-fpz2jfuj	82	19	,	,	,
cord-337302-fpz2jfuj	82	20	0.61	0.61	CD
cord-337302-fpz2jfuj	82	21	%	%	NN
cord-337302-fpz2jfuj	82	22	to	to	TO
cord-337302-fpz2jfuj	82	23	1.65	1.65	CD
cord-337302-fpz2jfuj	82	24	%	%	NN
cord-337302-fpz2jfuj	82	25	)	)	-RRB-
cord-337302-fpz2jfuj	82	26	,	,	,
cord-337302-fpz2jfuj	82	27	which	which	WDT
cord-337302-fpz2jfuj	82	28	was	be	VBD
cord-337302-fpz2jfuj	82	29	higher	high	JJR
cord-337302-fpz2jfuj	82	30	than	than	IN
cord-337302-fpz2jfuj	82	31	the	the	DT
cord-337302-fpz2jfuj	82	32	overall	overall	JJ
cord-337302-fpz2jfuj	82	33	cancer	cancer	NN
cord-337302-fpz2jfuj	82	34	risks	risk	NNS
cord-337302-fpz2jfuj	82	35	in	in	IN
cord-337302-fpz2jfuj	82	36	the	the	DT
cord-337302-fpz2jfuj	82	37	Chinese	chinese	JJ
cord-337302-fpz2jfuj	82	38	population	population	NN
cord-337302-fpz2jfuj	82	39	.	.	.
cord-337302-fpz2jfuj	83	1	25	25	CD
cord-337302-fpz2jfuj	83	2	Lung	Lung	NNP
cord-337302-fpz2jfuj	83	3	cancer	cancer	NN
cord-337302-fpz2jfuj	83	4	was	be	VBD
cord-337302-fpz2jfuj	83	5	similarly	similarly	RB
cord-337302-fpz2jfuj	83	6	the	the	DT
cord-337302-fpz2jfuj	83	7	most	most	RBS
cord-337302-fpz2jfuj	83	8	common	common	JJ
cord-337302-fpz2jfuj	83	9	type	type	NN
cord-337302-fpz2jfuj	83	10	of	of	IN
cord-337302-fpz2jfuj	83	11	disease	disease	NN
cord-337302-fpz2jfuj	83	12	from	from	IN
cord-337302-fpz2jfuj	83	13	this	this	DT
cord-337302-fpz2jfuj	83	14	cohort	cohort	NN
cord-337302-fpz2jfuj	83	15	,	,	,
cord-337302-fpz2jfuj	83	16	accounting	account	VBG
cord-337302-fpz2jfuj	83	17	for	for	IN
cord-337302-fpz2jfuj	83	18	28	28	CD
cord-337302-fpz2jfuj	83	19	%	%	NN
cord-337302-fpz2jfuj	83	20	.	.	.
cord-337302-fpz2jfuj	84	1	Their	-PRON-	PRP$
cord-337302-fpz2jfuj	84	2	subgroup	subgroup	NN
cord-337302-fpz2jfuj	84	3	analysis	analysis	NN
cord-337302-fpz2jfuj	84	4	also	also	RB
cord-337302-fpz2jfuj	84	5	reported	report	VBD
cord-337302-fpz2jfuj	84	6	lung	lung	NN
cord-337302-fpz2jfuj	84	7	cancer	cancer	NN
cord-337302-fpz2jfuj	84	8	patients	patient	NNS
cord-337302-fpz2jfuj	84	9	with	with	IN
cord-337302-fpz2jfuj	84	10	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	84	11	to	to	TO
cord-337302-fpz2jfuj	84	12	be	be	VB
cord-337302-fpz2jfuj	84	13	at	at	IN
cord-337302-fpz2jfuj	84	14	a	a	DT
cord-337302-fpz2jfuj	84	15	higher	high	JJR
cord-337302-fpz2jfuj	84	16	risk	risk	NN
cord-337302-fpz2jfuj	84	17	of	of	IN
cord-337302-fpz2jfuj	84	18	pulmonary	pulmonary	JJ
cord-337302-fpz2jfuj	84	19	complications	complication	NNS
cord-337302-fpz2jfuj	84	20	and	and	CC
cord-337302-fpz2jfuj	84	21	poor	poor	JJ
cord-337302-fpz2jfuj	84	22	outcomes	outcome	NNS
cord-337302-fpz2jfuj	84	23	from	from	IN
cord-337302-fpz2jfuj	84	24	the	the	DT
cord-337302-fpz2jfuj	84	25	use	use	NN
cord-337302-fpz2jfuj	84	26	of	of	IN
cord-337302-fpz2jfuj	84	27	chemotherapy	chemotherapy	NN
cord-337302-fpz2jfuj	84	28	.	.	.
cord-337302-fpz2jfuj	85	1	15	15	CD
cord-337302-fpz2jfuj	86	1	In	in	IN
cord-337302-fpz2jfuj	86	2	a	a	DT
cord-337302-fpz2jfuj	86	3	retrospective	retrospective	JJ
cord-337302-fpz2jfuj	86	4	cohort	cohort	NN
cord-337302-fpz2jfuj	86	5	study	study	NN
cord-337302-fpz2jfuj	86	6	of	of	IN
cord-337302-fpz2jfuj	86	7	28	28	CD
cord-337302-fpz2jfuj	86	8	COVID-19infected	covid-19infecte	VBN
cord-337302-fpz2jfuj	86	9	cancer	cancer	NN
cord-337302-fpz2jfuj	86	10	patients	patient	NNS
cord-337302-fpz2jfuj	86	11	with	with	IN
cord-337302-fpz2jfuj	86	12	laboratory	laboratory	NN
cord-337302-fpz2jfuj	86	13	-	-	HYPH
cord-337302-fpz2jfuj	86	14	confirmed	confirm	VBN
cord-337302-fpz2jfuj	86	15	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	86	16	from	from	IN
cord-337302-fpz2jfuj	86	17	three	three	CD
cord-337302-fpz2jfuj	86	18	hospitals	hospital	NNS
cord-337302-fpz2jfuj	86	19	in	in	IN
cord-337302-fpz2jfuj	86	20	China	China	NNP
cord-337302-fpz2jfuj	86	21	,	,	,
cord-337302-fpz2jfuj	86	22	a	a	DT
cord-337302-fpz2jfuj	86	23	total	total	NN
cord-337302-fpz2jfuj	86	24	of	of	IN
cord-337302-fpz2jfuj	86	25	15	15	CD
cord-337302-fpz2jfuj	86	26	(	(	-LRB-
cord-337302-fpz2jfuj	86	27	53.6	53.6	CD
cord-337302-fpz2jfuj	86	28	%	%	NN
cord-337302-fpz2jfuj	86	29	)	)	-RRB-
cord-337302-fpz2jfuj	86	30	patients	patient	NNS
cord-337302-fpz2jfuj	86	31	had	have	VBD
cord-337302-fpz2jfuj	86	32	severe	severe	JJ
cord-337302-fpz2jfuj	86	33	outcomes	outcome	NNS
cord-337302-fpz2jfuj	86	34	with	with	IN
cord-337302-fpz2jfuj	86	35	a	a	DT
cord-337302-fpz2jfuj	86	36	mortality	mortality	NN
cord-337302-fpz2jfuj	86	37	rate	rate	NN
cord-337302-fpz2jfuj	86	38	of	of	IN
cord-337302-fpz2jfuj	86	39	28.6	28.6	CD
cord-337302-fpz2jfuj	86	40	%	%	NN
cord-337302-fpz2jfuj	86	41	.	.	.
cord-337302-fpz2jfuj	87	1	Also	also	RB
cord-337302-fpz2jfuj	87	2	,	,	,
cord-337302-fpz2jfuj	87	3	tumor	tumor	NN
cord-337302-fpz2jfuj	87	4	treatment	treatment	NN
cord-337302-fpz2jfuj	87	5	within	within	IN
cord-337302-fpz2jfuj	87	6	last	last	JJ
cord-337302-fpz2jfuj	87	7	14	14	CD
cord-337302-fpz2jfuj	87	8	days	day	NNS
cord-337302-fpz2jfuj	87	9	seemed	seem	VBD
cord-337302-fpz2jfuj	87	10	to	to	TO
cord-337302-fpz2jfuj	87	11	significantly	significantly	RB
cord-337302-fpz2jfuj	87	12	increase	increase	VB
cord-337302-fpz2jfuj	87	13	the	the	DT
cord-337302-fpz2jfuj	87	14	risk	risk	NN
cord-337302-fpz2jfuj	87	15	of	of	IN
cord-337302-fpz2jfuj	87	16	severe	severe	JJ
cord-337302-fpz2jfuj	87	17	outcome	outcome	NN
cord-337302-fpz2jfuj	87	18	[	[	-LRB-
cord-337302-fpz2jfuj	87	19	hazard	hazard	NN
cord-337302-fpz2jfuj	87	20	ratio	ratio	NN
cord-337302-fpz2jfuj	87	21	(	(	-LRB-
cord-337302-fpz2jfuj	87	22	HR	HR	NNP
cord-337302-fpz2jfuj	87	23	)	)	-RRB-
cord-337302-fpz2jfuj	87	24	=	=	SYM
cord-337302-fpz2jfuj	87	25	4.079	4.079	CD
cord-337302-fpz2jfuj	87	26	,	,	,
cord-337302-fpz2jfuj	87	27	95	95	CD
cord-337302-fpz2jfuj	87	28	%	%	NN
cord-337302-fpz2jfuj	87	29	confidence	confidence	NN
cord-337302-fpz2jfuj	87	30	interval	interval	NN
cord-337302-fpz2jfuj	87	31	(	(	-LRB-
cord-337302-fpz2jfuj	87	32	CI	CI	NNP
cord-337302-fpz2jfuj	87	33	)	)	-RRB-
cord-337302-fpz2jfuj	87	34	1.086	1.086	CD
cord-337302-fpz2jfuj	87	35	-	-	SYM
cord-337302-fpz2jfuj	87	36	15.322	15.322	CD
cord-337302-fpz2jfuj	87	37	,	,	,
cord-337302-fpz2jfuj	87	38	P	p	NN
cord-337302-fpz2jfuj	87	39	=	=	SYM
cord-337302-fpz2jfuj	87	40	0.037	0.037	CD
cord-337302-fpz2jfuj	87	41	.	.	.
cord-337302-fpz2jfuj	88	1	26	26	CD
cord-337302-fpz2jfuj	89	1	However	however	RB
cord-337302-fpz2jfuj	89	2	,	,	,
cord-337302-fpz2jfuj	89	3	according	accord	VBG
cord-337302-fpz2jfuj	89	4	to	to	IN
cord-337302-fpz2jfuj	89	5	the	the	DT
cord-337302-fpz2jfuj	89	6	data	datum	NNS
cord-337302-fpz2jfuj	89	7	from	from	IN
cord-337302-fpz2jfuj	89	8	the	the	DT
cord-337302-fpz2jfuj	89	9	Chinese	Chinese	NNP
cord-337302-fpz2jfuj	89	10	Center	Center	NNP
cord-337302-fpz2jfuj	89	11	for	for	IN
cord-337302-fpz2jfuj	89	12	Disease	Disease	NNP
cord-337302-fpz2jfuj	89	13	Control	Control	NNP
cord-337302-fpz2jfuj	89	14	and	and	CC
cord-337302-fpz2jfuj	89	15	Prevention	Prevention	NNP
cord-337302-fpz2jfuj	89	16	,	,	,
cord-337302-fpz2jfuj	89	17	case	case	NN
cord-337302-fpz2jfuj	89	18	fatality	fatality	NN
cord-337302-fpz2jfuj	89	19	was	be	VBD
cord-337302-fpz2jfuj	89	20	higher	high	JJR
cord-337302-fpz2jfuj	89	21	in	in	IN
cord-337302-fpz2jfuj	89	22	patients	patient	NNS
cord-337302-fpz2jfuj	89	23	with	with	IN
cord-337302-fpz2jfuj	89	24	comorbidities	comorbiditie	NNS
cord-337302-fpz2jfuj	89	25	compared	compare	VBN
cord-337302-fpz2jfuj	89	26	to	to	IN
cord-337302-fpz2jfuj	89	27	those	those	DT
cord-337302-fpz2jfuj	89	28	without	without	IN
cord-337302-fpz2jfuj	89	29	.	.	.
cord-337302-fpz2jfuj	90	1	Among	among	IN
cord-337302-fpz2jfuj	90	2	these	these	DT
cord-337302-fpz2jfuj	90	3	,	,	,
cord-337302-fpz2jfuj	90	4	the	the	DT
cord-337302-fpz2jfuj	90	5	case	case	NN
cord-337302-fpz2jfuj	90	6	fatality	fatality	NN
cord-337302-fpz2jfuj	90	7	rate	rate	NN
cord-337302-fpz2jfuj	90	8	for	for	IN
cord-337302-fpz2jfuj	90	9	cancer	cancer	NN
cord-337302-fpz2jfuj	90	10	patients	patient	NNS
cord-337302-fpz2jfuj	90	11	was	be	VBD
cord-337302-fpz2jfuj	90	12	at	at	IN
cord-337302-fpz2jfuj	90	13	5.6	5.6	CD
cord-337302-fpz2jfuj	90	14	%	%	NN
cord-337302-fpz2jfuj	90	15	.	.	.
cord-337302-fpz2jfuj	91	1	27	27	CD
cord-337302-fpz2jfuj	92	1	A	a	DT
cord-337302-fpz2jfuj	92	2	review	review	NN
cord-337302-fpz2jfuj	92	3	of	of	IN
cord-337302-fpz2jfuj	92	4	355	355	CD
cord-337302-fpz2jfuj	92	5	COVID-19	covid-19	CD
cord-337302-fpz2jfuj	92	6	patients	patient	NNS
cord-337302-fpz2jfuj	92	7	who	who	WP
cord-337302-fpz2jfuj	92	8	died	die	VBD
cord-337302-fpz2jfuj	92	9	in	in	IN
cord-337302-fpz2jfuj	92	10	Italy	Italy	NNP
cord-337302-fpz2jfuj	92	11	showed	show	VBD
cord-337302-fpz2jfuj	92	12	old	old	JJ
cord-337302-fpz2jfuj	92	13	age	age	NN
cord-337302-fpz2jfuj	92	14	(	(	-LRB-
cord-337302-fpz2jfuj	92	15	mean	mean	VB
cord-337302-fpz2jfuj	92	16	79.5yrs	79.5yrs	CD
cord-337302-fpz2jfuj	92	17	)	)	-RRB-
cord-337302-fpz2jfuj	92	18	and	and	CC
cord-337302-fpz2jfuj	92	19	comorbidities	comorbiditie	NNS
cord-337302-fpz2jfuj	92	20	as	as	IN
cord-337302-fpz2jfuj	92	21	the	the	DT
cord-337302-fpz2jfuj	92	22	main	main	JJ
cord-337302-fpz2jfuj	92	23	contributing	contributing	NN
cord-337302-fpz2jfuj	92	24	factors	factor	NNS
cord-337302-fpz2jfuj	92	25	.	.	.
cord-337302-fpz2jfuj	93	1	Among	among	IN
cord-337302-fpz2jfuj	93	2	these	these	DT
cord-337302-fpz2jfuj	93	3	,	,	,
cord-337302-fpz2jfuj	93	4	72	72	CD
cord-337302-fpz2jfuj	93	5	patients	patient	NNS
cord-337302-fpz2jfuj	93	6	(	(	-LRB-
cord-337302-fpz2jfuj	93	7	20	20	CD
cord-337302-fpz2jfuj	93	8	%	%	NN
cord-337302-fpz2jfuj	93	9	)	)	-RRB-
cord-337302-fpz2jfuj	93	10	had	have	VBD
cord-337302-fpz2jfuj	93	11	active	active	JJ
cord-337302-fpz2jfuj	93	12	cancer	cancer	NN
cord-337302-fpz2jfuj	93	13	.	.	.
cord-337302-fpz2jfuj	94	1	28	28	CD
cord-337302-fpz2jfuj	95	1	In	in	IN
cord-337302-fpz2jfuj	95	2	a	a	DT
cord-337302-fpz2jfuj	95	3	multicenter	multicenter	JJ
cord-337302-fpz2jfuj	95	4	study	study	NN
cord-337302-fpz2jfuj	95	5	,	,	,
cord-337302-fpz2jfuj	95	6	patients	patient	NNS
cord-337302-fpz2jfuj	95	7	with	with	IN
cord-337302-fpz2jfuj	95	8	hematological	hematological	JJ
cord-337302-fpz2jfuj	95	9	and	and	CC
cord-337302-fpz2jfuj	95	10	metastatic	metastatic	JJ
cord-337302-fpz2jfuj	95	11	cancer	cancer	NN
cord-337302-fpz2jfuj	95	12	were	be	VBD
cord-337302-fpz2jfuj	95	13	found	find	VBN
cord-337302-fpz2jfuj	95	14	to	to	TO
cord-337302-fpz2jfuj	95	15	carry	carry	VB
cord-337302-fpz2jfuj	95	16	a	a	DT
cord-337302-fpz2jfuj	95	17	high	high	JJ
cord-337302-fpz2jfuj	95	18	risk	risk	NN
cord-337302-fpz2jfuj	95	19	for	for	IN
cord-337302-fpz2jfuj	95	20	SARS	SARS	NNP
cord-337302-fpz2jfuj	95	21	-	-	HYPH
cord-337302-fpz2jfuj	95	22	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	95	23	,	,	,
cord-337302-fpz2jfuj	95	24	which	which	WDT
cord-337302-fpz2jfuj	95	25	was	be	VBD
cord-337302-fpz2jfuj	95	26	similar	similar	JJ
cord-337302-fpz2jfuj	95	27	to	to	IN
cord-337302-fpz2jfuj	95	28	those	those	DT
cord-337302-fpz2jfuj	95	29	who	who	WP
cord-337302-fpz2jfuj	95	30	recently	recently	RB
cord-337302-fpz2jfuj	95	31	received	receive	VBD
cord-337302-fpz2jfuj	95	32	surgery	surgery	NN
cord-337302-fpz2jfuj	95	33	.	.	.
cord-337302-fpz2jfuj	96	1	Receiving	receive	VBG
cord-337302-fpz2jfuj	96	2	radiotherapy	radiotherapy	NN
cord-337302-fpz2jfuj	96	3	was	be	VBD
cord-337302-fpz2jfuj	96	4	not	not	RB
cord-337302-fpz2jfuj	96	5	found	find	VBN
cord-337302-fpz2jfuj	96	6	to	to	TO
cord-337302-fpz2jfuj	96	7	have	have	VB
cord-337302-fpz2jfuj	96	8	any	any	DT
cord-337302-fpz2jfuj	96	9	significant	significant	JJ
cord-337302-fpz2jfuj	96	10	differences	difference	NNS
cord-337302-fpz2jfuj	96	11	in	in	IN
cord-337302-fpz2jfuj	96	12	severe	severe	JJ
cord-337302-fpz2jfuj	96	13	outcomes	outcome	NNS
cord-337302-fpz2jfuj	96	14	when	when	WRB
cord-337302-fpz2jfuj	96	15	compared	compare	VBN
cord-337302-fpz2jfuj	96	16	to	to	IN
cord-337302-fpz2jfuj	96	17	non	non	JJ
cord-337302-fpz2jfuj	96	18	-	-	JJ
cord-337302-fpz2jfuj	96	19	cancer	cancer	JJ
cord-337302-fpz2jfuj	96	20	patients	patient	NNS
cord-337302-fpz2jfuj	96	21	.	.	.
cord-337302-fpz2jfuj	97	1	29	29	CD
cord-337302-fpz2jfuj	98	1	In	in	IN
cord-337302-fpz2jfuj	98	2	a	a	DT
cord-337302-fpz2jfuj	98	3	retrospective	retrospective	JJ
cord-337302-fpz2jfuj	98	4	analysis	analysis	NN
cord-337302-fpz2jfuj	98	5	of	of	IN
cord-337302-fpz2jfuj	98	6	the	the	DT
cord-337302-fpz2jfuj	98	7	perioperative	perioperative	JJ
cord-337302-fpz2jfuj	98	8	outcomes	outcome	NNS
cord-337302-fpz2jfuj	98	9	of	of	IN
cord-337302-fpz2jfuj	98	10	six	six	CD
cord-337302-fpz2jfuj	98	11	lung	lung	NN
cord-337302-fpz2jfuj	98	12	cancer	cancer	NN
cord-337302-fpz2jfuj	98	13	patients	patient	NNS
cord-337302-fpz2jfuj	98	14	with	with	IN
cord-337302-fpz2jfuj	98	15	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	98	16	,	,	,
cord-337302-fpz2jfuj	98	17	Cai	Cai	NNP
cord-337302-fpz2jfuj	98	18	et	et	FW
cord-337302-fpz2jfuj	98	19	al	al	NNP
cord-337302-fpz2jfuj	98	20	,	,	,
cord-337302-fpz2jfuj	98	21	found	find	VBD
cord-337302-fpz2jfuj	98	22	that	that	IN
cord-337302-fpz2jfuj	98	23	three	three	CD
cord-337302-fpz2jfuj	98	24	patients	patient	NNS
cord-337302-fpz2jfuj	98	25	died	die	VBD
cord-337302-fpz2jfuj	98	26	from	from	IN
cord-337302-fpz2jfuj	98	27	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	98	28	pneumonia	pneumonia	NN
cord-337302-fpz2jfuj	98	29	,	,	,
cord-337302-fpz2jfuj	98	30	indicating	indicate	VBG
cord-337302-fpz2jfuj	98	31	surgery	surgery	NN
cord-337302-fpz2jfuj	98	32	might	may	MD
cord-337302-fpz2jfuj	98	33	be	be	VB
cord-337302-fpz2jfuj	98	34	a	a	DT
cord-337302-fpz2jfuj	98	35	risk	risk	NN
cord-337302-fpz2jfuj	98	36	factor	factor	NN
cord-337302-fpz2jfuj	98	37	for	for	IN
cord-337302-fpz2jfuj	98	38	death	death	NN
cord-337302-fpz2jfuj	98	39	in	in	IN
cord-337302-fpz2jfuj	98	40	these	these	DT
cord-337302-fpz2jfuj	98	41	patients	patient	NNS
cord-337302-fpz2jfuj	98	42	.	.	.
cord-337302-fpz2jfuj	99	1	30	30	CD
cord-337302-fpz2jfuj	100	1	Similarly	similarly	RB
cord-337302-fpz2jfuj	100	2	,	,	,
cord-337302-fpz2jfuj	100	3	cancer	cancer	NN
cord-337302-fpz2jfuj	100	4	patients	patient	NNS
cord-337302-fpz2jfuj	100	5	with	with	IN
cord-337302-fpz2jfuj	100	6	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	100	7	were	be	VBD
cord-337302-fpz2jfuj	100	8	found	find	VBN
cord-337302-fpz2jfuj	100	9	to	to	TO
cord-337302-fpz2jfuj	100	10	have	have	VB
cord-337302-fpz2jfuj	100	11	a	a	DT
cord-337302-fpz2jfuj	100	12	higher	high	JJR
cord-337302-fpz2jfuj	100	13	risk	risk	NN
cord-337302-fpz2jfuj	100	14	of	of	IN
cord-337302-fpz2jfuj	100	15	severe	severe	JJ
cord-337302-fpz2jfuj	100	16	events	event	NNS
cord-337302-fpz2jfuj	100	17	(	(	-LRB-
cord-337302-fpz2jfuj	100	18	for	for	IN
cord-337302-fpz2jfuj	100	19	example	example	NN
cord-337302-fpz2jfuj	100	20	,	,	,
cord-337302-fpz2jfuj	100	21	need	need	VBP
cord-337302-fpz2jfuj	100	22	for	for	IN
cord-337302-fpz2jfuj	100	23	intensive	intensive	JJ
cord-337302-fpz2jfuj	100	24	care	care	NN
cord-337302-fpz2jfuj	100	25	unit	unit	NN
cord-337302-fpz2jfuj	100	26	and	and	CC
cord-337302-fpz2jfuj	100	27	invasive	invasive	JJ
cord-337302-fpz2jfuj	100	28	ventilation	ventilation	NN
cord-337302-fpz2jfuj	100	29	,	,	,
cord-337302-fpz2jfuj	100	30	or	or	CC
cord-337302-fpz2jfuj	100	31	even	even	RB
cord-337302-fpz2jfuj	100	32	death	death	NN
cord-337302-fpz2jfuj	100	33	)	)	-RRB-
cord-337302-fpz2jfuj	100	34	compared	compare	VBN
cord-337302-fpz2jfuj	100	35	with	with	IN
cord-337302-fpz2jfuj	100	36	patients	patient	NNS
cord-337302-fpz2jfuj	100	37	without	without	IN
cord-337302-fpz2jfuj	100	38	cancer	cancer	NN
cord-337302-fpz2jfuj	100	39	.	.	.
cord-337302-fpz2jfuj	101	1	31	31	CD
cord-337302-fpz2jfuj	102	1	Quantifying	quantify	VBG
cord-337302-fpz2jfuj	102	2	the	the	DT
cord-337302-fpz2jfuj	102	3	risks	risk	NNS
cord-337302-fpz2jfuj	102	4	of	of	IN
cord-337302-fpz2jfuj	102	5	COVID-19	covid-19	CD
cord-337302-fpz2jfuj	102	6	for	for	IN
cord-337302-fpz2jfuj	102	7	cancer	cancer	NN
cord-337302-fpz2jfuj	102	8	patients	patient	NNS
cord-337302-fpz2jfuj	102	9	hinges	hinge	NNS
cord-337302-fpz2jfuj	102	10	on	on	IN
cord-337302-fpz2jfuj	102	11	;	;	:
cord-337302-fpz2jfuj	102	12	the	the	DT
cord-337302-fpz2jfuj	102	13	absolute	absolute	JJ
cord-337302-fpz2jfuj	102	14	risk	risk	NN
cord-337302-fpz2jfuj	102	15	of	of	IN
cord-337302-fpz2jfuj	102	16	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	102	17	during	during	IN
cord-337302-fpz2jfuj	102	18	anticancer	anticancer	JJ
cord-337302-fpz2jfuj	102	19	therapy	therapy	NN
cord-337302-fpz2jfuj	102	20	and	and	CC
cord-337302-fpz2jfuj	102	21	the	the	DT
cord-337302-fpz2jfuj	102	22	additional	additional	JJ
cord-337302-fpz2jfuj	102	23	risk	risk	NN
cord-337302-fpz2jfuj	102	24	of	of	IN
cord-337302-fpz2jfuj	102	25	mortality	mortality	NN
cord-337302-fpz2jfuj	102	26	should	should	MD
cord-337302-fpz2jfuj	102	27	the	the	DT
cord-337302-fpz2jfuj	102	28	patient	patient	NN
cord-337302-fpz2jfuj	102	29	become	become	VB
cord-337302-fpz2jfuj	102	30	infected	infected	JJ
cord-337302-fpz2jfuj	102	31	.	.	.
cord-337302-fpz2jfuj	103	1	Because	because	IN
cord-337302-fpz2jfuj	103	2	of	of	IN
cord-337302-fpz2jfuj	103	3	resulting	result	VBG
cord-337302-fpz2jfuj	103	4	neutropenia	neutropenia	NN
cord-337302-fpz2jfuj	103	5	and	and	CC
cord-337302-fpz2jfuj	103	6	lymphopenia	lymphopenia	NNP
cord-337302-fpz2jfuj	103	7	and	and	CC
cord-337302-fpz2jfuj	103	8	interference	interference	NN
cord-337302-fpz2jfuj	103	9	with	with	IN
cord-337302-fpz2jfuj	103	10	both	both	DT
cord-337302-fpz2jfuj	103	11	innate	innate	JJ
cord-337302-fpz2jfuj	103	12	and	and	CC
cord-337302-fpz2jfuj	103	13	adaptive	adaptive	JJ
cord-337302-fpz2jfuj	103	14	immunity	immunity	NN
cord-337302-fpz2jfuj	103	15	from	from	IN
cord-337302-fpz2jfuj	103	16	cancer	cancer	NN
cord-337302-fpz2jfuj	103	17	drugs	drug	NNS
cord-337302-fpz2jfuj	103	18	,	,	,
cord-337302-fpz2jfuj	103	19	cancer	cancer	NN
cord-337302-fpz2jfuj	103	20	patients	patient	NNS
cord-337302-fpz2jfuj	103	21	can	can	MD
cord-337302-fpz2jfuj	103	22	have	have	VB
cord-337302-fpz2jfuj	103	23	a	a	DT
cord-337302-fpz2jfuj	103	24	worse	bad	JJR
cord-337302-fpz2jfuj	103	25	disease	disease	NN
cord-337302-fpz2jfuj	103	26	course	course	NN
cord-337302-fpz2jfuj	103	27	.	.	.
cord-337302-fpz2jfuj	104	1	32	32	CD
cord-337302-fpz2jfuj	105	1	In	in	IN
cord-337302-fpz2jfuj	105	2	a	a	DT
cord-337302-fpz2jfuj	105	3	pooled	pool	VBN
cord-337302-fpz2jfuj	105	4	analysis	analysis	NN
cord-337302-fpz2jfuj	105	5	by	by	IN
cord-337302-fpz2jfuj	105	6	Aakash	Aakash	NNP
cord-337302-fpz2jfuj	105	7	et	et	NNP
cord-337302-fpz2jfuj	105	8	al	al	NNP
cord-337302-fpz2jfuj	105	9	,	,	,
cord-337302-fpz2jfuj	105	10	a	a	DT
cord-337302-fpz2jfuj	105	11	2	2	CD
cord-337302-fpz2jfuj	105	12	%	%	NN
cord-337302-fpz2jfuj	105	13	cancer	cancer	NN
cord-337302-fpz2jfuj	105	14	prevalence	prevalence	NN
cord-337302-fpz2jfuj	105	15	was	be	VBD
cord-337302-fpz2jfuj	105	16	found	find	VBN
cord-337302-fpz2jfuj	105	17	among	among	IN
cord-337302-fpz2jfuj	105	18	admitted	admit	VBN
cord-337302-fpz2jfuj	105	19	patients	patient	NNS
cord-337302-fpz2jfuj	105	20	with	with	IN
cord-337302-fpz2jfuj	105	21	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	105	22	.	.	.
cord-337302-fpz2jfuj	106	1	33	33	CD
cord-337302-fpz2jfuj	107	1	Alarmingly	alarmingly	RB
cord-337302-fpz2jfuj	107	2	,	,	,
cord-337302-fpz2jfuj	107	3	even	even	RB
cord-337302-fpz2jfuj	107	4	a	a	DT
cord-337302-fpz2jfuj	107	5	past	past	JJ
cord-337302-fpz2jfuj	107	6	medical	medical	JJ
cord-337302-fpz2jfuj	107	7	history	history	NN
cord-337302-fpz2jfuj	107	8	of	of	IN
cord-337302-fpz2jfuj	107	9	cancer	cancer	NN
cord-337302-fpz2jfuj	107	10	in	in	IN
cord-337302-fpz2jfuj	107	11	the	the	DT
cord-337302-fpz2jfuj	107	12	setting	setting	NN
cord-337302-fpz2jfuj	107	13	of	of	IN
cord-337302-fpz2jfuj	107	14	cancer	cancer	NN
cord-337302-fpz2jfuj	107	15	survivors	survivor	NNS
cord-337302-fpz2jfuj	107	16	seemed	seem	VBD
cord-337302-fpz2jfuj	107	17	to	to	TO
cord-337302-fpz2jfuj	107	18	increase	increase	VB
cord-337302-fpz2jfuj	107	19	the	the	DT
cord-337302-fpz2jfuj	107	20	risk	risk	NN
cord-337302-fpz2jfuj	107	21	for	for	IN
cord-337302-fpz2jfuj	107	22	poor	poor	JJ
cord-337302-fpz2jfuj	107	23	outcomes	outcome	NNS
cord-337302-fpz2jfuj	107	24	due	due	JJ
cord-337302-fpz2jfuj	107	25	to	to	IN
cord-337302-fpz2jfuj	107	26	possible	possible	JJ
cord-337302-fpz2jfuj	107	27	immune	immune	JJ
cord-337302-fpz2jfuj	107	28	status	status	NN
cord-337302-fpz2jfuj	107	29	.	.	.
cord-337302-fpz2jfuj	108	1	However	however	RB
cord-337302-fpz2jfuj	108	2	,	,	,
cord-337302-fpz2jfuj	108	3	this	this	DT
cord-337302-fpz2jfuj	108	4	could	could	MD
cord-337302-fpz2jfuj	108	5	be	be	VB
cord-337302-fpz2jfuj	108	6	a	a	DT
cord-337302-fpz2jfuj	108	7	confounding	confounding	JJ
cord-337302-fpz2jfuj	108	8	factor	factor	NN
cord-337302-fpz2jfuj	108	9	related	relate	VBN
cord-337302-fpz2jfuj	108	10	to	to	IN
cord-337302-fpz2jfuj	108	11	old	old	JJ
cord-337302-fpz2jfuj	108	12	age	age	NN
cord-337302-fpz2jfuj	108	13	.	.	.
cord-337302-fpz2jfuj	109	1	19	19	CD
cord-337302-fpz2jfuj	109	2	A	a	DT
cord-337302-fpz2jfuj	109	3	case	case	NN
cord-337302-fpz2jfuj	109	4	report	report	NN
cord-337302-fpz2jfuj	109	5	from	from	IN
cord-337302-fpz2jfuj	109	6	Wenzhou	Wenzhou	NNP
cord-337302-fpz2jfuj	109	7	,	,	,
cord-337302-fpz2jfuj	109	8	China	China	NNP
cord-337302-fpz2jfuj	109	9	of	of	IN
cord-337302-fpz2jfuj	109	10	a	a	DT
cord-337302-fpz2jfuj	109	11	39-year	39-year	JJ
cord-337302-fpz2jfuj	109	12	-	-	HYPH
cord-337302-fpz2jfuj	109	13	old	old	JJ
cord-337302-fpz2jfuj	109	14	gentleman	gentleman	NN
cord-337302-fpz2jfuj	109	15	previously	previously	RB
cord-337302-fpz2jfuj	109	16	treated	treat	VBN
cord-337302-fpz2jfuj	109	17	for	for	IN
cord-337302-fpz2jfuj	109	18	non	non	JJ
cord-337302-fpz2jfuj	109	19	-	-	JJ
cord-337302-fpz2jfuj	109	20	Hodgkin	hodgkin	JJ
cord-337302-fpz2jfuj	109	21	lymphoma	lymphoma	NN
cord-337302-fpz2jfuj	109	22	and	and	CC
cord-337302-fpz2jfuj	109	23	chronic	chronic	JJ
cord-337302-fpz2jfuj	109	24	lymphocytic	lymphocytic	JJ
cord-337302-fpz2jfuj	109	25	leukemia	leukemia	NN
cord-337302-fpz2jfuj	109	26	(	(	-LRB-
cord-337302-fpz2jfuj	109	27	CLL	CLL	NNP
cord-337302-fpz2jfuj	109	28	)	)	-RRB-
cord-337302-fpz2jfuj	109	29	,	,	,
cord-337302-fpz2jfuj	109	30	was	be	VBD
cord-337302-fpz2jfuj	109	31	found	find	VBN
cord-337302-fpz2jfuj	109	32	to	to	TO
cord-337302-fpz2jfuj	109	33	have	have	VB
cord-337302-fpz2jfuj	109	34	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	109	35	,	,	,
cord-337302-fpz2jfuj	109	36	after	after	IN
cord-337302-fpz2jfuj	109	37	presenting	present	VBG
cord-337302-fpz2jfuj	109	38	with	with	IN
cord-337302-fpz2jfuj	109	39	atypical	atypical	JJ
cord-337302-fpz2jfuj	109	40	symptoms	symptom	NNS
cord-337302-fpz2jfuj	109	41	.	.	.
cord-337302-fpz2jfuj	110	1	The	the	DT
cord-337302-fpz2jfuj	110	2	authors	author	NNS
cord-337302-fpz2jfuj	110	3	conclude	conclude	VBP
cord-337302-fpz2jfuj	110	4	that	that	IN
cord-337302-fpz2jfuj	110	5	the	the	DT
cord-337302-fpz2jfuj	110	6	patient	patient	NN
cord-337302-fpz2jfuj	110	7	's	's	POS
cord-337302-fpz2jfuj	110	8	compromised	compromised	JJ
cord-337302-fpz2jfuj	110	9	weak	weak	JJ
cord-337302-fpz2jfuj	110	10	immune	immune	JJ
cord-337302-fpz2jfuj	110	11	system	system	NN
cord-337302-fpz2jfuj	110	12	and	and	CC
cord-337302-fpz2jfuj	110	13	CLL	CLL	NNP
cord-337302-fpz2jfuj	110	14	masked	mask	VBD
cord-337302-fpz2jfuj	110	15	the	the	DT
cord-337302-fpz2jfuj	110	16	infection	infection	NN
cord-337302-fpz2jfuj	110	17	.	.	.
cord-337302-fpz2jfuj	111	1	34	34	CD
cord-337302-fpz2jfuj	112	1	Another	another	DT
cord-337302-fpz2jfuj	112	2	case	case	NN
cord-337302-fpz2jfuj	112	3	report	report	NN
cord-337302-fpz2jfuj	112	4	from	from	IN
cord-337302-fpz2jfuj	112	5	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	112	6	of	of	IN
cord-337302-fpz2jfuj	112	7	a	a	DT
cord-337302-fpz2jfuj	112	8	multiple	multiple	JJ
cord-337302-fpz2jfuj	112	9	myeloma	myeloma	NN
cord-337302-fpz2jfuj	112	10	patient	patient	NN
cord-337302-fpz2jfuj	112	11	who	who	WP
cord-337302-fpz2jfuj	112	12	presented	present	VBD
cord-337302-fpz2jfuj	112	13	with	with	IN
cord-337302-fpz2jfuj	112	14	solitary	solitary	JJ
cord-337302-fpz2jfuj	112	15	chest	chest	NN
cord-337302-fpz2jfuj	112	16	tightness	tightness	NN
cord-337302-fpz2jfuj	112	17	was	be	VBD
cord-337302-fpz2jfuj	112	18	diagnosed	diagnose	VBN
cord-337302-fpz2jfuj	112	19	with	with	IN
cord-337302-fpz2jfuj	112	20	COVID	COVID	NNP
cord-337302-fpz2jfuj	112	21	and	and	CC
cord-337302-fpz2jfuj	112	22	successfully	successfully	RB
cord-337302-fpz2jfuj	112	23	treated	treat	VBN
cord-337302-fpz2jfuj	112	24	with	with	IN
cord-337302-fpz2jfuj	112	25	tocilizumab	tocilizumab	NNP
cord-337302-fpz2jfuj	112	26	.	.	.
cord-337302-fpz2jfuj	113	1	35	35	CD
cord-337302-fpz2jfuj	114	1	A	a	DT
cord-337302-fpz2jfuj	114	2	lung	lung	NN
cord-337302-fpz2jfuj	114	3	cancer	cancer	NN
cord-337302-fpz2jfuj	114	4	case	case	NN
cord-337302-fpz2jfuj	114	5	on	on	IN
cord-337302-fpz2jfuj	114	6	long	long	JJ
cord-337302-fpz2jfuj	114	7	-	-	HYPH
cord-337302-fpz2jfuj	114	8	term	term	NN
cord-337302-fpz2jfuj	114	9	Nivolumab	Nivolumab	NNP
cord-337302-fpz2jfuj	114	10	therapy	therapy	NN
cord-337302-fpz2jfuj	114	11	,	,	,
cord-337302-fpz2jfuj	114	12	a	a	DT
cord-337302-fpz2jfuj	114	13	sudden	sudden	JJ
cord-337302-fpz2jfuj	114	14	severe	severe	JJ
cord-337302-fpz2jfuj	114	15	interstitial	interstitial	JJ
cord-337302-fpz2jfuj	114	16	pneumonitis	pneumonitis	NN
cord-337302-fpz2jfuj	114	17	during	during	IN
cord-337302-fpz2jfuj	114	18	treatment	treatment	NN
cord-337302-fpz2jfuj	114	19	was	be	VBD
cord-337302-fpz2jfuj	114	20	noticed	notice	VBN
cord-337302-fpz2jfuj	114	21	,	,	,
cord-337302-fpz2jfuj	114	22	and	and	CC
cord-337302-fpz2jfuj	114	23	the	the	DT
cord-337302-fpz2jfuj	114	24	patient	patient	NN
cord-337302-fpz2jfuj	114	25	later	later	RB
cord-337302-fpz2jfuj	114	26	tested	test	VBD
cord-337302-fpz2jfuj	114	27	positive	positive	JJ
cord-337302-fpz2jfuj	114	28	for	for	IN
cord-337302-fpz2jfuj	114	29	SARS	SARS	NNP
cord-337302-fpz2jfuj	114	30	-	-	HYPH
cord-337302-fpz2jfuj	114	31	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	114	32	.	.	.
cord-337302-fpz2jfuj	115	1	Immunotherapy	immunotherapy	NN
cord-337302-fpz2jfuj	115	2	related	relate	VBN
cord-337302-fpz2jfuj	115	3	pneumonitis	pneumonitis	NN
cord-337302-fpz2jfuj	115	4	usually	usually	RB
cord-337302-fpz2jfuj	115	5	occurs	occur	VBZ
cord-337302-fpz2jfuj	115	6	during	during	IN
cord-337302-fpz2jfuj	115	7	the	the	DT
cord-337302-fpz2jfuj	115	8	first	first	JJ
cord-337302-fpz2jfuj	115	9	3	3	CD
cord-337302-fpz2jfuj	115	10	months	month	NNS
cord-337302-fpz2jfuj	115	11	of	of	IN
cord-337302-fpz2jfuj	115	12	therapy	therapy	NN
cord-337302-fpz2jfuj	115	13	,	,	,
cord-337302-fpz2jfuj	115	14	and	and	CC
cord-337302-fpz2jfuj	115	15	the	the	DT
cord-337302-fpz2jfuj	115	16	sudden	sudden	JJ
cord-337302-fpz2jfuj	115	17	onset	onset	NN
cord-337302-fpz2jfuj	115	18	could	could	MD
cord-337302-fpz2jfuj	115	19	be	be	VB
cord-337302-fpz2jfuj	115	20	attributed	attribute	VBN
cord-337302-fpz2jfuj	115	21	to	to	IN
cord-337302-fpz2jfuj	115	22	the	the	DT
cord-337302-fpz2jfuj	115	23	negative	negative	JJ
cord-337302-fpz2jfuj	115	24	synergy	synergy	NN
cord-337302-fpz2jfuj	115	25	of	of	IN
cord-337302-fpz2jfuj	115	26	the	the	DT
cord-337302-fpz2jfuj	115	27	36	36	CD
cord-337302-fpz2jfuj	115	28	A	a	DT
cord-337302-fpz2jfuj	115	29	pan	pan	JJ
cord-337302-fpz2jfuj	115	30	-	-	JJ
cord-337302-fpz2jfuj	115	31	cancer	cancer	NN
cord-337302-fpz2jfuj	115	32	analysis	analysis	NN
cord-337302-fpz2jfuj	115	33	by	by	IN
cord-337302-fpz2jfuj	115	34	Cai	Cai	NNP
cord-337302-fpz2jfuj	115	35	et	et	FW
cord-337302-fpz2jfuj	115	36	al	al	NNP
cord-337302-fpz2jfuj	115	37	that	that	WDT
cord-337302-fpz2jfuj	115	38	looked	look	VBD
cord-337302-fpz2jfuj	115	39	at	at	IN
cord-337302-fpz2jfuj	115	40	cancer	cancer	NN
cord-337302-fpz2jfuj	115	41	types	type	NNS
cord-337302-fpz2jfuj	115	42	with	with	IN
cord-337302-fpz2jfuj	115	43	the	the	DT
cord-337302-fpz2jfuj	115	44	highest	high	JJS
cord-337302-fpz2jfuj	115	45	risk	risk	NN
cord-337302-fpz2jfuj	115	46	for	for	IN
cord-337302-fpz2jfuj	115	47	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	115	48	found	find	VBD
cord-337302-fpz2jfuj	115	49	that	that	IN
cord-337302-fpz2jfuj	115	50	endometrial	endometrial	JJ
cord-337302-fpz2jfuj	115	51	carcinoma	carcinoma	NN
cord-337302-fpz2jfuj	115	52	expressed	express	VBD
cord-337302-fpz2jfuj	115	53	both	both	DT
cord-337302-fpz2jfuj	115	54	Transmembrane	Transmembrane	NNP
cord-337302-fpz2jfuj	115	55	Protease	Protease	NNP
cord-337302-fpz2jfuj	115	56	Serine	Serine	NNP
cord-337302-fpz2jfuj	115	57	2	2	CD
cord-337302-fpz2jfuj	115	58	(	(	-LRB-
cord-337302-fpz2jfuj	115	59	TMPRSS2	TMPRSS2	NNP
cord-337302-fpz2jfuj	115	60	)	)	-RRB-
cord-337302-fpz2jfuj	115	61	and	and	CC
cord-337302-fpz2jfuj	115	62	Angiotensin	Angiotensin	NNP
cord-337302-fpz2jfuj	115	63	-	-	HYPH
cord-337302-fpz2jfuj	115	64	Converting	convert	VBG
cord-337302-fpz2jfuj	115	65	Enzyme	Enzyme	NNP
cord-337302-fpz2jfuj	115	66	2	2	CD
cord-337302-fpz2jfuj	115	67	(	(	-LRB-
cord-337302-fpz2jfuj	115	68	ACE2	ACE2	NNP
cord-337302-fpz2jfuj	115	69	)	)	-RRB-
cord-337302-fpz2jfuj	115	70	receptors	receptor	NNS
cord-337302-fpz2jfuj	115	71	which	which	WDT
cord-337302-fpz2jfuj	115	72	are	be	VBP
cord-337302-fpz2jfuj	115	73	launching	launch	VBG
cord-337302-fpz2jfuj	115	74	pads	pad	NNS
cord-337302-fpz2jfuj	115	75	for	for	IN
cord-337302-fpz2jfuj	115	76	SARS	SARS	NNP
cord-337302-fpz2jfuj	115	77	-	-	HYPH
cord-337302-fpz2jfuj	115	78	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	115	79	.	.	.
cord-337302-fpz2jfuj	116	1	Therefore	therefore	RB
cord-337302-fpz2jfuj	116	2	,	,	,
cord-337302-fpz2jfuj	116	3	these	these	DT
cord-337302-fpz2jfuj	116	4	subgroups	subgroup	NNS
cord-337302-fpz2jfuj	116	5	of	of	IN
cord-337302-fpz2jfuj	116	6	cancer	cancer	NN
cord-337302-fpz2jfuj	116	7	patients	patient	NNS
cord-337302-fpz2jfuj	116	8	could	could	MD
cord-337302-fpz2jfuj	116	9	be	be	VB
cord-337302-fpz2jfuj	116	10	at	at	IN
cord-337302-fpz2jfuj	116	11	higher	high	JJR
cord-337302-fpz2jfuj	116	12	risk	risk	NN
cord-337302-fpz2jfuj	116	13	.	.	.
cord-337302-fpz2jfuj	117	1	37	37	CD
cord-337302-fpz2jfuj	118	1	In	in	IN
cord-337302-fpz2jfuj	118	2	New	New	NNP
cord-337302-fpz2jfuj	118	3	York	York	NNP
cord-337302-fpz2jfuj	118	4	,	,	,
cord-337302-fpz2jfuj	118	5	a	a	DT
cord-337302-fpz2jfuj	118	6	total	total	NN
cord-337302-fpz2jfuj	118	7	of	of	IN
cord-337302-fpz2jfuj	118	8	61	61	CD
cord-337302-fpz2jfuj	118	9	cancer	cancer	NN
cord-337302-fpz2jfuj	118	10	patients	patient	NNS
cord-337302-fpz2jfuj	118	11	succumbed	succumb	VBD
cord-337302-fpz2jfuj	118	12	to	to	IN
cord-337302-fpz2jfuj	118	13	COVID-19	covid-19	VB
cord-337302-fpz2jfuj	118	14	with	with	IN
cord-337302-fpz2jfuj	118	15	a	a	DT
cord-337302-fpz2jfuj	118	16	case	case	NN
cord-337302-fpz2jfuj	118	17	fatality	fatality	NN
cord-337302-fpz2jfuj	118	18	rate	rate	NN
cord-337302-fpz2jfuj	118	19	of	of	IN
cord-337302-fpz2jfuj	118	20	37	37	CD
cord-337302-fpz2jfuj	118	21	%	%	NN
cord-337302-fpz2jfuj	118	22	(	(	-LRB-
cord-337302-fpz2jfuj	118	23	20/54	20/54	CD
cord-337302-fpz2jfuj	118	24	)	)	-RRB-
cord-337302-fpz2jfuj	118	25	and	and	CC
cord-337302-fpz2jfuj	118	26	25	25	CD
cord-337302-fpz2jfuj	118	27	%	%	NN
cord-337302-fpz2jfuj	118	28	(	(	-LRB-
cord-337302-fpz2jfuj	118	29	41/164	41/164	CD
cord-337302-fpz2jfuj	118	30	)	)	-RRB-
cord-337302-fpz2jfuj	118	31	for	for	IN
cord-337302-fpz2jfuj	118	32	hematologic	hematologic	JJ
cord-337302-fpz2jfuj	118	33	and	and	CC
cord-337302-fpz2jfuj	118	34	solid	solid	JJ
cord-337302-fpz2jfuj	118	35	malignancies	malignancy	NNS
cord-337302-fpz2jfuj	118	36	,	,	,
cord-337302-fpz2jfuj	118	37	respectively	respectively	RB
cord-337302-fpz2jfuj	118	38	.	.	.
cord-337302-fpz2jfuj	119	1	Using	use	VBG
cord-337302-fpz2jfuj	119	2	multivariate	multivariate	JJ
cord-337302-fpz2jfuj	119	3	analysis	analysis	NN
cord-337302-fpz2jfuj	119	4	,	,	,
cord-337302-fpz2jfuj	119	5	older	old	JJR
cord-337302-fpz2jfuj	119	6	age	age	NN
cord-337302-fpz2jfuj	119	7	,	,	,
cord-337302-fpz2jfuj	119	8	comorbidities	comorbiditie	NNS
cord-337302-fpz2jfuj	119	9	,	,	,
cord-337302-fpz2jfuj	119	10	increased	increase	VBN
cord-337302-fpz2jfuj	119	11	levels	level	NNS
cord-337302-fpz2jfuj	119	12	of	of	IN
cord-337302-fpz2jfuj	119	13	lactate	lactate	NN
cord-337302-fpz2jfuj	119	14	,	,	,
cord-337302-fpz2jfuj	119	15	and	and	CC
cord-337302-fpz2jfuj	119	16	need	need	VBP
cord-337302-fpz2jfuj	119	17	for	for	IN
cord-337302-fpz2jfuj	119	18	intensive	intensive	JJ
cord-337302-fpz2jfuj	119	19	care	care	NN
cord-337302-fpz2jfuj	119	20	were	be	VBD
cord-337302-fpz2jfuj	119	21	associated	associate	VBN
cord-337302-fpz2jfuj	119	22	with	with	IN
cord-337302-fpz2jfuj	119	23	worse	bad	JJR
cord-337302-fpz2jfuj	119	24	outcomes	outcome	NNS
cord-337302-fpz2jfuj	119	25	.	.	.
cord-337302-fpz2jfuj	120	1	38	38	CD
cord-337302-fpz2jfuj	120	2	Report	report	NN
cord-337302-fpz2jfuj	120	3	from	from	IN
cord-337302-fpz2jfuj	120	4	the	the	DT
cord-337302-fpz2jfuj	120	5	Superior	Superior	NNP
cord-337302-fpz2jfuj	120	6	Institute	Institute	NNP
cord-337302-fpz2jfuj	120	7	of	of	IN
cord-337302-fpz2jfuj	120	8	Health	Health	NNP
cord-337302-fpz2jfuj	120	9	in	in	IN
cord-337302-fpz2jfuj	120	10	Italy	Italy	NNP
cord-337302-fpz2jfuj	120	11	shows	show	VBZ
cord-337302-fpz2jfuj	120	12	that	that	IN
cord-337302-fpz2jfuj	120	13	3200	3200	CD
cord-337302-fpz2jfuj	120	14	patients	patient	NNS
cord-337302-fpz2jfuj	120	15	who	who	WP
cord-337302-fpz2jfuj	120	16	died	die	VBD
cord-337302-fpz2jfuj	120	17	of	of	IN
cord-337302-fpz2jfuj	120	18	SARS	SARS	NNP
cord-337302-fpz2jfuj	120	19	-	-	HYPH
cord-337302-fpz2jfuj	120	20	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	120	21	,	,	,
cord-337302-fpz2jfuj	120	22	19.4	19.4	CD
cord-337302-fpz2jfuj	120	23	%	%	NN
cord-337302-fpz2jfuj	120	24	were	be	VBD
cord-337302-fpz2jfuj	120	25	patients	patient	NNS
cord-337302-fpz2jfuj	120	26	with	with	IN
cord-337302-fpz2jfuj	120	27	cancer	cancer	NN
cord-337302-fpz2jfuj	120	28	.	.	.
cord-337302-fpz2jfuj	121	1	The	the	DT
cord-337302-fpz2jfuj	121	2	report	report	NN
cord-337302-fpz2jfuj	121	3	further	further	RB
cord-337302-fpz2jfuj	121	4	indicates	indicate	VBZ
cord-337302-fpz2jfuj	121	5	,	,	,
cord-337302-fpz2jfuj	121	6	old	old	JJ
cord-337302-fpz2jfuj	121	7	age	age	NN
cord-337302-fpz2jfuj	121	8	and	and	CC
cord-337302-fpz2jfuj	121	9	other	other	JJ
cord-337302-fpz2jfuj	121	10	comorbidities	comorbiditie	NNS
cord-337302-fpz2jfuj	121	11	to	to	TO
cord-337302-fpz2jfuj	121	12	have	have	VB
cord-337302-fpz2jfuj	121	13	contributed	contribute	VBN
cord-337302-fpz2jfuj	121	14	to	to	IN
cord-337302-fpz2jfuj	121	15	these	these	DT
cord-337302-fpz2jfuj	121	16	adverse	adverse	JJ
cord-337302-fpz2jfuj	121	17	outcomes	outcome	NNS
cord-337302-fpz2jfuj	121	18	.	.	.
cord-337302-fpz2jfuj	122	1	39	39	CD
cord-337302-fpz2jfuj	123	1	Therefore	therefore	RB
cord-337302-fpz2jfuj	123	2	,	,	,
cord-337302-fpz2jfuj	123	3	a	a	DT
cord-337302-fpz2jfuj	123	4	risk	risk	NN
cord-337302-fpz2jfuj	123	5	-	-	HYPH
cord-337302-fpz2jfuj	123	6	benefit	benefit	NN
cord-337302-fpz2jfuj	123	7	analysis	analysis	NN
cord-337302-fpz2jfuj	123	8	of	of	IN
cord-337302-fpz2jfuj	123	9	systemic	systemic	JJ
cord-337302-fpz2jfuj	123	10	treatment	treatment	NN
cord-337302-fpz2jfuj	123	11	should	should	MD
cord-337302-fpz2jfuj	123	12	be	be	VB
cord-337302-fpz2jfuj	123	13	considered	consider	VBN
cord-337302-fpz2jfuj	123	14	in	in	IN
cord-337302-fpz2jfuj	123	15	this	this	DT
cord-337302-fpz2jfuj	123	16	patient	patient	NN
cord-337302-fpz2jfuj	123	17	group	group	NN
cord-337302-fpz2jfuj	123	18	,	,	,
cord-337302-fpz2jfuj	123	19	and	and	CC
cord-337302-fpz2jfuj	123	20	factors	factor	NNS
cord-337302-fpz2jfuj	123	21	like	like	IN
cord-337302-fpz2jfuj	123	22	age	age	NN
cord-337302-fpz2jfuj	123	23	>	>	XX
cord-337302-fpz2jfuj	123	24	70	70	CD
cord-337302-fpz2jfuj	123	25	,	,	,
cord-337302-fpz2jfuj	123	26	comorbidities	comorbiditie	NNS
cord-337302-fpz2jfuj	123	27	and	and	CC
cord-337302-fpz2jfuj	123	28	the	the	DT
cord-337302-fpz2jfuj	123	29	number	number	NN
cord-337302-fpz2jfuj	123	30	of	of	IN
cord-337302-fpz2jfuj	123	31	treatment	treatment	NN
cord-337302-fpz2jfuj	123	32	visits	visit	NNS
cord-337302-fpz2jfuj	123	33	required	require	VBN
cord-337302-fpz2jfuj	123	34	should	should	MD
cord-337302-fpz2jfuj	123	35	inform	inform	VB
cord-337302-fpz2jfuj	123	36	decisions	decision	NNS
cord-337302-fpz2jfuj	123	37	.	.	.
cord-337302-fpz2jfuj	124	1	40	40	CD
cord-337302-fpz2jfuj	124	2	Immunotherapy	Immunotherapy	NNP
cord-337302-fpz2jfuj	124	3	,	,	,
cord-337302-fpz2jfuj	124	4	as	as	IN
cord-337302-fpz2jfuj	124	5	one	one	CD
cord-337302-fpz2jfuj	124	6	of	of	IN
cord-337302-fpz2jfuj	124	7	the	the	DT
cord-337302-fpz2jfuj	124	8	armamentariums	armamentarium	NNS
cord-337302-fpz2jfuj	124	9	of	of	IN
cord-337302-fpz2jfuj	124	10	cancer	cancer	NN
cord-337302-fpz2jfuj	124	11	treatments	treatment	NNS
cord-337302-fpz2jfuj	124	12	,	,	,
cord-337302-fpz2jfuj	124	13	usually	usually	RB
cord-337302-fpz2jfuj	124	14	comes	come	VBZ
cord-337302-fpz2jfuj	124	15	with	with	IN
cord-337302-fpz2jfuj	124	16	immune	immune	NN
cord-337302-fpz2jfuj	124	17	-	-	HYPH
cord-337302-fpz2jfuj	124	18	related	relate	VBN
cord-337302-fpz2jfuj	124	19	adverse	adverse	JJ
cord-337302-fpz2jfuj	124	20	events	event	NNS
cord-337302-fpz2jfuj	124	21	in	in	IN
cord-337302-fpz2jfuj	124	22	a	a	DT
cord-337302-fpz2jfuj	124	23	subset	subset	NN
cord-337302-fpz2jfuj	124	24	of	of	IN
cord-337302-fpz2jfuj	124	25	patients	patient	NNS
cord-337302-fpz2jfuj	124	26	.	.	.
cord-337302-fpz2jfuj	125	1	Immune	immune	JJ
cord-337302-fpz2jfuj	125	2	checkpoint	checkpoint	NN
cord-337302-fpz2jfuj	125	3	inhibitors	inhibitor	NNS
cord-337302-fpz2jfuj	125	4	(	(	-LRB-
cord-337302-fpz2jfuj	125	5	ICI	ICI	NNP
cord-337302-fpz2jfuj	125	6	)	)	-RRB-
cord-337302-fpz2jfuj	125	7	are	be	VBP
cord-337302-fpz2jfuj	125	8	commonly	commonly	RB
cord-337302-fpz2jfuj	125	9	used	use	VBN
cord-337302-fpz2jfuj	125	10	to	to	TO
cord-337302-fpz2jfuj	125	11	treat	treat	VB
cord-337302-fpz2jfuj	125	12	solid	solid	JJ
cord-337302-fpz2jfuj	125	13	tumors	tumor	NNS
cord-337302-fpz2jfuj	125	14	such	such	JJ
cord-337302-fpz2jfuj	125	15	as	as	IN
cord-337302-fpz2jfuj	125	16	melanoma	melanoma	NN
cord-337302-fpz2jfuj	125	17	,	,	,
cord-337302-fpz2jfuj	125	18	lung	lung	NN
cord-337302-fpz2jfuj	125	19	cancer	cancer	NN
cord-337302-fpz2jfuj	125	20	,	,	,
cord-337302-fpz2jfuj	125	21	renal	renal	JJ
cord-337302-fpz2jfuj	125	22	carcinoma	carcinoma	NN
cord-337302-fpz2jfuj	125	23	,	,	,
cord-337302-fpz2jfuj	125	24	urothelial	urothelial	JJ
cord-337302-fpz2jfuj	125	25	cancers	cancer	NNS
cord-337302-fpz2jfuj	125	26	,	,	,
cord-337302-fpz2jfuj	125	27	and	and	CC
cord-337302-fpz2jfuj	125	28	head	head	NN
cord-337302-fpz2jfuj	125	29	and	and	CC
cord-337302-fpz2jfuj	125	30	neck	neck	NN
cord-337302-fpz2jfuj	125	31	tumors	tumor	NNS
cord-337302-fpz2jfuj	125	32	.	.	.
cord-337302-fpz2jfuj	126	1	41	41	CD
cord-337302-fpz2jfuj	127	1	However	however	RB
cord-337302-fpz2jfuj	127	2	,	,	,
cord-337302-fpz2jfuj	127	3	the	the	DT
cord-337302-fpz2jfuj	127	4	susceptibility	susceptibility	NN
cord-337302-fpz2jfuj	127	5	of	of	IN
cord-337302-fpz2jfuj	127	6	this	this	DT
cord-337302-fpz2jfuj	127	7	subset	subset	NN
cord-337302-fpz2jfuj	127	8	of	of	IN
cord-337302-fpz2jfuj	127	9	patients	patient	NNS
cord-337302-fpz2jfuj	127	10	to	to	TO
cord-337302-fpz2jfuj	127	11	contract	contract	VB
cord-337302-fpz2jfuj	127	12	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	127	13	or	or	CC
cord-337302-fpz2jfuj	127	14	other	other	JJ
cord-337302-fpz2jfuj	127	15	bacterial	bacterial	JJ
cord-337302-fpz2jfuj	127	16	,	,	,
cord-337302-fpz2jfuj	127	17	viral	viral	JJ
cord-337302-fpz2jfuj	127	18	infections	infection	NNS
cord-337302-fpz2jfuj	127	19	has	have	VBZ
cord-337302-fpz2jfuj	127	20	not	not	RB
cord-337302-fpz2jfuj	127	21	been	be	VBN
cord-337302-fpz2jfuj	127	22	well	well	RB
cord-337302-fpz2jfuj	127	23	studied	study	VBN
cord-337302-fpz2jfuj	127	24	.	.	.
cord-337302-fpz2jfuj	128	1	Granted	grant	VBN
cord-337302-fpz2jfuj	128	2	that	that	IN
cord-337302-fpz2jfuj	128	3	immunotherapy	immunotherapy	NN
cord-337302-fpz2jfuj	128	4	restores	restore	VBZ
cord-337302-fpz2jfuj	128	5	the	the	DT
cord-337302-fpz2jfuj	128	6	cellular	cellular	JJ
cord-337302-fpz2jfuj	128	7	immunocompetence	immunocompetence	NN
cord-337302-fpz2jfuj	128	8	of	of	IN
cord-337302-fpz2jfuj	128	9	these	these	DT
cord-337302-fpz2jfuj	128	10	patients	patient	NNS
cord-337302-fpz2jfuj	128	11	,	,	,
cord-337302-fpz2jfuj	128	12	there	there	EX
cord-337302-fpz2jfuj	128	13	could	could	MD
cord-337302-fpz2jfuj	128	14	be	be	VB
cord-337302-fpz2jfuj	128	15	a	a	DT
cord-337302-fpz2jfuj	128	16	plausible	plausible	JJ
cord-337302-fpz2jfuj	128	17	theory	theory	NN
cord-337302-fpz2jfuj	128	18	that	that	IN
cord-337302-fpz2jfuj	128	19	they	-PRON-	PRP
cord-337302-fpz2jfuj	128	20	are	be	VBP
cord-337302-fpz2jfuj	128	21	maybe	maybe	RB
cord-337302-fpz2jfuj	128	22	more	more	RBR
cord-337302-fpz2jfuj	128	23	immunocompetent	immunocompetent	JJ
cord-337302-fpz2jfuj	128	24	as	as	IN
cord-337302-fpz2jfuj	128	25	compared	compare	VBN
cord-337302-fpz2jfuj	128	26	with	with	IN
cord-337302-fpz2jfuj	128	27	patients	patient	NNS
cord-337302-fpz2jfuj	128	28	undergoing	undergo	VBG
cord-337302-fpz2jfuj	128	29	radiotherapy	radiotherapy	NN
cord-337302-fpz2jfuj	128	30	or	or	CC
cord-337302-fpz2jfuj	128	31	chemotherapy	chemotherapy	NN
cord-337302-fpz2jfuj	128	32	.	.	.
cord-337302-fpz2jfuj	129	1	42	42	CD
cord-337302-fpz2jfuj	130	1	In	in	IN
cord-337302-fpz2jfuj	130	2	an	an	DT
cord-337302-fpz2jfuj	130	3	analysis	analysis	NN
cord-337302-fpz2jfuj	130	4	that	that	WDT
cord-337302-fpz2jfuj	130	5	sort	sort	VBP
cord-337302-fpz2jfuj	130	6	to	to	TO
cord-337302-fpz2jfuj	130	7	look	look	VB
cord-337302-fpz2jfuj	130	8	for	for	IN
cord-337302-fpz2jfuj	130	9	the	the	DT
cord-337302-fpz2jfuj	130	10	correlation	correlation	NN
cord-337302-fpz2jfuj	130	11	between	between	IN
cord-337302-fpz2jfuj	130	12	the	the	DT
cord-337302-fpz2jfuj	130	13	history	history	NN
cord-337302-fpz2jfuj	130	14	of	of	IN
cord-337302-fpz2jfuj	130	15	immunotherapy	immunotherapy	NN
cord-337302-fpz2jfuj	130	16	drugs	drug	NNS
cord-337302-fpz2jfuj	130	17	in	in	IN
cord-337302-fpz2jfuj	130	18	lung	lung	NN
cord-337302-fpz2jfuj	130	19	cancer	cancer	NN
cord-337302-fpz2jfuj	130	20	patients	patient	NNS
cord-337302-fpz2jfuj	130	21	,	,	,
cord-337302-fpz2jfuj	130	22	the	the	DT
cord-337302-fpz2jfuj	130	23	authors	author	NNS
cord-337302-fpz2jfuj	130	24	did	do	VBD
cord-337302-fpz2jfuj	130	25	not	not	RB
cord-337302-fpz2jfuj	130	26	find	find	VB
cord-337302-fpz2jfuj	130	27	any	any	DT
cord-337302-fpz2jfuj	130	28	evidence	evidence	NN
cord-337302-fpz2jfuj	130	29	even	even	RB
cord-337302-fpz2jfuj	130	30	when	when	WRB
cord-337302-fpz2jfuj	130	31	adjusted	adjust	VBN
cord-337302-fpz2jfuj	130	32	for	for	IN
cord-337302-fpz2jfuj	130	33	smoking	smoke	VBG
cord-337302-fpz2jfuj	130	34	history	history	NN
cord-337302-fpz2jfuj	130	35	status	status	NN
cord-337302-fpz2jfuj	130	36	which	which	WDT
cord-337302-fpz2jfuj	130	37	Is	be	VBZ
cord-337302-fpz2jfuj	130	38	common	common	JJ
cord-337302-fpz2jfuj	130	39	in	in	IN
cord-337302-fpz2jfuj	130	40	these	these	DT
cord-337302-fpz2jfuj	130	41	patient	patient	NN
cord-337302-fpz2jfuj	130	42	group	group	NN
cord-337302-fpz2jfuj	130	43	.	.	.
cord-337302-fpz2jfuj	131	1	43	43	CD
cord-337302-fpz2jfuj	132	1	A	a	DT
cord-337302-fpz2jfuj	132	2	new	new	JJ
cord-337302-fpz2jfuj	132	3	hypothesis	hypothesis	NN
cord-337302-fpz2jfuj	132	4	on	on	IN
cord-337302-fpz2jfuj	132	5	the	the	DT
cord-337302-fpz2jfuj	132	6	role	role	NN
cord-337302-fpz2jfuj	132	7	of	of	IN
cord-337302-fpz2jfuj	132	8	androgen	androgen	NN
cord-337302-fpz2jfuj	132	9	hormone	hormone	NN
cord-337302-fpz2jfuj	132	10	in	in	IN
cord-337302-fpz2jfuj	132	11	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	132	12	,	,	,
cord-337302-fpz2jfuj	132	13	data	datum	NNS
cord-337302-fpz2jfuj	132	14	from	from	IN
cord-337302-fpz2jfuj	132	15	Italy	Italy	NNP
cord-337302-fpz2jfuj	132	16	shows	show	VBZ
cord-337302-fpz2jfuj	132	17	prostate	prostate	NN
cord-337302-fpz2jfuj	132	18	cancer	cancer	NN
cord-337302-fpz2jfuj	132	19	patients	patient	NNS
cord-337302-fpz2jfuj	132	20	receiving	receive	VBG
cord-337302-fpz2jfuj	132	21	androgen	androgen	NN
cord-337302-fpz2jfuj	132	22	deprivation	deprivation	NN
cord-337302-fpz2jfuj	132	23	therapy	therapy	NN
cord-337302-fpz2jfuj	132	24	had	have	VBD
cord-337302-fpz2jfuj	132	25	a	a	DT
cord-337302-fpz2jfuj	132	26	significant	significant	JJ
cord-337302-fpz2jfuj	132	27	fourfold	fourfold	NN
cord-337302-fpz2jfuj	132	28	reduced	reduce	VBN
cord-337302-fpz2jfuj	132	29	risk	risk	NN
cord-337302-fpz2jfuj	132	30	of	of	IN
cord-337302-fpz2jfuj	132	31	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	132	32	infections	infection	NNS
cord-337302-fpz2jfuj	132	33	compared	compare	VBN
cord-337302-fpz2jfuj	132	34	to	to	IN
cord-337302-fpz2jfuj	132	35	their	-PRON-	PRP$
cord-337302-fpz2jfuj	132	36	counterparts	counterpart	NNS
cord-337302-fpz2jfuj	132	37	.	.	.
cord-337302-fpz2jfuj	133	1	44	44	CD
cord-337302-fpz2jfuj	133	2	Currently	currently	RB
cord-337302-fpz2jfuj	133	3	,	,	,
cord-337302-fpz2jfuj	133	4	through	through	IN
cord-337302-fpz2jfuj	133	5	the	the	DT
cord-337302-fpz2jfuj	133	6	cyclic	cyclic	JJ
cord-337302-fpz2jfuj	133	7	media	medium	NNS
cord-337302-fpz2jfuj	133	8	news	news	NN
cord-337302-fpz2jfuj	133	9	,	,	,
cord-337302-fpz2jfuj	133	10	all	all	DT
cord-337302-fpz2jfuj	133	11	cancer	cancer	NN
cord-337302-fpz2jfuj	133	12	and	and	CC
cord-337302-fpz2jfuj	133	13	potential	potential	JJ
cord-337302-fpz2jfuj	133	14	cancer	cancer	NN
cord-337302-fpz2jfuj	133	15	patients	patient	NNS
cord-337302-fpz2jfuj	133	16	are	be	VBP
cord-337302-fpz2jfuj	133	17	more	more	RBR
cord-337302-fpz2jfuj	133	18	oriented	oriented	JJ
cord-337302-fpz2jfuj	133	19	toward	toward	IN
cord-337302-fpz2jfuj	133	20	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	133	21	symptoms	symptom	NNS
cord-337302-fpz2jfuj	133	22	and	and	CC
cord-337302-fpz2jfuj	133	23	could	could	MD
cord-337302-fpz2jfuj	133	24	potentially	potentially	RB
cord-337302-fpz2jfuj	133	25	ignore	ignore	VB
cord-337302-fpz2jfuj	133	26	any	any	DT
cord-337302-fpz2jfuj	133	27	ominous	ominous	JJ
cord-337302-fpz2jfuj	133	28	symptoms	symptom	NNS
cord-337302-fpz2jfuj	133	29	like	like	IN
cord-337302-fpz2jfuj	133	30	breast	breast	NN
cord-337302-fpz2jfuj	133	31	lump	lump	NN
cord-337302-fpz2jfuj	133	32	or	or	CC
cord-337302-fpz2jfuj	133	33	rectal	rectal	JJ
cord-337302-fpz2jfuj	133	34	bleeding	bleeding	NN
cord-337302-fpz2jfuj	133	35	that	that	WDT
cord-337302-fpz2jfuj	133	36	would	would	MD
cord-337302-fpz2jfuj	133	37	normally	normally	RB
cord-337302-fpz2jfuj	133	38	lead	lead	VB
cord-337302-fpz2jfuj	133	39	them	-PRON-	PRP
cord-337302-fpz2jfuj	133	40	to	to	TO
cord-337302-fpz2jfuj	133	41	see	see	VB
cord-337302-fpz2jfuj	133	42	a	a	DT
cord-337302-fpz2jfuj	133	43	doctor	doctor	NN
cord-337302-fpz2jfuj	133	44	.	.	.
cord-337302-fpz2jfuj	134	1	45	45	CD
cord-337302-fpz2jfuj	135	1	The	the	DT
cord-337302-fpz2jfuj	135	2	differential	differential	JJ
cord-337302-fpz2jfuj	135	3	diagnosis	diagnosis	NN
cord-337302-fpz2jfuj	135	4	of	of	IN
cord-337302-fpz2jfuj	135	5	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	135	6	,	,	,
cord-337302-fpz2jfuj	135	7	especially	especially	RB
cord-337302-fpz2jfuj	135	8	in	in	IN
cord-337302-fpz2jfuj	135	9	cancer	cancer	NN
cord-337302-fpz2jfuj	135	10	patients	patient	NNS
cord-337302-fpz2jfuj	135	11	,	,	,
cord-337302-fpz2jfuj	135	12	includes	include	VBZ
cord-337302-fpz2jfuj	135	13	all	all	DT
cord-337302-fpz2jfuj	135	14	types	type	NNS
cord-337302-fpz2jfuj	135	15	of	of	IN
cord-337302-fpz2jfuj	135	16	respiratory	respiratory	JJ
cord-337302-fpz2jfuj	135	17	viral	viral	JJ
cord-337302-fpz2jfuj	135	18	infections	infection	NNS
cord-337302-fpz2jfuj	135	19	and	and	CC
cord-337302-fpz2jfuj	135	20	bacterial	bacterial	JJ
cord-337302-fpz2jfuj	135	21	infections	infection	NNS
cord-337302-fpz2jfuj	135	22	,	,	,
cord-337302-fpz2jfuj	135	23	which	which	WDT
cord-337302-fpz2jfuj	135	24	often	often	RB
cord-337302-fpz2jfuj	135	25	present	present	VBP
cord-337302-fpz2jfuj	135	26	atypically	atypically	RB
cord-337302-fpz2jfuj	135	27	.	.	.
cord-337302-fpz2jfuj	136	1	Therefore	therefore	RB
cord-337302-fpz2jfuj	136	2	,	,	,
cord-337302-fpz2jfuj	136	3	travel	travel	NN
cord-337302-fpz2jfuj	136	4	history	history	NN
cord-337302-fpz2jfuj	136	5	is	be	VBZ
cord-337302-fpz2jfuj	136	6	essential	essential	JJ
cord-337302-fpz2jfuj	136	7	,	,	,
cord-337302-fpz2jfuj	136	8	and	and	CC
cord-337302-fpz2jfuj	136	9	oncologists	oncologist	NNS
cord-337302-fpz2jfuj	136	10	should	should	MD
cord-337302-fpz2jfuj	136	11	have	have	VB
cord-337302-fpz2jfuj	136	12	a	a	DT
cord-337302-fpz2jfuj	136	13	high	high	JJ
cord-337302-fpz2jfuj	136	14	index	index	NN
cord-337302-fpz2jfuj	136	15	of	of	IN
cord-337302-fpz2jfuj	136	16	suspicion	suspicion	NN
cord-337302-fpz2jfuj	136	17	.	.	.
cord-337302-fpz2jfuj	137	1	46	46	CD
cord-337302-fpz2jfuj	138	1	Above	above	IN
cord-337302-fpz2jfuj	138	2	all	all	DT
cord-337302-fpz2jfuj	138	3	,	,	,
cord-337302-fpz2jfuj	138	4	there	there	EX
cord-337302-fpz2jfuj	138	5	is	be	VBZ
cord-337302-fpz2jfuj	138	6	the	the	DT
cord-337302-fpz2jfuj	138	7	possibility	possibility	NN
cord-337302-fpz2jfuj	138	8	of	of	IN
cord-337302-fpz2jfuj	138	9	an	an	DT
cord-337302-fpz2jfuj	138	10	actual	actual	JJ
cord-337302-fpz2jfuj	138	11	higher	high	JJR
cord-337302-fpz2jfuj	138	12	prevalence	prevalence	NN
cord-337302-fpz2jfuj	138	13	of	of	IN
cord-337302-fpz2jfuj	138	14	SARS	SARS	NNP
cord-337302-fpz2jfuj	138	15	-	-	HYPH
cord-337302-fpz2jfuj	138	16	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	138	17	in	in	IN
cord-337302-fpz2jfuj	138	18	cancer	cancer	NN
cord-337302-fpz2jfuj	138	19	patients	patient	NNS
cord-337302-fpz2jfuj	138	20	than	than	IN
cord-337302-fpz2jfuj	138	21	it	-PRON-	PRP
cord-337302-fpz2jfuj	138	22	is	be	VBZ
cord-337302-fpz2jfuj	138	23	reported	report	VBN
cord-337302-fpz2jfuj	138	24	.	.	.
cord-337302-fpz2jfuj	139	1	This	this	DT
cord-337302-fpz2jfuj	139	2	is	be	VBZ
cord-337302-fpz2jfuj	139	3	further	further	RB
cord-337302-fpz2jfuj	139	4	confirmed	confirm	VBN
cord-337302-fpz2jfuj	139	5	by	by	IN
cord-337302-fpz2jfuj	139	6	the	the	DT
cord-337302-fpz2jfuj	139	7	higher	high	JJR
cord-337302-fpz2jfuj	139	8	number	number	NN
cord-337302-fpz2jfuj	139	9	of	of	IN
cord-337302-fpz2jfuj	139	10	young	young	JJ
cord-337302-fpz2jfuj	139	11	and	and	CC
cord-337302-fpz2jfuj	139	12	healthy	healthy	JJ
cord-337302-fpz2jfuj	139	13	young	young	JJ
cord-337302-fpz2jfuj	139	14	population	population	NN
cord-337302-fpz2jfuj	139	15	who	who	WP
cord-337302-fpz2jfuj	139	16	are	be	VBP
cord-337302-fpz2jfuj	139	17	probably	probably	RB
cord-337302-fpz2jfuj	139	18	carriers	carrier	NNS
cord-337302-fpz2jfuj	139	19	of	of	IN
cord-337302-fpz2jfuj	139	20	COVID-19	covid-19	CD
cord-337302-fpz2jfuj	139	21	with	with	IN
cord-337302-fpz2jfuj	139	22	mild	mild	JJ
cord-337302-fpz2jfuj	139	23	or	or	CC
cord-337302-fpz2jfuj	139	24	no	no	DT
cord-337302-fpz2jfuj	139	25	symptoms	symptom	NNS
cord-337302-fpz2jfuj	139	26	and	and	CC
cord-337302-fpz2jfuj	139	27	who	who	WP
cord-337302-fpz2jfuj	139	28	do	do	VBP
cord-337302-fpz2jfuj	139	29	not	not	RB
cord-337302-fpz2jfuj	139	30	require	require	VB
cord-337302-fpz2jfuj	139	31	hospital	hospital	NN
cord-337302-fpz2jfuj	139	32	admission	admission	NN
cord-337302-fpz2jfuj	139	33	,	,	,
cord-337302-fpz2jfuj	139	34	thus	thus	RB
cord-337302-fpz2jfuj	139	35	escaping	escape	VBG
cord-337302-fpz2jfuj	139	36	the	the	DT
cord-337302-fpz2jfuj	139	37	rapid	rapid	JJ
cord-337302-fpz2jfuj	139	38	laboratory	laboratory	NN
cord-337302-fpz2jfuj	139	39	testing	testing	NN
cord-337302-fpz2jfuj	139	40	.	.	.
cord-337302-fpz2jfuj	140	1	47	47	CD
cord-337302-fpz2jfuj	141	1	In	in	IN
cord-337302-fpz2jfuj	141	2	addition	addition	NN
cord-337302-fpz2jfuj	141	3	,	,	,
cord-337302-fpz2jfuj	141	4	SARS	SARS	NNP
cord-337302-fpz2jfuj	141	5	-	-	HYPH
cord-337302-fpz2jfuj	141	6	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	141	7	could	could	MD
cord-337302-fpz2jfuj	141	8	as	as	RB
cord-337302-fpz2jfuj	141	9	well	well	RB
cord-337302-fpz2jfuj	141	10	present	present	JJ
cord-337302-fpz2jfuj	141	11	with	with	IN
cord-337302-fpz2jfuj	141	12	genetic	genetic	JJ
cord-337302-fpz2jfuj	141	13	drift	drift	NN
cord-337302-fpz2jfuj	141	14	and	and	CC
cord-337302-fpz2jfuj	141	15	mutation	mutation	NN
cord-337302-fpz2jfuj	141	16	;	;	:
cord-337302-fpz2jfuj	141	17	hence	hence	RB
cord-337302-fpz2jfuj	141	18	should	should	MD
cord-337302-fpz2jfuj	141	19	be	be	VB
cord-337302-fpz2jfuj	141	20	closely	closely	RB
cord-337302-fpz2jfuj	141	21	monitored	monitor	VBN
cord-337302-fpz2jfuj	141	22	to	to	TO
cord-337302-fpz2jfuj	141	23	avoid	avoid	VB
cord-337302-fpz2jfuj	141	24	a	a	DT
cord-337302-fpz2jfuj	141	25	second	second	JJ
cord-337302-fpz2jfuj	141	26	wave	wave	NN
cord-337302-fpz2jfuj	141	27	which	which	WDT
cord-337302-fpz2jfuj	141	28	will	will	MD
cord-337302-fpz2jfuj	141	29	further	further	RB
cord-337302-fpz2jfuj	141	30	the	the	DT
cord-337302-fpz2jfuj	141	31	current	current	JJ
cord-337302-fpz2jfuj	141	32	effects	effect	NNS
cord-337302-fpz2jfuj	141	33	on	on	IN
cord-337302-fpz2jfuj	141	34	cancer	cancer	NN
cord-337302-fpz2jfuj	141	35	care	care	NN
cord-337302-fpz2jfuj	141	36	.	.	.
cord-337302-fpz2jfuj	142	1	5	5	LS
cord-337302-fpz2jfuj	142	2	More	More	JJR
cord-337302-fpz2jfuj	142	3	data	datum	NNS
cord-337302-fpz2jfuj	142	4	from	from	IN
cord-337302-fpz2jfuj	142	5	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	142	6	studies	study	NNS
cord-337302-fpz2jfuj	142	7	on	on	IN
cord-337302-fpz2jfuj	142	8	the	the	DT
cord-337302-fpz2jfuj	142	9	clinical	clinical	JJ
cord-337302-fpz2jfuj	142	10	characteristics	characteristic	NNS
cord-337302-fpz2jfuj	142	11	and	and	CC
cord-337302-fpz2jfuj	142	12	outcomes	outcome	NNS
cord-337302-fpz2jfuj	142	13	showed	show	VBD
cord-337302-fpz2jfuj	142	14	cancer	cancer	NN
cord-337302-fpz2jfuj	142	15	to	to	TO
cord-337302-fpz2jfuj	142	16	be	be	VB
cord-337302-fpz2jfuj	142	17	a	a	DT
cord-337302-fpz2jfuj	142	18	common	common	JJ
cord-337302-fpz2jfuj	142	19	comorbidity	comorbidity	NN
cord-337302-fpz2jfuj	142	20	with	with	IN
cord-337302-fpz2jfuj	142	21	varying	vary	VBG
cord-337302-fpz2jfuj	142	22	types	type	NNS
cord-337302-fpz2jfuj	142	23	,	,	,
cord-337302-fpz2jfuj	142	24	as	as	IN
cord-337302-fpz2jfuj	142	25	shown	show	VBN
cord-337302-fpz2jfuj	142	26	in	in	IN
cord-337302-fpz2jfuj	142	27	Table	Table	NNP
cord-337302-fpz2jfuj	142	28	1	1	CD
cord-337302-fpz2jfuj	142	29	below	below	RB
cord-337302-fpz2jfuj	142	30	.	.	.
cord-337302-fpz2jfuj	143	1	Taken	take	VBN
cord-337302-fpz2jfuj	143	2	all	all	DT
cord-337302-fpz2jfuj	143	3	together	together	RB
cord-337302-fpz2jfuj	143	4	,	,	,
cord-337302-fpz2jfuj	143	5	cancer	cancer	NN
cord-337302-fpz2jfuj	143	6	patients	patient	NNS
cord-337302-fpz2jfuj	143	7	are	be	VBP
cord-337302-fpz2jfuj	143	8	at	at	IN
cord-337302-fpz2jfuj	143	9	higher	high	JJR
cord-337302-fpz2jfuj	143	10	chances	chance	NNS
cord-337302-fpz2jfuj	143	11	to	to	TO
cord-337302-fpz2jfuj	143	12	contract	contract	VB
cord-337302-fpz2jfuj	143	13	and	and	CC
cord-337302-fpz2jfuj	143	14	die	die	VB
cord-337302-fpz2jfuj	143	15	from	from	IN
cord-337302-fpz2jfuj	143	16	COVID-19	covid-19	NN
cord-337302-fpz2jfuj	143	17	compared	compare	VBN
cord-337302-fpz2jfuj	143	18	to	to	IN
cord-337302-fpz2jfuj	143	19	the	the	DT
cord-337302-fpz2jfuj	143	20	general	general	JJ
cord-337302-fpz2jfuj	143	21	population	population	NN
cord-337302-fpz2jfuj	143	22	,	,	,
cord-337302-fpz2jfuj	143	23	and	and	CC
cord-337302-fpz2jfuj	143	24	proper	proper	JJ
cord-337302-fpz2jfuj	143	25	measures	measure	NNS
cord-337302-fpz2jfuj	143	26	to	to	TO
cord-337302-fpz2jfuj	143	27	address	address	VB
cord-337302-fpz2jfuj	143	28	this	this	DT
cord-337302-fpz2jfuj	143	29	should	should	MD
cord-337302-fpz2jfuj	143	30	be	be	VB
cord-337302-fpz2jfuj	143	31	adopted	adopt	VBN
cord-337302-fpz2jfuj	143	32	by	by	IN
cord-337302-fpz2jfuj	143	33	hospitals	hospital	NNS
cord-337302-fpz2jfuj	143	34	and	and	CC
cord-337302-fpz2jfuj	143	35	treatment	treatment	NN
cord-337302-fpz2jfuj	143	36	centers	center	NNS
cord-337302-fpz2jfuj	143	37	.	.	.
cord-337302-fpz2jfuj	144	1	The	the	DT
cord-337302-fpz2jfuj	144	2	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	144	3	pandemic	pandemic	NN
cord-337302-fpz2jfuj	144	4	presents	present	VBZ
cord-337302-fpz2jfuj	144	5	unprecedented	unprecedented	JJ
cord-337302-fpz2jfuj	144	6	challenges	challenge	NNS
cord-337302-fpz2jfuj	144	7	and	and	CC
cord-337302-fpz2jfuj	144	8	learning	learn	VBG
cord-337302-fpz2jfuj	144	9	opportunities	opportunity	NNS
cord-337302-fpz2jfuj	144	10	for	for	IN
cord-337302-fpz2jfuj	144	11	many	many	JJ
cord-337302-fpz2jfuj	144	12	cancer	cancer	NN
cord-337302-fpz2jfuj	144	13	care	care	NN
cord-337302-fpz2jfuj	144	14	providers	provider	NNS
cord-337302-fpz2jfuj	144	15	.	.	.
cord-337302-fpz2jfuj	145	1	Even	even	RB
cord-337302-fpz2jfuj	145	2	though	though	IN
cord-337302-fpz2jfuj	145	3	many	many	JJ
cord-337302-fpz2jfuj	145	4	patients	patient	NNS
cord-337302-fpz2jfuj	145	5	will	will	MD
cord-337302-fpz2jfuj	145	6	not	not	RB
cord-337302-fpz2jfuj	145	7	contract	contract	VB
cord-337302-fpz2jfuj	145	8	the	the	DT
cord-337302-fpz2jfuj	145	9	virus	virus	NN
cord-337302-fpz2jfuj	145	10	due	due	IN
cord-337302-fpz2jfuj	145	11	to	to	IN
cord-337302-fpz2jfuj	145	12	heightened	heighten	VBN
cord-337302-fpz2jfuj	145	13	precautions	precaution	NNS
cord-337302-fpz2jfuj	145	14	,	,	,
cord-337302-fpz2jfuj	145	15	people	people	NNS
cord-337302-fpz2jfuj	145	16	with	with	IN
cord-337302-fpz2jfuj	145	17	compromised	compromised	JJ
cord-337302-fpz2jfuj	145	18	immune	immune	JJ
cord-337302-fpz2jfuj	145	19	systems	system	NNS
cord-337302-fpz2jfuj	145	20	,	,	,
cord-337302-fpz2jfuj	145	21	including	include	VBG
cord-337302-fpz2jfuj	145	22	cancer	cancer	NN
cord-337302-fpz2jfuj	145	23	patients	patient	NNS
cord-337302-fpz2jfuj	145	24	and	and	CC
cord-337302-fpz2jfuj	145	25	cancer	cancer	NN
cord-337302-fpz2jfuj	145	26	survivors	survivor	NNS
cord-337302-fpz2jfuj	145	27	are	be	VBP
cord-337302-fpz2jfuj	145	28	at	at	IN
cord-337302-fpz2jfuj	145	29	increased	increase	VBN
cord-337302-fpz2jfuj	145	30	risk	risk	NN
cord-337302-fpz2jfuj	145	31	for	for	IN
cord-337302-fpz2jfuj	145	32	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	145	33	and	and	CC
cord-337302-fpz2jfuj	145	34	other	other	JJ
cord-337302-fpz2jfuj	145	35	infections	infection	NNS
cord-337302-fpz2jfuj	145	36	.	.	.
cord-337302-fpz2jfuj	146	1	48	48	CD
cord-337302-fpz2jfuj	147	1	The	the	DT
cord-337302-fpz2jfuj	147	2	highest	high	JJS
cord-337302-fpz2jfuj	147	3	risk	risk	NN
cord-337302-fpz2jfuj	147	4	group	group	NN
cord-337302-fpz2jfuj	147	5	in	in	IN
cord-337302-fpz2jfuj	147	6	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	147	7	transmission	transmission	NN
cord-337302-fpz2jfuj	147	8	are	be	VBP
cord-337302-fpz2jfuj	147	9	the	the	DT
cord-337302-fpz2jfuj	147	10	healthcare	healthcare	NN
cord-337302-fpz2jfuj	147	11	workers	worker	NNS
cord-337302-fpz2jfuj	147	12	.	.	.
cord-337302-fpz2jfuj	148	1	In	in	IN
cord-337302-fpz2jfuj	148	2	2002	2002	CD
cord-337302-fpz2jfuj	148	3	,	,	,
cord-337302-fpz2jfuj	148	4	healthcare	healthcare	NN
cord-337302-fpz2jfuj	148	5	workers	worker	NNS
cord-337302-fpz2jfuj	148	6	accounted	account	VBD
cord-337302-fpz2jfuj	148	7	for	for	IN
cord-337302-fpz2jfuj	148	8	21	21	CD
cord-337302-fpz2jfuj	148	9	%	%	NN
cord-337302-fpz2jfuj	148	10	of	of	IN
cord-337302-fpz2jfuj	148	11	those	those	DT
cord-337302-fpz2jfuj	148	12	affected	affect	VBN
cord-337302-fpz2jfuj	148	13	by	by	IN
cord-337302-fpz2jfuj	148	14	the	the	DT
cord-337302-fpz2jfuj	148	15	Severe	severe	JJ
cord-337302-fpz2jfuj	148	16	Acute	acute	JJ
cord-337302-fpz2jfuj	148	17	Respiratory	Respiratory	NNP
cord-337302-fpz2jfuj	148	18	Syndrome	Syndrome	NNP
cord-337302-fpz2jfuj	148	19	(	(	-LRB-
cord-337302-fpz2jfuj	148	20	SARS	SARS	NNP
cord-337302-fpz2jfuj	148	21	)	)	-RRB-
cord-337302-fpz2jfuj	148	22	outbreak	outbreak	NN
cord-337302-fpz2jfuj	148	23	.	.	.
cord-337302-fpz2jfuj	149	1	49	49	CD
cord-337302-fpz2jfuj	150	1	As	as	IN
cord-337302-fpz2jfuj	150	2	of	of	IN
cord-337302-fpz2jfuj	150	3	February	February	NNP
cord-337302-fpz2jfuj	150	4	2020	2020	CD
cord-337302-fpz2jfuj	150	5	,	,	,
cord-337302-fpz2jfuj	150	6	4.4	4.4	CD
cord-337302-fpz2jfuj	150	7	%	%	NN
cord-337302-fpz2jfuj	150	8	of	of	IN
cord-337302-fpz2jfuj	150	9	the	the	DT
cord-337302-fpz2jfuj	150	10	reported	report	VBN
cord-337302-fpz2jfuj	150	11	cases	case	NNS
cord-337302-fpz2jfuj	150	12	in	in	IN
cord-337302-fpz2jfuj	150	13	China	China	NNP
cord-337302-fpz2jfuj	150	14	were	be	VBD
cord-337302-fpz2jfuj	150	15	health	health	NN
cord-337302-fpz2jfuj	150	16	care	care	NN
cord-337302-fpz2jfuj	150	17	workers	worker	NNS
cord-337302-fpz2jfuj	150	18	,	,	,
cord-337302-fpz2jfuj	150	19	and	and	CC
cord-337302-fpz2jfuj	150	20	by	by	IN
cord-337302-fpz2jfuj	150	21	April	April	NNP
cord-337302-fpz2jfuj	150	22	2020	2020	CD
cord-337302-fpz2jfuj	150	23	,	,	,
cord-337302-fpz2jfuj	150	24	a	a	DT
cord-337302-fpz2jfuj	150	25	total	total	NN
cord-337302-fpz2jfuj	150	26	of	of	IN
cord-337302-fpz2jfuj	150	27	23	23	CD
cord-337302-fpz2jfuj	150	28	health	health	NN
cord-337302-fpz2jfuj	150	29	care	care	NN
cord-337302-fpz2jfuj	150	30	professionals	professional	NNS
cord-337302-fpz2jfuj	150	31	were	be	VBD
cord-337302-fpz2jfuj	150	32	among	among	IN
cord-337302-fpz2jfuj	150	33	the	the	DT
cord-337302-fpz2jfuj	150	34	3387	3387	CD
cord-337302-fpz2jfuj	150	35	deaths	death	NNS
cord-337302-fpz2jfuj	150	36	from	from	IN
cord-337302-fpz2jfuj	150	37	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	150	38	.	.	.
cord-337302-fpz2jfuj	151	1	50	50	CD
cord-337302-fpz2jfuj	152	1	A	a	DT
cord-337302-fpz2jfuj	152	2	study	study	NN
cord-337302-fpz2jfuj	152	3	by	by	IN
cord-337302-fpz2jfuj	152	4	Yu	Yu	NNP
cord-337302-fpz2jfuj	152	5	et	et	FW
cord-337302-fpz2jfuj	152	6	al	al	NNP
cord-337302-fpz2jfuj	152	7	(	(	-LRB-
cord-337302-fpz2jfuj	152	8	2020	2020	CD
cord-337302-fpz2jfuj	152	9	)	)	-RRB-
cord-337302-fpz2jfuj	153	1	24	24	CD
cord-337302-fpz2jfuj	153	2	risk	risk	NN
cord-337302-fpz2jfuj	153	3	of	of	IN
cord-337302-fpz2jfuj	153	4	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	153	5	in	in	IN
cord-337302-fpz2jfuj	153	6	comparison	comparison	NN
cord-337302-fpz2jfuj	153	7	to	to	IN
cord-337302-fpz2jfuj	153	8	the	the	DT
cord-337302-fpz2jfuj	153	9	general	general	JJ
cord-337302-fpz2jfuj	153	10	population	population	NN
cord-337302-fpz2jfuj	153	11	.	.	.
cord-337302-fpz2jfuj	154	1	They	-PRON-	PRP
cord-337302-fpz2jfuj	154	2	linked	link	VBD
cord-337302-fpz2jfuj	154	3	hospital	hospital	NN
cord-337302-fpz2jfuj	154	4	visits	visit	NNS
cord-337302-fpz2jfuj	154	5	to	to	TO
cord-337302-fpz2jfuj	154	6	be	be	VB
cord-337302-fpz2jfuj	154	7	a	a	DT
cord-337302-fpz2jfuj	154	8	contributing	contribute	VBG
cord-337302-fpz2jfuj	154	9	factor	factor	NN
cord-337302-fpz2jfuj	154	10	to	to	IN
cord-337302-fpz2jfuj	154	11	this	this	DT
cord-337302-fpz2jfuj	154	12	increased	increase	VBN
cord-337302-fpz2jfuj	154	13	incidence	incidence	NN
cord-337302-fpz2jfuj	154	14	.	.	.
cord-337302-fpz2jfuj	155	1	Also	also	RB
cord-337302-fpz2jfuj	155	2	,	,	,
cord-337302-fpz2jfuj	155	3	there	there	EX
cord-337302-fpz2jfuj	155	4	is	be	VBZ
cord-337302-fpz2jfuj	155	5	no	no	DT
cord-337302-fpz2jfuj	155	6	current	current	JJ
cord-337302-fpz2jfuj	155	7	clear	clear	JJ
cord-337302-fpz2jfuj	155	8	guideline	guideline	NN
cord-337302-fpz2jfuj	155	9	on	on	IN
cord-337302-fpz2jfuj	155	10	the	the	DT
cord-337302-fpz2jfuj	155	11	care	care	NN
cord-337302-fpz2jfuj	155	12	of	of	IN
cord-337302-fpz2jfuj	155	13	cancer	cancer	NN
cord-337302-fpz2jfuj	155	14	patients	patient	NNS
cord-337302-fpz2jfuj	155	15	concerning	concern	VBG
cord-337302-fpz2jfuj	155	16	their	-PRON-	PRP$
cord-337302-fpz2jfuj	155	17	cancer	cancer	NN
cord-337302-fpz2jfuj	155	18	types	type	NNS
cord-337302-fpz2jfuj	155	19	,	,	,
cord-337302-fpz2jfuj	155	20	therapy	therapy	NN
cord-337302-fpz2jfuj	155	21	types	type	NNS
cord-337302-fpz2jfuj	155	22	,	,	,
cord-337302-fpz2jfuj	155	23	or	or	CC
cord-337302-fpz2jfuj	155	24	subpopulation	subpopulation	NN
cord-337302-fpz2jfuj	155	25	of	of	IN
cord-337302-fpz2jfuj	155	26	cancer	cancer	NN
cord-337302-fpz2jfuj	155	27	patients	patient	NNS
cord-337302-fpz2jfuj	155	28	(	(	-LRB-
cord-337302-fpz2jfuj	155	29	eg	eg	NNS
cord-337302-fpz2jfuj	155	30	,	,	,
cord-337302-fpz2jfuj	155	31	children	child	NNS
cord-337302-fpz2jfuj	155	32	,	,	,
cord-337302-fpz2jfuj	155	33	elderly	elderly	JJ
cord-337302-fpz2jfuj	155	34	)	)	-RRB-
cord-337302-fpz2jfuj	155	35	.	.	.
cord-337302-fpz2jfuj	156	1	51	51	CD
cord-337302-fpz2jfuj	157	1	Due	due	IN
cord-337302-fpz2jfuj	157	2	to	to	IN
cord-337302-fpz2jfuj	157	3	the	the	DT
cord-337302-fpz2jfuj	157	4	looming	loom	VBG
cord-337302-fpz2jfuj	157	5	shortage	shortage	NN
cord-337302-fpz2jfuj	157	6	of	of	IN
cord-337302-fpz2jfuj	157	7	health	health	NN
cord-337302-fpz2jfuj	157	8	care	care	NN
cord-337302-fpz2jfuj	157	9	resources	resource	NNS
cord-337302-fpz2jfuj	157	10	,	,	,
cord-337302-fpz2jfuj	157	11	together	together	RB
cord-337302-fpz2jfuj	157	12	with	with	IN
cord-337302-fpz2jfuj	157	13	the	the	DT
cord-337302-fpz2jfuj	157	14	increased	increase	VBN
cord-337302-fpz2jfuj	157	15	risk	risk	NN
cord-337302-fpz2jfuj	157	16	of	of	IN
cord-337302-fpz2jfuj	157	17	cancer	cancer	NN
cord-337302-fpz2jfuj	157	18	treatment	treatment	NN
cord-337302-fpz2jfuj	157	19	during	during	IN
cord-337302-fpz2jfuj	157	20	this	this	DT
cord-337302-fpz2jfuj	157	21	pandemic	pandemic	NN
cord-337302-fpz2jfuj	157	22	,	,	,
cord-337302-fpz2jfuj	157	23	informed	informed	JJ
cord-337302-fpz2jfuj	157	24	decisions	decision	NNS
cord-337302-fpz2jfuj	157	25	about	about	IN
cord-337302-fpz2jfuj	157	26	how	how	WRB
cord-337302-fpz2jfuj	157	27	and	and	CC
cord-337302-fpz2jfuj	157	28	when	when	WRB
cord-337302-fpz2jfuj	157	29	to	to	TO
cord-337302-fpz2jfuj	157	30	provide	provide	VB
cord-337302-fpz2jfuj	157	31	cancer	cancer	NN
cord-337302-fpz2jfuj	157	32	treatment	treatment	NN
cord-337302-fpz2jfuj	157	33	,	,	,
cord-337302-fpz2jfuj	157	34	is	be	VBZ
cord-337302-fpz2jfuj	157	35	paramount	paramount	NN
cord-337302-fpz2jfuj	157	36	.	.	.
cord-337302-fpz2jfuj	158	1	48	48	CD
cord-337302-fpz2jfuj	159	1	The	the	DT
cord-337302-fpz2jfuj	159	2	American	American	NNP
cord-337302-fpz2jfuj	159	3	College	College	NNP
cord-337302-fpz2jfuj	159	4	of	of	IN
cord-337302-fpz2jfuj	159	5	Surgeons	Surgeons	NNPS
cord-337302-fpz2jfuj	159	6	recommends	recommend	VBZ
cord-337302-fpz2jfuj	159	7	a	a	DT
cord-337302-fpz2jfuj	159	8	delay	delay	NN
cord-337302-fpz2jfuj	159	9	of	of	IN
cord-337302-fpz2jfuj	159	10	life	life	NN
cord-337302-fpz2jfuj	159	11	-	-	HYPH
cord-337302-fpz2jfuj	159	12	saving	save	VBG
cord-337302-fpz2jfuj	159	13	cancer	cancer	NN
cord-337302-fpz2jfuj	159	14	surgeries	surgery	NNS
cord-337302-fpz2jfuj	159	15	and	and	CC
cord-337302-fpz2jfuj	159	16	the	the	DT
cord-337302-fpz2jfuj	159	17	cancellation	cancellation	NN
cord-337302-fpz2jfuj	159	18	of	of	IN
cord-337302-fpz2jfuj	159	19	elective	elective	JJ
cord-337302-fpz2jfuj	159	20	surgeries	surgery	NNS
cord-337302-fpz2jfuj	159	21	to	to	TO
cord-337302-fpz2jfuj	159	22	cushion	cushion	VB
cord-337302-fpz2jfuj	159	23	and	and	CC
cord-337302-fpz2jfuj	159	24	shift	shift	VB
cord-337302-fpz2jfuj	159	25	resources	resource	NNS
cord-337302-fpz2jfuj	159	26	to	to	IN
cord-337302-fpz2jfuj	159	27	COVID-19	covid-19	VB
cord-337302-fpz2jfuj	159	28	patients	patient	NNS
cord-337302-fpz2jfuj	159	29	.	.	.
cord-337302-fpz2jfuj	160	1	This	this	DT
cord-337302-fpz2jfuj	160	2	hugely	hugely	RB
cord-337302-fpz2jfuj	160	3	affects	affect	VBZ
cord-337302-fpz2jfuj	160	4	patients	patient	NNS
cord-337302-fpz2jfuj	160	5	and	and	CC
cord-337302-fpz2jfuj	160	6	could	could	MD
cord-337302-fpz2jfuj	160	7	lead	lead	VB
cord-337302-fpz2jfuj	160	8	to	to	IN
cord-337302-fpz2jfuj	160	9	loss	loss	NN
cord-337302-fpz2jfuj	160	10	of	of	IN
cord-337302-fpz2jfuj	160	11	vital	vital	JJ
cord-337302-fpz2jfuj	160	12	opportunities	opportunity	NNS
cord-337302-fpz2jfuj	160	13	in	in	IN
cord-337302-fpz2jfuj	160	14	many	many	JJ
cord-337302-fpz2jfuj	160	15	resectable	resectable	JJ
cord-337302-fpz2jfuj	160	16	cancers	cancer	NNS
cord-337302-fpz2jfuj	160	17	.	.	.
cord-337302-fpz2jfuj	161	1	52	52	CD
cord-337302-fpz2jfuj	162	1	A	a	DT
cord-337302-fpz2jfuj	162	2	survey	survey	NN
cord-337302-fpz2jfuj	162	3	by	by	IN
cord-337302-fpz2jfuj	162	4	the	the	DT
cord-337302-fpz2jfuj	162	5	American	American	NNP
cord-337302-fpz2jfuj	162	6	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	162	7	Society	Society	NNP
cord-337302-fpz2jfuj	162	8	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	162	9	Action	Action	NNP
cord-337302-fpz2jfuj	162	10	Network	Network	NNP
cord-337302-fpz2jfuj	162	11	shows	show	VBZ
cord-337302-fpz2jfuj	162	12	24	24	CD
cord-337302-fpz2jfuj	162	13	%	%	NN
cord-337302-fpz2jfuj	162	14	of	of	IN
cord-337302-fpz2jfuj	162	15	cancer	cancer	NN
cord-337302-fpz2jfuj	162	16	patients	patient	NNS
cord-337302-fpz2jfuj	162	17	reported	report	VBD
cord-337302-fpz2jfuj	162	18	delayed	delayed	JJ
cord-337302-fpz2jfuj	162	19	treatments	treatment	NNS
cord-337302-fpz2jfuj	162	20	,	,	,
cord-337302-fpz2jfuj	162	21	and	and	CC
cord-337302-fpz2jfuj	162	22	12	12	CD
cord-337302-fpz2jfuj	162	23	%	%	NN
cord-337302-fpz2jfuj	162	24	were	be	VBD
cord-337302-fpz2jfuj	162	25	worried	worried	JJ
cord-337302-fpz2jfuj	162	26	about	about	IN
cord-337302-fpz2jfuj	162	27	the	the	DT
cord-337302-fpz2jfuj	162	28	uncertainty	uncertainty	NN
cord-337302-fpz2jfuj	162	29	of	of	IN
cord-337302-fpz2jfuj	162	30	future	future	JJ
cord-337302-fpz2jfuj	162	31	therapies	therapy	NNS
cord-337302-fpz2jfuj	162	32	.	.	.
cord-337302-fpz2jfuj	163	1	53	53	CD
cord-337302-fpz2jfuj	164	1	In	in	IN
cord-337302-fpz2jfuj	164	2	the	the	DT
cord-337302-fpz2jfuj	164	3	UK	UK	NNP
cord-337302-fpz2jfuj	164	4	,	,	,
cord-337302-fpz2jfuj	164	5	urgent	urgent	JJ
cord-337302-fpz2jfuj	164	6	cancer	cancer	NN
cord-337302-fpz2jfuj	164	7	referrals	referral	NNS
cord-337302-fpz2jfuj	164	8	that	that	WDT
cord-337302-fpz2jfuj	164	9	are	be	VBP
cord-337302-fpz2jfuj	164	10	usually	usually	RB
cord-337302-fpz2jfuj	164	11	eligible	eligible	JJ
cord-337302-fpz2jfuj	164	12	for	for	IN
cord-337302-fpz2jfuj	164	13	a	a	DT
cord-337302-fpz2jfuj	164	14	two	two	CD
cord-337302-fpz2jfuj	164	15	-	-	HYPH
cord-337302-fpz2jfuj	164	16	week	week	NN
cord-337302-fpz2jfuj	164	17	wait	wait	VB
cord-337302-fpz2jfuj	164	18	target	target	NN
cord-337302-fpz2jfuj	164	19	are	be	VBP
cord-337302-fpz2jfuj	164	20	now	now	RB
cord-337302-fpz2jfuj	164	21	subject	subject	JJ
cord-337302-fpz2jfuj	164	22	to	to	IN
cord-337302-fpz2jfuj	164	23	prioritization	prioritization	NN
cord-337302-fpz2jfuj	164	24	rules	rule	NNS
cord-337302-fpz2jfuj	164	25	that	that	WDT
cord-337302-fpz2jfuj	164	26	will	will	MD
cord-337302-fpz2jfuj	164	27	cause	cause	VB
cord-337302-fpz2jfuj	164	28	delays	delay	NNS
cord-337302-fpz2jfuj	164	29	.	.	.
cord-337302-fpz2jfuj	165	1	Also	also	RB
cord-337302-fpz2jfuj	165	2	,	,	,
cord-337302-fpz2jfuj	165	3	cancer	cancer	NN
cord-337302-fpz2jfuj	165	4	screening	screening	NN
cord-337302-fpz2jfuj	165	5	programs	program	NNS
cord-337302-fpz2jfuj	165	6	have	have	VBP
cord-337302-fpz2jfuj	165	7	been	be	VBN
cord-337302-fpz2jfuj	165	8	halted	halt	VBN
cord-337302-fpz2jfuj	165	9	and	and	CC
cord-337302-fpz2jfuj	165	10	is	be	VBZ
cord-337302-fpz2jfuj	165	11	only	only	RB
cord-337302-fpz2jfuj	165	12	offered	offer	VBN
cord-337302-fpz2jfuj	165	13	to	to	IN
cord-337302-fpz2jfuj	165	14	symptomatic	symptomatic	JJ
cord-337302-fpz2jfuj	165	15	patients	patient	NNS
cord-337302-fpz2jfuj	165	16	.	.	.
cord-337302-fpz2jfuj	166	1	54	54	CD
cord-337302-fpz2jfuj	167	1	A	a	DT
cord-337302-fpz2jfuj	167	2	similar	similar	JJ
cord-337302-fpz2jfuj	167	3	modeling	modeling	NN
cord-337302-fpz2jfuj	167	4	study	study	NN
cord-337302-fpz2jfuj	167	5	from	from	IN
cord-337302-fpz2jfuj	167	6	the	the	DT
cord-337302-fpz2jfuj	167	7	UK	UK	NNP
cord-337302-fpz2jfuj	167	8	looking	look	VBG
cord-337302-fpz2jfuj	167	9	at	at	IN
cord-337302-fpz2jfuj	167	10	the	the	DT
cord-337302-fpz2jfuj	167	11	impacts	impact	NNS
cord-337302-fpz2jfuj	167	12	of	of	IN
cord-337302-fpz2jfuj	167	13	an	an	DT
cord-337302-fpz2jfuj	167	14	average	average	JJ
cord-337302-fpz2jfuj	167	15	2-weeks	2-weeks	CD
cord-337302-fpz2jfuj	167	16	delay	delay	NN
cord-337302-fpz2jfuj	167	17	in	in	IN
cord-337302-fpz2jfuj	167	18	cancer	cancer	NN
cord-337302-fpz2jfuj	167	19	patients	patient	NNS
cord-337302-fpz2jfuj	167	20	'	'	POS
cord-337302-fpz2jfuj	167	21	referrals	referral	NNS
cord-337302-fpz2jfuj	167	22	shows	show	VBZ
cord-337302-fpz2jfuj	167	23	84	84	CD
cord-337302-fpz2jfuj	167	24	%	%	NN
cord-337302-fpz2jfuj	167	25	reductions	reduction	NNS
cord-337302-fpz2jfuj	167	26	as	as	IN
cord-337302-fpz2jfuj	167	27	a	a	DT
cord-337302-fpz2jfuj	167	28	result	result	NN
cord-337302-fpz2jfuj	167	29	of	of	IN
cord-337302-fpz2jfuj	167	30	a	a	DT
cord-337302-fpz2jfuj	167	31	backlog	backlog	NN
cord-337302-fpz2jfuj	167	32	of	of	IN
cord-337302-fpz2jfuj	167	33	referrals	referral	NNS
cord-337302-fpz2jfuj	167	34	of	of	IN
cord-337302-fpz2jfuj	167	35	about	about	RB
cord-337302-fpz2jfuj	167	36	25	25	CD
cord-337302-fpz2jfuj	167	37	%	%	NN
cord-337302-fpz2jfuj	167	38	resulting	result	VBG
cord-337302-fpz2jfuj	167	39	from	from	IN
cord-337302-fpz2jfuj	167	40	the	the	DT
cord-337302-fpz2jfuj	167	41	lockdown	lockdown	NN
cord-337302-fpz2jfuj	167	42	.	.	.
cord-337302-fpz2jfuj	168	1	Therefore	therefore	RB
cord-337302-fpz2jfuj	168	2	,	,	,
cord-337302-fpz2jfuj	168	3	prompt	prompt	JJ
cord-337302-fpz2jfuj	168	4	prioritization	prioritization	NN
cord-337302-fpz2jfuj	168	5	of	of	IN
cord-337302-fpz2jfuj	168	6	patients	patient	NNS
cord-337302-fpz2jfuj	168	7	for	for	IN
cord-337302-fpz2jfuj	168	8	whom	whom	WP
cord-337302-fpz2jfuj	168	9	referral	referral	NN
cord-337302-fpz2jfuj	168	10	delays	delay	NNS
cord-337302-fpz2jfuj	168	11	would	would	MD
cord-337302-fpz2jfuj	168	12	lead	lead	VB
cord-337302-fpz2jfuj	168	13	in	in	IN
cord-337302-fpz2jfuj	168	14	most	most	JJS
cord-337302-fpz2jfuj	168	15	life	life	NN
cord-337302-fpz2jfuj	168	16	-	-	HYPH
cord-337302-fpz2jfuj	168	17	years	year	NNS
cord-337302-fpz2jfuj	168	18	lost	lose	VBN
cord-337302-fpz2jfuj	168	19	should	should	MD
cord-337302-fpz2jfuj	168	20	be	be	VB
cord-337302-fpz2jfuj	168	21	considered	consider	VBN
cord-337302-fpz2jfuj	168	22	.	.	.
cord-337302-fpz2jfuj	169	1	55	55	CD
cord-337302-fpz2jfuj	169	2	 	 	_SP
cord-337302-fpz2jfuj	170	1	In	in	IN
cord-337302-fpz2jfuj	170	2	the	the	DT
cord-337302-fpz2jfuj	170	3	Netherlands	Netherlands	NNP
cord-337302-fpz2jfuj	170	4	,	,	,
cord-337302-fpz2jfuj	170	5	a	a	DT
cord-337302-fpz2jfuj	170	6	country	country	NN
cord-337302-fpz2jfuj	170	7	of	of	IN
cord-337302-fpz2jfuj	170	8	17	17	CD
cord-337302-fpz2jfuj	170	9	million	million	CD
cord-337302-fpz2jfuj	170	10	people	people	NNS
cord-337302-fpz2jfuj	170	11	,	,	,
cord-337302-fpz2jfuj	170	12	the	the	DT
cord-337302-fpz2jfuj	170	13	overall	overall	JJ
cord-337302-fpz2jfuj	170	14	cancer	cancer	NN
cord-337302-fpz2jfuj	170	15	diagnosis	diagnosis	NN
cord-337302-fpz2jfuj	170	16	for	for	IN
cord-337302-fpz2jfuj	170	17	all	all	DT
cord-337302-fpz2jfuj	170	18	cancer	cancer	NN
cord-337302-fpz2jfuj	170	19	sites	site	NNS
cord-337302-fpz2jfuj	170	20	excluding	exclude	VBG
cord-337302-fpz2jfuj	170	21	skin	skin	NN
cord-337302-fpz2jfuj	170	22	cancer	cancer	NN
cord-337302-fpz2jfuj	170	23	dropped	drop	VBD
cord-337302-fpz2jfuj	170	24	by	by	IN
cord-337302-fpz2jfuj	170	25	25	25	CD
cord-337302-fpz2jfuj	170	26	%	%	NN
cord-337302-fpz2jfuj	170	27	from	from	IN
cord-337302-fpz2jfuj	170	28	January	January	NNP
cord-337302-fpz2jfuj	170	29	to	to	IN
cord-337302-fpz2jfuj	170	30	April	April	NNP
cord-337302-fpz2jfuj	170	31	2020	2020	CD
cord-337302-fpz2jfuj	170	32	.	.	.
cord-337302-fpz2jfuj	171	1	Furthermore	furthermore	RB
cord-337302-fpz2jfuj	171	2	,	,	,
cord-337302-fpz2jfuj	171	3	skin	skin	NN
cord-337302-fpz2jfuj	171	4	cancer	cancer	NN
cord-337302-fpz2jfuj	171	5	,	,	,
cord-337302-fpz2jfuj	171	6	excluding	exclude	VBG
cord-337302-fpz2jfuj	171	7	basal	basal	NN
cord-337302-fpz2jfuj	171	8	cell	cell	NN
cord-337302-fpz2jfuj	171	9	carcinoma	carcinoma	NN
cord-337302-fpz2jfuj	171	10	,	,	,
cord-337302-fpz2jfuj	171	11	decreased	decrease	VBN
cord-337302-fpz2jfuj	171	12	by	by	IN
cord-337302-fpz2jfuj	171	13	60	60	CD
cord-337302-fpz2jfuj	171	14	%	%	NN
cord-337302-fpz2jfuj	171	15	in	in	IN
cord-337302-fpz2jfuj	171	16	the	the	DT
cord-337302-fpz2jfuj	171	17	same	same	JJ
cord-337302-fpz2jfuj	171	18	time	time	NN
cord-337302-fpz2jfuj	171	19	frame	frame	NN
cord-337302-fpz2jfuj	171	20	.	.	.
cord-337302-fpz2jfuj	172	1	56	56	CD
cord-337302-fpz2jfuj	173	1	The	the	DT
cord-337302-fpz2jfuj	173	2	pandemic	pandemic	NN
cord-337302-fpz2jfuj	173	3	also	also	RB
cord-337302-fpz2jfuj	173	4	poses	pose	VBZ
cord-337302-fpz2jfuj	173	5	significant	significant	JJ
cord-337302-fpz2jfuj	173	6	risks	risk	NNS
cord-337302-fpz2jfuj	173	7	to	to	IN
cord-337302-fpz2jfuj	173	8	specific	specific	JJ
cord-337302-fpz2jfuj	173	9	cancer	cancer	NN
cord-337302-fpz2jfuj	173	10	patients	patient	NNS
cord-337302-fpz2jfuj	173	11	,	,	,
cord-337302-fpz2jfuj	173	12	such	such	JJ
cord-337302-fpz2jfuj	173	13	as	as	IN
cord-337302-fpz2jfuj	173	14	leukemia	leukemia	NN
cord-337302-fpz2jfuj	173	15	patients	patient	NNS
cord-337302-fpz2jfuj	173	16	.	.	.
cord-337302-fpz2jfuj	174	1	Approximately	approximately	RB
cord-337302-fpz2jfuj	174	2	5075	5075	CD
cord-337302-fpz2jfuj	174	3	%	%	NN
cord-337302-fpz2jfuj	174	4	of	of	IN
cord-337302-fpz2jfuj	174	5	patients	patient	NNS
cord-337302-fpz2jfuj	174	6	with	with	IN
cord-337302-fpz2jfuj	174	7	acute	acute	JJ
cord-337302-fpz2jfuj	174	8	leukemia	leukemia	NN
cord-337302-fpz2jfuj	174	9	present	present	JJ
cord-337302-fpz2jfuj	174	10	with	with	IN
cord-337302-fpz2jfuj	174	11	fever	fever	NN
cord-337302-fpz2jfuj	174	12	and	and	CC
cord-337302-fpz2jfuj	174	13	are	be	VBP
cord-337302-fpz2jfuj	174	14	at	at	IN
cord-337302-fpz2jfuj	174	15	risk	risk	NN
cord-337302-fpz2jfuj	174	16	of	of	IN
cord-337302-fpz2jfuj	174	17	misdiagnosis	misdiagnosis	NN
cord-337302-fpz2jfuj	174	18	.	.	.
cord-337302-fpz2jfuj	175	1	Similarly	similarly	RB
cord-337302-fpz2jfuj	175	2	,	,	,
cord-337302-fpz2jfuj	175	3	other	other	JJ
cord-337302-fpz2jfuj	175	4	cancers	cancer	NNS
cord-337302-fpz2jfuj	175	5	(	(	-LRB-
cord-337302-fpz2jfuj	175	6	mediastinal	mediastinal	JJ
cord-337302-fpz2jfuj	175	7	tumors	tumor	NNS
cord-337302-fpz2jfuj	175	8	or	or	CC
cord-337302-fpz2jfuj	175	9	lung	lung	NN
cord-337302-fpz2jfuj	175	10	cancer	cancer	NN
cord-337302-fpz2jfuj	175	11	,	,	,
cord-337302-fpz2jfuj	175	12	for	for	IN
cord-337302-fpz2jfuj	175	13	example	example	NN
cord-337302-fpz2jfuj	175	14	)	)	-RRB-
cord-337302-fpz2jfuj	175	15	who	who	WP
cord-337302-fpz2jfuj	175	16	present	present	VBP
cord-337302-fpz2jfuj	175	17	with	with	IN
cord-337302-fpz2jfuj	175	18	respiratory	respiratory	JJ
cord-337302-fpz2jfuj	175	19	symptoms	symptom	NNS
cord-337302-fpz2jfuj	175	20	like	like	IN
cord-337302-fpz2jfuj	175	21	cough	cough	NN
cord-337302-fpz2jfuj	175	22	and	and	CC
cord-337302-fpz2jfuj	175	23	are	be	VBP
cord-337302-fpz2jfuj	175	24	likely	likely	JJ
cord-337302-fpz2jfuj	175	25	to	to	TO
cord-337302-fpz2jfuj	175	26	be	be	VB
cord-337302-fpz2jfuj	175	27	dismissed	dismiss	VBN
cord-337302-fpz2jfuj	175	28	after	after	IN
cord-337302-fpz2jfuj	175	29	testing	test	VBG
cord-337302-fpz2jfuj	175	30	negative	negative	JJ
cord-337302-fpz2jfuj	175	31	for	for	IN
cord-337302-fpz2jfuj	175	32	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	175	33	.	.	.
cord-337302-fpz2jfuj	176	1	Also	also	RB
cord-337302-fpz2jfuj	176	2	,	,	,
cord-337302-fpz2jfuj	176	3	stem	stem	VB
cord-337302-fpz2jfuj	176	4	cell	cell	NN
cord-337302-fpz2jfuj	176	5	transplantation	transplantation	NN
cord-337302-fpz2jfuj	176	6	services	service	NNS
cord-337302-fpz2jfuj	176	7	are	be	VBP
cord-337302-fpz2jfuj	176	8	affected	affect	VBN
cord-337302-fpz2jfuj	176	9	in	in	IN
cord-337302-fpz2jfuj	176	10	terms	term	NNS
cord-337302-fpz2jfuj	176	11	of	of	IN
cord-337302-fpz2jfuj	176	12	risks	risk	NNS
cord-337302-fpz2jfuj	176	13	of	of	IN
cord-337302-fpz2jfuj	176	14	transplantation	transplantation	NN
cord-337302-fpz2jfuj	176	15	,	,	,
cord-337302-fpz2jfuj	176	16	the	the	DT
cord-337302-fpz2jfuj	176	17	number	number	NN
cord-337302-fpz2jfuj	176	18	of	of	IN
cord-337302-fpz2jfuj	176	19	procedures	procedure	NNS
cord-337302-fpz2jfuj	176	20	done	do	VBN
cord-337302-fpz2jfuj	176	21	,	,	,
cord-337302-fpz2jfuj	176	22	and	and	CC
cord-337302-fpz2jfuj	176	23	the	the	DT
cord-337302-fpz2jfuj	176	24	availability	availability	NN
cord-337302-fpz2jfuj	176	25	of	of	IN
cord-337302-fpz2jfuj	176	26	a	a	DT
cord-337302-fpz2jfuj	176	27	matched	match	VBN
cord-337302-fpz2jfuj	176	28	donor	donor	NN
cord-337302-fpz2jfuj	176	29	.	.	.
cord-337302-fpz2jfuj	177	1	Such	such	JJ
cord-337302-fpz2jfuj	177	2	situations	situation	NNS
cord-337302-fpz2jfuj	177	3	could	could	MD
cord-337302-fpz2jfuj	177	4	have	have	VB
cord-337302-fpz2jfuj	177	5	a	a	DT
cord-337302-fpz2jfuj	177	6	negative	negative	JJ
cord-337302-fpz2jfuj	177	7	impact	impact	NN
cord-337302-fpz2jfuj	177	8	on	on	IN
cord-337302-fpz2jfuj	177	9	survival	survival	NN
cord-337302-fpz2jfuj	177	10	.	.	.
cord-337302-fpz2jfuj	178	1	57	57	CD
cord-337302-fpz2jfuj	178	2	Most	Most	JJS
cord-337302-fpz2jfuj	178	3	of	of	IN
cord-337302-fpz2jfuj	178	4	the	the	DT
cord-337302-fpz2jfuj	178	5	cancer	cancer	NN
cord-337302-fpz2jfuj	178	6	clinical	clinical	JJ
cord-337302-fpz2jfuj	178	7	research	research	NN
cord-337302-fpz2jfuj	178	8	programs	program	NNS
cord-337302-fpz2jfuj	178	9	including	include	VBG
cord-337302-fpz2jfuj	178	10	,	,	,
cord-337302-fpz2jfuj	178	11	clinical	clinical	JJ
cord-337302-fpz2jfuj	178	12	trials	trial	NNS
cord-337302-fpz2jfuj	178	13	,	,	,
cord-337302-fpz2jfuj	178	14	have	have	VBP
cord-337302-fpz2jfuj	178	15	experienced	experience	VBN
cord-337302-fpz2jfuj	178	16	operational	operational	JJ
cord-337302-fpz2jfuj	178	17	changes	change	NNS
cord-337302-fpz2jfuj	178	18	,	,	,
cord-337302-fpz2jfuj	178	19	including	include	VBG
cord-337302-fpz2jfuj	178	20	delays	delay	NNS
cord-337302-fpz2jfuj	178	21	in	in	IN
cord-337302-fpz2jfuj	178	22	accruals	accrual	NNS
cord-337302-fpz2jfuj	178	23	during	during	IN
cord-337302-fpz2jfuj	178	24	the	the	DT
cord-337302-fpz2jfuj	178	25	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	178	26	pandemic	pandemic	NN
cord-337302-fpz2jfuj	178	27	,	,	,
cord-337302-fpz2jfuj	178	28	according	accord	VBG
cord-337302-fpz2jfuj	178	29	to	to	IN
cord-337302-fpz2jfuj	178	30	a	a	DT
cord-337302-fpz2jfuj	178	31	report	report	NN
cord-337302-fpz2jfuj	178	32	by	by	IN
cord-337302-fpz2jfuj	178	33	an	an	DT
cord-337302-fpz2jfuj	178	34	international	international	JJ
cord-337302-fpz2jfuj	178	35	collaborative	collaborative	JJ
cord-337302-fpz2jfuj	178	36	group	group	NN
cord-337302-fpz2jfuj	178	37	that	that	WDT
cord-337302-fpz2jfuj	178	38	looked	look	VBD
cord-337302-fpz2jfuj	178	39	at	at	IN
cord-337302-fpz2jfuj	178	40	the	the	DT
cord-337302-fpz2jfuj	178	41	impacts	impact	NNS
cord-337302-fpz2jfuj	178	42	of	of	IN
cord-337302-fpz2jfuj	178	43	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	178	44	on	on	IN
cord-337302-fpz2jfuj	178	45	cancer	cancer	NN
cord-337302-fpz2jfuj	178	46	care	care	NN
cord-337302-fpz2jfuj	178	47	.	.	.
cord-337302-fpz2jfuj	179	1	58	58	CD
cord-337302-fpz2jfuj	179	2	,	,	,
cord-337302-fpz2jfuj	179	3	59	59	CD
cord-337302-fpz2jfuj	179	4	Training	training	NN
cord-337302-fpz2jfuj	179	5	and	and	CC
cord-337302-fpz2jfuj	179	6	education	education	NN
cord-337302-fpz2jfuj	179	7	in	in	IN
cord-337302-fpz2jfuj	179	8	the	the	DT
cord-337302-fpz2jfuj	179	9	oncology	oncology	NN
cord-337302-fpz2jfuj	179	10	department	department	NNP
cord-337302-fpz2jfuj	179	11	have	have	VBP
cord-337302-fpz2jfuj	179	12	been	be	VBN
cord-337302-fpz2jfuj	179	13	equally	equally	RB
cord-337302-fpz2jfuj	179	14	affected	affect	VBN
cord-337302-fpz2jfuj	179	15	.	.	.
cord-337302-fpz2jfuj	180	1	Medical	medical	JJ
cord-337302-fpz2jfuj	180	2	students	student	NNS
cord-337302-fpz2jfuj	180	3	'	'	POS
cord-337302-fpz2jfuj	180	4	training	training	NN
cord-337302-fpz2jfuj	180	5	programs	program	NNS
cord-337302-fpz2jfuj	180	6	are	be	VBP
cord-337302-fpz2jfuj	180	7	not	not	RB
cord-337302-fpz2jfuj	180	8	ongoing	ongoing	JJ
cord-337302-fpz2jfuj	180	9	.	.	.
cord-337302-fpz2jfuj	181	1	Hospital	hospital	NN
cord-337302-fpz2jfuj	181	2	morning	morning	NN
cord-337302-fpz2jfuj	181	3	rounds	round	NNS
cord-337302-fpz2jfuj	181	4	,	,	,
cord-337302-fpz2jfuj	181	5	meetings	meeting	NNS
cord-337302-fpz2jfuj	181	6	and	and	CC
cord-337302-fpz2jfuj	181	7	journal	journal	NN
cord-337302-fpz2jfuj	181	8	clubs	club	NNS
cord-337302-fpz2jfuj	181	9	have	have	VBP
cord-337302-fpz2jfuj	181	10	been	be	VBN
cord-337302-fpz2jfuj	181	11	suspended	suspend	VBN
cord-337302-fpz2jfuj	181	12	,	,	,
cord-337302-fpz2jfuj	181	13	and	and	CC
cord-337302-fpz2jfuj	181	14	are	be	VBP
cord-337302-fpz2jfuj	181	15	only	only	RB
cord-337302-fpz2jfuj	181	16	accessible	accessible	JJ
cord-337302-fpz2jfuj	181	17	via	via	IN
cord-337302-fpz2jfuj	181	18	teleconference	teleconference	NN
cord-337302-fpz2jfuj	181	19	.	.	.
cord-337302-fpz2jfuj	182	1	60	60	CD
cord-337302-fpz2jfuj	182	2	Cancer	cancer	NN
cord-337302-fpz2jfuj	182	3	care	care	NN
cord-337302-fpz2jfuj	182	4	providers	provider	NNS
cord-337302-fpz2jfuj	182	5	are	be	VBP
cord-337302-fpz2jfuj	182	6	at	at	IN
cord-337302-fpz2jfuj	182	7	increased	increase	VBN
cord-337302-fpz2jfuj	182	8	risk	risk	NN
cord-337302-fpz2jfuj	182	9	for	for	IN
cord-337302-fpz2jfuj	182	10	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	182	11	infection	infection	NN
cord-337302-fpz2jfuj	182	12	.	.	.
cord-337302-fpz2jfuj	183	1	Many	many	JJ
cord-337302-fpz2jfuj	183	2	healthcare	healthcare	NN
cord-337302-fpz2jfuj	183	3	workers	worker	NNS
cord-337302-fpz2jfuj	183	4	succumbed	succumb	VBD
cord-337302-fpz2jfuj	183	5	to	to	IN
cord-337302-fpz2jfuj	183	6	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	183	7	,	,	,
cord-337302-fpz2jfuj	183	8	representing	represent	VBG
cord-337302-fpz2jfuj	183	9	8.3	8.3	CD
cord-337302-fpz2jfuj	183	10	%	%	NN
cord-337302-fpz2jfuj	183	11	of	of	IN
cord-337302-fpz2jfuj	183	12	Italy	Italy	NNP
cord-337302-fpz2jfuj	183	13	cases	case	NNS
cord-337302-fpz2jfuj	183	14	by	by	IN
cord-337302-fpz2jfuj	183	15	19th	19th	JJ
cord-337302-fpz2jfuj	183	16	March	March	NNP
cord-337302-fpz2jfuj	183	17	2020	2020	CD
cord-337302-fpz2jfuj	183	18	.	.	.
cord-337302-fpz2jfuj	184	1	Working	work	VBG
cord-337302-fpz2jfuj	184	2	under	under	IN
cord-337302-fpz2jfuj	184	3	pressure	pressure	NN
cord-337302-fpz2jfuj	184	4	and	and	CC
cord-337302-fpz2jfuj	184	5	burn	burn	VB
cord-337302-fpz2jfuj	184	6	out	out	RP
cord-337302-fpz2jfuj	184	7	are	be	VBP
cord-337302-fpz2jfuj	184	8	likely	likely	JJ
cord-337302-fpz2jfuj	184	9	to	to	TO
cord-337302-fpz2jfuj	184	10	be	be	VB
cord-337302-fpz2jfuj	184	11	experienced	experience	VBN
cord-337302-fpz2jfuj	184	12	by	by	IN
cord-337302-fpz2jfuj	184	13	cancer	cancer	NN
cord-337302-fpz2jfuj	184	14	care	care	NN
cord-337302-fpz2jfuj	184	15	providers	provider	NNS
cord-337302-fpz2jfuj	184	16	during	during	IN
cord-337302-fpz2jfuj	184	17	this	this	DT
cord-337302-fpz2jfuj	184	18	pandemic	pandemic	NN
cord-337302-fpz2jfuj	184	19	.	.	.
cord-337302-fpz2jfuj	185	1	51	51	CD
cord-337302-fpz2jfuj	185	2	Mental	mental	JJ
cord-337302-fpz2jfuj	185	3	health	health	NN
cord-337302-fpz2jfuj	185	4	and	and	CC
cord-337302-fpz2jfuj	185	5	psychological	psychological	JJ
cord-337302-fpz2jfuj	185	6	stress	stress	NN
cord-337302-fpz2jfuj	185	7	,	,	,
cord-337302-fpz2jfuj	185	8	especially	especially	RB
cord-337302-fpz2jfuj	185	9	vicarious	vicarious	JJ
cord-337302-fpz2jfuj	185	10	traumatization	traumatization	NN
cord-337302-fpz2jfuj	185	11	in	in	IN
cord-337302-fpz2jfuj	185	12	caregivers	caregiver	NNS
cord-337302-fpz2jfuj	185	13	,	,	,
cord-337302-fpz2jfuj	185	14	can	can	MD
cord-337302-fpz2jfuj	185	15	be	be	VB
cord-337302-fpz2jfuj	185	16	caused	cause	VBN
cord-337302-fpz2jfuj	185	17	by	by	IN
cord-337302-fpz2jfuj	185	18	the	the	DT
cord-337302-fpz2jfuj	185	19	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	185	20	pandemic	pandemic	NN
cord-337302-fpz2jfuj	185	21	.	.	.
cord-337302-fpz2jfuj	186	1	In	in	IN
cord-337302-fpz2jfuj	186	2	a	a	DT
cord-337302-fpz2jfuj	186	3	recent	recent	JJ
cord-337302-fpz2jfuj	186	4	study	study	NN
cord-337302-fpz2jfuj	186	5	from	from	IN
cord-337302-fpz2jfuj	186	6	China	China	NNP
cord-337302-fpz2jfuj	186	7	that	that	WDT
cord-337302-fpz2jfuj	186	8	enrolled	enrol	VBD
cord-337302-fpz2jfuj	186	9	front	front	JJ
cord-337302-fpz2jfuj	186	10	-	-	HYPH
cord-337302-fpz2jfuj	186	11	line	line	NN
cord-337302-fpz2jfuj	186	12	nurses	nurse	NNS
cord-337302-fpz2jfuj	186	13	to	to	TO
cord-337302-fpz2jfuj	186	14	evaluate	evaluate	VB
cord-337302-fpz2jfuj	186	15	vicarious	vicarious	JJ
cord-337302-fpz2jfuj	186	16	traumatization	traumatization	NN
cord-337302-fpz2jfuj	186	17	scores	score	NNS
cord-337302-fpz2jfuj	186	18	via	via	IN
cord-337302-fpz2jfuj	186	19	a	a	DT
cord-337302-fpz2jfuj	186	20	mobile	mobile	JJ
cord-337302-fpz2jfuj	186	21	app	app	NN
cord-337302-fpz2jfuj	186	22	-	-	HYPH
cord-337302-fpz2jfuj	186	23	based	base	VBN
cord-337302-fpz2jfuj	186	24	questionnaire	questionnaire	NN
cord-337302-fpz2jfuj	186	25	showed	show	VBD
cord-337302-fpz2jfuj	186	26	significant	significant	JJ
cord-337302-fpz2jfuj	186	27	prevalence	prevalence	NN
cord-337302-fpz2jfuj	186	28	.	.	.
cord-337302-fpz2jfuj	187	1	[	[	-LRB-
cord-337302-fpz2jfuj	187	2	61	61	CD
cord-337302-fpz2jfuj	187	3	]	]	-RRB-
cord-337302-fpz2jfuj	187	4	[	[	-LRB-
cord-337302-fpz2jfuj	187	5	62	62	CD
cord-337302-fpz2jfuj	187	6	]	]	-RRB-
cord-337302-fpz2jfuj	188	1	[	[	-LRB-
cord-337302-fpz2jfuj	188	2	63	63	CD
cord-337302-fpz2jfuj	188	3	]	]	-RRB-
cord-337302-fpz2jfuj	188	4	Recommendations	Recommendations	NNPS
cord-337302-fpz2jfuj	188	5	Currently	currently	RB
cord-337302-fpz2jfuj	188	6	,	,	,
cord-337302-fpz2jfuj	188	7	there	there	EX
cord-337302-fpz2jfuj	188	8	are	be	VBP
cord-337302-fpz2jfuj	188	9	no	no	DT
cord-337302-fpz2jfuj	188	10	harmonized	harmonize	VBN
cord-337302-fpz2jfuj	188	11	guidelines	guideline	NNS
cord-337302-fpz2jfuj	188	12	on	on	IN
cord-337302-fpz2jfuj	188	13	the	the	DT
cord-337302-fpz2jfuj	188	14	management	management	NN
cord-337302-fpz2jfuj	188	15	of	of	IN
cord-337302-fpz2jfuj	188	16	cancer	cancer	NN
cord-337302-fpz2jfuj	188	17	patients	patient	NNS
cord-337302-fpz2jfuj	188	18	with	with	IN
cord-337302-fpz2jfuj	188	19	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	188	20	.	.	.
cord-337302-fpz2jfuj	189	1	Institutionbased	institutionbased	JJ
cord-337302-fpz2jfuj	189	2	guidelines	guideline	NNS
cord-337302-fpz2jfuj	189	3	are	be	VBP
cord-337302-fpz2jfuj	189	4	followed	follow	VBN
cord-337302-fpz2jfuj	189	5	,	,	,
cord-337302-fpz2jfuj	189	6	and	and	CC
cord-337302-fpz2jfuj	189	7	this	this	DT
cord-337302-fpz2jfuj	189	8	varies	vary	VBZ
cord-337302-fpz2jfuj	189	9	from	from	IN
cord-337302-fpz2jfuj	189	10	center	center	NN
cord-337302-fpz2jfuj	189	11	to	to	IN
cord-337302-fpz2jfuj	189	12	center	center	NN
cord-337302-fpz2jfuj	189	13	.	.	.
cord-337302-fpz2jfuj	190	1	This	this	DT
cord-337302-fpz2jfuj	190	2	has	have	VBZ
cord-337302-fpz2jfuj	190	3	posed	pose	VBN
cord-337302-fpz2jfuj	190	4	significant	significant	JJ
cord-337302-fpz2jfuj	190	5	challenges	challenge	NNS
cord-337302-fpz2jfuj	190	6	,	,	,
cord-337302-fpz2jfuj	190	7	especially	especially	RB
cord-337302-fpz2jfuj	190	8	for	for	IN
cord-337302-fpz2jfuj	190	9	integrative	integrative	JJ
cord-337302-fpz2jfuj	190	10	cancer	cancer	NN
cord-337302-fpz2jfuj	190	11	treatments	treatment	NNS
cord-337302-fpz2jfuj	190	12	.	.	.
cord-337302-fpz2jfuj	191	1	31	31	CD
cord-337302-fpz2jfuj	191	2	,	,	,
cord-337302-fpz2jfuj	191	3	51	51	CD
cord-337302-fpz2jfuj	191	4	American	American	NNP
cord-337302-fpz2jfuj	191	5	Society	Society	NNP
cord-337302-fpz2jfuj	191	6	of	of	IN
cord-337302-fpz2jfuj	191	7	Clinical	Clinical	NNP
cord-337302-fpz2jfuj	191	8	Oncology	Oncology	NNP
cord-337302-fpz2jfuj	191	9	(	(	-LRB-
cord-337302-fpz2jfuj	191	10	ASCO	ASCO	NNP
cord-337302-fpz2jfuj	191	11	)	)	-RRB-
cord-337302-fpz2jfuj	191	12	recently	recently	RB
cord-337302-fpz2jfuj	191	13	released	release	VBD
cord-337302-fpz2jfuj	191	14	a	a	DT
cord-337302-fpz2jfuj	191	15	COVID-19	covid-19	NN
cord-337302-fpz2jfuj	191	16	related	relate	VBN
cord-337302-fpz2jfuj	191	17	frequently	frequently	RB
cord-337302-fpz2jfuj	191	18	asked	ask	VBN
cord-337302-fpz2jfuj	191	19	questions	question	NNS
cord-337302-fpz2jfuj	191	20	document	document	NN
cord-337302-fpz2jfuj	191	21	addressing	address	VBG
cord-337302-fpz2jfuj	191	22	the	the	DT
cord-337302-fpz2jfuj	191	23	recommendations	recommendation	NNS
cord-337302-fpz2jfuj	191	24	on	on	IN
cord-337302-fpz2jfuj	191	25	screening	screening	NN
cord-337302-fpz2jfuj	191	26	of	of	IN
cord-337302-fpz2jfuj	191	27	cancer	cancer	NN
cord-337302-fpz2jfuj	191	28	patients	patient	NNS
cord-337302-fpz2jfuj	191	29	,	,	,
cord-337302-fpz2jfuj	191	30	in	in	IN
cord-337302-fpz2jfuj	191	31	-	-	HYPH
cord-337302-fpz2jfuj	191	32	patients	patient	NNS
cord-337302-fpz2jfuj	191	33	and	and	CC
cord-337302-fpz2jfuj	191	34	outpatients	outpatient	NNS
cord-337302-fpz2jfuj	191	35	visits	visit	NNS
cord-337302-fpz2jfuj	191	36	,	,	,
cord-337302-fpz2jfuj	191	37	collection	collection	NN
cord-337302-fpz2jfuj	191	38	of	of	IN
cord-337302-fpz2jfuj	191	39	laboratory	laboratory	NN
cord-337302-fpz2jfuj	191	40	samples	sample	NNS
cord-337302-fpz2jfuj	191	41	,	,	,
cord-337302-fpz2jfuj	191	42	home	home	NN
cord-337302-fpz2jfuj	191	43	drug	drug	NN
cord-337302-fpz2jfuj	191	44	infusion	infusion	NN
cord-337302-fpz2jfuj	191	45	options	option	NNS
cord-337302-fpz2jfuj	191	46	and	and	CC
cord-337302-fpz2jfuj	191	47	engaging	engage	VBG
cord-337302-fpz2jfuj	191	48	in	in	IN
cord-337302-fpz2jfuj	191	49	telehealth	telehealth	NN
cord-337302-fpz2jfuj	191	50	.	.	.
cord-337302-fpz2jfuj	192	1	64	64	CD
cord-337302-fpz2jfuj	192	2	Multiple	multiple	JJ
cord-337302-fpz2jfuj	192	3	registries	registry	NNS
cord-337302-fpz2jfuj	192	4	of	of	IN
cord-337302-fpz2jfuj	192	5	COVID-19	covid-19	CD
cord-337302-fpz2jfuj	192	6	in	in	IN
cord-337302-fpz2jfuj	192	7	cancer	cancer	NN
cord-337302-fpz2jfuj	192	8	patients	patient	NNS
cord-337302-fpz2jfuj	192	9	have	have	VBP
cord-337302-fpz2jfuj	192	10	been	be	VBN
cord-337302-fpz2jfuj	192	11	launched	launch	VBN
cord-337302-fpz2jfuj	192	12	in	in	IN
cord-337302-fpz2jfuj	192	13	order	order	NN
cord-337302-fpz2jfuj	192	14	to	to	TO
cord-337302-fpz2jfuj	192	15	characterize	characterize	VB
cord-337302-fpz2jfuj	192	16	the	the	DT
cord-337302-fpz2jfuj	192	17	severity	severity	NN
cord-337302-fpz2jfuj	192	18	and	and	CC
cord-337302-fpz2jfuj	192	19	clinical	clinical	JJ
cord-337302-fpz2jfuj	192	20	outcomes	outcome	NNS
cord-337302-fpz2jfuj	192	21	of	of	IN
cord-337302-fpz2jfuj	192	22	cancer	cancer	NN
cord-337302-fpz2jfuj	192	23	patients	patient	NNS
cord-337302-fpz2jfuj	192	24	.	.	.
cord-337302-fpz2jfuj	193	1	A	a	DT
cord-337302-fpz2jfuj	193	2	new	new	JJ
cord-337302-fpz2jfuj	193	3	registry	registry	NN
cord-337302-fpz2jfuj	193	4	of	of	IN
cord-337302-fpz2jfuj	193	5	such	such	JJ
cord-337302-fpz2jfuj	193	6	is	be	VBZ
cord-337302-fpz2jfuj	193	7	TERAVOLT	TERAVOLT	NNP
cord-337302-fpz2jfuj	193	8	(	(	-LRB-
cord-337302-fpz2jfuj	193	9	Thoracic	Thoracic	NNP
cord-337302-fpz2jfuj	193	10	cancERs	cancers	CC
cord-337302-fpz2jfuj	193	11	international	international	JJ
cord-337302-fpz2jfuj	193	12	coVid	covid	JJ
cord-337302-fpz2jfuj	193	13	19	19	CD
cord-337302-fpz2jfuj	193	14	cOLlaboraTion	collaboration	NN
cord-337302-fpz2jfuj	193	15	)	)	-RRB-
cord-337302-fpz2jfuj	193	16	that	that	WDT
cord-337302-fpz2jfuj	193	17	collect	collect	VBP
cord-337302-fpz2jfuj	193	18	lung	lung	NN
cord-337302-fpz2jfuj	193	19	cancer	cancer	NN
cord-337302-fpz2jfuj	193	20	tailored	tailor	VBN
cord-337302-fpz2jfuj	193	21	risk	risk	NN
cord-337302-fpz2jfuj	193	22	-	-	HYPH
cord-337302-fpz2jfuj	193	23	assessment	assessment	NN
cord-337302-fpz2jfuj	193	24	data	datum	NNS
cord-337302-fpz2jfuj	193	25	across	across	IN
cord-337302-fpz2jfuj	193	26	multiple	multiple	JJ
cord-337302-fpz2jfuj	193	27	international	international	JJ
cord-337302-fpz2jfuj	193	28	centers	center	NNS
cord-337302-fpz2jfuj	193	29	.	.	.
cord-337302-fpz2jfuj	194	1	65	65	CD
cord-337302-fpz2jfuj	195	1	In	in	IN
cord-337302-fpz2jfuj	195	2	ten	ten	CD
cord-337302-fpz2jfuj	195	3	-	-	HYPH
cord-337302-fpz2jfuj	195	4	point	point	NN
cord-337302-fpz2jfuj	195	5	recommendations	recommendation	NNS
cord-337302-fpz2jfuj	195	6	for	for	IN
cord-337302-fpz2jfuj	195	7	oncology	oncology	NN
cord-337302-fpz2jfuj	195	8	practices	practice	NNS
cord-337302-fpz2jfuj	195	9	on	on	IN
cord-337302-fpz2jfuj	195	10	the	the	DT
cord-337302-fpz2jfuj	195	11	safety	safety	NN
cord-337302-fpz2jfuj	195	12	of	of	IN
cord-337302-fpz2jfuj	195	13	cancer	cancer	NN
cord-337302-fpz2jfuj	195	14	patients	patient	NNS
cord-337302-fpz2jfuj	195	15	and	and	CC
cord-337302-fpz2jfuj	195	16	their	-PRON-	PRP$
cord-337302-fpz2jfuj	195	17	caregivers	caregiver	NNS
cord-337302-fpz2jfuj	195	18	,	,	,
cord-337302-fpz2jfuj	195	19	Pelin	Pelin	NNP
cord-337302-fpz2jfuj	195	20	et	et	NNP
cord-337302-fpz2jfuj	195	21	al	al	NNP
cord-337302-fpz2jfuj	195	22	,	,	,
cord-337302-fpz2jfuj	195	23	suggest	suggest	VBP
cord-337302-fpz2jfuj	195	24	prescreening	prescreening	NN
cord-337302-fpz2jfuj	195	25	,	,	,
cord-337302-fpz2jfuj	195	26	telemedicine	telemedicine	NN
cord-337302-fpz2jfuj	195	27	,	,	,
cord-337302-fpz2jfuj	195	28	switch	switch	VB
cord-337302-fpz2jfuj	195	29	therapy	therapy	NN
cord-337302-fpz2jfuj	195	30	,	,	,
cord-337302-fpz2jfuj	195	31	among	among	IN
cord-337302-fpz2jfuj	195	32	others	other	NNS
cord-337302-fpz2jfuj	195	33	during	during	IN
cord-337302-fpz2jfuj	195	34	this	this	DT
cord-337302-fpz2jfuj	195	35	pandemic	pandemic	NN
cord-337302-fpz2jfuj	195	36	.	.	.
cord-337302-fpz2jfuj	196	1	66	66	CD
cord-337302-fpz2jfuj	197	1	The	the	DT
cord-337302-fpz2jfuj	197	2	World	World	NNP
cord-337302-fpz2jfuj	197	3	Health	Health	NNP
cord-337302-fpz2jfuj	197	4	Organization	Organization	NNP
cord-337302-fpz2jfuj	197	5	67	67	CD
cord-337302-fpz2jfuj	197	6	has	have	VBZ
cord-337302-fpz2jfuj	197	7	given	give	VBN
cord-337302-fpz2jfuj	197	8	several	several	JJ
cord-337302-fpz2jfuj	197	9	general	general	JJ
cord-337302-fpz2jfuj	197	10	recommendations	recommendation	NNS
cord-337302-fpz2jfuj	197	11	,	,	,
cord-337302-fpz2jfuj	197	12	which	which	WDT
cord-337302-fpz2jfuj	197	13	include	include	VBP
cord-337302-fpz2jfuj	197	14	;	;	:
cord-337302-fpz2jfuj	197	15	adopting	adopt	VBG
cord-337302-fpz2jfuj	197	16	isolate	isolate	NN
cord-337302-fpz2jfuj	197	17	,	,	,
cord-337302-fpz2jfuj	197	18	test	test	VBP
cord-337302-fpz2jfuj	197	19	,	,	,
cord-337302-fpz2jfuj	197	20	treat	treat	VB
cord-337302-fpz2jfuj	197	21	and	and	CC
cord-337302-fpz2jfuj	197	22	trace	trace	NN
cord-337302-fpz2jfuj	197	23	policy	policy	NN
cord-337302-fpz2jfuj	197	24	,	,	,
cord-337302-fpz2jfuj	197	25	hand	hand	NN
cord-337302-fpz2jfuj	197	26	washing	washing	NN
cord-337302-fpz2jfuj	197	27	after	after	IN
cord-337302-fpz2jfuj	197	28	visiting	visit	VBG
cord-337302-fpz2jfuj	197	29	every	every	DT
cord-337302-fpz2jfuj	197	30	patient	patient	NN
cord-337302-fpz2jfuj	197	31	,	,	,
cord-337302-fpz2jfuj	197	32	screening	screening	NN
cord-337302-fpz2jfuj	197	33	,	,	,
cord-337302-fpz2jfuj	197	34	and	and	CC
cord-337302-fpz2jfuj	197	35	isolation	isolation	NN
cord-337302-fpz2jfuj	197	36	of	of	IN
cord-337302-fpz2jfuj	197	37	suspected	suspect	VBN
cord-337302-fpz2jfuj	197	38	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	197	39	cancer	cancer	NN
cord-337302-fpz2jfuj	197	40	patients	patient	NNS
cord-337302-fpz2jfuj	197	41	in	in	IN
cord-337302-fpz2jfuj	197	42	different	different	JJ
cord-337302-fpz2jfuj	197	43	wards	ward	NNS
cord-337302-fpz2jfuj	197	44	.	.	.
cord-337302-fpz2jfuj	198	1	Additionally	additionally	RB
cord-337302-fpz2jfuj	198	2	,	,	,
cord-337302-fpz2jfuj	198	3	care	care	NN
cord-337302-fpz2jfuj	198	4	providers	provider	NNS
cord-337302-fpz2jfuj	198	5	are	be	VBP
cord-337302-fpz2jfuj	198	6	advised	advise	VBN
cord-337302-fpz2jfuj	198	7	to	to	TO
cord-337302-fpz2jfuj	198	8	limit	limit	VB
cord-337302-fpz2jfuj	198	9	the	the	DT
cord-337302-fpz2jfuj	198	10	use	use	NN
cord-337302-fpz2jfuj	198	11	of	of	IN
cord-337302-fpz2jfuj	198	12	aerosol	aerosol	NN
cord-337302-fpz2jfuj	198	13	-	-	HYPH
cord-337302-fpz2jfuj	198	14	generating	generate	VBG
cord-337302-fpz2jfuj	198	15	procedures	procedure	NNS
cord-337302-fpz2jfuj	198	16	like	like	IN
cord-337302-fpz2jfuj	198	17	intubations	intubation	NNS
cord-337302-fpz2jfuj	198	18	in	in	IN
cord-337302-fpz2jfuj	198	19	cancer	cancer	NN
cord-337302-fpz2jfuj	198	20	patients	patient	NNS
cord-337302-fpz2jfuj	198	21	.	.	.
cord-337302-fpz2jfuj	199	1	51	51	CD
cord-337302-fpz2jfuj	200	1	The	the	DT
cord-337302-fpz2jfuj	200	2	Center	Center	NNP
cord-337302-fpz2jfuj	200	3	for	for	IN
cord-337302-fpz2jfuj	200	4	Disease	Disease	NNP
cord-337302-fpz2jfuj	200	5	Control	Control	NNP
cord-337302-fpz2jfuj	200	6	(	(	-LRB-
cord-337302-fpz2jfuj	200	7	CDC	CDC	NNP
cord-337302-fpz2jfuj	200	8	)	)	-RRB-
cord-337302-fpz2jfuj	200	9	recommends	recommend	VBZ
cord-337302-fpz2jfuj	200	10	high	high	JJ
cord-337302-fpz2jfuj	200	11	-	-	HYPH
cord-337302-fpz2jfuj	200	12	risk	risk	NN
cord-337302-fpz2jfuj	200	13	individuals	individual	NNS
cord-337302-fpz2jfuj	200	14	like	like	IN
cord-337302-fpz2jfuj	200	15	cancer	cancer	NN
cord-337302-fpz2jfuj	200	16	patients	patient	NNS
cord-337302-fpz2jfuj	200	17	to	to	TO
cord-337302-fpz2jfuj	200	18	stay	stay	VB
cord-337302-fpz2jfuj	200	19	home	home	RB
cord-337302-fpz2jfuj	200	20	and	and	CC
cord-337302-fpz2jfuj	200	21	should	should	MD
cord-337302-fpz2jfuj	200	22	avoid	avoid	VB
cord-337302-fpz2jfuj	200	23	cruise	cruise	NN
cord-337302-fpz2jfuj	200	24	ship	ship	NN
cord-337302-fpz2jfuj	200	25	and	and	CC
cord-337302-fpz2jfuj	200	26	nonessential	nonessential	JJ
cord-337302-fpz2jfuj	200	27	air	air	NN
cord-337302-fpz2jfuj	200	28	travel	travel	NN
cord-337302-fpz2jfuj	200	29	.	.	.
cord-337302-fpz2jfuj	201	1	However	however	RB
cord-337302-fpz2jfuj	201	2	,	,	,
cord-337302-fpz2jfuj	201	3	they	-PRON-	PRP
cord-337302-fpz2jfuj	201	4	should	should	MD
cord-337302-fpz2jfuj	201	5	be	be	VB
cord-337302-fpz2jfuj	201	6	provided	provide	VBN
cord-337302-fpz2jfuj	201	7	access	access	NN
cord-337302-fpz2jfuj	201	8	to	to	IN
cord-337302-fpz2jfuj	201	9	several	several	JJ
cord-337302-fpz2jfuj	201	10	weeks	week	NNS
cord-337302-fpz2jfuj	201	11	of	of	IN
cord-337302-fpz2jfuj	201	12	medication	medication	NN
cord-337302-fpz2jfuj	201	13	.	.	.
cord-337302-fpz2jfuj	202	1	68	68	CD
cord-337302-fpz2jfuj	203	1	During	during	IN
cord-337302-fpz2jfuj	203	2	the	the	DT
cord-337302-fpz2jfuj	203	3	Middle	Middle	NNP
cord-337302-fpz2jfuj	203	4	East	East	NNP
cord-337302-fpz2jfuj	203	5	Respiratory	Respiratory	NNP
cord-337302-fpz2jfuj	203	6	Syndrome	Syndrome	NNP
cord-337302-fpz2jfuj	203	7	Coronavirus	Coronavirus	NNP
cord-337302-fpz2jfuj	203	8	(	(	-LRB-
cord-337302-fpz2jfuj	203	9	MERS	MERS	NNP
cord-337302-fpz2jfuj	203	10	-	-	HYPH
cord-337302-fpz2jfuj	203	11	CoV	CoV	NNP
cord-337302-fpz2jfuj	203	12	)	)	-RRB-
cord-337302-fpz2jfuj	203	13	,	,	,
cord-337302-fpz2jfuj	203	14	leaders	leader	NNS
cord-337302-fpz2jfuj	203	15	in	in	IN
cord-337302-fpz2jfuj	203	16	oncology	oncology	NN
cord-337302-fpz2jfuj	203	17	care	care	NN
cord-337302-fpz2jfuj	203	18	instituted	institute	VBD
cord-337302-fpz2jfuj	203	19	a	a	DT
cord-337302-fpz2jfuj	203	20	plan	plan	NN
cord-337302-fpz2jfuj	203	21	to	to	TO
cord-337302-fpz2jfuj	203	22	manage	manage	VB
cord-337302-fpz2jfuj	203	23	the	the	DT
cord-337302-fpz2jfuj	203	24	crisis	crisis	NN
cord-337302-fpz2jfuj	203	25	in	in	IN
cord-337302-fpz2jfuj	203	26	cancer	cancer	NN
cord-337302-fpz2jfuj	203	27	patients	patient	NNS
cord-337302-fpz2jfuj	203	28	.	.	.
cord-337302-fpz2jfuj	204	1	The	the	DT
cord-337302-fpz2jfuj	204	2	main	main	JJ
cord-337302-fpz2jfuj	204	3	components	component	NNS
cord-337302-fpz2jfuj	204	4	of	of	IN
cord-337302-fpz2jfuj	204	5	this	this	DT
cord-337302-fpz2jfuj	204	6	plan	plan	NN
cord-337302-fpz2jfuj	204	7	include	include	VBP
cord-337302-fpz2jfuj	204	8	;	;	:
cord-337302-fpz2jfuj	204	9	leadership	leadership	NN
cord-337302-fpz2jfuj	204	10	and	and	CC
cord-337302-fpz2jfuj	204	11	communication	communication	NN
cord-337302-fpz2jfuj	204	12	,	,	,
cord-337302-fpz2jfuj	204	13	staff	staff	NN
cord-337302-fpz2jfuj	204	14	management	management	NN
cord-337302-fpz2jfuj	204	15	,	,	,
cord-337302-fpz2jfuj	204	16	infection	infection	NN
cord-337302-fpz2jfuj	204	17	control	control	NN
cord-337302-fpz2jfuj	204	18	,	,	,
cord-337302-fpz2jfuj	204	19	patient	patient	JJ
cord-337302-fpz2jfuj	204	20	management	management	NN
cord-337302-fpz2jfuj	204	21	,	,	,
cord-337302-fpz2jfuj	204	22	and	and	CC
cord-337302-fpz2jfuj	204	23	recovery	recovery	NN
cord-337302-fpz2jfuj	204	24	plan	plan	NN
cord-337302-fpz2jfuj	204	25	.	.	.
cord-337302-fpz2jfuj	205	1	Such	such	JJ
cord-337302-fpz2jfuj	205	2	a	a	DT
cord-337302-fpz2jfuj	205	3	plan	plan	NN
cord-337302-fpz2jfuj	205	4	presents	present	VBZ
cord-337302-fpz2jfuj	205	5	a	a	DT
cord-337302-fpz2jfuj	205	6	template	template	NN
cord-337302-fpz2jfuj	205	7	for	for	IN
cord-337302-fpz2jfuj	205	8	the	the	DT
cord-337302-fpz2jfuj	205	9	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	205	10	epidemic	epidemic	NN
cord-337302-fpz2jfuj	205	11	and	and	CC
cord-337302-fpz2jfuj	205	12	should	should	MD
cord-337302-fpz2jfuj	205	13	be	be	VB
cord-337302-fpz2jfuj	205	14	adopted	adopt	VBN
cord-337302-fpz2jfuj	205	15	for	for	IN
cord-337302-fpz2jfuj	205	16	the	the	DT
cord-337302-fpz2jfuj	205	17	benefit	benefit	NN
cord-337302-fpz2jfuj	205	18	of	of	IN
cord-337302-fpz2jfuj	205	19	immunosuppressed	immunosuppressed	JJ
cord-337302-fpz2jfuj	205	20	groups	group	NNS
cord-337302-fpz2jfuj	205	21	like	like	IN
cord-337302-fpz2jfuj	205	22	cancer	cancer	NN
cord-337302-fpz2jfuj	205	23	patients	patient	NNS
cord-337302-fpz2jfuj	205	24	.	.	.
cord-337302-fpz2jfuj	206	1	69	69	CD
cord-337302-fpz2jfuj	207	1	A	a	DT
cord-337302-fpz2jfuj	207	2	recently	recently	RB
cord-337302-fpz2jfuj	207	3	published	publish	VBN
cord-337302-fpz2jfuj	207	4	experience	experience	NN
cord-337302-fpz2jfuj	207	5	from	from	IN
cord-337302-fpz2jfuj	207	6	China	China	NNP
cord-337302-fpz2jfuj	207	7	on	on	IN
cord-337302-fpz2jfuj	207	8	the	the	DT
cord-337302-fpz2jfuj	207	9	countermeasures	countermeasure	NNS
cord-337302-fpz2jfuj	207	10	against	against	IN
cord-337302-fpz2jfuj	207	11	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	207	12	in	in	IN
cord-337302-fpz2jfuj	207	13	cancer	cancer	NN
cord-337302-fpz2jfuj	207	14	recommends	recommend	VBZ
cord-337302-fpz2jfuj	207	15	postponing	postpone	VBG
cord-337302-fpz2jfuj	207	16	elective	elective	JJ
cord-337302-fpz2jfuj	207	17	surgery	surgery	NN
cord-337302-fpz2jfuj	207	18	or	or	CC
cord-337302-fpz2jfuj	207	19	adjuvant	adjuvant	JJ
cord-337302-fpz2jfuj	207	20	chemotherapy	chemotherapy	NN
cord-337302-fpz2jfuj	207	21	for	for	IN
cord-337302-fpz2jfuj	207	22	stable	stable	JJ
cord-337302-fpz2jfuj	207	23	patients	patient	NNS
cord-337302-fpz2jfuj	207	24	and	and	CC
cord-337302-fpz2jfuj	207	25	those	those	DT
cord-337302-fpz2jfuj	207	26	with	with	IN
cord-337302-fpz2jfuj	207	27	advanced	advanced	JJ
cord-337302-fpz2jfuj	207	28	cancer	cancer	NN
cord-337302-fpz2jfuj	207	29	in	in	IN
cord-337302-fpz2jfuj	207	30	endemic	endemic	JJ
cord-337302-fpz2jfuj	207	31	areas	area	NNS
cord-337302-fpz2jfuj	207	32	.	.	.
cord-337302-fpz2jfuj	208	1	Strict	strict	JJ
cord-337302-fpz2jfuj	208	2	and	and	CC
cord-337302-fpz2jfuj	208	3	thorough	thorough	JJ
cord-337302-fpz2jfuj	208	4	surveillance	surveillance	NN
cord-337302-fpz2jfuj	208	5	should	should	MD
cord-337302-fpz2jfuj	208	6	be	be	VB
cord-337302-fpz2jfuj	208	7	considered	consider	VBN
cord-337302-fpz2jfuj	208	8	if	if	IN
cord-337302-fpz2jfuj	208	9	cancer	cancer	NN
cord-337302-fpz2jfuj	208	10	patients	patient	NNS
cord-337302-fpz2jfuj	208	11	are	be	VBP
cord-337302-fpz2jfuj	208	12	infected	infect	VBN
cord-337302-fpz2jfuj	208	13	with	with	IN
cord-337302-fpz2jfuj	208	14	SARS	SARS	NNP
cord-337302-fpz2jfuj	208	15	-	-	HYPH
cord-337302-fpz2jfuj	208	16	CoV	CoV	NNP
cord-337302-fpz2jfuj	208	17	-2	-2	NNP
cord-337302-fpz2jfuj	208	18	,	,	,
cord-337302-fpz2jfuj	208	19	especially	especially	RB
cord-337302-fpz2jfuj	208	20	elderly	elderly	JJ
cord-337302-fpz2jfuj	208	21	patients	patient	NNS
cord-337302-fpz2jfuj	208	22	and	and	CC
cord-337302-fpz2jfuj	208	23	those	those	DT
cord-337302-fpz2jfuj	208	24	with	with	IN
cord-337302-fpz2jfuj	208	25	other	other	JJ
cord-337302-fpz2jfuj	208	26	comorbidities	comorbiditie	NNS
cord-337302-fpz2jfuj	208	27	.	.	.
cord-337302-fpz2jfuj	209	1	15	15	CD
cord-337302-fpz2jfuj	209	2	,	,	,
cord-337302-fpz2jfuj	209	3	31	31	CD
cord-337302-fpz2jfuj	209	4	The	the	DT
cord-337302-fpz2jfuj	209	5	Italian	italian	JJ
cord-337302-fpz2jfuj	209	6	authors	author	NNS
cord-337302-fpz2jfuj	209	7	recommend	recommend	VBP
cord-337302-fpz2jfuj	209	8	the	the	DT
cord-337302-fpz2jfuj	209	9	importance	importance	NN
cord-337302-fpz2jfuj	209	10	of	of	IN
cord-337302-fpz2jfuj	209	11	prioritizing	prioritize	VBG
cord-337302-fpz2jfuj	209	12	urgent	urgent	JJ
cord-337302-fpz2jfuj	209	13	cancer	cancer	NN
cord-337302-fpz2jfuj	209	14	treatment	treatment	NN
cord-337302-fpz2jfuj	209	15	,	,	,
cord-337302-fpz2jfuj	209	16	especially	especially	RB
cord-337302-fpz2jfuj	209	17	in	in	IN
cord-337302-fpz2jfuj	209	18	the	the	DT
cord-337302-fpz2jfuj	209	19	setting	setting	NN
cord-337302-fpz2jfuj	209	20	of	of	IN
cord-337302-fpz2jfuj	209	21	colorectal	colorectal	JJ
cord-337302-fpz2jfuj	209	22	surgery	surgery	NN
cord-337302-fpz2jfuj	209	23	.	.	.
cord-337302-fpz2jfuj	210	1	Minimally	minimally	RB
cord-337302-fpz2jfuj	210	2	invasive	invasive	JJ
cord-337302-fpz2jfuj	210	3	procedures	procedure	NNS
cord-337302-fpz2jfuj	210	4	should	should	MD
cord-337302-fpz2jfuj	210	5	be	be	VB
cord-337302-fpz2jfuj	210	6	preferred	prefer	VBN
cord-337302-fpz2jfuj	210	7	and	and	CC
cord-337302-fpz2jfuj	210	8	done	do	VBN
cord-337302-fpz2jfuj	210	9	only	only	RB
cord-337302-fpz2jfuj	210	10	on	on	IN
cord-337302-fpz2jfuj	210	11	highly	highly	RB
cord-337302-fpz2jfuj	210	12	selected	select	VBN
cord-337302-fpz2jfuj	210	13	patients	patient	NNS
cord-337302-fpz2jfuj	210	14	.	.	.
cord-337302-fpz2jfuj	211	1	Radiotherapy	Radiotherapy	NNP
cord-337302-fpz2jfuj	211	2	,	,	,
cord-337302-fpz2jfuj	211	3	as	as	IN
cord-337302-fpz2jfuj	211	4	an	an	DT
cord-337302-fpz2jfuj	211	5	essential	essential	JJ
cord-337302-fpz2jfuj	211	6	treatment	treatment	NN
cord-337302-fpz2jfuj	211	7	modality	modality	NN
cord-337302-fpz2jfuj	211	8	,	,	,
cord-337302-fpz2jfuj	211	9	can	can	MD
cord-337302-fpz2jfuj	211	10	be	be	VB
cord-337302-fpz2jfuj	211	11	used	use	VBN
cord-337302-fpz2jfuj	211	12	as	as	IN
cord-337302-fpz2jfuj	211	13	an	an	DT
cord-337302-fpz2jfuj	211	14	alternative	alternative	NN
cord-337302-fpz2jfuj	211	15	to	to	IN
cord-337302-fpz2jfuj	211	16	surgery	surgery	NN
cord-337302-fpz2jfuj	211	17	where	where	WRB
cord-337302-fpz2jfuj	211	18	feasible	feasible	JJ
cord-337302-fpz2jfuj	211	19	,	,	,
cord-337302-fpz2jfuj	211	20	especially	especially	RB
cord-337302-fpz2jfuj	211	21	by	by	IN
cord-337302-fpz2jfuj	211	22	the	the	DT
cord-337302-fpz2jfuj	211	23	use	use	NN
cord-337302-fpz2jfuj	211	24	of	of	IN
cord-337302-fpz2jfuj	211	25	hypofractionated	hypofractionate	VBN
cord-337302-fpz2jfuj	211	26	regimens	regimen	NNS
cord-337302-fpz2jfuj	211	27	,	,	,
cord-337302-fpz2jfuj	211	28	as	as	IN
cord-337302-fpz2jfuj	211	29	this	this	DT
cord-337302-fpz2jfuj	211	30	will	will	MD
cord-337302-fpz2jfuj	211	31	minimize	minimize	VB
cord-337302-fpz2jfuj	211	32	the	the	DT
cord-337302-fpz2jfuj	211	33	number	number	NN
cord-337302-fpz2jfuj	211	34	of	of	IN
cord-337302-fpz2jfuj	211	35	visits	visit	NNS
cord-337302-fpz2jfuj	211	36	.	.	.
cord-337302-fpz2jfuj	212	1	70	70	CD
cord-337302-fpz2jfuj	212	2	Delaying	delay	VBG
cord-337302-fpz2jfuj	212	3	radiotherapy	radiotherapy	NN
cord-337302-fpz2jfuj	212	4	poses	pose	VBZ
cord-337302-fpz2jfuj	212	5	detrimental	detrimental	JJ
cord-337302-fpz2jfuj	212	6	effects	effect	NNS
cord-337302-fpz2jfuj	212	7	,	,	,
cord-337302-fpz2jfuj	212	8	especially	especially	RB
cord-337302-fpz2jfuj	212	9	in	in	IN
cord-337302-fpz2jfuj	212	10	patients	patient	NNS
cord-337302-fpz2jfuj	212	11	who	who	WP
cord-337302-fpz2jfuj	212	12	need	need	VBP
cord-337302-fpz2jfuj	212	13	palliative	palliative	JJ
cord-337302-fpz2jfuj	212	14	radiotherapy	radiotherapy	NN
cord-337302-fpz2jfuj	212	15	.	.	.
cord-337302-fpz2jfuj	213	1	Similarly	similarly	RB
cord-337302-fpz2jfuj	213	2	,	,	,
cord-337302-fpz2jfuj	213	3	according	accord	VBG
cord-337302-fpz2jfuj	213	4	to	to	IN
cord-337302-fpz2jfuj	213	5	the	the	DT
cord-337302-fpz2jfuj	213	6	Early	early	JJ
cord-337302-fpz2jfuj	213	7	Breast	Breast	NNP
cord-337302-fpz2jfuj	213	8	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	213	9	Trialists	Trialists	NNPS
cord-337302-fpz2jfuj	213	10	'	'	POS
cord-337302-fpz2jfuj	213	11	Collaborative	Collaborative	NNP
cord-337302-fpz2jfuj	213	12	Group	Group	NNP
cord-337302-fpz2jfuj	213	13	,	,	,
cord-337302-fpz2jfuj	213	14	radiotherapy	radiotherapy	NN
cord-337302-fpz2jfuj	213	15	delays	delay	NNS
cord-337302-fpz2jfuj	213	16	obviate	obviate	VBP
cord-337302-fpz2jfuj	213	17	survival	survival	NN
cord-337302-fpz2jfuj	213	18	benefits	benefit	NNS
cord-337302-fpz2jfuj	213	19	associated	associate	VBN
cord-337302-fpz2jfuj	213	20	with	with	IN
cord-337302-fpz2jfuj	213	21	the	the	DT
cord-337302-fpz2jfuj	213	22	adjuvant	adjuvant	JJ
cord-337302-fpz2jfuj	213	23	treatments	treatment	NNS
cord-337302-fpz2jfuj	213	24	of	of	IN
cord-337302-fpz2jfuj	213	25	breast	breast	NN
cord-337302-fpz2jfuj	213	26	cancer	cancer	NN
cord-337302-fpz2jfuj	213	27	.	.	.
cord-337302-fpz2jfuj	214	1	71	71	CD
cord-337302-fpz2jfuj	215	1	European	european	JJ
cord-337302-fpz2jfuj	215	2	/	/	SYM
cord-337302-fpz2jfuj	215	3	American	American	NNP
cord-337302-fpz2jfuj	215	4	Society	Society	NNP
cord-337302-fpz2jfuj	215	5	for	for	IN
cord-337302-fpz2jfuj	215	6	Radiation	Radiation	NNP
cord-337302-fpz2jfuj	215	7	Oncology	Oncology	NNP
cord-337302-fpz2jfuj	216	1	(	(	-LRB-
cord-337302-fpz2jfuj	216	2	ESTRO	ESTRO	NNP
cord-337302-fpz2jfuj	216	3	-	-	HYPH
cord-337302-fpz2jfuj	216	4	ASTRO	ASTRO	NNP
cord-337302-fpz2jfuj	216	5	)	)	-RRB-
cord-337302-fpz2jfuj	216	6	issued	issue	VBD
cord-337302-fpz2jfuj	216	7	a	a	DT
cord-337302-fpz2jfuj	216	8	consensus	consensus	NN
cord-337302-fpz2jfuj	216	9	statement	statement	NN
cord-337302-fpz2jfuj	216	10	on	on	IN
cord-337302-fpz2jfuj	216	11	lung	lung	NN
cord-337302-fpz2jfuj	216	12	cancer	cancer	NN
cord-337302-fpz2jfuj	216	13	radiotherapy	radiotherapy	NN
cord-337302-fpz2jfuj	216	14	during	during	IN
cord-337302-fpz2jfuj	216	15	the	the	DT
cord-337302-fpz2jfuj	216	16	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	216	17	pandemic	pandemic	NN
cord-337302-fpz2jfuj	216	18	.	.	.
cord-337302-fpz2jfuj	217	1	This	this	DT
cord-337302-fpz2jfuj	217	2	practice	practice	NN
cord-337302-fpz2jfuj	217	3	recommendation	recommendation	NN
cord-337302-fpz2jfuj	217	4	addresses	address	VBZ
cord-337302-fpz2jfuj	217	5	six	six	CD
cord-337302-fpz2jfuj	217	6	different	different	JJ
cord-337302-fpz2jfuj	217	7	lung	lung	NN
cord-337302-fpz2jfuj	217	8	cancer	cancer	NN
cord-337302-fpz2jfuj	217	9	cases	case	NNS
cord-337302-fpz2jfuj	217	10	and	and	CC
cord-337302-fpz2jfuj	217	11	the	the	DT
cord-337302-fpz2jfuj	217	12	prioritization	prioritization	NN
cord-337302-fpz2jfuj	217	13	of	of	IN
cord-337302-fpz2jfuj	217	14	hypofractionation	hypofractionation	NN
cord-337302-fpz2jfuj	217	15	in	in	IN
cord-337302-fpz2jfuj	217	16	the	the	DT
cord-337302-fpz2jfuj	217	17	setting	setting	NN
cord-337302-fpz2jfuj	217	18	of	of	IN
cord-337302-fpz2jfuj	217	19	risk	risk	NN
cord-337302-fpz2jfuj	217	20	mitigation	mitigation	NN
cord-337302-fpz2jfuj	217	21	and	and	CC
cord-337302-fpz2jfuj	217	22	reduced	reduced	JJ
cord-337302-fpz2jfuj	217	23	resources	resource	NNS
cord-337302-fpz2jfuj	217	24	.	.	.
cord-337302-fpz2jfuj	218	1	72	72	CD
cord-337302-fpz2jfuj	219	1	In	in	IN
cord-337302-fpz2jfuj	219	2	a	a	DT
cord-337302-fpz2jfuj	219	3	special	special	JJ
cord-337302-fpz2jfuj	219	4	issue	issue	NN
cord-337302-fpz2jfuj	219	5	about	about	IN
cord-337302-fpz2jfuj	219	6	their	-PRON-	PRP$
cord-337302-fpz2jfuj	219	7	experience	experience	NN
cord-337302-fpz2jfuj	219	8	from	from	IN
cord-337302-fpz2jfuj	219	9	the	the	DT
cord-337302-fpz2jfuj	219	10	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	219	11	epicenter	epicenter	NN
cord-337302-fpz2jfuj	219	12	in	in	IN
cord-337302-fpz2jfuj	219	13	the	the	DT
cord-337302-fpz2jfuj	219	14	United	United	NNP
cord-337302-fpz2jfuj	219	15	States	States	NNP
cord-337302-fpz2jfuj	219	16	,	,	,
cord-337302-fpz2jfuj	219	17	Masumi	Masumi	NNP
cord-337302-fpz2jfuj	219	18	et	et	NNP
cord-337302-fpz2jfuj	219	19	al	al	NNP
cord-337302-fpz2jfuj	219	20	recommend	recommend	VB
cord-337302-fpz2jfuj	219	21	the	the	DT
cord-337302-fpz2jfuj	219	22	continuation	continuation	NN
cord-337302-fpz2jfuj	219	23	of	of	IN
cord-337302-fpz2jfuj	219	24	therapy	therapy	NN
cord-337302-fpz2jfuj	219	25	in	in	IN
cord-337302-fpz2jfuj	219	26	patients	patient	NNS
cord-337302-fpz2jfuj	219	27	with	with	IN
cord-337302-fpz2jfuj	219	28	curative	curative	JJ
cord-337302-fpz2jfuj	219	29	intent	intent	NN
cord-337302-fpz2jfuj	219	30	.	.	.
cord-337302-fpz2jfuj	220	1	Hematologic	Hematologic	NNP
cord-337302-fpz2jfuj	220	2	malignancy	malignancy	NN
cord-337302-fpz2jfuj	220	3	like	like	IN
cord-337302-fpz2jfuj	220	4	acute	acute	JJ
cord-337302-fpz2jfuj	220	5	leukemias	leukemia	NNS
cord-337302-fpz2jfuj	220	6	needs	need	VBZ
cord-337302-fpz2jfuj	220	7	greater	great	JJR
cord-337302-fpz2jfuj	220	8	urgency	urgency	NN
cord-337302-fpz2jfuj	220	9	;	;	:
cord-337302-fpz2jfuj	220	10	hence	hence	RB
cord-337302-fpz2jfuj	220	11	should	should	MD
cord-337302-fpz2jfuj	220	12	be	be	VB
cord-337302-fpz2jfuj	220	13	handled	handle	VBN
cord-337302-fpz2jfuj	220	14	as	as	IN
cord-337302-fpz2jfuj	220	15	such	such	JJ
cord-337302-fpz2jfuj	220	16	.	.	.
cord-337302-fpz2jfuj	221	1	And	and	CC
cord-337302-fpz2jfuj	221	2	finally	finally	RB
cord-337302-fpz2jfuj	221	3	,	,	,
cord-337302-fpz2jfuj	221	4	cellular	cellular	JJ
cord-337302-fpz2jfuj	221	5	immunotherapies	immunotherapy	NNS
cord-337302-fpz2jfuj	221	6	and	and	CC
cord-337302-fpz2jfuj	221	7	hematopoietic	hematopoietic	JJ
cord-337302-fpz2jfuj	221	8	stem	stem	NN
cord-337302-fpz2jfuj	221	9	cell	cell	NN
cord-337302-fpz2jfuj	221	10	transplantation	transplantation	NN
cord-337302-fpz2jfuj	221	11	are	be	VBP
cord-337302-fpz2jfuj	221	12	invaluable	invaluable	JJ
cord-337302-fpz2jfuj	221	13	curative	curative	JJ
cord-337302-fpz2jfuj	221	14	interventions	intervention	NNS
cord-337302-fpz2jfuj	221	15	for	for	IN
cord-337302-fpz2jfuj	221	16	most	most	JJS
cord-337302-fpz2jfuj	221	17	patients	patient	NNS
cord-337302-fpz2jfuj	221	18	with	with	IN
cord-337302-fpz2jfuj	221	19	aggressive	aggressive	JJ
cord-337302-fpz2jfuj	221	20	disease	disease	NN
cord-337302-fpz2jfuj	221	21	;	;	:
cord-337302-fpz2jfuj	221	22	therefore	therefore	RB
cord-337302-fpz2jfuj	221	23	should	should	MD
cord-337302-fpz2jfuj	221	24	not	not	RB
cord-337302-fpz2jfuj	221	25	be	be	VB
cord-337302-fpz2jfuj	221	26	delayed	delay	VBN
cord-337302-fpz2jfuj	221	27	if	if	IN
cord-337302-fpz2jfuj	221	28	possible	possible	JJ
cord-337302-fpz2jfuj	221	29	.	.	.
cord-337302-fpz2jfuj	222	1	48	48	CD
cord-337302-fpz2jfuj	222	2	Patients	patient	NNS
cord-337302-fpz2jfuj	222	3	on	on	IN
cord-337302-fpz2jfuj	222	4	immunotherapy	immunotherapy	NN
cord-337302-fpz2jfuj	222	5	with	with	IN
cord-337302-fpz2jfuj	222	6	underlying	underlie	VBG
cord-337302-fpz2jfuj	222	7	lung	lung	NN
cord-337302-fpz2jfuj	222	8	diseases	disease	NNS
cord-337302-fpz2jfuj	222	9	like	like	IN
cord-337302-fpz2jfuj	222	10	interstitial	interstitial	JJ
cord-337302-fpz2jfuj	222	11	pneumopathy	pneumopathy	NNP
cord-337302-fpz2jfuj	222	12	are	be	VBP
cord-337302-fpz2jfuj	222	13	considered	consider	VBN
cord-337302-fpz2jfuj	222	14	a	a	DT
cord-337302-fpz2jfuj	222	15	highrisk	highrisk	JJ
cord-337302-fpz2jfuj	222	16	group	group	NN
cord-337302-fpz2jfuj	222	17	for	for	IN
cord-337302-fpz2jfuj	222	18	immunotherapy	immunotherapy	NN
cord-337302-fpz2jfuj	222	19	related	relate	VBN
cord-337302-fpz2jfuj	222	20	pneumonitis	pneumonitis	NN
cord-337302-fpz2jfuj	222	21	.	.	.
cord-337302-fpz2jfuj	223	1	As	as	IN
cord-337302-fpz2jfuj	223	2	mentioned	mention	VBN
cord-337302-fpz2jfuj	223	3	above	above	RB
cord-337302-fpz2jfuj	223	4	,	,	,
cord-337302-fpz2jfuj	223	5	there	there	EX
cord-337302-fpz2jfuj	223	6	are	be	VBP
cord-337302-fpz2jfuj	223	7	controversies	controversy	NNS
cord-337302-fpz2jfuj	223	8	about	about	IN
cord-337302-fpz2jfuj	223	9	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	223	10	and	and	CC
cord-337302-fpz2jfuj	223	11	anticancer	anticancer	JJ
cord-337302-fpz2jfuj	223	12	treatment	treatment	NN
cord-337302-fpz2jfuj	223	13	with	with	IN
cord-337302-fpz2jfuj	223	14	ICI	ICI	NNP
cord-337302-fpz2jfuj	223	15	.	.	.
cord-337302-fpz2jfuj	224	1	However	however	RB
cord-337302-fpz2jfuj	224	2	,	,	,
cord-337302-fpz2jfuj	224	3	patients	patient	NNS
cord-337302-fpz2jfuj	224	4	should	should	MD
cord-337302-fpz2jfuj	224	5	not	not	RB
cord-337302-fpz2jfuj	224	6	be	be	VB
cord-337302-fpz2jfuj	224	7	denied	deny	VBN
cord-337302-fpz2jfuj	224	8	the	the	DT
cord-337302-fpz2jfuj	224	9	crucial	crucial	JJ
cord-337302-fpz2jfuj	224	10	benefits	benefit	NNS
cord-337302-fpz2jfuj	224	11	of	of	IN
cord-337302-fpz2jfuj	224	12	ICI	ICI	NNP
cord-337302-fpz2jfuj	224	13	treatment	treatment	NN
cord-337302-fpz2jfuj	224	14	,	,	,
cord-337302-fpz2jfuj	224	15	especially	especially	RB
cord-337302-fpz2jfuj	224	16	in	in	IN
cord-337302-fpz2jfuj	224	17	highly	highly	RB
cord-337302-fpz2jfuj	224	18	responsive	responsive	JJ
cord-337302-fpz2jfuj	224	19	diseases	disease	NNS
cord-337302-fpz2jfuj	224	20	.	.	.
cord-337302-fpz2jfuj	225	1	73	73	CD
cord-337302-fpz2jfuj	226	1	A	a	DT
cord-337302-fpz2jfuj	226	2	panel	panel	NN
cord-337302-fpz2jfuj	226	3	made	make	VBD
cord-337302-fpz2jfuj	226	4	up	up	RP
cord-337302-fpz2jfuj	226	5	of	of	IN
cord-337302-fpz2jfuj	226	6	15	15	CD
cord-337302-fpz2jfuj	226	7	experts	expert	NNS
cord-337302-fpz2jfuj	226	8	in	in	IN
cord-337302-fpz2jfuj	226	9	the	the	DT
cord-337302-fpz2jfuj	226	10	UK	UK	NNP
cord-337302-fpz2jfuj	226	11	has	have	VBZ
cord-337302-fpz2jfuj	226	12	recently	recently	RB
cord-337302-fpz2jfuj	226	13	published	publish	VBN
cord-337302-fpz2jfuj	226	14	updated	update	VBN
cord-337302-fpz2jfuj	226	15	recommendations	recommendation	NNS
cord-337302-fpz2jfuj	226	16	during	during	IN
cord-337302-fpz2jfuj	226	17	the	the	DT
cord-337302-fpz2jfuj	226	18	ongoing	ongoing	JJ
cord-337302-fpz2jfuj	226	19	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	226	20	pandemic	pandemic	NN
cord-337302-fpz2jfuj	226	21	in	in	IN
cord-337302-fpz2jfuj	226	22	the	the	DT
cord-337302-fpz2jfuj	226	23	radiotherapy	radiotherapy	NN
cord-337302-fpz2jfuj	226	24	setting	set	VBG
cord-337302-fpz2jfuj	226	25	recommending	recommend	VBG
cord-337302-fpz2jfuj	226	26	hypofractionation	hypofractionation	NN
cord-337302-fpz2jfuj	226	27	for	for	IN
cord-337302-fpz2jfuj	226	28	bowel	bowel	NN
cord-337302-fpz2jfuj	226	29	cancer	cancer	NN
cord-337302-fpz2jfuj	226	30	to	to	TO
cord-337302-fpz2jfuj	226	31	minimize	minimize	VB
cord-337302-fpz2jfuj	226	32	visits	visit	NNS
cord-337302-fpz2jfuj	226	33	while	while	IN
cord-337302-fpz2jfuj	226	34	maintaining	maintain	VBG
cord-337302-fpz2jfuj	226	35	the	the	DT
cord-337302-fpz2jfuj	226	36	efficacy	efficacy	NN
cord-337302-fpz2jfuj	226	37	of	of	IN
cord-337302-fpz2jfuj	226	38	treatment	treatment	NN
cord-337302-fpz2jfuj	226	39	.	.	.
cord-337302-fpz2jfuj	227	1	The	the	DT
cord-337302-fpz2jfuj	227	2	panel	panel	NN
cord-337302-fpz2jfuj	227	3	also	also	RB
cord-337302-fpz2jfuj	227	4	recommends	recommend	VBZ
cord-337302-fpz2jfuj	227	5	delaying	delay	VBG
cord-337302-fpz2jfuj	227	6	any	any	DT
cord-337302-fpz2jfuj	227	7	therapy	therapy	NN
cord-337302-fpz2jfuj	227	8	in	in	IN
cord-337302-fpz2jfuj	227	9	elderly	elderly	JJ
cord-337302-fpz2jfuj	227	10	patients	patient	NNS
cord-337302-fpz2jfuj	227	11	and	and	CC
cord-337302-fpz2jfuj	227	12	patients	patient	NNS
cord-337302-fpz2jfuj	227	13	with	with	IN
cord-337302-fpz2jfuj	227	14	poor	poor	JJ
cord-337302-fpz2jfuj	227	15	performance	performance	NN
cord-337302-fpz2jfuj	227	16	status	status	NN
cord-337302-fpz2jfuj	227	17	or	or	CC
cord-337302-fpz2jfuj	227	18	those	those	DT
cord-337302-fpz2jfuj	227	19	who	who	WP
cord-337302-fpz2jfuj	227	20	are	be	VBP
cord-337302-fpz2jfuj	227	21	unfit	unfit	JJ
cord-337302-fpz2jfuj	227	22	for	for	IN
cord-337302-fpz2jfuj	227	23	chemotherapy	chemotherapy	NN
cord-337302-fpz2jfuj	227	24	.	.	.
cord-337302-fpz2jfuj	228	1	60	60	CD
cord-337302-fpz2jfuj	228	2	,	,	,
cord-337302-fpz2jfuj	228	3	74	74	CD
cord-337302-fpz2jfuj	228	4	Canadian	canadian	JJ
cord-337302-fpz2jfuj	228	5	guidelines	guideline	NNS
cord-337302-fpz2jfuj	228	6	on	on	IN
cord-337302-fpz2jfuj	228	7	prioritizing	prioritize	VBG
cord-337302-fpz2jfuj	228	8	systemic	systemic	JJ
cord-337302-fpz2jfuj	228	9	therapies	therapy	NNS
cord-337302-fpz2jfuj	228	10	for	for	IN
cord-337302-fpz2jfuj	228	11	genitourinary	genitourinary	JJ
cord-337302-fpz2jfuj	228	12	malignancies	malignancy	NNS
cord-337302-fpz2jfuj	228	13	during	during	IN
cord-337302-fpz2jfuj	228	14	this	this	DT
cord-337302-fpz2jfuj	228	15	pandemic	pandemic	NN
cord-337302-fpz2jfuj	228	16	recommend	recommend	VBP
cord-337302-fpz2jfuj	228	17	the	the	DT
cord-337302-fpz2jfuj	228	18	use	use	NN
cord-337302-fpz2jfuj	228	19	of	of	IN
cord-337302-fpz2jfuj	228	20	radium	radium	NN
cord-337302-fpz2jfuj	228	21	223	223	CD
cord-337302-fpz2jfuj	228	22	,	,	,
cord-337302-fpz2jfuj	228	23	especially	especially	RB
cord-337302-fpz2jfuj	228	24	in	in	IN
cord-337302-fpz2jfuj	228	25	patients	patient	NNS
cord-337302-fpz2jfuj	228	26	with	with	IN
cord-337302-fpz2jfuj	228	27	bone	bone	NN
cord-337302-fpz2jfuj	228	28	-	-	HYPH
cord-337302-fpz2jfuj	228	29	only	only	JJ
cord-337302-fpz2jfuj	228	30	lesions	lesion	NNS
cord-337302-fpz2jfuj	228	31	and	and	CC
cord-337302-fpz2jfuj	228	32	androgen	androgen	NN
cord-337302-fpz2jfuj	228	33	-	-	HYPH
cord-337302-fpz2jfuj	228	34	receptor	receptor	NN
cord-337302-fpz2jfuj	228	35	-axis	-axis	HYPH
cord-337302-fpz2jfuj	228	36	targeted	target	VBN
cord-337302-fpz2jfuj	228	37	therapies	therapy	NNS
cord-337302-fpz2jfuj	228	38	in	in	IN
cord-337302-fpz2jfuj	228	39	metastatic	metastatic	JJ
cord-337302-fpz2jfuj	228	40	prostate	prostate	NN
cord-337302-fpz2jfuj	228	41	cancer	cancer	NN
cord-337302-fpz2jfuj	228	42	while	while	IN
cord-337302-fpz2jfuj	228	43	also	also	RB
cord-337302-fpz2jfuj	228	44	carefully	carefully	RB
cord-337302-fpz2jfuj	228	45	weighing	weigh	VBG
cord-337302-fpz2jfuj	228	46	the	the	DT
cord-337302-fpz2jfuj	228	47	risk	risk	NN
cord-337302-fpz2jfuj	228	48	of	of	IN
cord-337302-fpz2jfuj	228	49	taxanes	taxane	NNS
cord-337302-fpz2jfuj	228	50	related	relate	VBN
cord-337302-fpz2jfuj	228	51	neutropenias	neutropenias	NNP
cord-337302-fpz2jfuj	228	52	.	.	.
cord-337302-fpz2jfuj	229	1	They	-PRON-	PRP
cord-337302-fpz2jfuj	229	2	also	also	RB
cord-337302-fpz2jfuj	229	3	recommend	recommend	VBP
cord-337302-fpz2jfuj	229	4	the	the	DT
cord-337302-fpz2jfuj	229	5	use	use	NN
cord-337302-fpz2jfuj	229	6	of	of	IN
cord-337302-fpz2jfuj	229	7	virtual	virtual	JJ
cord-337302-fpz2jfuj	229	8	care	care	NN
cord-337302-fpz2jfuj	229	9	of	of	IN
cord-337302-fpz2jfuj	229	10	cancer	cancer	NN
cord-337302-fpz2jfuj	229	11	patients	patient	NNS
cord-337302-fpz2jfuj	229	12	at	at	IN
cord-337302-fpz2jfuj	229	13	this	this	DT
cord-337302-fpz2jfuj	229	14	time	time	NN
cord-337302-fpz2jfuj	229	15	to	to	TO
cord-337302-fpz2jfuj	229	16	minimize	minimize	VB
cord-337302-fpz2jfuj	229	17	visits	visit	NNS
cord-337302-fpz2jfuj	229	18	.	.	.
cord-337302-fpz2jfuj	230	1	75	75	CD
cord-337302-fpz2jfuj	231	1	The	the	DT
cord-337302-fpz2jfuj	231	2	National	National	NNP
cord-337302-fpz2jfuj	231	3	Institute	Institute	NNP
cord-337302-fpz2jfuj	231	4	for	for	IN
cord-337302-fpz2jfuj	231	5	Health	Health	NNP
cord-337302-fpz2jfuj	231	6	and	and	CC
cord-337302-fpz2jfuj	231	7	Care	Care	NNP
cord-337302-fpz2jfuj	231	8	Excellence	Excellence	NNP
cord-337302-fpz2jfuj	231	9	(	(	-LRB-
cord-337302-fpz2jfuj	231	10	NICE	NICE	NNP
cord-337302-fpz2jfuj	231	11	)	)	-RRB-
cord-337302-fpz2jfuj	231	12	and	and	CC
cord-337302-fpz2jfuj	231	13	the	the	DT
cord-337302-fpz2jfuj	231	14	European	european	JJ
cord-337302-fpz2jfuj	231	15	society	society	NN
cord-337302-fpz2jfuj	231	16	of	of	IN
cord-337302-fpz2jfuj	231	17	medical	medical	JJ
cord-337302-fpz2jfuj	231	18	oncology	oncology	NN
cord-337302-fpz2jfuj	231	19	(	(	-LRB-
cord-337302-fpz2jfuj	231	20	ESMO	ESMO	NNP
cord-337302-fpz2jfuj	231	21	)	)	-RRB-
cord-337302-fpz2jfuj	231	22	issued	issue	VBD
cord-337302-fpz2jfuj	231	23	tiered	tiered	JJ
cord-337302-fpz2jfuj	231	24	approach	approach	NN
cord-337302-fpz2jfuj	231	25	guidelines	guideline	NNS
cord-337302-fpz2jfuj	231	26	in	in	IN
cord-337302-fpz2jfuj	231	27	delivering	deliver	VBG
cord-337302-fpz2jfuj	231	28	cancer	cancer	NN
cord-337302-fpz2jfuj	231	29	care	care	NN
cord-337302-fpz2jfuj	231	30	during	during	IN
cord-337302-fpz2jfuj	231	31	the	the	DT
cord-337302-fpz2jfuj	231	32	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	231	33	pandemic	pandemic	NN
cord-337302-fpz2jfuj	231	34	.	.	.
cord-337302-fpz2jfuj	232	1	It	-PRON-	PRP
cord-337302-fpz2jfuj	232	2	's	be	VBZ
cord-337302-fpz2jfuj	232	3	designed	design	VBN
cord-337302-fpz2jfuj	232	4	on	on	IN
cord-337302-fpz2jfuj	232	5	three	three	CD
cord-337302-fpz2jfuj	232	6	levels	level	NNS
cord-337302-fpz2jfuj	232	7	:	:	:
cord-337302-fpz2jfuj	232	8	high	high	JJ
cord-337302-fpz2jfuj	232	9	,	,	,
cord-337302-fpz2jfuj	232	10	medium	medium	NN
cord-337302-fpz2jfuj	232	11	,	,	,
cord-337302-fpz2jfuj	232	12	and	and	CC
cord-337302-fpz2jfuj	232	13	low	low	JJ
cord-337302-fpz2jfuj	232	14	priority	priority	NN
cord-337302-fpz2jfuj	232	15	using	use	VBG
cord-337302-fpz2jfuj	232	16	the	the	DT
cord-337302-fpz2jfuj	232	17	criteria	criterion	NNS
cord-337302-fpz2jfuj	232	18	of	of	IN
cord-337302-fpz2jfuj	232	19	the	the	DT
cord-337302-fpz2jfuj	232	20	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	232	21	Care	Care	NNP
cord-337302-fpz2jfuj	232	22	Ontario	Ontario	NNP
cord-337302-fpz2jfuj	232	23	and	and	CC
cord-337302-fpz2jfuj	232	24	Magnitude	magnitude	NN
cord-337302-fpz2jfuj	232	25	of	of	IN
cord-337302-fpz2jfuj	232	26	Clinical	Clinical	NNP
cord-337302-fpz2jfuj	232	27	Benefit	benefit	NN
cord-337302-fpz2jfuj	232	28	Scale	Scale	NNP
cord-337302-fpz2jfuj	232	29	(	(	-LRB-
cord-337302-fpz2jfuj	232	30	MCBS	MCBS	NNP
cord-337302-fpz2jfuj	232	31	)	)	-RRB-
cord-337302-fpz2jfuj	232	32	,	,	,
cord-337302-fpz2jfuj	232	33	as	as	IN
cord-337302-fpz2jfuj	232	34	described	describe	VBN
cord-337302-fpz2jfuj	232	35	in	in	IN
cord-337302-fpz2jfuj	232	36	Table	Table	NNP
cord-337302-fpz2jfuj	232	37	2	2	CD
cord-337302-fpz2jfuj	232	38	.	.	.
cord-337302-fpz2jfuj	233	1	76	76	CD
cord-337302-fpz2jfuj	233	2	Patients	patient	NNS
cord-337302-fpz2jfuj	233	3	with	with	IN
cord-337302-fpz2jfuj	233	4	a	a	DT
cord-337302-fpz2jfuj	233	5	terminal	terminal	JJ
cord-337302-fpz2jfuj	233	6	disease	disease	NN
cord-337302-fpz2jfuj	233	7	or	or	CC
cord-337302-fpz2jfuj	233	8	with	with	IN
cord-337302-fpz2jfuj	233	9	comorbid	comorbid	NN
cord-337302-fpz2jfuj	233	10	health	health	NN
cord-337302-fpz2jfuj	233	11	who	who	WP
cord-337302-fpz2jfuj	233	12	contract	contract	VBP
cord-337302-fpz2jfuj	233	13	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	233	14	and	and	CC
cord-337302-fpz2jfuj	233	15	require	require	VB
cord-337302-fpz2jfuj	233	16	mechanical	mechanical	JJ
cord-337302-fpz2jfuj	233	17	ventilation	ventilation	NN
cord-337302-fpz2jfuj	233	18	could	could	MD
cord-337302-fpz2jfuj	233	19	have	have	VB
cord-337302-fpz2jfuj	233	20	a	a	DT
cord-337302-fpz2jfuj	233	21	dismal	dismal	JJ
cord-337302-fpz2jfuj	233	22	prognosis	prognosis	NN
cord-337302-fpz2jfuj	233	23	.	.	.
cord-337302-fpz2jfuj	234	1	A	a	DT
cord-337302-fpz2jfuj	234	2	retrospective	retrospective	JJ
cord-337302-fpz2jfuj	234	3	study	study	NN
cord-337302-fpz2jfuj	234	4	from	from	IN
cord-337302-fpz2jfuj	234	5	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	234	6	reported	report	VBD
cord-337302-fpz2jfuj	234	7	the	the	DT
cord-337302-fpz2jfuj	234	8	survival	survival	NN
cord-337302-fpz2jfuj	234	9	of	of	IN
cord-337302-fpz2jfuj	234	10	only	only	RB
cord-337302-fpz2jfuj	234	11	one	one	CD
cord-337302-fpz2jfuj	234	12	patient	patient	NN
cord-337302-fpz2jfuj	234	13	among	among	IN
cord-337302-fpz2jfuj	234	14	the	the	DT
cord-337302-fpz2jfuj	234	15	32	32	CD
cord-337302-fpz2jfuj	235	1	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	235	2	patients	patient	NNS
cord-337302-fpz2jfuj	235	3	who	who	WP
cord-337302-fpz2jfuj	235	4	were	be	VBD
cord-337302-fpz2jfuj	235	5	severely	severely	RB
cord-337302-fpz2jfuj	235	6	ill	ill	JJ
cord-337302-fpz2jfuj	235	7	and	and	CC
cord-337302-fpz2jfuj	235	8	required	require	VBN
cord-337302-fpz2jfuj	235	9	mechanical	mechanical	JJ
cord-337302-fpz2jfuj	235	10	ventilation	ventilation	NN
cord-337302-fpz2jfuj	235	11	.	.	.
cord-337302-fpz2jfuj	236	1	77	77	CD
cord-337302-fpz2jfuj	237	1	Therefore	therefore	RB
cord-337302-fpz2jfuj	237	2	,	,	,
cord-337302-fpz2jfuj	237	3	oncologists	oncologist	NNS
cord-337302-fpz2jfuj	237	4	need	need	VBP
cord-337302-fpz2jfuj	237	5	to	to	TO
cord-337302-fpz2jfuj	237	6	have	have	VB
cord-337302-fpz2jfuj	237	7	advance	advance	NN
cord-337302-fpz2jfuj	237	8	care	care	NN
cord-337302-fpz2jfuj	237	9	planning	planning	NN
cord-337302-fpz2jfuj	237	10	and	and	CC
cord-337302-fpz2jfuj	237	11	discussions	discussion	NNS
cord-337302-fpz2jfuj	237	12	with	with	IN
cord-337302-fpz2jfuj	237	13	cancer	cancer	NN
cord-337302-fpz2jfuj	237	14	patients	patient	NNS
cord-337302-fpz2jfuj	237	15	and	and	CC
cord-337302-fpz2jfuj	237	16	their	-PRON-	PRP$
cord-337302-fpz2jfuj	237	17	families	family	NNS
cord-337302-fpz2jfuj	237	18	on	on	IN
cord-337302-fpz2jfuj	237	19	such	such	JJ
cord-337302-fpz2jfuj	237	20	possible	possible	JJ
cord-337302-fpz2jfuj	237	21	outcomes	outcome	NNS
cord-337302-fpz2jfuj	237	22	.	.	.
cord-337302-fpz2jfuj	238	1	78	78	CD
cord-337302-fpz2jfuj	239	1	Similarly	similarly	RB
cord-337302-fpz2jfuj	239	2	,	,	,
cord-337302-fpz2jfuj	239	3	the	the	DT
cord-337302-fpz2jfuj	239	4	National	National	NNP
cord-337302-fpz2jfuj	239	5	Comprehensive	Comprehensive	NNP
cord-337302-fpz2jfuj	239	6	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	239	7	Network	Network	NNP
cord-337302-fpz2jfuj	239	8	(	(	-LRB-
cord-337302-fpz2jfuj	239	9	NCCN	NCCN	NNP
cord-337302-fpz2jfuj	239	10	)	)	-RRB-
cord-337302-fpz2jfuj	239	11	,	,	,
cord-337302-fpz2jfuj	239	12	48	48	CD
cord-337302-fpz2jfuj	239	13	underscores	underscore	VBZ
cord-337302-fpz2jfuj	239	14	the	the	DT
cord-337302-fpz2jfuj	239	15	importance	importance	NN
cord-337302-fpz2jfuj	239	16	of	of	IN
cord-337302-fpz2jfuj	239	17	supportive	supportive	JJ
cord-337302-fpz2jfuj	239	18	care	care	NN
cord-337302-fpz2jfuj	239	19	discussions	discussion	NNS
cord-337302-fpz2jfuj	239	20	with	with	IN
cord-337302-fpz2jfuj	239	21	cancer	cancer	NN
cord-337302-fpz2jfuj	239	22	patients	patient	NNS
cord-337302-fpz2jfuj	240	1	should	should	MD
cord-337302-fpz2jfuj	240	2	they	-PRON-	PRP
cord-337302-fpz2jfuj	240	3	become	become	VB
cord-337302-fpz2jfuj	240	4	infected	infect	VBN
cord-337302-fpz2jfuj	240	5	with	with	IN
cord-337302-fpz2jfuj	240	6	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	240	7	.	.	.
cord-337302-fpz2jfuj	241	1	With	with	IN
cord-337302-fpz2jfuj	241	2	scarce	scarce	JJ
cord-337302-fpz2jfuj	241	3	resources	resource	NNS
cord-337302-fpz2jfuj	241	4	,	,	,
cord-337302-fpz2jfuj	241	5	Oncologists	oncologist	NNS
cord-337302-fpz2jfuj	241	6	should	should	MD
cord-337302-fpz2jfuj	241	7	prioritize	prioritize	VB
cord-337302-fpz2jfuj	241	8	what	what	WDT
cord-337302-fpz2jfuj	241	9	treatments	treatment	NNS
cord-337302-fpz2jfuj	241	10	are	be	VBP
cord-337302-fpz2jfuj	241	11	most	most	RBS
cord-337302-fpz2jfuj	241	12	likely	likely	JJ
cord-337302-fpz2jfuj	241	13	to	to	TO
cord-337302-fpz2jfuj	241	14	be	be	VB
cord-337302-fpz2jfuj	241	15	successful	successful	JJ
cord-337302-fpz2jfuj	241	16	,	,	,
cord-337302-fpz2jfuj	241	17	symptom	symptom	NN
cord-337302-fpz2jfuj	241	18	-	-	HYPH
cord-337302-fpz2jfuj	241	19	relieving	relieve	VBG
cord-337302-fpz2jfuj	241	20	,	,	,
cord-337302-fpz2jfuj	241	21	and	and	CC
cord-337302-fpz2jfuj	241	22	which	which	WDT
cord-337302-fpz2jfuj	241	23	patients	patient	NNS
cord-337302-fpz2jfuj	241	24	are	be	VBP
cord-337302-fpz2jfuj	241	25	likely	likely	JJ
cord-337302-fpz2jfuj	241	26	to	to	TO
cord-337302-fpz2jfuj	241	27	benefit	benefit	VB
cord-337302-fpz2jfuj	241	28	from	from	IN
cord-337302-fpz2jfuj	241	29	such	such	JJ
cord-337302-fpz2jfuj	241	30	treatments	treatment	NNS
cord-337302-fpz2jfuj	241	31	.	.	.
cord-337302-fpz2jfuj	242	1	Finally	finally	RB
cord-337302-fpz2jfuj	242	2	,	,	,
cord-337302-fpz2jfuj	242	3	Oncologists	oncologist	NNS
cord-337302-fpz2jfuj	242	4	should	should	MD
cord-337302-fpz2jfuj	242	5	always	always	RB
cord-337302-fpz2jfuj	242	6	be	be	VB
cord-337302-fpz2jfuj	242	7	compassionate	compassionate	JJ
cord-337302-fpz2jfuj	242	8	and	and	CC
cord-337302-fpz2jfuj	242	9	do	do	VBP
cord-337302-fpz2jfuj	242	10	no	no	DT
cord-337302-fpz2jfuj	242	11	harm	harm	NN
cord-337302-fpz2jfuj	242	12	-	-	HYPH
cord-337302-fpz2jfuj	242	13	primum	primum	NN
cord-337302-fpz2jfuj	242	14	non	non	FW
cord-337302-fpz2jfuj	242	15	nocere	nocere	FW
cord-337302-fpz2jfuj	242	16	.	.	.
cord-337302-fpz2jfuj	243	1	Fortunately	fortunately	RB
cord-337302-fpz2jfuj	243	2	,	,	,
cord-337302-fpz2jfuj	243	3	there	there	EX
cord-337302-fpz2jfuj	243	4	have	have	VBP
cord-337302-fpz2jfuj	243	5	been	be	VBN
cord-337302-fpz2jfuj	243	6	no	no	DT
cord-337302-fpz2jfuj	243	7	cases	case	NNS
cord-337302-fpz2jfuj	243	8	of	of	IN
cord-337302-fpz2jfuj	243	9	COVID-19	covid-19	CD
cord-337302-fpz2jfuj	243	10	in	in	IN
cord-337302-fpz2jfuj	243	11	our	-PRON-	PRP$
cord-337302-fpz2jfuj	243	12	oncology	oncology	NN
cord-337302-fpz2jfuj	243	13	department	department	NN
cord-337302-fpz2jfuj	243	14	,	,	,
cord-337302-fpz2jfuj	243	15	but	but	CC
cord-337302-fpz2jfuj	243	16	that	that	DT
cord-337302-fpz2jfuj	243	17	is	be	VBZ
cord-337302-fpz2jfuj	243	18	not	not	RB
cord-337302-fpz2jfuj	243	19	without	without	IN
cord-337302-fpz2jfuj	243	20	contingency	contingency	NN
cord-337302-fpz2jfuj	243	21	measures	measure	NNS
cord-337302-fpz2jfuj	243	22	put	put	VBN
cord-337302-fpz2jfuj	243	23	in	in	IN
cord-337302-fpz2jfuj	243	24	place	place	NN
cord-337302-fpz2jfuj	243	25	.	.	.
cord-337302-fpz2jfuj	244	1	First	first	RB
cord-337302-fpz2jfuj	244	2	,	,	,
cord-337302-fpz2jfuj	244	3	all	all	DT
cord-337302-fpz2jfuj	244	4	medical	medical	JJ
cord-337302-fpz2jfuj	244	5	staff	staff	NN
cord-337302-fpz2jfuj	244	6	is	be	VBZ
cord-337302-fpz2jfuj	244	7	trained	train	VBN
cord-337302-fpz2jfuj	244	8	on	on	IN
cord-337302-fpz2jfuj	244	9	the	the	DT
cord-337302-fpz2jfuj	244	10	latest	late	JJS
cord-337302-fpz2jfuj	244	11	information	information	NN
cord-337302-fpz2jfuj	244	12	on	on	IN
cord-337302-fpz2jfuj	244	13	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	244	14	and	and	CC
cord-337302-fpz2jfuj	244	15	how	how	WRB
cord-337302-fpz2jfuj	244	16	to	to	TO
cord-337302-fpz2jfuj	244	17	carry	carry	VB
cord-337302-fpz2jfuj	244	18	out	out	RP
cord-337302-fpz2jfuj	244	19	case	case	NN
cord-337302-fpz2jfuj	244	20	-	-	HYPH
cord-337302-fpz2jfuj	244	21	finding	finding	NN
cord-337302-fpz2jfuj	244	22	in	in	IN
cord-337302-fpz2jfuj	244	23	their	-PRON-	PRP$
cord-337302-fpz2jfuj	244	24	respective	respective	JJ
cord-337302-fpz2jfuj	244	25	departments	department	NNS
cord-337302-fpz2jfuj	244	26	.	.	.
cord-337302-fpz2jfuj	245	1	Secondly	secondly	RB
cord-337302-fpz2jfuj	245	2	,	,	,
cord-337302-fpz2jfuj	245	3	a	a	DT
cord-337302-fpz2jfuj	245	4	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	245	5	ad	ad	FW
cord-337302-fpz2jfuj	245	6	hoc	hoc	FW
cord-337302-fpz2jfuj	245	7	expert	expert	NN
cord-337302-fpz2jfuj	245	8	committee	committee	NN
cord-337302-fpz2jfuj	245	9	comprising	comprising	NN
cord-337302-fpz2jfuj	245	10	of	of	IN
cord-337302-fpz2jfuj	245	11	High	high	JJ
cord-337302-fpz2jfuj	245	12	priority	priority	NN
cord-337302-fpz2jfuj	245	13	:	:	:
cord-337302-fpz2jfuj	245	14	patient	patient	JJ
cord-337302-fpz2jfuj	245	15	condition	condition	NN
cord-337302-fpz2jfuj	245	16	is	be	VBZ
cord-337302-fpz2jfuj	245	17	immediately	immediately	RB
cord-337302-fpz2jfuj	245	18	life	life	NN
cord-337302-fpz2jfuj	245	19	threatening	threaten	VBG
cord-337302-fpz2jfuj	245	20	,	,	,
cord-337302-fpz2jfuj	245	21	clinically	clinically	RB
cord-337302-fpz2jfuj	245	22	unstable	unstable	JJ
cord-337302-fpz2jfuj	245	23	,	,	,
cord-337302-fpz2jfuj	245	24	and/or	and/or	CC
cord-337302-fpz2jfuj	246	1	the	the	DT
cord-337302-fpz2jfuj	246	2	magnitude	magnitude	NN
cord-337302-fpz2jfuj	246	3	of	of	IN
cord-337302-fpz2jfuj	246	4	benefit	benefit	NN
cord-337302-fpz2jfuj	246	5	qualifies	qualify	VBZ
cord-337302-fpz2jfuj	246	6	the	the	DT
cord-337302-fpz2jfuj	246	7	intervention	intervention	NN
cord-337302-fpz2jfuj	246	8	as	as	IN
cord-337302-fpz2jfuj	246	9	high	high	JJ
cord-337302-fpz2jfuj	246	10	priority	priority	NN
cord-337302-fpz2jfuj	246	11	(	(	-LRB-
cord-337302-fpz2jfuj	246	12	eg	eg	IN
cord-337302-fpz2jfuj	246	13	significant	significant	JJ
cord-337302-fpz2jfuj	246	14	overall	overall	JJ
cord-337302-fpz2jfuj	246	15	survival	survival	NN
cord-337302-fpz2jfuj	246	16	gain	gain	NN
cord-337302-fpz2jfuj	246	17	and/or	and/or	CC
cord-337302-fpz2jfuj	246	18	substantial	substantial	JJ
cord-337302-fpz2jfuj	246	19	improvement	improvement	NN
cord-337302-fpz2jfuj	246	20	in	in	IN
cord-337302-fpz2jfuj	246	21	quality	quality	NN
cord-337302-fpz2jfuj	246	22	of	of	IN
cord-337302-fpz2jfuj	246	23	life	life	NN
cord-337302-fpz2jfuj	246	24	)	)	-RRB-
cord-337302-fpz2jfuj	246	25	.	.	.
cord-337302-fpz2jfuj	247	1	Medium	medium	NN
cord-337302-fpz2jfuj	247	2	priority	priority	NN
cord-337302-fpz2jfuj	247	3	:	:	:
cord-337302-fpz2jfuj	247	4	patient	patient	JJ
cord-337302-fpz2jfuj	247	5	situation	situation	NN
cord-337302-fpz2jfuj	247	6	is	be	VBZ
cord-337302-fpz2jfuj	247	7	non	non	JJ
cord-337302-fpz2jfuj	247	8	-	-	JJ
cord-337302-fpz2jfuj	247	9	critical	critical	JJ
cord-337302-fpz2jfuj	247	10	but	but	CC
cord-337302-fpz2jfuj	247	11	delay	delay	NN
cord-337302-fpz2jfuj	247	12	beyond	beyond	IN
cord-337302-fpz2jfuj	247	13	6	6	CD
cord-337302-fpz2jfuj	247	14	weeks	week	NNS
cord-337302-fpz2jfuj	247	15	could	could	MD
cord-337302-fpz2jfuj	247	16	potentially	potentially	RB
cord-337302-fpz2jfuj	247	17	impact	impact	VB
cord-337302-fpz2jfuj	247	18	overall	overall	JJ
cord-337302-fpz2jfuj	247	19	outcome	outcome	NN
cord-337302-fpz2jfuj	247	20	and/or	and/or	CC
cord-337302-fpz2jfuj	247	21	the	the	DT
cord-337302-fpz2jfuj	247	22	magnitude	magnitude	NN
cord-337302-fpz2jfuj	247	23	of	of	IN
cord-337302-fpz2jfuj	247	24	benefit	benefit	NN
cord-337302-fpz2jfuj	247	25	qualifies	qualify	VBZ
cord-337302-fpz2jfuj	247	26	for	for	IN
cord-337302-fpz2jfuj	247	27	intermediate	intermediate	JJ
cord-337302-fpz2jfuj	247	28	priority	priority	NN
cord-337302-fpz2jfuj	247	29	.	.	.
cord-337302-fpz2jfuj	248	1	Low	low	JJ
cord-337302-fpz2jfuj	248	2	priority	priority	NN
cord-337302-fpz2jfuj	248	3	:	:	:
cord-337302-fpz2jfuj	248	4	patient	patient	NN
cord-337302-fpz2jfuj	248	5	's	's	POS
cord-337302-fpz2jfuj	248	6	condition	condition	NN
cord-337302-fpz2jfuj	248	7	is	be	VBZ
cord-337302-fpz2jfuj	248	8	stable	stable	JJ
cord-337302-fpz2jfuj	248	9	enough	enough	RB
cord-337302-fpz2jfuj	248	10	that	that	IN
cord-337302-fpz2jfuj	248	11	services	service	NNS
cord-337302-fpz2jfuj	248	12	can	can	MD
cord-337302-fpz2jfuj	248	13	be	be	VB
cord-337302-fpz2jfuj	248	14	delayed	delay	VBN
cord-337302-fpz2jfuj	248	15	for	for	IN
cord-337302-fpz2jfuj	248	16	the	the	DT
cord-337302-fpz2jfuj	248	17	duration	duration	NN
cord-337302-fpz2jfuj	248	18	of	of	IN
cord-337302-fpz2jfuj	248	19	the	the	DT
cord-337302-fpz2jfuj	248	20	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	248	21	pandemic	pandemic	NN
cord-337302-fpz2jfuj	248	22	and/or	and/or	CC
cord-337302-fpz2jfuj	248	23	the	the	DT
cord-337302-fpz2jfuj	248	24	intervention	intervention	NN
cord-337302-fpz2jfuj	248	25	is	be	VBZ
cord-337302-fpz2jfuj	248	26	non	non	JJ
cord-337302-fpz2jfuj	248	27	-	-	JJ
cord-337302-fpz2jfuj	248	28	priority	priority	JJ
cord-337302-fpz2jfuj	248	29	based	base	VBN
cord-337302-fpz2jfuj	248	30	on	on	IN
cord-337302-fpz2jfuj	248	31	the	the	DT
cord-337302-fpz2jfuj	248	32	magnitude	magnitude	NN
cord-337302-fpz2jfuj	248	33	of	of	IN
cord-337302-fpz2jfuj	248	34	benefit	benefit	NN
cord-337302-fpz2jfuj	248	35	(	(	-LRB-
cord-337302-fpz2jfuj	248	36	eg	eg	IN
cord-337302-fpz2jfuj	248	37	no	no	DT
cord-337302-fpz2jfuj	248	38	survival	survival	NN
cord-337302-fpz2jfuj	248	39	gain	gain	VB
cord-337302-fpz2jfuj	248	40	with	with	IN
cord-337302-fpz2jfuj	248	41	no	no	DT
cord-337302-fpz2jfuj	248	42	change	change	NN
cord-337302-fpz2jfuj	248	43	nor	nor	CC
cord-337302-fpz2jfuj	248	44	reduced	reduce	VBN
cord-337302-fpz2jfuj	248	45	QoL	qol	NN
cord-337302-fpz2jfuj	248	46	)	)	-RRB-
cord-337302-fpz2jfuj	249	1	Abdihamid	Abdihamid	NNP
cord-337302-fpz2jfuj	249	2	et	et	FW
cord-337302-fpz2jfuj	249	3	al	al	NNP
cord-337302-fpz2jfuj	249	4	DovePress	DovePress	NNP
cord-337302-fpz2jfuj	249	5	infectious	infectious	JJ
cord-337302-fpz2jfuj	249	6	disease	disease	NN
cord-337302-fpz2jfuj	249	7	experts	expert	NNS
cord-337302-fpz2jfuj	249	8	,	,	,
cord-337302-fpz2jfuj	249	9	hematologists	hematologist	NNS
cord-337302-fpz2jfuj	249	10	and	and	CC
cord-337302-fpz2jfuj	249	11	oncologists	oncologist	NNS
cord-337302-fpz2jfuj	249	12	,	,	,
cord-337302-fpz2jfuj	249	13	pharmacists	pharmacist	NNS
cord-337302-fpz2jfuj	249	14	and	and	CC
cord-337302-fpz2jfuj	249	15	radiologists	radiologist	NNS
cord-337302-fpz2jfuj	249	16	has	have	VBZ
cord-337302-fpz2jfuj	249	17	been	be	VBN
cord-337302-fpz2jfuj	249	18	set	set	VBN
cord-337302-fpz2jfuj	249	19	up	up	RP
cord-337302-fpz2jfuj	249	20	and	and	CC
cord-337302-fpz2jfuj	249	21	institutional	institutional	JJ
cord-337302-fpz2jfuj	249	22	guidelines	guideline	NNS
cord-337302-fpz2jfuj	249	23	put	put	VBN
cord-337302-fpz2jfuj	249	24	in	in	IN
cord-337302-fpz2jfuj	249	25	place	place	NN
cord-337302-fpz2jfuj	249	26	.	.	.
cord-337302-fpz2jfuj	250	1	Thirdly	thirdly	RB
cord-337302-fpz2jfuj	250	2	,	,	,
cord-337302-fpz2jfuj	250	3	to	to	TO
cord-337302-fpz2jfuj	250	4	minimize	minimize	VB
cord-337302-fpz2jfuj	250	5	crossinfection	crossinfection	NN
cord-337302-fpz2jfuj	250	6	,	,	,
cord-337302-fpz2jfuj	250	7	staff	staff	NN
cord-337302-fpz2jfuj	250	8	should	should	MD
cord-337302-fpz2jfuj	250	9	not	not	RB
cord-337302-fpz2jfuj	250	10	enter	enter	VB
cord-337302-fpz2jfuj	250	11	other	other	JJ
cord-337302-fpz2jfuj	250	12	departments	department	NNS
cord-337302-fpz2jfuj	250	13	other	other	JJ
cord-337302-fpz2jfuj	250	14	than	than	IN
cord-337302-fpz2jfuj	250	15	their	-PRON-	PRP$
cord-337302-fpz2jfuj	250	16	own	own	JJ
cord-337302-fpz2jfuj	250	17	without	without	IN
cord-337302-fpz2jfuj	250	18	permission	permission	NN
cord-337302-fpz2jfuj	250	19	.	.	.
cord-337302-fpz2jfuj	251	1	Fourthly	fourthly	RB
cord-337302-fpz2jfuj	251	2	,	,	,
cord-337302-fpz2jfuj	251	3	the	the	DT
cord-337302-fpz2jfuj	251	4	zoning	zoning	NN
cord-337302-fpz2jfuj	251	5	of	of	IN
cord-337302-fpz2jfuj	251	6	the	the	DT
cord-337302-fpz2jfuj	251	7	institution	institution	NN
cord-337302-fpz2jfuj	251	8	into	into	IN
cord-337302-fpz2jfuj	251	9	four	four	CD
cord-337302-fpz2jfuj	251	10	special	special	JJ
cord-337302-fpz2jfuj	251	11	categories	category	NNS
cord-337302-fpz2jfuj	251	12	was	be	VBD
cord-337302-fpz2jfuj	251	13	used	use	VBN
cord-337302-fpz2jfuj	251	14	to	to	TO
cord-337302-fpz2jfuj	251	15	screen	screen	VB
cord-337302-fpz2jfuj	251	16	for	for	IN
cord-337302-fpz2jfuj	251	17	incoming	incoming	JJ
cord-337302-fpz2jfuj	251	18	patients	patient	NNS
cord-337302-fpz2jfuj	251	19	.	.	.
cord-337302-fpz2jfuj	252	1	Zone	zone	NN
cord-337302-fpz2jfuj	252	2	1	1	CD
cord-337302-fpz2jfuj	252	3	(	(	-LRB-
cord-337302-fpz2jfuj	252	4	screening	screening	NN
cord-337302-fpz2jfuj	252	5	and	and	CC
cord-337302-fpz2jfuj	252	6	surveillance	surveillance	NN
cord-337302-fpz2jfuj	252	7	zone	zone	NN
cord-337302-fpz2jfuj	252	8	)	)	-RRB-
cord-337302-fpz2jfuj	252	9	is	be	VBZ
cord-337302-fpz2jfuj	252	10	for	for	IN
cord-337302-fpz2jfuj	252	11	patients	patient	NNS
cord-337302-fpz2jfuj	252	12	who	who	WP
cord-337302-fpz2jfuj	252	13	need	need	VBP
cord-337302-fpz2jfuj	252	14	surveillance	surveillance	NN
cord-337302-fpz2jfuj	252	15	as	as	IN
cord-337302-fpz2jfuj	252	16	directed	direct	VBN
cord-337302-fpz2jfuj	252	17	by	by	IN
cord-337302-fpz2jfuj	252	18	the	the	DT
cord-337302-fpz2jfuj	252	19	committee	committee	NN
cord-337302-fpz2jfuj	252	20	of	of	IN
cord-337302-fpz2jfuj	252	21	experts	expert	NNS
cord-337302-fpz2jfuj	252	22	in	in	IN
cord-337302-fpz2jfuj	252	23	-	-	HYPH
cord-337302-fpz2jfuj	252	24	order	order	NN
cord-337302-fpz2jfuj	252	25	to	to	TO
cord-337302-fpz2jfuj	252	26	rule	rule	VB
cord-337302-fpz2jfuj	252	27	out	out	RP
cord-337302-fpz2jfuj	252	28	potential	potential	JJ
cord-337302-fpz2jfuj	252	29	infection	infection	NN
cord-337302-fpz2jfuj	252	30	.	.	.
cord-337302-fpz2jfuj	253	1	Each	each	DT
cord-337302-fpz2jfuj	253	2	patient	patient	NN
cord-337302-fpz2jfuj	253	3	must	must	MD
cord-337302-fpz2jfuj	253	4	be	be	VB
cord-337302-fpz2jfuj	253	5	isolated	isolate	VBN
cord-337302-fpz2jfuj	253	6	in	in	IN
cord-337302-fpz2jfuj	253	7	a	a	DT
cord-337302-fpz2jfuj	253	8	single	single	JJ
cord-337302-fpz2jfuj	253	9	room	room	NN
cord-337302-fpz2jfuj	253	10	.	.	.
cord-337302-fpz2jfuj	254	1	Zone	zone	NN
cord-337302-fpz2jfuj	254	2	2	2	CD
cord-337302-fpz2jfuj	254	3	(	(	-LRB-
cord-337302-fpz2jfuj	254	4	quarantine	quarantine	NN
cord-337302-fpz2jfuj	254	5	zone	zone	NN
cord-337302-fpz2jfuj	254	6	)	)	-RRB-
cord-337302-fpz2jfuj	254	7	is	be	VBZ
cord-337302-fpz2jfuj	254	8	for	for	IN
cord-337302-fpz2jfuj	254	9	suspected	suspect	VBN
cord-337302-fpz2jfuj	254	10	cases	case	NNS
cord-337302-fpz2jfuj	254	11	,	,	,
cord-337302-fpz2jfuj	254	12	and	and	CC
cord-337302-fpz2jfuj	254	13	therefore	therefore	RB
cord-337302-fpz2jfuj	254	14	each	each	DT
cord-337302-fpz2jfuj	254	15	patient	patient	NN
cord-337302-fpz2jfuj	254	16	must	must	MD
cord-337302-fpz2jfuj	254	17	be	be	VB
cord-337302-fpz2jfuj	254	18	quarantined	quarantine	VBN
cord-337302-fpz2jfuj	254	19	in	in	IN
cord-337302-fpz2jfuj	254	20	a	a	DT
cord-337302-fpz2jfuj	254	21	single	single	JJ
cord-337302-fpz2jfuj	254	22	room	room	NN
cord-337302-fpz2jfuj	254	23	.	.	.
cord-337302-fpz2jfuj	255	1	Zone	zone	NN
cord-337302-fpz2jfuj	255	2	3	3	CD
cord-337302-fpz2jfuj	255	3	(	(	-LRB-
cord-337302-fpz2jfuj	255	4	confirmed	confirm	VBN
cord-337302-fpz2jfuj	255	5	quarantine	quarantine	NN
cord-337302-fpz2jfuj	255	6	zone	zone	NN
cord-337302-fpz2jfuj	255	7	)	)	-RRB-
cord-337302-fpz2jfuj	255	8	is	be	VBZ
cord-337302-fpz2jfuj	255	9	a	a	DT
cord-337302-fpz2jfuj	255	10	treatment	treatment	NN
cord-337302-fpz2jfuj	255	11	zone	zone	NN
cord-337302-fpz2jfuj	255	12	for	for	IN
cord-337302-fpz2jfuj	255	13	patients	patient	NNS
cord-337302-fpz2jfuj	255	14	with	with	IN
cord-337302-fpz2jfuj	255	15	confirmed	confirm	VBN
cord-337302-fpz2jfuj	255	16	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	255	17	.	.	.
cord-337302-fpz2jfuj	256	1	Zone	zone	NN
cord-337302-fpz2jfuj	256	2	4	4	CD
cord-337302-fpz2jfuj	256	3	(	(	-LRB-
cord-337302-fpz2jfuj	256	4	oncology	oncology	NNP
cord-337302-fpz2jfuj	256	5	ward	ward	NNP
cord-337302-fpz2jfuj	256	6	)	)	-RRB-
cord-337302-fpz2jfuj	256	7	is	be	VBZ
cord-337302-fpz2jfuj	256	8	used	use	VBN
cord-337302-fpz2jfuj	256	9	as	as	IN
cord-337302-fpz2jfuj	256	10	the	the	DT
cord-337302-fpz2jfuj	256	11	treatment	treatment	NN
cord-337302-fpz2jfuj	256	12	zone	zone	NN
cord-337302-fpz2jfuj	256	13	for	for	IN
cord-337302-fpz2jfuj	256	14	cancer	cancer	NN
cord-337302-fpz2jfuj	256	15	patients	patient	NNS
cord-337302-fpz2jfuj	256	16	who	who	WP
cord-337302-fpz2jfuj	256	17	do	do	VBP
cord-337302-fpz2jfuj	256	18	not	not	RB
cord-337302-fpz2jfuj	256	19	have	have	VB
cord-337302-fpz2jfuj	256	20	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	256	21	.	.	.
cord-337302-fpz2jfuj	257	1	The	the	DT
cord-337302-fpz2jfuj	257	2	full	full	JJ
cord-337302-fpz2jfuj	257	3	protocol	protocol	NN
cord-337302-fpz2jfuj	257	4	is	be	VBZ
cord-337302-fpz2jfuj	257	5	shown	show	VBN
cord-337302-fpz2jfuj	257	6	in	in	IN
cord-337302-fpz2jfuj	257	7	Figure	figure	NN
cord-337302-fpz2jfuj	257	8	1	1	CD
cord-337302-fpz2jfuj	257	9	Even	even	RB
cord-337302-fpz2jfuj	257	10	though	though	IN
cord-337302-fpz2jfuj	257	11	cases	case	NNS
cord-337302-fpz2jfuj	257	12	in	in	IN
cord-337302-fpz2jfuj	257	13	china	china	NNP
cord-337302-fpz2jfuj	257	14	have	have	VBP
cord-337302-fpz2jfuj	257	15	exponentially	exponentially	RB
cord-337302-fpz2jfuj	257	16	dropped	drop	VBN
cord-337302-fpz2jfuj	257	17	and	and	CC
cord-337302-fpz2jfuj	257	18	the	the	DT
cord-337302-fpz2jfuj	257	19	curve	curve	NN
cord-337302-fpz2jfuj	257	20	flattened	flatten	VBD
cord-337302-fpz2jfuj	257	21	,	,	,
cord-337302-fpz2jfuj	257	22	continuous	continuous	JJ
cord-337302-fpz2jfuj	257	23	screening	screening	NN
cord-337302-fpz2jfuj	257	24	of	of	IN
cord-337302-fpz2jfuj	257	25	cancer	cancer	NN
cord-337302-fpz2jfuj	257	26	patients	patient	NNS
cord-337302-fpz2jfuj	257	27	for	for	IN
cord-337302-fpz2jfuj	257	28	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	257	29	before	before	IN
cord-337302-fpz2jfuj	257	30	admission	admission	NN
cord-337302-fpz2jfuj	257	31	or	or	CC
cord-337302-fpz2jfuj	257	32	before	before	IN
cord-337302-fpz2jfuj	257	33	therapy	therapy	NN
cord-337302-fpz2jfuj	257	34	is	be	VBZ
cord-337302-fpz2jfuj	257	35	still	still	RB
cord-337302-fpz2jfuj	257	36	strictly	strictly	RB
cord-337302-fpz2jfuj	257	37	followed	follow	VBN
cord-337302-fpz2jfuj	257	38	in	in	IN
cord-337302-fpz2jfuj	257	39	our	-PRON-	PRP$
cord-337302-fpz2jfuj	257	40	institution	institution	NN
cord-337302-fpz2jfuj	257	41	.	.	.
cord-337302-fpz2jfuj	258	1	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	258	2	has	have	VBZ
cord-337302-fpz2jfuj	258	3	changed	change	VBN
cord-337302-fpz2jfuj	258	4	the	the	DT
cord-337302-fpz2jfuj	258	5	world	world	NN
cord-337302-fpz2jfuj	258	6	order	order	NN
cord-337302-fpz2jfuj	258	7	and	and	CC
cord-337302-fpz2jfuj	258	8	,	,	,
cord-337302-fpz2jfuj	258	9	more	more	RBR
cord-337302-fpz2jfuj	258	10	so	so	RB
cord-337302-fpz2jfuj	258	11	,	,	,
cord-337302-fpz2jfuj	258	12	the	the	DT
cord-337302-fpz2jfuj	258	13	order	order	NN
cord-337302-fpz2jfuj	258	14	of	of	IN
cord-337302-fpz2jfuj	258	15	cancer	cancer	NN
cord-337302-fpz2jfuj	258	16	care	care	NN
cord-337302-fpz2jfuj	258	17	.	.	.
cord-337302-fpz2jfuj	259	1	Cancer	cancer	NN
cord-337302-fpz2jfuj	259	2	patients	patient	NNS
cord-337302-fpz2jfuj	259	3	and	and	CC
cord-337302-fpz2jfuj	259	4	cancer	cancer	NN
cord-337302-fpz2jfuj	259	5	survivors	survivor	NNS
cord-337302-fpz2jfuj	259	6	are	be	VBP
cord-337302-fpz2jfuj	259	7	at	at	IN
cord-337302-fpz2jfuj	259	8	high	high	JJ
cord-337302-fpz2jfuj	259	9	risk	risk	NN
cord-337302-fpz2jfuj	259	10	for	for	IN
cord-337302-fpz2jfuj	259	11	contracting	contracting	NN
cord-337302-fpz2jfuj	259	12	and	and	CC
cord-337302-fpz2jfuj	259	13	dying	die	VBG
cord-337302-fpz2jfuj	259	14	from	from	IN
cord-337302-fpz2jfuj	259	15	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	259	16	.	.	.
cord-337302-fpz2jfuj	260	1	The	the	DT
cord-337302-fpz2jfuj	260	2	incidence	incidence	NN
cord-337302-fpz2jfuj	260	3	data	datum	NNS
cord-337302-fpz2jfuj	260	4	of	of	IN
cord-337302-fpz2jfuj	260	5	COVID-19	covid-19	CD
cord-337302-fpz2jfuj	260	6	in	in	IN
cord-337302-fpz2jfuj	260	7	the	the	DT
cord-337302-fpz2jfuj	260	8	cancer	cancer	NN
cord-337302-fpz2jfuj	260	9	patient	patient	NN
cord-337302-fpz2jfuj	260	10	population	population	NN
cord-337302-fpz2jfuj	260	11	is	be	VBZ
cord-337302-fpz2jfuj	260	12	still	still	RB
cord-337302-fpz2jfuj	260	13	emerging	emerge	VBG
cord-337302-fpz2jfuj	260	14	and	and	CC
cord-337302-fpz2jfuj	260	15	could	could	MD
cord-337302-fpz2jfuj	260	16	be	be	VB
cord-337302-fpz2jfuj	260	17	higher	high	JJR
cord-337302-fpz2jfuj	260	18	than	than	IN
cord-337302-fpz2jfuj	260	19	it	-PRON-	PRP
cord-337302-fpz2jfuj	260	20	is	be	VBZ
cord-337302-fpz2jfuj	260	21	reported	report	VBN
cord-337302-fpz2jfuj	260	22	.	.	.
cord-337302-fpz2jfuj	261	1	The	the	DT
cord-337302-fpz2jfuj	261	2	symptomology	symptomology	NN
cord-337302-fpz2jfuj	261	3	of	of	IN
cord-337302-fpz2jfuj	261	4	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	261	5	in	in	IN
cord-337302-fpz2jfuj	261	6	cancer	cancer	NN
cord-337302-fpz2jfuj	261	7	patients	patient	NNS
cord-337302-fpz2jfuj	261	8	is	be	VBZ
cord-337302-fpz2jfuj	261	9	atypical	atypical	JJ
cord-337302-fpz2jfuj	261	10	and	and	CC
cord-337302-fpz2jfuj	261	11	masked	mask	VBN
cord-337302-fpz2jfuj	261	12	;	;	:
cord-337302-fpz2jfuj	261	13	hence	hence	RB
cord-337302-fpz2jfuj	261	14	misdiagnosis	misdiagnosis	NN
cord-337302-fpz2jfuj	261	15	is	be	VBZ
cord-337302-fpz2jfuj	261	16	possible	possible	JJ
cord-337302-fpz2jfuj	261	17	,	,	,
cord-337302-fpz2jfuj	261	18	so	so	IN
cord-337302-fpz2jfuj	261	19	Oncologists	oncologist	NNS
cord-337302-fpz2jfuj	261	20	should	should	MD
cord-337302-fpz2jfuj	261	21	have	have	VB
cord-337302-fpz2jfuj	261	22	a	a	DT
cord-337302-fpz2jfuj	261	23	high	high	JJ
cord-337302-fpz2jfuj	261	24	index	index	NN
cord-337302-fpz2jfuj	261	25	of	of	IN
cord-337302-fpz2jfuj	261	26	suspicion	suspicion	NN
cord-337302-fpz2jfuj	261	27	.	.	.
cord-337302-fpz2jfuj	262	1	Early	early	JJ
cord-337302-fpz2jfuj	262	2	screening	screening	NN
cord-337302-fpz2jfuj	262	3	,	,	,
cord-337302-fpz2jfuj	262	4	diagnosis	diagnosis	NN
cord-337302-fpz2jfuj	262	5	,	,	,
cord-337302-fpz2jfuj	262	6	isolation	isolation	NN
cord-337302-fpz2jfuj	262	7	,	,	,
cord-337302-fpz2jfuj	262	8	treatment	treatment	NN
cord-337302-fpz2jfuj	262	9	,	,	,
cord-337302-fpz2jfuj	262	10	and	and	CC
cord-337302-fpz2jfuj	262	11	education	education	NN
cord-337302-fpz2jfuj	262	12	of	of	IN
cord-337302-fpz2jfuj	262	13	cancer	cancer	NN
cord-337302-fpz2jfuj	262	14	patients	patient	NNS
cord-337302-fpz2jfuj	262	15	are	be	VBP
cord-337302-fpz2jfuj	262	16	of	of	IN
cord-337302-fpz2jfuj	262	17	utmost	utmost	JJ
cord-337302-fpz2jfuj	262	18	importance	importance	NN
cord-337302-fpz2jfuj	262	19	.	.	.
cord-337302-fpz2jfuj	263	1	Social	social	JJ
cord-337302-fpz2jfuj	263	2	distancing	distancing	NN
cord-337302-fpz2jfuj	263	3	,	,	,
cord-337302-fpz2jfuj	263	4	handwashing	handwashing	NN
cord-337302-fpz2jfuj	263	5	should	should	MD
cord-337302-fpz2jfuj	263	6	be	be	VB
cord-337302-fpz2jfuj	263	7	observed	observe	VBN
cord-337302-fpz2jfuj	263	8	by	by	IN
cord-337302-fpz2jfuj	263	9	cancer	cancer	NN
cord-337302-fpz2jfuj	263	10	patients	patient	NNS
cord-337302-fpz2jfuj	263	11	.	.	.
cord-337302-fpz2jfuj	264	1	Similarly	similarly	RB
cord-337302-fpz2jfuj	264	2	,	,	,
cord-337302-fpz2jfuj	264	3	hospital	hospital	NN
cord-337302-fpz2jfuj	264	4	visits	visit	NNS
cord-337302-fpz2jfuj	264	5	should	should	MD
cord-337302-fpz2jfuj	264	6	be	be	VB
cord-337302-fpz2jfuj	264	7	avoided	avoid	VBN
cord-337302-fpz2jfuj	264	8	,	,	,
cord-337302-fpz2jfuj	264	9	and	and	CC
cord-337302-fpz2jfuj	264	10	clinicians	clinician	NNS
cord-337302-fpz2jfuj	264	11	should	should	MD
cord-337302-fpz2jfuj	264	12	engage	engage	VB
cord-337302-fpz2jfuj	264	13	in	in	IN
cord-337302-fpz2jfuj	264	14	virtual	virtual	JJ
cord-337302-fpz2jfuj	264	15	care	care	NN
cord-337302-fpz2jfuj	264	16	.	.	.
cord-337302-fpz2jfuj	265	1	Patients	patient	NNS
cord-337302-fpz2jfuj	265	2	'	'	POS
cord-337302-fpz2jfuj	265	3	age	age	NN
cord-337302-fpz2jfuj	265	4	,	,	,
cord-337302-fpz2jfuj	265	5	tumor	tumor	NN
cord-337302-fpz2jfuj	265	6	type	type	NN
cord-337302-fpz2jfuj	265	7	,	,	,
cord-337302-fpz2jfuj	265	8	underlying	underlie	VBG
cord-337302-fpz2jfuj	265	9	comorbidities	comorbiditie	NNS
cord-337302-fpz2jfuj	265	10	,	,	,
cord-337302-fpz2jfuj	265	11	stage	stage	NN
cord-337302-fpz2jfuj	265	12	of	of	IN
cord-337302-fpz2jfuj	265	13	the	the	DT
cord-337302-fpz2jfuj	265	14	disease	disease	NN
cord-337302-fpz2jfuj	265	15	,	,	,
cord-337302-fpz2jfuj	265	16	and	and	CC
cord-337302-fpz2jfuj	265	17	treatment	treatment	NN
cord-337302-fpz2jfuj	265	18	type	type	NN
cord-337302-fpz2jfuj	265	19	all	all	DT
cord-337302-fpz2jfuj	265	20	affect	affect	VBP
cord-337302-fpz2jfuj	265	21	the	the	DT
cord-337302-fpz2jfuj	265	22	risk	risk	NN
cord-337302-fpz2jfuj	265	23	and	and	CC
cord-337302-fpz2jfuj	265	24	outcomes	outcome	NNS
cord-337302-fpz2jfuj	265	25	of	of	IN
cord-337302-fpz2jfuj	265	26	contracting	contract	VBG
cord-337302-fpz2jfuj	265	27	SARS	SARS	NNP
cord-337302-fpz2jfuj	265	28	-	-	HYPH
cord-337302-fpz2jfuj	265	29	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	265	30	in	in	IN
cord-337302-fpz2jfuj	265	31	cancer	cancer	NN
cord-337302-fpz2jfuj	265	32	patients	patient	NNS
cord-337302-fpz2jfuj	265	33	.	.	.
cord-337302-fpz2jfuj	266	1	However	however	RB
cord-337302-fpz2jfuj	266	2	,	,	,
cord-337302-fpz2jfuj	266	3	recent	recent	JJ
cord-337302-fpz2jfuj	266	4	evidence	evidence	NN
cord-337302-fpz2jfuj	266	5	shows	show	VBZ
cord-337302-fpz2jfuj	266	6	that	that	IN
cord-337302-fpz2jfuj	266	7	mortality	mortality	NN
cord-337302-fpz2jfuj	266	8	in	in	IN
cord-337302-fpz2jfuj	266	9	cancer	cancer	NN
cord-337302-fpz2jfuj	266	10	patients	patient	NNS
cord-337302-fpz2jfuj	266	11	from	from	IN
cord-337302-fpz2jfuj	266	12	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	266	13	is	be	VBZ
cord-337302-fpz2jfuj	266	14	mainly	mainly	RB
cord-337302-fpz2jfuj	266	15	driven	drive	VBN
cord-337302-fpz2jfuj	266	16	by	by	IN
cord-337302-fpz2jfuj	266	17	old	old	JJ
cord-337302-fpz2jfuj	266	18	age	age	NN
cord-337302-fpz2jfuj	266	19	and	and	CC
cord-337302-fpz2jfuj	266	20	comorbidities	comorbiditie	NNS
cord-337302-fpz2jfuj	266	21	and	and	CC
cord-337302-fpz2jfuj	266	22	less	less	RBR
cord-337302-fpz2jfuj	266	23	likely	likely	JJ
cord-337302-fpz2jfuj	266	24	by	by	IN
cord-337302-fpz2jfuj	266	25	the	the	DT
cord-337302-fpz2jfuj	266	26	use	use	NN
cord-337302-fpz2jfuj	266	27	of	of	IN
cord-337302-fpz2jfuj	266	28	cytotoxic	cytotoxic	JJ
cord-337302-fpz2jfuj	266	29	drugs	drug	NNS
cord-337302-fpz2jfuj	266	30	.	.	.
cord-337302-fpz2jfuj	267	1	Impacts	impact	NNS
cord-337302-fpz2jfuj	267	2	of	of	IN
cord-337302-fpz2jfuj	267	3	this	this	DT
cord-337302-fpz2jfuj	267	4	pandemic	pandemic	NN
cord-337302-fpz2jfuj	267	5	in	in	IN
cord-337302-fpz2jfuj	267	6	cancer	cancer	NN
cord-337302-fpz2jfuj	267	7	care	care	NN
cord-337302-fpz2jfuj	267	8	include	include	VBP
cord-337302-fpz2jfuj	267	9	;	;	:
cord-337302-fpz2jfuj	267	10	Increased	increase	VBN
cord-337302-fpz2jfuj	267	11	risk	risk	NN
cord-337302-fpz2jfuj	267	12	of	of	IN
cord-337302-fpz2jfuj	267	13	mortality	mortality	NN
cord-337302-fpz2jfuj	267	14	,	,	,
cord-337302-fpz2jfuj	267	15	missed	miss	VBD
cord-337302-fpz2jfuj	267	16	early	early	JJ
cord-337302-fpz2jfuj	267	17	cancer	cancer	NN
cord-337302-fpz2jfuj	267	18	diagnosis	diagnosis	NN
cord-337302-fpz2jfuj	267	19	opportunities	opportunity	NNS
cord-337302-fpz2jfuj	267	20	,	,	,
cord-337302-fpz2jfuj	267	21	cancelation	cancelation	NN
cord-337302-fpz2jfuj	267	22	,	,	,
cord-337302-fpz2jfuj	267	23	or	or	CC
cord-337302-fpz2jfuj	267	24	interruptions	interruption	NNS
cord-337302-fpz2jfuj	267	25	of	of	IN
cord-337302-fpz2jfuj	267	26	life	life	NN
cord-337302-fpz2jfuj	267	27	-	-	HYPH
cord-337302-fpz2jfuj	267	28	saving	save	VBG
cord-337302-fpz2jfuj	267	29	therapies	therapy	NNS
cord-337302-fpz2jfuj	267	30	,	,	,
cord-337302-fpz2jfuj	267	31	distraction	distraction	NN
cord-337302-fpz2jfuj	267	32	effects	effect	NNS
cord-337302-fpz2jfuj	267	33	and	and	CC
cord-337302-fpz2jfuj	267	34	diagnostic	diagnostic	JJ
cord-337302-fpz2jfuj	267	35	overshadowing	overshadowing	NN
cord-337302-fpz2jfuj	267	36	.	.	.
cord-337302-fpz2jfuj	268	1	Also	also	RB
cord-337302-fpz2jfuj	268	2	,	,	,
cord-337302-fpz2jfuj	268	3	important	important	JJ
cord-337302-fpz2jfuj	268	4	clinical	clinical	JJ
cord-337302-fpz2jfuj	268	5	trials	trial	NNS
cord-337302-fpz2jfuj	268	6	,	,	,
cord-337302-fpz2jfuj	268	7	research	research	NN
cord-337302-fpz2jfuj	268	8	,	,	,
cord-337302-fpz2jfuj	268	9	and	and	CC
cord-337302-fpz2jfuj	268	10	academic	academic	JJ
cord-337302-fpz2jfuj	268	11	programs	program	NNS
cord-337302-fpz2jfuj	268	12	and	and	CC
cord-337302-fpz2jfuj	268	13	have	have	VBP
cord-337302-fpz2jfuj	268	14	all	all	DT
cord-337302-fpz2jfuj	268	15	been	be	VBN
cord-337302-fpz2jfuj	268	16	severely	severely	RB
cord-337302-fpz2jfuj	268	17	affected	affect	VBN
cord-337302-fpz2jfuj	268	18	.	.	.
cord-337302-fpz2jfuj	269	1	As	as	IN
cord-337302-fpz2jfuj	269	2	more	more	JJR
cord-337302-fpz2jfuj	269	3	data	data	NN
cord-337302-fpz2jfuj	269	4	emerges	emerge	VBZ
cord-337302-fpz2jfuj	269	5	,	,	,
cord-337302-fpz2jfuj	269	6	the	the	DT
cord-337302-fpz2jfuj	269	7	landscape	landscape	NN
cord-337302-fpz2jfuj	269	8	of	of	IN
cord-337302-fpz2jfuj	269	9	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	269	10	will	will	MD
cord-337302-fpz2jfuj	269	11	be	be	VB
cord-337302-fpz2jfuj	269	12	understood	understand	VBN
cord-337302-fpz2jfuj	269	13	,	,	,
cord-337302-fpz2jfuj	269	14	but	but	CC
cord-337302-fpz2jfuj	269	15	as	as	IN
cord-337302-fpz2jfuj	269	16	of	of	IN
cord-337302-fpz2jfuj	269	17	now	now	RB
cord-337302-fpz2jfuj	269	18	,	,	,
cord-337302-fpz2jfuj	269	19	the	the	DT
cord-337302-fpz2jfuj	269	20	guidelines	guideline	NNS
cord-337302-fpz2jfuj	269	21	issued	issue	VBN
cord-337302-fpz2jfuj	269	22	by	by	IN
cord-337302-fpz2jfuj	269	23	the	the	DT
cord-337302-fpz2jfuj	269	24	relevant	relevant	JJ
cord-337302-fpz2jfuj	269	25	cancer	cancer	NN
cord-337302-fpz2jfuj	269	26	organizations	organization	NNS
cord-337302-fpz2jfuj	269	27	should	should	MD
cord-337302-fpz2jfuj	269	28	be	be	VB
cord-337302-fpz2jfuj	269	29	strictly	strictly	RB
cord-337302-fpz2jfuj	269	30	followed	follow	VBN
cord-337302-fpz2jfuj	269	31	to	to	TO
cord-337302-fpz2jfuj	269	32	protect	protect	VB
cord-337302-fpz2jfuj	269	33	cancer	cancer	NN
cord-337302-fpz2jfuj	269	34	patients	patient	NNS
cord-337302-fpz2jfuj	269	35	.	.	.
cord-337302-fpz2jfuj	270	1	Preventative	preventative	JJ
cord-337302-fpz2jfuj	270	2	measures	measure	NNS
cord-337302-fpz2jfuj	270	3	remain	remain	VBP
cord-337302-fpz2jfuj	270	4	the	the	DT
cord-337302-fpz2jfuj	270	5	only	only	JJ
cord-337302-fpz2jfuj	270	6	effective	effective	JJ
cord-337302-fpz2jfuj	270	7	arsenal	arsenal	NN
cord-337302-fpz2jfuj	270	8	against	against	IN
cord-337302-fpz2jfuj	270	9	this	this	DT
cord-337302-fpz2jfuj	270	10	invisible	invisible	JJ
cord-337302-fpz2jfuj	270	11	pathogen	pathogen	NN
cord-337302-fpz2jfuj	270	12	.	.	.
cord-337302-fpz2jfuj	270	13	 	 	_SP
cord-337302-fpz2jfuj	271	1	Early	early	JJ
cord-337302-fpz2jfuj	271	2	transmission	transmission	NN
cord-337302-fpz2jfuj	271	3	dynamics	dynamic	NNS
cord-337302-fpz2jfuj	271	4	in	in	IN
cord-337302-fpz2jfuj	271	5	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	271	6	,	,	,
cord-337302-fpz2jfuj	271	7	China	China	NNP
cord-337302-fpz2jfuj	271	8	,	,	,
cord-337302-fpz2jfuj	271	9	of	of	IN
cord-337302-fpz2jfuj	271	10	novel	novel	JJ
cord-337302-fpz2jfuj	271	11	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	271	12	-	-	HYPH
cord-337302-fpz2jfuj	271	13	infected	infect	VBN
cord-337302-fpz2jfuj	271	14	pneumonia	pneumonia	NN
cord-337302-fpz2jfuj	271	15	WHO	who	WP
cord-337302-fpz2jfuj	271	16	.	.	.
cord-337302-fpz2jfuj	272	1	Novel	Novel	NNP
cord-337302-fpz2jfuj	272	2	Coronavirus	Coronavirus	NNP
cord-337302-fpz2jfuj	272	3	(	(	-LRB-
cord-337302-fpz2jfuj	272	4	2019-nCoV	2019-ncov	CD
cord-337302-fpz2jfuj	272	5	)	)	-RRB-
cord-337302-fpz2jfuj	272	6	SITUATION	situation	NN
cord-337302-fpz2jfuj	272	7	REPORT	report	NN
cord-337302-fpz2jfuj	272	8	-1	-1	.
cord-337302-fpz2jfuj	273	1	21	21	CD
cord-337302-fpz2jfuj	273	2	JANUARY	JANUARY	NNP
cord-337302-fpz2jfuj	273	3	2020	2020	CD
cord-337302-fpz2jfuj	273	4	.	.	.
cord-337302-fpz2jfuj	274	1	SITUATION	situation	NN
cord-337302-fpz2jfuj	274	2	REPORT	REPORT	NNP
cord-337302-fpz2jfuj	274	3	-1	-1	.
cord-337302-fpz2jfuj	275	1	21	21	CD
cord-337302-fpz2jfuj	276	1	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	276	2	infection	infection	NN
cord-337302-fpz2jfuj	276	3	:	:	:
cord-337302-fpz2jfuj	276	4	origin	origin	NN
cord-337302-fpz2jfuj	276	5	,	,	,
cord-337302-fpz2jfuj	276	6	transmission	transmission	NN
cord-337302-fpz2jfuj	276	7	,	,	,
cord-337302-fpz2jfuj	276	8	and	and	CC
cord-337302-fpz2jfuj	276	9	characteristics	characteristic	NNS
cord-337302-fpz2jfuj	276	10	of	of	IN
cord-337302-fpz2jfuj	276	11	human	human	JJ
cord-337302-fpz2jfuj	276	12	coronaviruses	coronaviruse	NNS
cord-337302-fpz2jfuj	276	13	Insight	Insight	NNP
cord-337302-fpz2jfuj	276	14	into	into	IN
cord-337302-fpz2jfuj	276	15	2019	2019	CD
cord-337302-fpz2jfuj	276	16	novel	novel	JJ
cord-337302-fpz2jfuj	276	17	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	276	18	-an	-an	ADD
cord-337302-fpz2jfuj	276	19	updated	update	VBN
cord-337302-fpz2jfuj	276	20	interim	interim	JJ
cord-337302-fpz2jfuj	276	21	review	review	NN
cord-337302-fpz2jfuj	276	22	and	and	CC
cord-337302-fpz2jfuj	276	23	lessons	lesson	NNS
cord-337302-fpz2jfuj	276	24	from	from	IN
cord-337302-fpz2jfuj	276	25	SARS	SARS	NNP
cord-337302-fpz2jfuj	276	26	-	-	HYPH
cord-337302-fpz2jfuj	276	27	CoV	CoV	NNP
cord-337302-fpz2jfuj	276	28	and	and	CC
cord-337302-fpz2jfuj	276	29	MERS	MERS	NNP
cord-337302-fpz2jfuj	276	30	-	-	HYPH
cord-337302-fpz2jfuj	276	31	CoV	cov	NN
cord-337302-fpz2jfuj	276	32	Chinese	chinese	JJ
cord-337302-fpz2jfuj	276	33	clinical	clinical	JJ
cord-337302-fpz2jfuj	276	34	guidance	guidance	NN
cord-337302-fpz2jfuj	276	35	for	for	IN
cord-337302-fpz2jfuj	276	36	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	276	37	pneumonia	pneumonia	NN
cord-337302-fpz2jfuj	276	38	diagnosis	diagnosis	NN
cord-337302-fpz2jfuj	276	39	and	and	CC
cord-337302-fpz2jfuj	276	40	treatment	treatment	NN
cord-337302-fpz2jfuj	276	41	World	World	NNP
cord-337302-fpz2jfuj	276	42	Health	Health	NNP
cord-337302-fpz2jfuj	276	43	Organization	Organization	NNP
cord-337302-fpz2jfuj	276	44	declares	declare	VBZ
cord-337302-fpz2jfuj	276	45	global	global	JJ
cord-337302-fpz2jfuj	276	46	emergency	emergency	NN
cord-337302-fpz2jfuj	276	47	:	:	:
cord-337302-fpz2jfuj	276	48	A	a	DT
cord-337302-fpz2jfuj	276	49	review	review	NN
cord-337302-fpz2jfuj	276	50	of	of	IN
cord-337302-fpz2jfuj	276	51	the	the	DT
cord-337302-fpz2jfuj	276	52	2019	2019	CD
cord-337302-fpz2jfuj	276	53	novel	novel	NN
cord-337302-fpz2jfuj	276	54	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	276	55	(	(	-LRB-
cord-337302-fpz2jfuj	276	56	COVID-19	covid-19	VB
cord-337302-fpz2jfuj	276	57	)	)	-RRB-
cord-337302-fpz2jfuj	276	58	Situation	situation	NN
cord-337302-fpz2jfuj	276	59	report-202	report-202	NN
cord-337302-fpz2jfuj	276	60	Emerging	Emerging	NNP
cord-337302-fpz2jfuj	276	61	coronaviruses	coronaviruse	NNS
cord-337302-fpz2jfuj	276	62	:	:	:
cord-337302-fpz2jfuj	276	63	genome	genome	NN
cord-337302-fpz2jfuj	276	64	structure	structure	NN
cord-337302-fpz2jfuj	276	65	,	,	,
cord-337302-fpz2jfuj	276	66	replication	replication	NN
cord-337302-fpz2jfuj	276	67	,	,	,
cord-337302-fpz2jfuj	276	68	and	and	CC
cord-337302-fpz2jfuj	276	69	pathogenesis	pathogenesis	NN
cord-337302-fpz2jfuj	277	1	A	a	DT
cord-337302-fpz2jfuj	277	2	familial	familial	JJ
cord-337302-fpz2jfuj	277	3	cluster	cluster	NN
cord-337302-fpz2jfuj	277	4	of	of	IN
cord-337302-fpz2jfuj	277	5	pneumonia	pneumonia	NN
cord-337302-fpz2jfuj	277	6	associated	associate	VBN
cord-337302-fpz2jfuj	277	7	with	with	IN
cord-337302-fpz2jfuj	277	8	the	the	DT
cord-337302-fpz2jfuj	277	9	2019	2019	CD
cord-337302-fpz2jfuj	277	10	novel	novel	NN
cord-337302-fpz2jfuj	277	11	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	277	12	indicating	indicate	VBG
cord-337302-fpz2jfuj	277	13	person	person	NN
cord-337302-fpz2jfuj	277	14	-	-	HYPH
cord-337302-fpz2jfuj	277	15	toperson	toperson	NN
cord-337302-fpz2jfuj	277	16	transmission	transmission	NN
cord-337302-fpz2jfuj	277	17	:	:	:
cord-337302-fpz2jfuj	277	18	a	a	DT
cord-337302-fpz2jfuj	277	19	study	study	NN
cord-337302-fpz2jfuj	277	20	of	of	IN
cord-337302-fpz2jfuj	277	21	a	a	DT
cord-337302-fpz2jfuj	277	22	family	family	NN
cord-337302-fpz2jfuj	277	23	cluster	cluster	NN
cord-337302-fpz2jfuj	277	24	Report	report	NN
cord-337302-fpz2jfuj	277	25	of	of	IN
cord-337302-fpz2jfuj	277	26	the	the	DT
cord-337302-fpz2jfuj	277	27	WHO	WHO	NNP
cord-337302-fpz2jfuj	277	28	-	-	HYPH
cord-337302-fpz2jfuj	277	29	China	China	NNP
cord-337302-fpz2jfuj	277	30	Joint	Joint	NNP
cord-337302-fpz2jfuj	277	31	Mission	Mission	NNP
cord-337302-fpz2jfuj	277	32	on	on	IN
cord-337302-fpz2jfuj	277	33	Coronavirus	Coronavirus	NNP
cord-337302-fpz2jfuj	277	34	Disease	Disease	NNP
cord-337302-fpz2jfuj	277	35	2019	2019	CD
cord-337302-fpz2jfuj	278	1	(	(	-LRB-
cord-337302-fpz2jfuj	278	2	COVID-19	covid-19	VB
cord-337302-fpz2jfuj	278	3	)	)	-RRB-
cord-337302-fpz2jfuj	278	4	Outcome	outcome	NN
cord-337302-fpz2jfuj	278	5	of	of	IN
cord-337302-fpz2jfuj	278	6	oncology	oncology	NN
cord-337302-fpz2jfuj	278	7	patients	patient	NNS
cord-337302-fpz2jfuj	278	8	infected	infect	VBN
cord-337302-fpz2jfuj	278	9	with	with	IN
cord-337302-fpz2jfuj	278	10	corona	corona	NNP
cord-337302-fpz2jfuj	278	11	virus	virus	NN
cord-337302-fpz2jfuj	278	12	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	278	13	mortality	mortality	NN
cord-337302-fpz2jfuj	278	14	in	in	IN
cord-337302-fpz2jfuj	278	15	patients	patient	NNS
cord-337302-fpz2jfuj	278	16	with	with	IN
cord-337302-fpz2jfuj	278	17	cancer	cancer	NN
cord-337302-fpz2jfuj	278	18	on	on	IN
cord-337302-fpz2jfuj	278	19	chemotherapy	chemotherapy	NN
cord-337302-fpz2jfuj	278	20	or	or	CC
cord-337302-fpz2jfuj	278	21	other	other	JJ
cord-337302-fpz2jfuj	278	22	anticancer	anticancer	JJ
cord-337302-fpz2jfuj	278	23	treatments	treatment	NNS
cord-337302-fpz2jfuj	279	1	:	:	:
cord-337302-fpz2jfuj	279	2	a	a	DT
cord-337302-fpz2jfuj	279	3	prospective	prospective	JJ
cord-337302-fpz2jfuj	279	4	cohort	cohort	NN
cord-337302-fpz2jfuj	279	5	study	study	NN
cord-337302-fpz2jfuj	279	6	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	279	7	infection	infection	NN
cord-337302-fpz2jfuj	279	8	in	in	IN
cord-337302-fpz2jfuj	279	9	cancer	cancer	NN
cord-337302-fpz2jfuj	279	10	patients	patient	NNS
cord-337302-fpz2jfuj	279	11	:	:	:
cord-337302-fpz2jfuj	279	12	early	early	JJ
cord-337302-fpz2jfuj	279	13	observations	observation	NNS
cord-337302-fpz2jfuj	279	14	and	and	CC
cord-337302-fpz2jfuj	279	15	unanswered	unanswered	JJ
cord-337302-fpz2jfuj	279	16	questions	question	NNS
cord-337302-fpz2jfuj	280	1	Cancer	cancer	NN
cord-337302-fpz2jfuj	280	2	patients	patient	NNS
cord-337302-fpz2jfuj	280	3	in	in	IN
cord-337302-fpz2jfuj	280	4	SARS	SARS	NNP
cord-337302-fpz2jfuj	280	5	-	-	HYPH
cord-337302-fpz2jfuj	280	6	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	280	7	infection	infection	NN
cord-337302-fpz2jfuj	280	8	:	:	:
cord-337302-fpz2jfuj	280	9	a	a	DT
cord-337302-fpz2jfuj	280	10	nationwide	nationwide	JJ
cord-337302-fpz2jfuj	280	11	analysis	analysis	NN
cord-337302-fpz2jfuj	280	12	in	in	IN
cord-337302-fpz2jfuj	280	13	China	China	NNP
cord-337302-fpz2jfuj	280	14	Active	Active	NNP
cord-337302-fpz2jfuj	280	15	and	and	CC
cord-337302-fpz2jfuj	280	16	effective	effective	JJ
cord-337302-fpz2jfuj	280	17	measures	measure	NNS
cord-337302-fpz2jfuj	280	18	for	for	IN
cord-337302-fpz2jfuj	280	19	the	the	DT
cord-337302-fpz2jfuj	280	20	care	care	NN
cord-337302-fpz2jfuj	280	21	of	of	IN
cord-337302-fpz2jfuj	280	22	patients	patient	NNS
cord-337302-fpz2jfuj	280	23	with	with	IN
cord-337302-fpz2jfuj	280	24	cancer	cancer	NN
cord-337302-fpz2jfuj	280	25	during	during	IN
cord-337302-fpz2jfuj	280	26	the	the	DT
cord-337302-fpz2jfuj	280	27	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	280	28	spread	spread	NN
cord-337302-fpz2jfuj	280	29	in	in	IN
cord-337302-fpz2jfuj	280	30	China	China	NNP
cord-337302-fpz2jfuj	281	1	Managing	manage	VBG
cord-337302-fpz2jfuj	281	2	COVID-19	covid-19	CD
cord-337302-fpz2jfuj	281	3	in	in	IN
cord-337302-fpz2jfuj	281	4	the	the	DT
cord-337302-fpz2jfuj	281	5	oncology	oncology	NN
cord-337302-fpz2jfuj	281	6	clinic	clinic	NN
cord-337302-fpz2jfuj	281	7	and	and	CC
cord-337302-fpz2jfuj	281	8	avoiding	avoid	VBG
cord-337302-fpz2jfuj	281	9	the	the	DT
cord-337302-fpz2jfuj	281	10	distraction	distraction	NN
cord-337302-fpz2jfuj	281	11	effect	effect	NN
cord-337302-fpz2jfuj	281	12	Preparedness	Preparedness	NNP
cord-337302-fpz2jfuj	281	13	for	for	IN
cord-337302-fpz2jfuj	281	14	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	281	15	in	in	IN
cord-337302-fpz2jfuj	281	16	the	the	DT
cord-337302-fpz2jfuj	281	17	oncology	oncology	NN
cord-337302-fpz2jfuj	281	18	community	community	NN
cord-337302-fpz2jfuj	281	19	in	in	IN
cord-337302-fpz2jfuj	281	20	Africa	Africa	NNP
cord-337302-fpz2jfuj	281	21	Risk	Risk	NNP
cord-337302-fpz2jfuj	281	22	of	of	IN
cord-337302-fpz2jfuj	281	23	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	281	24	for	for	IN
cord-337302-fpz2jfuj	281	25	patients	patient	NNS
cord-337302-fpz2jfuj	281	26	with	with	IN
cord-337302-fpz2jfuj	281	27	cancer	cancer	NN
cord-337302-fpz2jfuj	281	28	Between	between	IN
cord-337302-fpz2jfuj	281	29	Scylla	Scylla	NNP
cord-337302-fpz2jfuj	281	30	and	and	CC
cord-337302-fpz2jfuj	281	31	Charybdis	Charybdis	NNP
cord-337302-fpz2jfuj	281	32	-oncologic	-oncologic	JJ
cord-337302-fpz2jfuj	281	33	decision	decision	NN
cord-337302-fpz2jfuj	281	34	making	making	NN
cord-337302-fpz2jfuj	281	35	in	in	IN
cord-337302-fpz2jfuj	281	36	the	the	DT
cord-337302-fpz2jfuj	281	37	time	time	NN
cord-337302-fpz2jfuj	281	38	of	of	IN
cord-337302-fpz2jfuj	282	1	Covid-19	covid-19	VB
cord-337302-fpz2jfuj	282	2	On	on	IN
cord-337302-fpz2jfuj	282	3	the	the	DT
cord-337302-fpz2jfuj	282	4	origin	origin	NN
cord-337302-fpz2jfuj	282	5	and	and	CC
cord-337302-fpz2jfuj	282	6	continuing	continue	VBG
cord-337302-fpz2jfuj	282	7	evolution	evolution	NN
cord-337302-fpz2jfuj	282	8	of	of	IN
cord-337302-fpz2jfuj	282	9	SARS	SARS	NNP
cord-337302-fpz2jfuj	282	10	-	-	HYPH
cord-337302-fpz2jfuj	282	11	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	282	12	Prevalence	prevalence	NN
cord-337302-fpz2jfuj	282	13	of	of	IN
cord-337302-fpz2jfuj	282	14	underlying	underlie	VBG
cord-337302-fpz2jfuj	282	15	diseases	disease	NNS
cord-337302-fpz2jfuj	282	16	in	in	IN
cord-337302-fpz2jfuj	282	17	hospitalized	hospitalize	VBN
cord-337302-fpz2jfuj	282	18	patients	patient	NNS
cord-337302-fpz2jfuj	282	19	with	with	IN
cord-337302-fpz2jfuj	282	20	COVID-19-a	COVID-19-a	NNP
cord-337302-fpz2jfuj	282	21	systematic	systematic	JJ
cord-337302-fpz2jfuj	282	22	review	review	NN
cord-337302-fpz2jfuj	282	23	and	and	CC
cord-337302-fpz2jfuj	282	24	meta	meta	NNP
cord-337302-fpz2jfuj	282	25	-	-	HYPH
cord-337302-fpz2jfuj	282	26	analysis	analysis	NN
cord-337302-fpz2jfuj	282	27	Caring	care	VBG
cord-337302-fpz2jfuj	282	28	for	for	IN
cord-337302-fpz2jfuj	282	29	older	old	JJR
cord-337302-fpz2jfuj	282	30	patients	patient	NNS
cord-337302-fpz2jfuj	282	31	with	with	IN
cord-337302-fpz2jfuj	282	32	cancer	cancer	NN
cord-337302-fpz2jfuj	282	33	during	during	IN
cord-337302-fpz2jfuj	282	34	the	the	DT
cord-337302-fpz2jfuj	282	35	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	282	36	pandemic	pandemic	NN
cord-337302-fpz2jfuj	282	37	:	:	:
cord-337302-fpz2jfuj	282	38	a	a	DT
cord-337302-fpz2jfuj	282	39	young	young	JJ
cord-337302-fpz2jfuj	282	40	international	international	JJ
cord-337302-fpz2jfuj	282	41	Society	Society	NNP
cord-337302-fpz2jfuj	282	42	of	of	IN
cord-337302-fpz2jfuj	282	43	Geriatric	Geriatric	NNP
cord-337302-fpz2jfuj	282	44	Oncology	Oncology	NNP
cord-337302-fpz2jfuj	283	1	(	(	-LRB-
cord-337302-fpz2jfuj	283	2	SIOG	SIOG	NNP
cord-337302-fpz2jfuj	283	3	)	)	-RRB-
cord-337302-fpz2jfuj	283	4	global	global	JJ
cord-337302-fpz2jfuj	283	5	perspective	perspective	NN
cord-337302-fpz2jfuj	284	1	SARS	SARS	NNP
cord-337302-fpz2jfuj	284	2	-	-	HYPH
cord-337302-fpz2jfuj	284	3	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	284	4	transmission	transmission	NN
cord-337302-fpz2jfuj	284	5	in	in	IN
cord-337302-fpz2jfuj	284	6	patients	patient	NNS
cord-337302-fpz2jfuj	284	7	with	with	IN
cord-337302-fpz2jfuj	284	8	cancer	cancer	NN
cord-337302-fpz2jfuj	284	9	at	at	IN
cord-337302-fpz2jfuj	284	10	a	a	DT
cord-337302-fpz2jfuj	284	11	tertiary	tertiary	JJ
cord-337302-fpz2jfuj	284	12	care	care	NN
cord-337302-fpz2jfuj	284	13	hospital	hospital	NN
cord-337302-fpz2jfuj	284	14	in	in	IN
cord-337302-fpz2jfuj	284	15	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	284	16	,	,	,
cord-337302-fpz2jfuj	284	17	China	China	NNP
cord-337302-fpz2jfuj	284	18	Report	Report	NNP
cord-337302-fpz2jfuj	284	19	of	of	IN
cord-337302-fpz2jfuj	284	20	cancer	cancer	NN
cord-337302-fpz2jfuj	284	21	epidemiology	epidemiology	NN
cord-337302-fpz2jfuj	284	22	in	in	IN
cord-337302-fpz2jfuj	284	23	China	China	NNP
cord-337302-fpz2jfuj	284	24	Clinical	clinical	JJ
cord-337302-fpz2jfuj	284	25	characteristics	characteristic	NNS
cord-337302-fpz2jfuj	284	26	of	of	IN
cord-337302-fpz2jfuj	284	27	COVID-19-infected	COVID-19-infected	NNP
cord-337302-fpz2jfuj	284	28	cancer	cancer	NN
cord-337302-fpz2jfuj	284	29	patients	patient	NNS
cord-337302-fpz2jfuj	284	30	:	:	:
cord-337302-fpz2jfuj	284	31	a	a	DT
cord-337302-fpz2jfuj	284	32	retrospective	retrospective	JJ
cord-337302-fpz2jfuj	284	33	case	case	NN
cord-337302-fpz2jfuj	284	34	study	study	NN
cord-337302-fpz2jfuj	284	35	in	in	IN
cord-337302-fpz2jfuj	284	36	three	three	CD
cord-337302-fpz2jfuj	284	37	hospitals	hospital	NNS
cord-337302-fpz2jfuj	284	38	within	within	IN
cord-337302-fpz2jfuj	284	39	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	284	40	,	,	,
cord-337302-fpz2jfuj	284	41	China	China	NNP
cord-337302-fpz2jfuj	285	1	The	the	DT
cord-337302-fpz2jfuj	285	2	epidemiological	epidemiological	JJ
cord-337302-fpz2jfuj	285	3	characteristics	characteristic	NNS
cord-337302-fpz2jfuj	285	4	of	of	IN
cord-337302-fpz2jfuj	285	5	an	an	DT
cord-337302-fpz2jfuj	285	6	outbreak	outbreak	NN
cord-337302-fpz2jfuj	285	7	of	of	IN
cord-337302-fpz2jfuj	285	8	2019	2019	CD
cord-337302-fpz2jfuj	285	9	Novel	Novel	NNP
cord-337302-fpz2jfuj	285	10	Coronavirus	Coronavirus	NNP
cord-337302-fpz2jfuj	285	11	Diseases	Diseases	NNPS
cord-337302-fpz2jfuj	285	12	(	(	-LRB-
cord-337302-fpz2jfuj	285	13	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	285	14	)	)	-RRB-
cord-337302-fpz2jfuj	285	15	-china	-china	.
cord-337302-fpz2jfuj	285	16	Case	case	NN
cord-337302-fpz2jfuj	285	17	-	-	HYPH
cord-337302-fpz2jfuj	285	18	fatality	fatality	NN
cord-337302-fpz2jfuj	285	19	rate	rate	NN
cord-337302-fpz2jfuj	285	20	and	and	CC
cord-337302-fpz2jfuj	285	21	characteristics	characteristic	NNS
cord-337302-fpz2jfuj	285	22	of	of	IN
cord-337302-fpz2jfuj	285	23	patients	patient	NNS
cord-337302-fpz2jfuj	285	24	dying	die	VBG
cord-337302-fpz2jfuj	285	25	in	in	IN
cord-337302-fpz2jfuj	285	26	relation	relation	NN
cord-337302-fpz2jfuj	285	27	to	to	IN
cord-337302-fpz2jfuj	285	28	COVID-19	covid-19	VB
cord-337302-fpz2jfuj	285	29	in	in	IN
cord-337302-fpz2jfuj	285	30	Italy	Italy	NNP
cord-337302-fpz2jfuj	285	31	Patients	Patients	NNP
cord-337302-fpz2jfuj	285	32	with	with	IN
cord-337302-fpz2jfuj	285	33	cancer	cancer	NN
cord-337302-fpz2jfuj	285	34	appear	appear	VBP
cord-337302-fpz2jfuj	285	35	more	more	RBR
cord-337302-fpz2jfuj	285	36	vulnerable	vulnerable	JJ
cord-337302-fpz2jfuj	285	37	to	to	IN
cord-337302-fpz2jfuj	285	38	SARS	SARS	NNP
cord-337302-fpz2jfuj	285	39	-	-	HYPH
cord-337302-fpz2jfuj	285	40	COV-2	COV-2	NNP
cord-337302-fpz2jfuj	285	41	:	:	:
cord-337302-fpz2jfuj	285	42	a	a	DT
cord-337302-fpz2jfuj	285	43	multi	multi	JJ
cord-337302-fpz2jfuj	285	44	-	-	JJ
cord-337302-fpz2jfuj	285	45	center	center	JJ
cord-337302-fpz2jfuj	285	46	study	study	NN
cord-337302-fpz2jfuj	285	47	during	during	IN
cord-337302-fpz2jfuj	285	48	the	the	DT
cord-337302-fpz2jfuj	285	49	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	285	50	outbreak	outbreak	NN
cord-337302-fpz2jfuj	285	51	Coronavirus	Coronavirus	NNP
cord-337302-fpz2jfuj	285	52	disease	disease	NN
cord-337302-fpz2jfuj	285	53	2019	2019	CD
cord-337302-fpz2jfuj	285	54	in	in	IN
cord-337302-fpz2jfuj	285	55	the	the	DT
cord-337302-fpz2jfuj	285	56	perioperative	perioperative	JJ
cord-337302-fpz2jfuj	285	57	period	period	NN
cord-337302-fpz2jfuj	285	58	of	of	IN
cord-337302-fpz2jfuj	285	59	lung	lung	NN
cord-337302-fpz2jfuj	285	60	resection	resection	NN
cord-337302-fpz2jfuj	285	61	:	:	:
cord-337302-fpz2jfuj	285	62	a	a	DT
cord-337302-fpz2jfuj	285	63	brief	brief	JJ
cord-337302-fpz2jfuj	285	64	report	report	NN
cord-337302-fpz2jfuj	285	65	from	from	IN
cord-337302-fpz2jfuj	285	66	a	a	DT
cord-337302-fpz2jfuj	285	67	single	single	JJ
cord-337302-fpz2jfuj	285	68	thoracic	thoracic	JJ
cord-337302-fpz2jfuj	285	69	surgery	surgery	NN
cord-337302-fpz2jfuj	285	70	department	department	NN
cord-337302-fpz2jfuj	285	71	in	in	IN
cord-337302-fpz2jfuj	285	72	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	285	73	,	,	,
cord-337302-fpz2jfuj	285	74	People	People	NNPS
cord-337302-fpz2jfuj	285	75	's	's	POS
cord-337302-fpz2jfuj	285	76	Republic	Republic	NNP
cord-337302-fpz2jfuj	285	77	of	of	IN
cord-337302-fpz2jfuj	285	78	China	China	NNP
cord-337302-fpz2jfuj	285	79	Challenges	Challenges	NNPS
cord-337302-fpz2jfuj	285	80	and	and	CC
cord-337302-fpz2jfuj	285	81	countermeasures	countermeasure	NNS
cord-337302-fpz2jfuj	285	82	of	of	IN
cord-337302-fpz2jfuj	285	83	integrative	integrative	JJ
cord-337302-fpz2jfuj	285	84	cancer	cancer	NN
cord-337302-fpz2jfuj	285	85	therapy	therapy	NN
cord-337302-fpz2jfuj	285	86	in	in	IN
cord-337302-fpz2jfuj	285	87	the	the	DT
cord-337302-fpz2jfuj	285	88	epidemic	epidemic	NN
cord-337302-fpz2jfuj	285	89	of	of	IN
cord-337302-fpz2jfuj	285	90	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	285	91	Caring	care	VBG
cord-337302-fpz2jfuj	285	92	for	for	IN
cord-337302-fpz2jfuj	285	93	patients	patient	NNS
cord-337302-fpz2jfuj	285	94	with	with	IN
cord-337302-fpz2jfuj	285	95	cancer	cancer	NN
cord-337302-fpz2jfuj	285	96	in	in	IN
cord-337302-fpz2jfuj	285	97	the	the	DT
cord-337302-fpz2jfuj	285	98	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	285	99	era	era	NN
cord-337302-fpz2jfuj	285	100	COVID-19	covid-19	NN
cord-337302-fpz2jfuj	285	101	and	and	CC
cord-337302-fpz2jfuj	285	102	cancer	cancer	NN
cord-337302-fpz2jfuj	285	103	:	:	:
cord-337302-fpz2jfuj	285	104	lessons	lesson	NNS
cord-337302-fpz2jfuj	285	105	from	from	IN
cord-337302-fpz2jfuj	285	106	a	a	DT
cord-337302-fpz2jfuj	285	107	pooled	pool	VBN
cord-337302-fpz2jfuj	285	108	meta	meta	NNP
cord-337302-fpz2jfuj	285	109	-	-	HYPH
cord-337302-fpz2jfuj	285	110	analysis	analysis	NNP
cord-337302-fpz2jfuj	285	111	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	285	112	in	in	IN
cord-337302-fpz2jfuj	285	113	a	a	DT
cord-337302-fpz2jfuj	285	114	patient	patient	NN
cord-337302-fpz2jfuj	285	115	with	with	IN
cord-337302-fpz2jfuj	285	116	chronic	chronic	JJ
cord-337302-fpz2jfuj	285	117	lymphocytic	lymphocytic	JJ
cord-337302-fpz2jfuj	285	118	leukaemia	leukaemia	NN
cord-337302-fpz2jfuj	286	1	First	first	JJ
cord-337302-fpz2jfuj	286	2	case	case	NN
cord-337302-fpz2jfuj	286	3	of	of	IN
cord-337302-fpz2jfuj	286	4	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	286	5	in	in	IN
cord-337302-fpz2jfuj	286	6	a	a	DT
cord-337302-fpz2jfuj	286	7	patient	patient	NN
cord-337302-fpz2jfuj	286	8	with	with	IN
cord-337302-fpz2jfuj	286	9	multiple	multiple	JJ
cord-337302-fpz2jfuj	286	10	myeloma	myeloma	NN
cord-337302-fpz2jfuj	286	11	successfully	successfully	RB
cord-337302-fpz2jfuj	286	12	treated	treat	VBN
cord-337302-fpz2jfuj	286	13	with	with	IN
cord-337302-fpz2jfuj	286	14	tocilizumab	tocilizumab	NNP
cord-337302-fpz2jfuj	286	15	.	.	.
cord-337302-fpz2jfuj	287	1	Blood	blood	NN
cord-337302-fpz2jfuj	287	2	Advances	advance	VBZ
cord-337302-fpz2jfuj	287	3	Immune	immune	JJ
cord-337302-fpz2jfuj	287	4	checkpoint	checkpoint	NN
cord-337302-fpz2jfuj	287	5	inhibitors	inhibitor	NNS
cord-337302-fpz2jfuj	287	6	in	in	IN
cord-337302-fpz2jfuj	287	7	SARS	SARS	NNP
cord-337302-fpz2jfuj	287	8	-	-	HYPH
cord-337302-fpz2jfuj	287	9	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	287	10	infected	infected	JJ
cord-337302-fpz2jfuj	287	11	cancer	cancer	NN
cord-337302-fpz2jfuj	287	12	patients	patient	NNS
cord-337302-fpz2jfuj	287	13	:	:	:
cord-337302-fpz2jfuj	287	14	the	the	DT
cord-337302-fpz2jfuj	287	15	spark	spark	NN
cord-337302-fpz2jfuj	287	16	that	that	WDT
cord-337302-fpz2jfuj	287	17	ignites	ignite	VBZ
cord-337302-fpz2jfuj	287	18	the	the	DT
cord-337302-fpz2jfuj	287	19	fire	fire	NN
cord-337302-fpz2jfuj	287	20	?	?	.
cord-337302-fpz2jfuj	288	1	Lung	lung	NN
cord-337302-fpz2jfuj	288	2	Cancer	cancer	NN
cord-337302-fpz2jfuj	289	1	Which	which	WDT
cord-337302-fpz2jfuj	289	2	cancer	cancer	NN
cord-337302-fpz2jfuj	289	3	type	type	NN
cord-337302-fpz2jfuj	289	4	has	have	VBZ
cord-337302-fpz2jfuj	289	5	the	the	DT
cord-337302-fpz2jfuj	289	6	highest	high	JJS
cord-337302-fpz2jfuj	289	7	risk	risk	NN
cord-337302-fpz2jfuj	289	8	of	of	IN
cord-337302-fpz2jfuj	289	9	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	289	10	infection	infection	NN
cord-337302-fpz2jfuj	289	11	?	?	.
cord-337302-fpz2jfuj	290	1	Case	case	NN
cord-337302-fpz2jfuj	290	2	fatality	fatality	NN
cord-337302-fpz2jfuj	290	3	rate	rate	NN
cord-337302-fpz2jfuj	290	4	of	of	IN
cord-337302-fpz2jfuj	290	5	cancer	cancer	NN
cord-337302-fpz2jfuj	290	6	patients	patient	NNS
cord-337302-fpz2jfuj	290	7	with	with	IN
cord-337302-fpz2jfuj	290	8	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	290	9	in	in	IN
cord-337302-fpz2jfuj	290	10	a	a	DT
cord-337302-fpz2jfuj	290	11	New	New	NNP
cord-337302-fpz2jfuj	290	12	York	York	NNP
cord-337302-fpz2jfuj	290	13	hospital	hospital	NN
cord-337302-fpz2jfuj	290	14	system	system	NN
cord-337302-fpz2jfuj	290	15	Characteristics	characteristic	NNS
cord-337302-fpz2jfuj	290	16	of	of	IN
cord-337302-fpz2jfuj	290	17	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	290	18	patients	patient	NNS
cord-337302-fpz2jfuj	290	19	dying	die	VBG
cord-337302-fpz2jfuj	290	20	in	in	IN
cord-337302-fpz2jfuj	290	21	Italy	Italy	NNP
cord-337302-fpz2jfuj	290	22	report	report	NN
cord-337302-fpz2jfuj	290	23	based	base	VBN
cord-337302-fpz2jfuj	290	24	on	on	IN
cord-337302-fpz2jfuj	290	25	available	available	JJ
cord-337302-fpz2jfuj	290	26	data	datum	NNS
cord-337302-fpz2jfuj	290	27	on	on	IN
cord-337302-fpz2jfuj	290	28	How	how	WRB
cord-337302-fpz2jfuj	290	29	we	-PRON-	PRP
cord-337302-fpz2jfuj	290	30	treat	treat	VBP
cord-337302-fpz2jfuj	290	31	patients	patient	NNS
cord-337302-fpz2jfuj	290	32	with	with	IN
cord-337302-fpz2jfuj	290	33	lung	lung	NN
cord-337302-fpz2jfuj	290	34	cancer	cancer	NN
cord-337302-fpz2jfuj	290	35	during	during	IN
cord-337302-fpz2jfuj	290	36	the	the	DT
cord-337302-fpz2jfuj	290	37	SARS	SARS	NNP
cord-337302-fpz2jfuj	290	38	-	-	HYPH
cord-337302-fpz2jfuj	290	39	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	290	40	pandemic	pandemic	NN
cord-337302-fpz2jfuj	290	41	:	:	:
cord-337302-fpz2jfuj	290	42	primum	primum	NN
cord-337302-fpz2jfuj	290	43	non	non	FW
cord-337302-fpz2jfuj	290	44	nocere	nocere	FW
cord-337302-fpz2jfuj	291	1	INfluenza	influenza	JJ
cord-337302-fpz2jfuj	291	2	vaccine	vaccine	NN
cord-337302-fpz2jfuj	291	3	indication	indication	NN
cord-337302-fpz2jfuj	291	4	during	during	IN
cord-337302-fpz2jfuj	291	5	therapy	therapy	NN
cord-337302-fpz2jfuj	291	6	with	with	IN
cord-337302-fpz2jfuj	291	7	immune	immune	JJ
cord-337302-fpz2jfuj	291	8	checkpoint	checkpoint	NN
cord-337302-fpz2jfuj	291	9	inhibitors	inhibitor	NNS
cord-337302-fpz2jfuj	291	10	:	:	:
cord-337302-fpz2jfuj	291	11	a	a	DT
cord-337302-fpz2jfuj	291	12	transversal	transversal	JJ
cord-337302-fpz2jfuj	291	13	challenge	challenge	NN
cord-337302-fpz2jfuj	291	14	.	.	.
cord-337302-fpz2jfuj	292	1	The	the	DT
cord-337302-fpz2jfuj	292	2	INVIDIa	INVIDIa	NNS
cord-337302-fpz2jfuj	292	3	study	study	NN
cord-337302-fpz2jfuj	292	4	Influenza	Influenza	NNP
cord-337302-fpz2jfuj	292	5	vaccine	vaccine	NN
cord-337302-fpz2jfuj	292	6	indication	indication	NN
cord-337302-fpz2jfuj	292	7	during	during	IN
cord-337302-fpz2jfuj	292	8	therapy	therapy	NN
cord-337302-fpz2jfuj	292	9	with	with	IN
cord-337302-fpz2jfuj	292	10	immune	immune	JJ
cord-337302-fpz2jfuj	292	11	checkpoint	checkpoint	NN
cord-337302-fpz2jfuj	292	12	inhibitors	inhibitor	NNS
cord-337302-fpz2jfuj	292	13	:	:	:
cord-337302-fpz2jfuj	292	14	a	a	DT
cord-337302-fpz2jfuj	292	15	transversal	transversal	JJ
cord-337302-fpz2jfuj	292	16	challenge	challenge	NN
cord-337302-fpz2jfuj	292	17	.	.	.
cord-337302-fpz2jfuj	293	1	The	the	DT
cord-337302-fpz2jfuj	293	2	INVIDIa	INVIDIa	NNS
cord-337302-fpz2jfuj	293	3	study	study	NN
cord-337302-fpz2jfuj	293	4	Impact	impact	NN
cord-337302-fpz2jfuj	293	5	of	of	IN
cord-337302-fpz2jfuj	293	6	PD-1	PD-1	NNP
cord-337302-fpz2jfuj	293	7	blockade	blockade	NN
cord-337302-fpz2jfuj	293	8	on	on	IN
cord-337302-fpz2jfuj	293	9	severity	severity	NN
cord-337302-fpz2jfuj	293	10	of	of	IN
cord-337302-fpz2jfuj	293	11	COVID-19	covid-19	NN
cord-337302-fpz2jfuj	293	12	in	in	IN
cord-337302-fpz2jfuj	293	13	patients	patient	NNS
cord-337302-fpz2jfuj	293	14	with	with	IN
cord-337302-fpz2jfuj	293	15	lung	lung	NN
cord-337302-fpz2jfuj	293	16	cancers	cancer	NNS
cord-337302-fpz2jfuj	294	1	Androgen	androgen	NN
cord-337302-fpz2jfuj	294	2	-	-	HYPH
cord-337302-fpz2jfuj	294	3	deprivation	deprivation	NN
cord-337302-fpz2jfuj	294	4	therapies	therapy	NNS
cord-337302-fpz2jfuj	294	5	for	for	IN
cord-337302-fpz2jfuj	294	6	prostate	prostate	NN
cord-337302-fpz2jfuj	294	7	cancer	cancer	NN
cord-337302-fpz2jfuj	294	8	and	and	CC
cord-337302-fpz2jfuj	294	9	risk	risk	NN
cord-337302-fpz2jfuj	294	10	of	of	IN
cord-337302-fpz2jfuj	294	11	infection	infection	NN
cord-337302-fpz2jfuj	294	12	by	by	IN
cord-337302-fpz2jfuj	294	13	SARS	SARS	NNP
cord-337302-fpz2jfuj	294	14	-	-	HYPH
cord-337302-fpz2jfuj	294	15	CoV-2	CoV-2	NNP
cord-337302-fpz2jfuj	294	16	:	:	:
cord-337302-fpz2jfuj	294	17	a	a	DT
cord-337302-fpz2jfuj	294	18	population	population	NN
cord-337302-fpz2jfuj	294	19	-	-	HYPH
cord-337302-fpz2jfuj	294	20	based	base	VBN
cord-337302-fpz2jfuj	294	21	study	study	NN
cord-337302-fpz2jfuj	294	22	(	(	-LRB-
cord-337302-fpz2jfuj	294	23	n=4532	n=4532	NNP
cord-337302-fpz2jfuj	294	24	)	)	-RRB-
cord-337302-fpz2jfuj	294	25	Cancer	cancer	NN
cord-337302-fpz2jfuj	294	26	and	and	CC
cord-337302-fpz2jfuj	294	27	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	294	28	disease	disease	NN
cord-337302-fpz2jfuj	294	29	2019	2019	CD
cord-337302-fpz2jfuj	295	1	;	;	:
cord-337302-fpz2jfuj	295	2	how	how	WRB
cord-337302-fpz2jfuj	295	3	do	do	VBP
cord-337302-fpz2jfuj	295	4	we	-PRON-	PRP
cord-337302-fpz2jfuj	295	5	manage	manage	VB
cord-337302-fpz2jfuj	295	6	cancer	cancer	NN
cord-337302-fpz2jfuj	295	7	optimally	optimally	RB
cord-337302-fpz2jfuj	295	8	through	through	IN
cord-337302-fpz2jfuj	295	9	a	a	DT
cord-337302-fpz2jfuj	295	10	public	public	JJ
cord-337302-fpz2jfuj	295	11	health	health	NN
cord-337302-fpz2jfuj	295	12	crisis	crisis	NN
cord-337302-fpz2jfuj	295	13	?	?	.
cord-337302-fpz2jfuj	296	1	Review	Review	NNP
cord-337302-fpz2jfuj	296	2	of	of	IN
cord-337302-fpz2jfuj	296	3	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	296	4	disease-2019	disease-2019	NNP
cord-337302-fpz2jfuj	296	5	(	(	-LRB-
cord-337302-fpz2jfuj	296	6	COVID-19	covid-19	VB
cord-337302-fpz2jfuj	296	7	)	)	-RRB-
cord-337302-fpz2jfuj	296	8	Presumed	presume	VBN
cord-337302-fpz2jfuj	296	9	asymptomatic	asymptomatic	JJ
cord-337302-fpz2jfuj	296	10	carrier	carrier	NN
cord-337302-fpz2jfuj	296	11	transmission	transmission	NN
cord-337302-fpz2jfuj	296	12	of	of	IN
cord-337302-fpz2jfuj	296	13	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	296	14	Managing	manage	VBG
cord-337302-fpz2jfuj	296	15	cancer	cancer	NN
cord-337302-fpz2jfuj	296	16	care	care	NN
cord-337302-fpz2jfuj	296	17	during	during	IN
cord-337302-fpz2jfuj	296	18	the	the	DT
cord-337302-fpz2jfuj	296	19	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	296	20	pandemic	pandemic	NN
cord-337302-fpz2jfuj	296	21	:	:	:
cord-337302-fpz2jfuj	296	22	agility	agility	NN
cord-337302-fpz2jfuj	296	23	and	and	CC
cord-337302-fpz2jfuj	296	24	collaboration	collaboration	NN
cord-337302-fpz2jfuj	296	25	toward	toward	IN
cord-337302-fpz2jfuj	296	26	a	a	DT
cord-337302-fpz2jfuj	296	27	common	common	JJ
cord-337302-fpz2jfuj	296	28	goal	goal	NN
cord-337302-fpz2jfuj	296	29	Protecting	protect	VBG
cord-337302-fpz2jfuj	296	30	health	health	NN
cord-337302-fpz2jfuj	296	31	-	-	HYPH
cord-337302-fpz2jfuj	296	32	care	care	NN
cord-337302-fpz2jfuj	296	33	workers	worker	NNS
cord-337302-fpz2jfuj	296	34	from	from	IN
cord-337302-fpz2jfuj	296	35	subclinical	subclinical	JJ
cord-337302-fpz2jfuj	296	36	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	296	37	infection	infection	NN
cord-337302-fpz2jfuj	296	38	Death	death	NN
cord-337302-fpz2jfuj	296	39	from	from	IN
cord-337302-fpz2jfuj	296	40	Covid-19	covid-19	NN
cord-337302-fpz2jfuj	296	41	of	of	IN
cord-337302-fpz2jfuj	296	42	23	23	CD
cord-337302-fpz2jfuj	296	43	health	health	NN
cord-337302-fpz2jfuj	296	44	care	care	NN
cord-337302-fpz2jfuj	296	45	workers	worker	NNS
cord-337302-fpz2jfuj	296	46	in	in	IN
cord-337302-fpz2jfuj	296	47	China	China	NNP
cord-337302-fpz2jfuj	296	48	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	296	49	care	care	NN
cord-337302-fpz2jfuj	296	50	delivery	delivery	NN
cord-337302-fpz2jfuj	296	51	challenges	challenge	NNS
cord-337302-fpz2jfuj	296	52	amidst	amidst	IN
cord-337302-fpz2jfuj	296	53	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	296	54	disease	disease	NN
cord-337302-fpz2jfuj	296	55	-19	-19	:
cord-337302-fpz2jfuj	296	56	(	(	-LRB-
cord-337302-fpz2jfuj	296	57	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	296	58	)	)	-RRB-
cord-337302-fpz2jfuj	296	59	outbreak	outbreak	NN
cord-337302-fpz2jfuj	296	60	:	:	:
cord-337302-fpz2jfuj	296	61	specific	specific	JJ
cord-337302-fpz2jfuj	296	62	precautions	precaution	NNS
cord-337302-fpz2jfuj	296	63	for	for	IN
cord-337302-fpz2jfuj	296	64	cancer	cancer	NN
cord-337302-fpz2jfuj	296	65	patients	patient	NNS
cord-337302-fpz2jfuj	296	66	and	and	CC
cord-337302-fpz2jfuj	296	67	cancer	cancer	NN
cord-337302-fpz2jfuj	296	68	care	care	NN
cord-337302-fpz2jfuj	296	69	providers	provider	NNS
cord-337302-fpz2jfuj	296	70	to	to	TO
cord-337302-fpz2jfuj	296	71	prevent	prevent	VB
cord-337302-fpz2jfuj	296	72	spread	spread	NN
cord-337302-fpz2jfuj	297	1	COVID-19	covid-19	VB
cord-337302-fpz2jfuj	297	2	:	:	:
cord-337302-fpz2jfuj	297	3	Recommendations	Recommendations	NNPS
cord-337302-fpz2jfuj	297	4	for	for	IN
cord-337302-fpz2jfuj	297	5	Management	Management	NNP
cord-337302-fpz2jfuj	297	6	of	of	IN
cord-337302-fpz2jfuj	297	7	Elective	Elective	NNP
cord-337302-fpz2jfuj	297	8	Surgical	Surgical	NNP
cord-337302-fpz2jfuj	297	9	Procedures	procedure	NNS
cord-337302-fpz2jfuj	298	1	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	298	2	pandemic	pandemic	JJ
cord-337302-fpz2jfuj	298	3	impact	impact	NN
cord-337302-fpz2jfuj	298	4	on	on	IN
cord-337302-fpz2jfuj	298	5	cancer	cancer	NN
cord-337302-fpz2jfuj	298	6	patients	patient	NNS
cord-337302-fpz2jfuj	298	7	and	and	CC
cord-337302-fpz2jfuj	298	8	survivors	survivor	NNS
cord-337302-fpz2jfuj	298	9	survey	survey	VBP
cord-337302-fpz2jfuj	298	10	findings	finding	NNS
cord-337302-fpz2jfuj	298	11	summary	summary	NN
cord-337302-fpz2jfuj	298	12	.	.	.
cord-337302-fpz2jfuj	299	1	Am	be	VBP
cord-337302-fpz2jfuj	299	2	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	299	3	Society	Society	NNP
cord-337302-fpz2jfuj	300	1	The	the	DT
cord-337302-fpz2jfuj	300	2	Lancet	Lancet	NNP
cord-337302-fpz2jfuj	300	3	O.	O.	NNP
cord-337302-fpz2jfuj	300	4	Safeguarding	Safeguarding	NNP
cord-337302-fpz2jfuj	300	5	cancer	cancer	NN
cord-337302-fpz2jfuj	300	6	care	care	NN
cord-337302-fpz2jfuj	300	7	in	in	IN
cord-337302-fpz2jfuj	300	8	a	a	DT
cord-337302-fpz2jfuj	300	9	post	post	JJ
cord-337302-fpz2jfuj	300	10	-	-	JJ
cord-337302-fpz2jfuj	300	11	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	300	12	world	world	NN
cord-337302-fpz2jfuj	300	13	Effect	effect	NN
cord-337302-fpz2jfuj	300	14	of	of	IN
cord-337302-fpz2jfuj	300	15	delays	delay	NNS
cord-337302-fpz2jfuj	300	16	in	in	IN
cord-337302-fpz2jfuj	300	17	the	the	DT
cord-337302-fpz2jfuj	300	18	2-week	2-week	CD
cord-337302-fpz2jfuj	300	19	-	-	HYPH
cord-337302-fpz2jfuj	300	20	wait	wait	NN
cord-337302-fpz2jfuj	300	21	cancer	cancer	NN
cord-337302-fpz2jfuj	300	22	referral	referral	NN
cord-337302-fpz2jfuj	300	23	pathway	pathway	NN
cord-337302-fpz2jfuj	300	24	during	during	IN
cord-337302-fpz2jfuj	300	25	the	the	DT
cord-337302-fpz2jfuj	300	26	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	300	27	pandemic	pandemic	NN
cord-337302-fpz2jfuj	300	28	on	on	IN
cord-337302-fpz2jfuj	300	29	cancer	cancer	NN
cord-337302-fpz2jfuj	300	30	survival	survival	NN
cord-337302-fpz2jfuj	300	31	in	in	IN
cord-337302-fpz2jfuj	300	32	the	the	DT
cord-337302-fpz2jfuj	300	33	UK	UK	NNP
cord-337302-fpz2jfuj	300	34	:	:	:
cord-337302-fpz2jfuj	300	35	a	a	DT
cord-337302-fpz2jfuj	300	36	modelling	modelling	NN
cord-337302-fpz2jfuj	300	37	study	study	NN
cord-337302-fpz2jfuj	301	1	Fewer	few	JJR
cord-337302-fpz2jfuj	301	2	cancer	cancer	NN
cord-337302-fpz2jfuj	301	3	diagnosis	diagnosis	NN
cord-337302-fpz2jfuj	301	4	during	during	IN
cord-337302-fpz2jfuj	301	5	the	the	DT
cord-337302-fpz2jfuj	301	6	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	301	7	epidemic	epidemic	NN
cord-337302-fpz2jfuj	301	8	in	in	IN
cord-337302-fpz2jfuj	301	9	the	the	DT
cord-337302-fpz2jfuj	301	10	Netherlands	Netherlands	NNP
cord-337302-fpz2jfuj	301	11	Acute	Acute	NNP
cord-337302-fpz2jfuj	301	12	leukemia	leukemia	NN
cord-337302-fpz2jfuj	301	13	in	in	IN
cord-337302-fpz2jfuj	301	14	the	the	DT
cord-337302-fpz2jfuj	301	15	time	time	NN
cord-337302-fpz2jfuj	301	16	of	of	IN
cord-337302-fpz2jfuj	301	17	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	301	18	A	a	DT
cord-337302-fpz2jfuj	301	19	practical	practical	JJ
cord-337302-fpz2jfuj	301	20	approach	approach	NN
cord-337302-fpz2jfuj	301	21	to	to	IN
cord-337302-fpz2jfuj	301	22	the	the	DT
cord-337302-fpz2jfuj	301	23	management	management	NN
cord-337302-fpz2jfuj	301	24	of	of	IN
cord-337302-fpz2jfuj	301	25	cancer	cancer	NN
cord-337302-fpz2jfuj	301	26	patients	patient	NNS
cord-337302-fpz2jfuj	301	27	during	during	IN
cord-337302-fpz2jfuj	301	28	the	the	DT
cord-337302-fpz2jfuj	301	29	novel	novel	JJ
cord-337302-fpz2jfuj	301	30	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	301	31	disease	disease	NN
cord-337302-fpz2jfuj	301	32	2019	2019	CD
cord-337302-fpz2jfuj	302	1	(	(	-LRB-
cord-337302-fpz2jfuj	302	2	COVID	COVID	NNP
cord-337302-fpz2jfuj	302	3	−19	−19	NNP
cord-337302-fpz2jfuj	302	4	)	)	-RRB-
cord-337302-fpz2jfuj	302	5	pandemic	pandemic	NN
cord-337302-fpz2jfuj	302	6	:	:	:
cord-337302-fpz2jfuj	303	1	an	an	DT
cord-337302-fpz2jfuj	303	2	international	international	JJ
cord-337302-fpz2jfuj	303	3	collaborative	collaborative	JJ
cord-337302-fpz2jfuj	303	4	group	group	NN
cord-337302-fpz2jfuj	303	5	Oncology	Oncology	NNP
cord-337302-fpz2jfuj	303	6	practice	practice	NN
cord-337302-fpz2jfuj	303	7	during	during	IN
cord-337302-fpz2jfuj	303	8	the	the	DT
cord-337302-fpz2jfuj	303	9	COVID-19	covid-19	CD
cord-337302-fpz2jfuj	303	10	pandemic	pandemic	NN
cord-337302-fpz2jfuj	303	11	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	303	12	guidelines	guideline	NNS
cord-337302-fpz2jfuj	303	13	during	during	IN
cord-337302-fpz2jfuj	303	14	the	the	DT
cord-337302-fpz2jfuj	303	15	COVID-19	covid-19	CD
cord-337302-fpz2jfuj	303	16	pandemic	pandemic	NN
cord-337302-fpz2jfuj	303	17	Vicarious	vicarious	JJ
cord-337302-fpz2jfuj	303	18	traumatization	traumatization	NN
cord-337302-fpz2jfuj	303	19	in	in	IN
cord-337302-fpz2jfuj	303	20	the	the	DT
cord-337302-fpz2jfuj	303	21	general	general	JJ
cord-337302-fpz2jfuj	303	22	public	public	NN
cord-337302-fpz2jfuj	303	23	,	,	,
cord-337302-fpz2jfuj	303	24	members	member	NNS
cord-337302-fpz2jfuj	303	25	,	,	,
cord-337302-fpz2jfuj	303	26	and	and	CC
cord-337302-fpz2jfuj	303	27	non	non	NNS
cord-337302-fpz2jfuj	303	28	-	-	NNS
cord-337302-fpz2jfuj	303	29	members	member	NNS
cord-337302-fpz2jfuj	303	30	of	of	IN
cord-337302-fpz2jfuj	303	31	medical	medical	JJ
cord-337302-fpz2jfuj	303	32	teams	team	NNS
cord-337302-fpz2jfuj	303	33	aiding	aid	VBG
cord-337302-fpz2jfuj	303	34	in	in	IN
cord-337302-fpz2jfuj	303	35	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	303	36	control	control	NN
cord-337302-fpz2jfuj	303	37	Traumatization	Traumatization	NNP
cord-337302-fpz2jfuj	303	38	in	in	IN
cord-337302-fpz2jfuj	303	39	medical	medical	JJ
cord-337302-fpz2jfuj	303	40	staff	staff	NN
cord-337302-fpz2jfuj	303	41	helping	help	VBG
cord-337302-fpz2jfuj	303	42	with	with	IN
cord-337302-fpz2jfuj	303	43	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	303	44	control	control	NN
cord-337302-fpz2jfuj	303	45	2019-nCoV	2019-ncov	CD
cord-337302-fpz2jfuj	303	46	epidemic	epidemic	NN
cord-337302-fpz2jfuj	303	47	:	:	:
cord-337302-fpz2jfuj	303	48	address	address	VB
cord-337302-fpz2jfuj	303	49	mental	mental	JJ
cord-337302-fpz2jfuj	303	50	health	health	NN
cord-337302-fpz2jfuj	303	51	care	care	NN
cord-337302-fpz2jfuj	303	52	to	to	TO
cord-337302-fpz2jfuj	303	53	empower	empower	VB
cord-337302-fpz2jfuj	303	54	society	society	NN
cord-337302-fpz2jfuj	304	1	ASCO	ASCO	NNP
cord-337302-fpz2jfuj	304	2	special	special	JJ
cord-337302-fpz2jfuj	304	3	report	report	NN
cord-337302-fpz2jfuj	304	4	:	:	:
cord-337302-fpz2jfuj	305	1	A	a	DT
cord-337302-fpz2jfuj	305	2	Guide	Guide	NNP
cord-337302-fpz2jfuj	305	3	to	to	TO
cord-337302-fpz2jfuj	305	4	cancer	cancer	NN
cord-337302-fpz2jfuj	305	5	care	care	NN
cord-337302-fpz2jfuj	305	6	delivery	delivery	NN
cord-337302-fpz2jfuj	305	7	during	during	IN
cord-337302-fpz2jfuj	305	8	the	the	DT
cord-337302-fpz2jfuj	305	9	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	305	10	pandemic	pandemic	NN
cord-337302-fpz2jfuj	305	11	Thoracic	Thoracic	NNP
cord-337302-fpz2jfuj	305	12	cancERs	cancers	CC
cord-337302-fpz2jfuj	305	13	international	international	JJ
cord-337302-fpz2jfuj	305	14	coVid	covid	JJ
cord-337302-fpz2jfuj	305	15	19	19	CD
cord-337302-fpz2jfuj	305	16	cOLlaboraTion	collaboration	NN
cord-337302-fpz2jfuj	305	17	)	)	-RRB-
cord-337302-fpz2jfuj	305	18	Safety	safety	NN
cord-337302-fpz2jfuj	305	19	at	at	IN
cord-337302-fpz2jfuj	305	20	the	the	DT
cord-337302-fpz2jfuj	305	21	time	time	NN
cord-337302-fpz2jfuj	305	22	of	of	IN
cord-337302-fpz2jfuj	305	23	the	the	DT
cord-337302-fpz2jfuj	305	24	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	305	25	pandemic	pandemic	NN
cord-337302-fpz2jfuj	305	26	:	:	:
cord-337302-fpz2jfuj	305	27	how	how	WRB
cord-337302-fpz2jfuj	305	28	to	to	TO
cord-337302-fpz2jfuj	305	29	keep	keep	VB
cord-337302-fpz2jfuj	305	30	our	-PRON-	PRP$
cord-337302-fpz2jfuj	305	31	oncology	oncology	NN
cord-337302-fpz2jfuj	305	32	patients	patient	NNS
cord-337302-fpz2jfuj	305	33	and	and	CC
cord-337302-fpz2jfuj	305	34	healthcare	healthcare	NN
cord-337302-fpz2jfuj	305	35	workers	worker	NNS
cord-337302-fpz2jfuj	305	36	safe	safe	JJ
cord-337302-fpz2jfuj	305	37	Novel	Novel	NNP
cord-337302-fpz2jfuj	305	38	Coronavirus	Coronavirus	NNP
cord-337302-fpz2jfuj	305	39	(	(	-LRB-
cord-337302-fpz2jfuj	305	40	2019-nCoV	2019-ncov	CD
cord-337302-fpz2jfuj	305	41	)	)	-RRB-
cord-337302-fpz2jfuj	305	42	Situation	situation	NN
cord-337302-fpz2jfuj	305	43	Report	Report	NNP
cord-337302-fpz2jfuj	305	44	.	.	.
cord-337302-fpz2jfuj	306	1	11	11	CD
cord-337302-fpz2jfuj	306	2	Interim	interim	JJ
cord-337302-fpz2jfuj	306	3	infection	infection	NN
cord-337302-fpz2jfuj	306	4	prevention	prevention	NN
cord-337302-fpz2jfuj	306	5	and	and	CC
cord-337302-fpz2jfuj	306	6	control	control	NN
cord-337302-fpz2jfuj	306	7	recommendations	recommendation	NNS
cord-337302-fpz2jfuj	306	8	for	for	IN
cord-337302-fpz2jfuj	306	9	patients	patient	NNS
cord-337302-fpz2jfuj	306	10	with	with	IN
cord-337302-fpz2jfuj	306	11	suspected	suspect	VBN
cord-337302-fpz2jfuj	306	12	or	or	CC
cord-337302-fpz2jfuj	306	13	confirmed	confirm	VBN
cord-337302-fpz2jfuj	306	14	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	306	15	disease	disease	NN
cord-337302-fpz2jfuj	306	16	2019	2019	CD
cord-337302-fpz2jfuj	306	17	(	(	-LRB-
cord-337302-fpz2jfuj	306	18	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	306	19	)	)	-RRB-
cord-337302-fpz2jfuj	306	20	in	in	IN
cord-337302-fpz2jfuj	306	21	healthcare	healthcare	NN
cord-337302-fpz2jfuj	306	22	settings	setting	NNS
cord-337302-fpz2jfuj	306	23	print	print	NN
cord-337302-fpz2jfuj	306	24	page	page	NN
cord-337302-fpz2jfuj	306	25	Managing	manage	VBG
cord-337302-fpz2jfuj	306	26	oncology	oncology	NN
cord-337302-fpz2jfuj	306	27	services	service	NNS
cord-337302-fpz2jfuj	306	28	during	during	IN
cord-337302-fpz2jfuj	306	29	a	a	DT
cord-337302-fpz2jfuj	306	30	major	major	JJ
cord-337302-fpz2jfuj	306	31	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	306	32	outbreak	outbreak	NN
cord-337302-fpz2jfuj	306	33	lessons	lesson	NNS
cord-337302-fpz2jfuj	306	34	from	from	IN
cord-337302-fpz2jfuj	306	35	the	the	DT
cord-337302-fpz2jfuj	306	36	saudi	saudi	NNP
cord-337302-fpz2jfuj	306	37	arabia	arabia	NNP
cord-337302-fpz2jfuj	306	38	experience	experience	NN
cord-337302-fpz2jfuj	306	39	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	306	40	and	and	CC
cord-337302-fpz2jfuj	306	41	COVID-19	covid-19	VB
cord-337302-fpz2jfuj	306	42	-potentially	-potentially	JJ
cord-337302-fpz2jfuj	306	43	deleterious	deleterious	JJ
cord-337302-fpz2jfuj	306	44	effects	effect	NNS
cord-337302-fpz2jfuj	306	45	of	of	IN
cord-337302-fpz2jfuj	306	46	delaying	delay	VBG
cord-337302-fpz2jfuj	306	47	radiotherapy	radiotherapy	NN
cord-337302-fpz2jfuj	306	48	Effect	effect	NN
cord-337302-fpz2jfuj	306	49	of	of	IN
cord-337302-fpz2jfuj	306	50	radiotherapy	radiotherapy	NN
cord-337302-fpz2jfuj	306	51	after	after	IN
cord-337302-fpz2jfuj	306	52	breast	breast	NN
cord-337302-fpz2jfuj	306	53	-	-	HYPH
cord-337302-fpz2jfuj	306	54	conserving	conserve	VBG
cord-337302-fpz2jfuj	306	55	surgery	surgery	NN
cord-337302-fpz2jfuj	306	56	on	on	IN
cord-337302-fpz2jfuj	306	57	10-year	10-year	CD
cord-337302-fpz2jfuj	306	58	recurrence	recurrence	NN
cord-337302-fpz2jfuj	306	59	and	and	CC
cord-337302-fpz2jfuj	306	60	15-year	15-year	JJ
cord-337302-fpz2jfuj	306	61	breast	breast	NN
cord-337302-fpz2jfuj	306	62	cancer	cancer	NN
cord-337302-fpz2jfuj	306	63	death	death	NN
cord-337302-fpz2jfuj	306	64	:	:	:
cord-337302-fpz2jfuj	306	65	metaanalysis	metaanalysis	NN
cord-337302-fpz2jfuj	306	66	of	of	IN
cord-337302-fpz2jfuj	306	67	individual	individual	JJ
cord-337302-fpz2jfuj	306	68	patient	patient	NN
cord-337302-fpz2jfuj	306	69	data	datum	NNS
cord-337302-fpz2jfuj	306	70	for	for	IN
cord-337302-fpz2jfuj	306	71	10	10	CD
cord-337302-fpz2jfuj	306	72	801	801	CD
cord-337302-fpz2jfuj	306	73	women	woman	NNS
cord-337302-fpz2jfuj	306	74	in	in	IN
cord-337302-fpz2jfuj	306	75	17	17	CD
cord-337302-fpz2jfuj	306	76	randomised	randomised	JJ
cord-337302-fpz2jfuj	306	77	trials	trial	NNS
cord-337302-fpz2jfuj	307	1	Practice	practice	NN
cord-337302-fpz2jfuj	307	2	recommendations	recommendation	NNS
cord-337302-fpz2jfuj	307	3	for	for	IN
cord-337302-fpz2jfuj	307	4	lung	lung	NN
cord-337302-fpz2jfuj	307	5	cancer	cancer	NN
cord-337302-fpz2jfuj	307	6	radiotherapy	radiotherapy	NN
cord-337302-fpz2jfuj	307	7	during	during	IN
cord-337302-fpz2jfuj	307	8	the	the	DT
cord-337302-fpz2jfuj	307	9	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	307	10	pandemic	pandemic	NN
cord-337302-fpz2jfuj	307	11	:	:	:
cord-337302-fpz2jfuj	307	12	an	an	DT
cord-337302-fpz2jfuj	307	13	ESTRO	ESTRO	NNP
cord-337302-fpz2jfuj	307	14	-	-	HYPH
cord-337302-fpz2jfuj	307	15	ASTRO	ASTRO	NNP
cord-337302-fpz2jfuj	307	16	consensus	consensus	NN
cord-337302-fpz2jfuj	307	17	statement	statement	NN
cord-337302-fpz2jfuj	307	18	Controversies	controversy	NNS
cord-337302-fpz2jfuj	308	1	about	about	IN
cord-337302-fpz2jfuj	308	2	COVID-19	COVID-19	,
cord-337302-fpz2jfuj	308	3	and	and	CC
cord-337302-fpz2jfuj	308	4	anticancer	anticancer	JJ
cord-337302-fpz2jfuj	308	5	International	International	NNP
cord-337302-fpz2jfuj	308	6	expert	expert	JJ
cord-337302-fpz2jfuj	308	7	consensus	consensus	NN
cord-337302-fpz2jfuj	308	8	statement	statement	NN
cord-337302-fpz2jfuj	308	9	regarding	regard	VBG
cord-337302-fpz2jfuj	308	10	radiotherapy	radiotherapy	NN
cord-337302-fpz2jfuj	308	11	treatment	treatment	NN
cord-337302-fpz2jfuj	308	12	op	op	NNP
cord-337302-fpz2jfuj	308	13	-	-	HYPH
cord-337302-fpz2jfuj	308	14	tions	tion	NNS
cord-337302-fpz2jfuj	308	15	for	for	IN
cord-337302-fpz2jfuj	308	16	rectal	rectal	JJ
cord-337302-fpz2jfuj	308	17	cancer	cancer	NN
cord-337302-fpz2jfuj	308	18	during	during	IN
cord-337302-fpz2jfuj	308	19	the	the	DT
cord-337302-fpz2jfuj	308	20	COVID	COVID	NNP
cord-337302-fpz2jfuj	308	21	19	19	CD
cord-337302-fpz2jfuj	308	22	pandemic	pandemic	NN
cord-337302-fpz2jfuj	308	23	Prioritizing	prioritize	VBG
cord-337302-fpz2jfuj	308	24	systemic	systemic	JJ
cord-337302-fpz2jfuj	308	25	therapies	therapy	NNS
cord-337302-fpz2jfuj	308	26	for	for	IN
cord-337302-fpz2jfuj	308	27	genitourinary	genitourinary	JJ
cord-337302-fpz2jfuj	308	28	malignancies	malignancy	NNS
cord-337302-fpz2jfuj	308	29	:	:	:
cord-337302-fpz2jfuj	309	1	canadian	canadian	JJ
cord-337302-fpz2jfuj	309	2	recommendations	recommendation	NNS
cord-337302-fpz2jfuj	309	3	during	during	IN
cord-337302-fpz2jfuj	309	4	the	the	DT
cord-337302-fpz2jfuj	309	5	COVID-19	covid-19	CD
cord-337302-fpz2jfuj	309	6	pandemic	pandemic	NN
cord-337302-fpz2jfuj	309	7	Ontario	Ontario	NNP
cord-337302-fpz2jfuj	309	8	Health	Health	NNP
cord-337302-fpz2jfuj	309	9	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	309	10	Care	Care	NNP
cord-337302-fpz2jfuj	309	11	HCI	HCI	NNP
cord-337302-fpz2jfuj	309	12	.	.	.
cord-337302-fpz2jfuj	310	1	Pandemic	pandemic	NN
cord-337302-fpz2jfuj	310	2	planning	plan	VBG
cord-337302-fpz2jfuj	310	3	clinical	clinical	JJ
cord-337302-fpz2jfuj	310	4	guideline	guideline	NN
cord-337302-fpz2jfuj	310	5	for	for	IN
cord-337302-fpz2jfuj	310	6	patients	patient	NNS
cord-337302-fpz2jfuj	310	7	with	with	IN
cord-337302-fpz2jfuj	310	8	cancer	cancer	NN
cord-337302-fpz2jfuj	310	9	Clinical	clinical	JJ
cord-337302-fpz2jfuj	310	10	course	course	NN
cord-337302-fpz2jfuj	310	11	and	and	CC
cord-337302-fpz2jfuj	310	12	risk	risk	NN
cord-337302-fpz2jfuj	310	13	factors	factor	NNS
cord-337302-fpz2jfuj	310	14	for	for	IN
cord-337302-fpz2jfuj	310	15	mortality	mortality	NN
cord-337302-fpz2jfuj	310	16	of	of	IN
cord-337302-fpz2jfuj	310	17	adult	adult	NN
cord-337302-fpz2jfuj	310	18	inpatients	inpatient	NNS
cord-337302-fpz2jfuj	310	19	with	with	IN
cord-337302-fpz2jfuj	310	20	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	310	21	in	in	IN
cord-337302-fpz2jfuj	310	22	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	310	23	,	,	,
cord-337302-fpz2jfuj	310	24	China	China	NNP
cord-337302-fpz2jfuj	310	25	:	:	:
cord-337302-fpz2jfuj	311	1	a	a	DT
cord-337302-fpz2jfuj	311	2	retrospective	retrospective	JJ
cord-337302-fpz2jfuj	311	3	cohort	cohort	NN
cord-337302-fpz2jfuj	311	4	study	study	NN
cord-337302-fpz2jfuj	311	5	The	the	DT
cord-337302-fpz2jfuj	311	6	importance	importance	NN
cord-337302-fpz2jfuj	311	7	of	of	IN
cord-337302-fpz2jfuj	311	8	addressing	address	VBG
cord-337302-fpz2jfuj	311	9	advance	advance	NN
cord-337302-fpz2jfuj	311	10	care	care	NN
cord-337302-fpz2jfuj	311	11	planning	planning	NN
cord-337302-fpz2jfuj	311	12	and	and	CC
cord-337302-fpz2jfuj	311	13	decisions	decision	NNS
cord-337302-fpz2jfuj	311	14	about	about	IN
cord-337302-fpz2jfuj	311	15	do	do	VB
cord-337302-fpz2jfuj	311	16	-	-	HYPH
cord-337302-fpz2jfuj	311	17	not	not	RB
cord-337302-fpz2jfuj	311	18	-	-	HYPH
cord-337302-fpz2jfuj	311	19	resuscitate	resuscitate	VB
cord-337302-fpz2jfuj	311	20	orders	order	NNS
cord-337302-fpz2jfuj	311	21	during	during	IN
cord-337302-fpz2jfuj	311	22	novel	novel	JJ
cord-337302-fpz2jfuj	311	23	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	311	24	2019	2019	CD
cord-337302-fpz2jfuj	311	25	(	(	-LRB-
cord-337302-fpz2jfuj	311	26	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	311	27	)	)	-RRB-
cord-337302-fpz2jfuj	311	28	COVID-19	covid-19	VBP
cord-337302-fpz2jfuj	311	29	in	in	IN
cord-337302-fpz2jfuj	311	30	patients	patient	NNS
cord-337302-fpz2jfuj	311	31	with	with	IN
cord-337302-fpz2jfuj	311	32	thoracic	thoracic	JJ
cord-337302-fpz2jfuj	311	33	malignancies	malignancy	NNS
cord-337302-fpz2jfuj	311	34	(	(	-LRB-
cord-337302-fpz2jfuj	311	35	TERAVOLT	TERAVOLT	NNP
cord-337302-fpz2jfuj	311	36	)	)	-RRB-
cord-337302-fpz2jfuj	311	37	:	:	:
cord-337302-fpz2jfuj	312	1	first	first	JJ
cord-337302-fpz2jfuj	312	2	results	result	NNS
cord-337302-fpz2jfuj	312	3	of	of	IN
cord-337302-fpz2jfuj	312	4	an	an	DT
cord-337302-fpz2jfuj	312	5	international	international	JJ
cord-337302-fpz2jfuj	312	6	,	,	,
cord-337302-fpz2jfuj	312	7	registry	registry	NN
cord-337302-fpz2jfuj	312	8	-	-	HYPH
cord-337302-fpz2jfuj	312	9	based	base	VBN
cord-337302-fpz2jfuj	312	10	,	,	,
cord-337302-fpz2jfuj	312	11	cohort	cohort	NN
cord-337302-fpz2jfuj	312	12	study	study	NN
cord-337302-fpz2jfuj	312	13	Clinical	clinical	JJ
cord-337302-fpz2jfuj	312	14	characteristics	characteristic	NNS
cord-337302-fpz2jfuj	312	15	,	,	,
cord-337302-fpz2jfuj	312	16	outcomes	outcome	NNS
cord-337302-fpz2jfuj	312	17	,	,	,
cord-337302-fpz2jfuj	312	18	and	and	CC
cord-337302-fpz2jfuj	312	19	risk	risk	NN
cord-337302-fpz2jfuj	312	20	factors	factor	NNS
cord-337302-fpz2jfuj	312	21	for	for	IN
cord-337302-fpz2jfuj	312	22	mortality	mortality	NN
cord-337302-fpz2jfuj	312	23	in	in	IN
cord-337302-fpz2jfuj	312	24	patients	patient	NNS
cord-337302-fpz2jfuj	312	25	with	with	IN
cord-337302-fpz2jfuj	312	26	cancer	cancer	NN
cord-337302-fpz2jfuj	312	27	and	and	CC
cord-337302-fpz2jfuj	312	28	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	312	29	in	in	IN
cord-337302-fpz2jfuj	312	30	Hubei	Hubei	NNP
cord-337302-fpz2jfuj	312	31	,	,	,
cord-337302-fpz2jfuj	312	32	China	China	NNP
cord-337302-fpz2jfuj	312	33	:	:	:
cord-337302-fpz2jfuj	312	34	a	a	DT
cord-337302-fpz2jfuj	312	35	multicentre	multicentre	NNP
cord-337302-fpz2jfuj	312	36	,	,	,
cord-337302-fpz2jfuj	312	37	retrospective	retrospective	JJ
cord-337302-fpz2jfuj	312	38	,	,	,
cord-337302-fpz2jfuj	312	39	cohort	cohort	NN
cord-337302-fpz2jfuj	312	40	study	study	NN
cord-337302-fpz2jfuj	312	41	Clinical	clinical	JJ
cord-337302-fpz2jfuj	312	42	characteristics	characteristic	NNS
cord-337302-fpz2jfuj	312	43	of	of	IN
cord-337302-fpz2jfuj	312	44	113	113	CD
cord-337302-fpz2jfuj	312	45	deceased	deceased	JJ
cord-337302-fpz2jfuj	312	46	patients	patient	NNS
cord-337302-fpz2jfuj	312	47	with	with	IN
cord-337302-fpz2jfuj	312	48	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	312	49	disease	disease	NN
cord-337302-fpz2jfuj	312	50	2019	2019	CD
cord-337302-fpz2jfuj	312	51	:	:	:
cord-337302-fpz2jfuj	313	1	retrospective	retrospective	JJ
cord-337302-fpz2jfuj	313	2	study	study	NNP
cord-337302-fpz2jfuj	314	1	Clinical	clinical	JJ
cord-337302-fpz2jfuj	314	2	features	feature	NNS
cord-337302-fpz2jfuj	314	3	of	of	IN
cord-337302-fpz2jfuj	314	4	95	95	CD
cord-337302-fpz2jfuj	314	5	sequential	sequential	JJ
cord-337302-fpz2jfuj	314	6	hospitalised	hospitalise	VBN
cord-337302-fpz2jfuj	314	7	patients	patient	NNS
cord-337302-fpz2jfuj	314	8	with	with	IN
cord-337302-fpz2jfuj	314	9	novel	novel	JJ
cord-337302-fpz2jfuj	314	10	coronavirus	coronavirus	NN
cord-337302-fpz2jfuj	314	11	2019	2019	CD
cord-337302-fpz2jfuj	314	12	disease	disease	NN
cord-337302-fpz2jfuj	314	13	(	(	-LRB-
cord-337302-fpz2jfuj	314	14	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	314	15	)	)	-RRB-
cord-337302-fpz2jfuj	314	16	,	,	,
cord-337302-fpz2jfuj	314	17	the	the	DT
cord-337302-fpz2jfuj	314	18	first	first	JJ
cord-337302-fpz2jfuj	314	19	UK	UK	NNP
cord-337302-fpz2jfuj	314	20	cohort	cohort	NN
cord-337302-fpz2jfuj	314	21	Coronavirus	Coronavirus	NNP
cord-337302-fpz2jfuj	314	22	disease	disease	NN
cord-337302-fpz2jfuj	314	23	19	19	CD
cord-337302-fpz2jfuj	314	24	infection	infection	NN
cord-337302-fpz2jfuj	314	25	does	do	VBZ
cord-337302-fpz2jfuj	314	26	not	not	RB
cord-337302-fpz2jfuj	314	27	result	result	VB
cord-337302-fpz2jfuj	314	28	in	in	IN
cord-337302-fpz2jfuj	314	29	acute	acute	JJ
cord-337302-fpz2jfuj	314	30	kidney	kidney	NN
cord-337302-fpz2jfuj	314	31	injury	injury	NN
cord-337302-fpz2jfuj	314	32	:	:	:
cord-337302-fpz2jfuj	314	33	an	an	DT
cord-337302-fpz2jfuj	314	34	analysis	analysis	NN
cord-337302-fpz2jfuj	314	35	of	of	IN
cord-337302-fpz2jfuj	314	36	116	116	CD
cord-337302-fpz2jfuj	314	37	hospitalized	hospitalize	VBN
cord-337302-fpz2jfuj	314	38	patients	patient	NNS
cord-337302-fpz2jfuj	314	39	from	from	IN
cord-337302-fpz2jfuj	314	40	Wuhan	Wuhan	NNP
cord-337302-fpz2jfuj	314	41	,	,	,
cord-337302-fpz2jfuj	314	42	China	China	NNP
cord-337302-fpz2jfuj	314	43	Clinical	clinical	JJ
cord-337302-fpz2jfuj	314	44	characteristics	characteristic	NNS
cord-337302-fpz2jfuj	314	45	of	of	IN
cord-337302-fpz2jfuj	314	46	COVID-19	covid-19	JJ
cord-337302-fpz2jfuj	314	47	patients	patient	NNS
cord-337302-fpz2jfuj	314	48	with	with	IN
cord-337302-fpz2jfuj	314	49	digestive	digestive	JJ
cord-337302-fpz2jfuj	314	50	symptoms	symptom	NNS
cord-337302-fpz2jfuj	314	51	in	in	IN
cord-337302-fpz2jfuj	314	52	Hubei	Hubei	NNP
cord-337302-fpz2jfuj	314	53	,	,	,
cord-337302-fpz2jfuj	314	54	China	China	NNP
cord-337302-fpz2jfuj	314	55	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	314	56	in	in	IN
cord-337302-fpz2jfuj	314	57	intensive	intensive	JJ
cord-337302-fpz2jfuj	314	58	care	care	NN
cord-337302-fpz2jfuj	314	59	unit	unit	NN
cord-337302-fpz2jfuj	314	60	patients	patient	NNS
cord-337302-fpz2jfuj	314	61	with	with	IN
cord-337302-fpz2jfuj	314	62	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	314	63	COVID-19	COVID-19	NNP
cord-337302-fpz2jfuj	314	64	with	with	IN
cord-337302-fpz2jfuj	314	65	different	different	JJ
cord-337302-fpz2jfuj	314	66	severities	severity	NNS
cord-337302-fpz2jfuj	314	67	:	:	:
cord-337302-fpz2jfuj	314	68	a	a	DT
cord-337302-fpz2jfuj	314	69	multicenter	multicenter	JJ
cord-337302-fpz2jfuj	314	70	study	study	NN
cord-337302-fpz2jfuj	314	71	of	of	IN
cord-337302-fpz2jfuj	314	72	clinical	clinical	JJ
cord-337302-fpz2jfuj	314	73	features	feature	NNS
cord-337302-fpz2jfuj	315	1	The	the	DT
cord-337302-fpz2jfuj	315	2	authors	author	NNS
cord-337302-fpz2jfuj	315	3	received	receive	VBD
cord-337302-fpz2jfuj	315	4	no	no	DT
cord-337302-fpz2jfuj	315	5	funding	funding	NN
cord-337302-fpz2jfuj	315	6	for	for	IN
cord-337302-fpz2jfuj	315	7	this	this	DT
cord-337302-fpz2jfuj	315	8	work	work	NN
cord-337302-fpz2jfuj	315	9	and	and	CC
cord-337302-fpz2jfuj	315	10	report	report	VB
cord-337302-fpz2jfuj	315	11	no	no	DT
cord-337302-fpz2jfuj	315	12	financial	financial	JJ
cord-337302-fpz2jfuj	315	13	or	or	CC
cord-337302-fpz2jfuj	315	14	non	non	JJ
cord-337302-fpz2jfuj	315	15	-	-	JJ
cord-337302-fpz2jfuj	315	16	financial	financial	JJ
cord-337302-fpz2jfuj	315	17	conflicts	conflict	NNS
cord-337302-fpz2jfuj	315	18	of	of	IN
cord-337302-fpz2jfuj	315	19	interest	interest	NN
cord-337302-fpz2jfuj	315	20	.	.	.
cord-337302-fpz2jfuj	316	1	Cancer	Cancer	NNP
cord-337302-fpz2jfuj	316	2	Management	Management	NNP
cord-337302-fpz2jfuj	316	3	and	and	CC
cord-337302-fpz2jfuj	316	4	Research	Research	NNP
cord-337302-fpz2jfuj	316	5	is	be	VBZ
cord-337302-fpz2jfuj	316	6	an	an	DT
cord-337302-fpz2jfuj	316	7	international	international	JJ
cord-337302-fpz2jfuj	316	8	,	,	,
cord-337302-fpz2jfuj	316	9	peer	peer	NN
cord-337302-fpz2jfuj	316	10	-	-	HYPH
cord-337302-fpz2jfuj	316	11	reviewed	review	VBN
cord-337302-fpz2jfuj	316	12	open	open	JJ
cord-337302-fpz2jfuj	316	13	access	access	NN
cord-337302-fpz2jfuj	316	14	journal	journal	NN
cord-337302-fpz2jfuj	316	15	focusing	focus	VBG
cord-337302-fpz2jfuj	316	16	on	on	IN
cord-337302-fpz2jfuj	316	17	cancer	cancer	NN
cord-337302-fpz2jfuj	316	18	research	research	NN
cord-337302-fpz2jfuj	316	19	and	and	CC
cord-337302-fpz2jfuj	316	20	the	the	DT
cord-337302-fpz2jfuj	316	21	optimal	optimal	JJ
cord-337302-fpz2jfuj	316	22	use	use	NN
cord-337302-fpz2jfuj	316	23	of	of	IN
cord-337302-fpz2jfuj	316	24	preventative	preventative	JJ
cord-337302-fpz2jfuj	316	25	and	and	CC
cord-337302-fpz2jfuj	316	26	integrated	integrated	JJ
cord-337302-fpz2jfuj	316	27	treatment	treatment	NN
cord-337302-fpz2jfuj	316	28	interventions	intervention	NNS
cord-337302-fpz2jfuj	316	29	to	to	TO
cord-337302-fpz2jfuj	316	30	achieve	achieve	VB
cord-337302-fpz2jfuj	316	31	improved	improved	JJ
cord-337302-fpz2jfuj	316	32	outcomes	outcome	NNS
cord-337302-fpz2jfuj	316	33	,	,	,
cord-337302-fpz2jfuj	316	34	enhanced	enhance	VBN
cord-337302-fpz2jfuj	316	35	survival	survival	NN
cord-337302-fpz2jfuj	316	36	and	and	CC
cord-337302-fpz2jfuj	316	37	quality	quality	NN
cord-337302-fpz2jfuj	316	38	of	of	IN
cord-337302-fpz2jfuj	316	39	life	life	NN
cord-337302-fpz2jfuj	316	40	for	for	IN
cord-337302-fpz2jfuj	316	41	the	the	DT
cord-337302-fpz2jfuj	316	42	cancer	cancer	NN
cord-337302-fpz2jfuj	316	43	patient	patient	NN
cord-337302-fpz2jfuj	316	44	.	.	.
cord-337302-fpz2jfuj	317	1	The	the	DT
cord-337302-fpz2jfuj	317	2	manuscript	manuscript	NN
cord-337302-fpz2jfuj	317	3	management	management	NN
cord-337302-fpz2jfuj	317	4	system	system	NN
cord-337302-fpz2jfuj	317	5	is	be	VBZ
cord-337302-fpz2jfuj	317	6	completely	completely	RB
cord-337302-fpz2jfuj	317	7	online	online	JJ
cord-337302-fpz2jfuj	317	8	and	and	CC
cord-337302-fpz2jfuj	317	9	includes	include	VBZ
cord-337302-fpz2jfuj	317	10	a	a	DT
cord-337302-fpz2jfuj	317	11	very	very	RB
cord-337302-fpz2jfuj	317	12	quick	quick	JJ
cord-337302-fpz2jfuj	317	13	and	and	CC
cord-337302-fpz2jfuj	317	14	fair	fair	JJ
cord-337302-fpz2jfuj	317	15	peer	peer	NN
cord-337302-fpz2jfuj	317	16	-	-	HYPH
cord-337302-fpz2jfuj	317	17	review	review	NN
cord-337302-fpz2jfuj	317	18	system	system	NN
cord-337302-fpz2jfuj	317	19	,	,	,
cord-337302-fpz2jfuj	317	20	which	which	WDT
cord-337302-fpz2jfuj	317	21	is	be	VBZ
cord-337302-fpz2jfuj	317	22	all	all	RB
cord-337302-fpz2jfuj	317	23	easy	easy	JJ
cord-337302-fpz2jfuj	317	24	to	to	TO
cord-337302-fpz2jfuj	317	25	use	use	VB
cord-337302-fpz2jfuj	317	26	.	.	.
cord-337302-fpz2jfuj	318	1	Visit	visit	VB
cord-337302-fpz2jfuj	318	2	http://www.dovepress.com/testimonials.php	http://www.dovepress.com/testimonials.php	NNP
cord-337302-fpz2jfuj	318	3	to	to	TO
cord-337302-fpz2jfuj	318	4	read	read	VB
cord-337302-fpz2jfuj	318	5	real	real	JJ
cord-337302-fpz2jfuj	318	6	quotes	quote	NNS
cord-337302-fpz2jfuj	318	7	from	from	IN
cord-337302-fpz2jfuj	318	8	published	publish	VBN
cord-337302-fpz2jfuj	318	9	authors	author	NNS
cord-337302-fpz2jfuj	318	10	.	.	.
cord-337302-fpz2jfuj	318	11	 	 	_SP